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Abstract
Huntington's disease (HD) is a fatal brain disorder characterised by a progressive 
motor, psychiatric and cognitive decline, often manifesting in midlife. Since the 
identification of the gene responsible for HD and the development of predictive 
testing, it has become apparent that asymptomatic patients often exhibit early 
cognitive deficits. In particular, an impairment in recognition memory that is evident 
prior to the onset of classical symptoms and trank cell death. The perirhinal cortex is 
believed to be involved in processing aspects of recognition memory, specifically the 
discrimination between novel and familiar cues. Evidence suggests that activity- 
dependent decrements in neuronal activity within the perirhinal region could underlie 
this cognitive process and that the synaptic mechanism may be one of long-term 
depression (LTD).
In the R6/1 mouse model of HD, synaptic plasticity is progressively altered in 
the perirhinal cortex in vitro. LTD expression is enhanced at one month, but then 
declines and is absent by 7 months of age. Dopamine is shown here to be a 
neuromodulator at normal perirhinal cortical synapses. Fluorescent 
immunohistochemical techniques are used to demonstrate altered dopamine receptor 
expression in the R6/1 perirhinal cortex that correlates with the aberrant synaptic 
plasticity. By exposing normal mouse slices to a D2 dopamine receptor antagonist, it 
is possible to recapitulate the R6/1 perirhinal synaptic phenotype. Importantly, the 
alteration of synaptic fiinction and loss of LTD in R6/1 mice can be restored by 
applying an agonist of dopamine receptors to brain slices.
These data suggest that impaired perirhinal LTD may contribute to poor 
recognition memory and that the defect is at the level of the dopaminergic system. 
Moreover, dopaminergic therapy, targeted to the cortex, may be beneficial in HD.
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1. Introduction
1.1 Overview
Huntington's disease (HD) is a genetic and fatal neurodegenerative disorder, 
commonly characterised by a midlife decline in motor and cognitive skills. Following 
the identification of the gene and the development of predictive testing it has been 
realised that, many years prior to the onset of the classical symptoms, subtle cognitive 
deficits are apparent. In particular, impairments in the ability to discriminate between 
novel and familiar cues (recognition memory) are readily discernable. The first part of 
this introduction will describe the symptoms of HD and the mechanisms identified to 
date that are considered to be involved in this devastating disorder. It also summarises 
the available animal models used to study HD. The second part discusses synaptic 
plasticity; the cellular mechanism widely believed to underlie learning and cognitive 
processing. Studies describing changes in hippocampal synaptic plasticity in mouse 
models of HD are described in the third part. Given the impairment in recognition 
memory detectable in asymptomatic HD patients, the final part of the introduction 
describes the perirhinal cortex, a cortical brain region thought to be involved in the 
process of novelty discrimination.
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1.2 Huntington’s disease
Huntington’s disease is a fatal neurological disorder affecting approximately three in 
every 10, 000 of the population. The disease is named after Dr. George Huntington, 
M. D. (figure 1.2.1), who, in 1872, presented a comprehensive report on this disorder 
(Huntington, 1872). Although our understanding of the disease has increased 
dramatically since its identification, a cure has yet to be found and current approaches 
to treatment are similar to that used in the 19^  ^century; they remain palliative and not 
curative. The disease is a genetic condition and is inherited in an autosomal dominant 
fashion. Symptoms usually manifest in the third to fourth decade of life, often after 
the individual has unknowingly passed on the defective gene to their offspring. 
Classical symptoms include a loss of motor control and psychological changes. The 
loss of motor control is characterised by dance-like movements, known as chorea 
(derived from the Greek (choros), to dance), after which the disease was 
originally called. (Huntington’s chorea has recently been renamed Huntington’s 
disease when it was recognised by clinicians that almost half of cases present with 
other symptoms and the absence of choreatic movements; the term Huntington’s 
disease therefore describes the full syndrome rather than just one symptom.) Upon 
post-mortem examination massive cell death is observed, particularly within the 
striatum and cerebrum, resulting in enlargement of the ventricles and thinning of the 
cortical mantle respectively. The identification of the gene has enabled predictive 
testing and it is now apparent that, prior to the onset of overt symptoms and cell death, 
there is a subtle decline in cognitive functions and it is possible that alterations in the 
communication between neurones may underlie these changes in cognition.
18
1.2.1 An historical background
Reports of hereditary chorea date back as early as 1832 (see Harper, 2002), however 
the first fully descriptive report of the disorder that was later to become known as 
Huntington’s chorea was in a letter by Charles Oscar Waters (1841). In his letter 
Walters describes a chorea with a hereditary nature and how it progresses, ultimately 
leaving the patient demented. Another detailed description, this time from Europe, 
was published in 1860 (Lund). This report was originally overlooked as it was written 
in Norwegian and its importance has only come to the fore since its translation in 1959 
(Orbeck). Despite these and other reports, it was George Huntington’s paper, 
published in the Philadelphia journal The Medical and Surgical Reporter in 1872 
(Huntington, 1872), that caught the attention of other medical practitioners. The first 
part of the report contains a general description of non-hereditary forms of chorea, 
their causes and treatments available at the time. The second part describes a 
hereditary form of chorea. This account was in fact a concise and comprehensive 
portrayal of the condition later to bear Huntington’s name. The manuscript describes 
the adult onset, progressive nature and fatal outcome; the choreic movements and 
psychological impairments; the effect socially on the patient and family; and the 
pattern of inheritance. Huntington had drawn not only on his own observations, but 
that of his father and grandfather, both of whom had held practices in Long Island 
spanning over 60 years. It is perhaps the presence of verifiable cases in Huntington’s 
report, along with the brief yet accurate description of the disease, which made this 
work the seminal paper that it has become.
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"... an heirloom... hardly ever manifesting until 
middle life, and then coming on gradually but 
surely until the hapless sufferer is but a quivering 
wreck of his former self ”
Figure 1.2.1: Dr. George Huntington (1850-1916) {top). (Reproduced from Bates et 
al, 2002). Bottom: A quote from George Huntington’s report, published in 1872, 
which describes the devastating nature of the disorder later to bear his name.
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Over the next century our knowledge of HD did progress, however the 
isolation of the gene in 1993 (Huntington's Disease Collaborative Research Group) 
sparked an exponential increase in our understanding of the processes involved in the 
early stages of the disease. Huntington’s disease is caused by a mutation in the gene 
that encodes the protein huntingtin, the function of which is still unclear, although 
there are indications that it is involved in regulation of gene transcription, vesicle 
transport and regulation of processes occurring at the synapse. Near to the amino 
terminal of the gene in exon 1 is found a cytosine-adenine-guanine (CAG) repeat that 
encodes a tract of glutamines (Huntington's Disease Collaborative Research Group, 
1993). When the number of glutamines exceeds a threshold the disease will develop 
at some point in the individual’s lifetime. Interestingly the length of this expanded 
repeat determines, to a degree, the age of onset and the severity of the disease; longer 
repeats give rise to an earlier, more aggressive syndrome with very high repeat 
numbers resulting in a pernicious juvenile form.
Prior to the identification of the gene, the best animal models of the disease 
were based on recapitulating the pattern of cell loss using chemical lesions in rats (for 
review see Yohrling IV & Cha, 2002). While these models replicate the end-stages of 
the disease, they do not characterise the progressive nature of the disorder and only 
reveal limited information about the pathogenic mechanisms underlying 
neurodegeneration. The principal advance that identification of the gene enabled was 
the development of genetic models of HD. Gene expression has been achieved in a 
range of hosts, from single cells through invertebrates to rodents. These models have 
been highly successful and have provided many key insights into the early stages of 
the disorder.
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1.2.2 Symptoms of Huntington^s disease
Huntington’s disease is a progressive disorder that is usually associated with a midlife 
onset, generally characterised by a gradual loss of both voluntary and involuntary 
motor control. The most striking motor disorder is the choreic movements that can 
affect the trunk, head and limbs, causing uncoordinated flailing movements (figure 
1.2 .2).
As the disease progresses subcortical and, later, cortical dementias develop. 
Subcortical dementias arise as neurones within the basal ganglia, particularly the 
striatum, die. This gives rise to personality changes, reduced attention span and 
slowed thinking. As the cells within the cerebral cortex start to atrophy, cortical 
dementia also develops. Cortical dementia affects higher cognitive processes, such as 
planning, recall and recognition.
Following the identification of the gene, and the development of a genetic test 
for HD gene carriers, it has been realised that many patients present with dementia in 
the absence of motor deficits and that subtle cognitive changes can occur many years 
before classical symptoms and cell death are detectable. These subtle changes occur 
long before evidence of neuropathological changes, suggesting that events other than 
cell death underlie the early cognitive deficits. Given that alterations in the 
communication between neurones are believed to underlie learning and memory, it is 
possible that abnormalities in these processes could underpin the early deficits in 
cognition seen in HD.
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1.2.2.1 “Presymptomatic” patients
The onset of Huntington’s disease is generally viewed as the presence of the specific 
motor disorder (Kremer, 2002). However, following the isolation of the gene 
responsible for Huntington’s disease (Huntington's Disease Collaborative Research 
Group, 1993), predictive testing has been developed and it has thus become possible to 
study gene carriers prior to the development of an overt motor disorder. It has become 
apparent that, long before the onset of classical symptoms and evidence of cell death, 
gene carriers often show some neurological changes, including altered brain function 
(see neuropathology, section 1.2.3) and a decline in cognition and motor control.
The motor abnormalities that are observed in preclinical patients are minor. In 
a seven year follow-up study of asymptomatic individuals, in which genetic status was 
confirmed using a marker known to be linked to HD, distinct abnormalities were 
identified. Abnormalities included general restlessness, hyperreflexia, excessive and 
inappropriate movements of the fingers, toes, hands and feet, abnormal eye 
movements and an impaired ability for finger tapping and these symptoms become 
particularly apparent during emotional stress (Penney et a l, 1990).
A range of cognitive parameters have been tested, with some reports 
highlighting deficits (discussed below), while others show no decline (for example see 
Campodonico et a l, 1996; Gomez-Tortosa et a l, 1996; de Boo et a l, 1997). The 
inconsistency in detecting early cognitive deficiencies may be due to small sample 
sizes, the age of the subjects (or rather their closeness to clinical presentation) and the 
sensitivity of the tests employed. Indeed, as the tests employed to assess cognitive
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processing become more sensitive and specific, an increasing number of abnormalities 
have become apparent.
Early studies highlighted underperformance in tests to assess attention and 
planning skills (Rosenberg et a l, 1995), poor ability to sequence pictures and 
categorise objects (Foroud et a l, 1995; Lawrence et al, 1998) and impairments in 
visual and verbal memory (Jason et al, 1988; Hahn-Barma al, 1998). Others report 
a reduced reaction time to visual stimuli (Siemers et a l, 1996) although this may 
(arguably) be attributable to motor impairments rather than cognitive dysftmction. 
Emotional recognition is also affected, with gene carriers showing poor identification 
of faces displaying disgust, while showing good performance on background tests and 
identification of other facial expressions including happiness, sadness, surprise, anger 
and fear (Gray fl/., 1997).
Recognition memory
The article by Hahn-Barma et al (1998) also highlighted significant differences 
between age-matched non-gene carriers and asymptomatic gene carriers in several 
parameters of the California verbal learning test. Parts of this test assess the ability to 
discriminate between novel and familiar items from two previously learnt shopping 
lists. Gene carriers show significantly less object recognitions and significant 
impairments in recognition discriminablity (an index of recognition accuracy that 
takes into account both misses and false positives).
More recently the significance of impairments in recognition memory was 
highlighted by a different test, that of signal detection. Signal detection provides a 
sliding scale of familiarity continuum, with “new” items at the lower end and “old”
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items at the upper end. Variability in the familiarity of stimuli gives rise to two 
overlapping distributions for new and old cues and from these distributions a d ’ 
threshold can be obtained as an assessment for recognition impairment (see Yonelinas 
et a l, 1996 for a brief review). Individuals undergoing predictive testing at the 
Predictive Huntington’s Disease Clinic at Addenbrooke’s Hospital, Cambridge, U. K. 
underwent a wide range of psychiatric, cognitive and neurological tests designed to 
gauge the patients health, including neurological, personality deviance, depression, 
irritability, dissociation (failure to integrate thoughts, feelings and actions into 
consciousness) and a host of cognitive parameters. Following neurological and 
psychiatric testing, subjects were divided into gene positive and gene negative 
(control) groups. Based on CAG repeat length, age of onset was estimated according 
to the logarithmic algorithm proposed by Rubinsztein et al (1997) and the mean age 
of the gene positive group was 13.8 ± 5.6 years below the estimated age of onset. It 
was found that recognition memory and increased irritability were the only significant 
deficits observed in otherwise asymptomatic gene-carriers compared to the age 
matched gene-negative group (Berrios et a l, 2002).
It appears, therefore, that impaired recognition memory is one of the earliest 
detectable deficits observed in Huntington’s disease. It is also clear that the age of 
disease onset should not be considered to be the development of an overt motor 
disorder. Rather, the motor phenotype is a phase of Huntington’s disease, which is 
often preceded by other symptoms, particularly cognitive deficits.
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1.2.2.2 The “classical” symptoms
Although the classical symptoms of Huntington's disease usually present in midlife, 
the disease can occur at any age, with the youngest patient ever reported being two 
years of age, while at the other extreme, some patients do not present symptoms until 
their mid eighties (Roos et al, 1991). The mean age of onset is usually considered as 
40 years with a standard deviation of about 10 years, although this value may be 
misleading as the age of onset does not follow a normal distribution (see Kremer, 
2002) and may be further confounded by sampling methods where late-onset cases 
may be excluded due to their lack of symptoms. Some studies have, therefore, only 
considered individuals that are considered “at risk” and are already deceased, thereby 
including all cases of HD, including those with exceptionally late-onsets. By 
considering only deceased patients, disease duration can also be assessed. One such 
study of 800 deceased Dutch patients gave a mean age of onset as late as 55.8 years 
with a duration of 15.6 years (Roos et al, 1993).
In ninety percent of cases the most prominent symptom is chorea (see figure 
1.2.2). Choreiform activity has been defined as ‘excessive, spontaneous movements, 
irregularly timed, randomly distributed and abrupt’ (Barbeau et a l, \9%\). The 
severity of choreal movements can, however, vary from restlessness through an 
unstable dance-like gait to violent, uncontrolled movements. Choreic movements are 
continuously present in the awake state and cannot be effectively suppressed by the 
patient (Fish et a l, 1991). Chorea can affect various portions of the body. Facial 
chorea results in pouting of the lips, grimacing and twitching and may involve the 
neck, leading to head rotation and bending. Choreic activity of the trunk causes the
26
whole body to be moved about and can cause irregular breathing. Choreiform of the 
limbs leads to flexing of the fingers and toes; arms and legs may be constantly crossed 
and uncrossed (Kremer, 2002). The series of still photographs in figure 1.2.2 shows a 
patient with choreic movements.
As the disease progresses chorea tends to abate and a syndrome akin to 
Parkinson’s disease develops. Bradykinesia and rigidity gradually occur and in some 
cases the patient becomes severely rigid (Young et al, 1986; Penney et a l, 1990). 
Dystonia also develops in the later stages of HD (Young et al, 1986) and is usually 
characterised by abnormal posturing of the extremities and the head. The prevalence 
of dystonia has been reported as high as 95 per cent (Kremer, 2002), however the 
similarity to chorea makes a distinction between the two movement disorders difficult.
The cognitive and psychiatric problems are very prominent and complex. 
Cognitive deficits are primarily of executive function i.e. the ability to plan, organise, 
and show mental flexibility. Furthermore, procedural memory and psychomotor 
functions are affected, whereas skills such as language are relatively spared (although 
speech is impaired as a result of motor dysfunction); for review see Craufurd and 
Snowden (2002). By the time patients reach moderately advanced stages of the 
disease there are clear deficiencies in visual and verbal recall and the deficits in 
recognition memory become more pronounced (Lange et al, 1995; Lang et a l, 2000).
Psychiatric problems include dysphoria, euphoria, agitation, irritability, apathy, 
anxiety, disinhibition, delusions and hallucinations (Paulsen et a l, 2001), all of which 
can be very trying for both patients and their carers.
27
Figure 1.2.2: Chorea. The above set of stills shows a patient attempting to sit up. All 
her limbs show uncontrolled choreic movements. Images courtesy of Huntington’s 
Dance Foundation.
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1.2.2.3 Late- to end-stage
From the sufferer and his carer’s point of view the late-stages of Huntington’s disease 
are dominated by the increasing dependence on others for normal activities in day-to- 
day living and therefore patients are often cared for in nursing homes. Severe 
bradykinesia and rigidity result in decreased manual dexterity. Speech is often 
impaired leading to communication problems and swallowing becomes difficult 
causing problems with feeding (Kremer, 2002). Systemic disorders are very common, 
the most striking of which is weight loss, probably due to a decrease in dietary intake 
and possibly confounded by increased energy expenditure. There are often altered 
sleep patterns including reduced rapid eye movement and slow wave sleep, increased 
sleep onset latency and a reversal of day-night sleep patterns (Sishta et a l, 1974; 
Wiegand et a l, \99\', Kremer, 2002).
Cognitive assessment reveals a severe deterioration in all cognitive functions 
(Kremer, 2002). Severe psychiatric problems are often the cause of the patient’s 
placement within nursing homes and require the use of psychotropic drugs, which in 
themselves can compound the problems of rigidity, gait and swallowing (Magnuson et 
al, 2000; Stubner et al, 2004). The extreme personality changes are particularly 
harsh on the patient’s family and friends, particularly offspring who may be 
witnessing their own fate.
Following the onset of the “classical” symptoms of the disorder, patients 
generally live for a further 15 to 20 years (Roos et al, 1993; Foroud et a l, 1999). 
Death, however, is not caused by Huntington’s disease per se, but rather by associated 
complications. The most common causes of death of HD patients includes pneumonia 
(one third of all patients), heart failure (although heart disease, cerebrovascular disease
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and atherosclerosis show no increase), choking and nutritional deficiencies (Lanska et 
al, 1988). Suicide is an associated risk, with suicide rates of up to 7.3 per cent of all 
patient deaths; four times that of the general population (Di Maio et al, 1993). This 
rather taboo subject is likely to be under-reported, with up to 27 per cent of possibly 
affected individuals attempting suicide at least once (Kremer, 2002). Likewise, 
suicide in the general population is likely to be underestimated; however, some reports 
have accounted for this and still find a significant increase in suicide rate amongst HD 
patients (for example see Schoenfeld et al, 1984).
1.2.3 Neuropathology of HD
The classical hallmarks of Huntington’s disease are believed to be attributable to 
neuronal cell loss within particular brain structures. For example, chorea is thought to 
be due to a loss of the GABAergic neurones of the motor pathway within the basal 
ganglia. The recently described early cognitive decline may be a consequence of 
subtle changes in neuronal function. For example, as discussed below, a loss of 
dopamine receptors has been closely correlated with the cognitive decline seen in 
asymptomatic patients and the loss of other neurochemical markers (e.g. other 
neurotransmitter receptors and neurotransmitter synthetic/degradatory enzymes) and 
subtle neuropathology may underlie these deficits.
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1.2.3.1 The post-mortem HD brain
Examination ofpost-mortem brains from advanced HD patients reveals marked 
atrophy in selective areas (figure 1.2.3). Total brain weight is reduced by 10-20 per 
cent compared to age matched controls (Gutekunst et al, 2002). In 1985 a grading 
system was established to rate the degree of atrophy (Vonsattel et al, 1985). There 
are four Vonsattel grades (1-4), plus grade 0 (no cell loss). All grades show a loss in 
brain volume with up to 30% attributable to cell death. The basal ganglia show the 
greatest cell loss and the loss of this region is perhaps the most striking difference 
observed in HD post-mortem brain. The loss of cells within the striatum leads to 
enlargement of the ventricles and this is clearly seen in figure 1.2.3.
The basal ganglia are composed of the striatum (putamen and caudate), the 
subthalamic nucleus, the internal and external segments of the globus pallidus and the 
substantia nigra, which consists of the pars compacta and pars reticula (Graybiel,
1990, see figure 1.2.4). The primary excitatory input into the striatum derives from 
the cerebral cortex, which activates a doubly inhibitory striatopallidothalamic pathway 
mediated by y-aminobutyric acid (GABA) containing neurones, constituting a positive 
feed-back loop. There is also an indirect pathway via the subthalamic nuclei that 
provides inhibition to the thalamus, thereby regulating this feed-back loop. This basic 
circuitry is further modulated by inputs arising from the substantia nigra and these are 
mediated by the neurotransmitter dopamine. Other modulators active within the 
pathway include acetylcholine (ACh), substance P, encephalin, somatostatin and 
neuropetide Y (Graybiel, 1990).
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Figure 1.2.3: Neurodegeneration seen in the human brain as a result of 
Huntington’s disease. The images on the left of this series are of post-mortem tissue 
from a 48 year old HD patient. The right hand images are from a 34 year old that did 
not suffer from HD. There is a general decrease in brain mass. Frank 
neurodegeneration can be seen in the striatum (S) evidenced by enlarged ventricles. 
Cortical (Ctx) atrophy is evident as a thinning of the cortical mantle and enlarged 
sulci. (Images adapted from Colb, 2003.)
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The spiny GABAergic neurones are particularly susceptible to neuronal cell 
death, while the intemeurones are relatively spared. The loss of neurones in this area 
goes hand-in-hand with the loss of neuronal markers. In particular the loss of medium 
spiny neurones in the striatum is marked by the loss of glutamic acid decarboxylase, 
substance P, calcineurin, calbindin, and adenosine, acetylcholine,
5-hydroxytryptamine (5-HT; serotonin) and dopamine receptors.
Within the striatum the density of the dopamine synthetic enzyme, 
tyrosine hydroxylase, is reported as unchanged. Given there is an overall loss of 
GABAergic neurones within this region, it would therefore appear that there is a 
down-regulation in dopaminergic levels (Yohrling IV & Cha, 2002). In support of 
this, the expression of the Di and D2 subclasses of dopamine receptor are reduced in 
the HD brain, particularly within the striatum where they are located on the medium­
sized spiny neurones (MSSNs, Reisine et al, 1977; 1978).
Importantly, there is also a marked loss of cells within the cerebral cortex, with 
up to 33% reduction in neurone number (Vonsattel et al, 1985; Heinsen et al, 1994). 
As mentioned earlier, this is evident in the post-mortem brain, manifesting as thinning 
of the cortical mantle and increased invagination of the sulci (see figure 1.2.3). The 
pyramidal cell layers III and V are particularly affected (Braak & Braak, 1992; 
Gutekunst et al, 2002) while the granular layer IV cells are relatively spared, leaving 
a conspicuous band between layers III and V (Heinsen et al, 1994). This is 
particularly clear in the temporal, frontal and parietal lobes where preferential loss is 
seen of the layer III pyramidal cells.
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Figure 1.2.4: Neuronal circuitry of the basal ganglia. The nuclei that constitute the 
basal ganglia are interconnected in a complex network and are believed to be involved 
in motor coordination, cognitive function and subcortical processes. The striatum is 
the main input into the basal ganglia pathways and receives excitatory innervation 
from all areas of cortex, particularly the motor cortex. The direct pathway is 
composed of the double inhibitory striatopallidothalamic circuit and forms a positive 
feedback loop. The indirect pathway, via the subthalamic nuclei, provides an 
inhibitory regulation of the direct pathway. Dopaminergic modulation of the network 
derives from the substantia nigra. In Huntington’s disease the GABAergic medium­
sized spiny neurones are particularly susceptible to degeneration leading to loss of 
motor control. Abbreviations: Red arrow, glutamatergic neurone; Blue arrows, 
GABAergic neurone; Purple arrow, dopaminergic neurone; GPe, globus pallidus 
external segment; GPi, globus pallidus internal segment; SNr, substantia nigra pars 
reticulata; SNc, substantia nigra pars compacta; STN, subthalamic nucleus; THAT, 
thalamus. (Adapted from Schmidt, 1998.)
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The loss of eortieal neurones also goes hand-in-hand with a loss of 
neurochemical markers, although changes in neurochemical markers within the 
cerebral cortex is less characterised than in the striatum. In particular the level of the 
neurotransmitter GABA has been shown to be low. The neurotransmitters glutamate 
and GABA are reduced in the temporal and frontal cortices of the HD post-mortem 
brain (Pearson & Reynolds, 1994) while metabolites of dopamine are increased 
(Pearson & Reynolds, 1994). Furthermore, both glutamate and dopamine receptors 
are also reduced within the post-mortem HD cortical mantle (Yohrling IV & Cha, 
2002).
Other affected areas include the hippocampus, particularly the CAl field 
(Spargo et al, 1993). The cerebellum, brainstem and spinal cord are generally 
considered as being spared, however this is only relative as degeneration is often 
observed within these brain regions (Gutekunst et a l , 2002).
Protein aggregates are commonly observed throughout the HD brain (DiFiglia 
et al, 1997; Gutekunst et al, 1999; Sieradzan et al, 1999). They primarily contain 
fragments of the mutant protein responsible for Huntington’s disease (see genetics, 
section 1.2.4; and Molecular biology, section 1.2.5). The precise role of aggregates in 
the pathogenesis of HD is still under debate, some arguing them to be neurotoxic and 
others as neuroprotective. Such aggregates are present in all areas of the brain, 
including the hippocampus and cerebellum, but are particularly high within the 
cortical mantle and corpus striatum.
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1.2.3.2 Presymptomatic neuropathology
With the development of imaging techniques it has become possible to study 
neuropathological changes within the brain prior to death. Consistent with the 
impairments observed by cognitive testing, neuroimaging studies repeatedly 
demonstrate various deficiencies in the preclinical Huntington’s disease brain. 
Positron emission tomography (PET) studies of asymptomatic HD gene carriers have 
demonstrated decreases in basal ganglia glucose metabolism (Antonini et al, 1996), 
decreased dopamine receptor binding in both striatum (Antonini et al, 1996; Andrews 
et al, 1999; Weeks et al, 1996; Pavese et al, 2003) and cortex (Sedvall et al, 1994; 
Pavese et al, 2003; Andrews et al, 1999). Cortical and striatal loss of dopamine 
receptors in an asymptomatic patient can be seen in figure 1.2.5. Structural magnetic 
resonance imaging has also revealed a decrease in basal ganglia volume many years 
before the predicted age of onset (Aylward et a l , 1996).
The decline in dopamine receptor expression parallels the decreased detection 
of mRNA for Di and D2 in patients in the early stages of HD (Vonsattel grades 0 and 
1, Augood et al, 1997). Moreover, the reduction in Di and D2 dopamine receptors in 
“asymptomatic” gene-carriers correlates well with the learning deficits observed upon 
cognitive testing (Backman & Farde, 2001).
In light of the changes observed in the brains of gene carriers prior to the onset 
of classical symptoms, it seems likely that the preclinical cognitive deficits are indeed 
real and may be seated in the loss of neurochemical markers.
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Figure 1.2.5: PET scans demonstrating a progressive loss of dopamine receptors 
in an asymptomatic patient. Baseline and repeat [^^C]SCH23390* (Di) and 
[^^CJraclopride  ^(D2) PET binding potential maps in an asymptomatic individual 
carrying an expanded CAG repeat in the HD gene. Scans were performed at an 
interval of 33 months. Loss of both Di and D2 binding is apparent in both the basal 
ganglia and cortex. (Adapted from Andrews et al, 1999.)
SCH23390 is a Di dopamine receptor antagonist 
Raclopride is a D 2 dopamine receptor antagonist
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1.2.3.3 Neuropathology of symptomatic individuals
As clinical symptoms begin to manifest the changes within the brain become more 
apparent. These neuropathological changes are strongly correlated with both the 
motor and cognitive decline observed at this stage of disease progress. In particular, 
the loss of motor control is may be caused by the loss of the spiny GABA containing 
neurones within the striatum, which constitute the motor pathway. Loss of inhibition 
within this pathway leads to inappropriate excitatory outputs and hence decline in 
motor control.
Anatomical changes of neuronal processes are frequently seen within the HD 
brain. Dendritic remodelling is quite dramatic, even before overt cell death. 
Dendrites undergo truncation and swelling and there is a marked loss of spines 
(Sotrel et al, 1993; Gutekunst et al, 1999). Axonal projections become condensed, 
convoluted and fragmented with dystrophic cortical neurites present, particularly in 
the cortical pyramidal layers III and V (Jackson et al, 1995).
Aggregates become apparent at this stage, appearing first within the cortex 
and latter in the striatum and hippocampus. Within the cortex aggregates are 
commonly observed in the neuropil. More specifically, within layer III of the cortex, 
60-100% of aggregates are cytoplasmic, while in layer V up to 65% are located 
within the nucleus. Inclusions within the striatum are most regularly found as 
nuclear aggregates (Gutekunst et al, 1999).
Changes in neurotransmitter receptor binding and blood flow are observed, as 
measured by PET and single photon emission computerised tomography (SPECT) 
respectively (for review see Brooks & Andrews, 2002). Several PET studies reveal
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marked reductions in agonist binding to both D% and D2 dopamine receptors in 
striatum, amygdala and temporal and frontal cortices (Ginovart et al, 1997; Andrews 
et al, 1999; Pavese et al, 2003). Further evidence for abnormal cortical function 
comes from measurements of blood flow using SPECT during the performance of 
tests designed to assess various aspects of cognition. Impairments in tests to assess 
language, perception and word recognition strongly correlate with a decrease in 
cortical blood flow (Hasselbalch et al, 1992).
Taken together these data suggest that an array of changes may take place 
within the cerebral cortex during HD and that the resulting cortical dysfunction may 
underlie the deficits in cognitive processes associated with the cerebrum.
1.2.3.4 Pathogenic mechanisms
Several mechanisms of pathogenesis have been proposed to play roles in 
Huntington’s disease, including excitotoxicity and oxidative stress. It has also been 
proposed that the presence of aggregates could he causative of neuronal cell death. 
These mechanisms will be described in more detail in later sections of this chapter.
Excitotoxicity
Inappropriate activity of excitatory neurotransmitter systems have been implicated in 
the pathology observed in HD. Evidence to support this theory has come mostly 
from animal models, where administration of neurotransmitter analogues have been 
shown to mimic the pattern of cell loss observed in HD (see Animal models, section
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1.2.7). Excitotoxicity is thought to be mediated by altered neurotransmitter receptor 
activity, resulting in elevated calcium levels within the cell, which is known to 
induce cell swelling and subsequent cell death (see Garthwaite, 1994 for review).
Oxidative stress
Evidence that oxidative stress could play a role in HD come from the identification 
of increased levels of the oxidative damage products malondialdehyde, 
8-hydroxydeoxyguanosine, 3-nitrotyrosine and heme oxygenase in nuclear DNA 
within brain regions particularly affected in HD (Browne et al, 1997; 1999). The 
presence of these epitopes could, however, he either the cause of cellular death or he 
a by-product of the cell death cascade.
Aggregation
Many have proposed that the huild up of mutant protein could be the cause of 
atrophy. The basis of this idea is that they pre-date cellular loss. In contrast, their 
distribution does not reflect the pattern of cell loss observed in HD. For example 
aggregates appear first in the cortex, while the greatest cell loss is within the 
striatum; aggregates are common within Purkinje cells of the cerebellum, but this 
region is relatively spared. It has therefore been argued that aggregation is a 
protective mechanism allowing the toxic protein to be removed from the system 
following failure of other mechanisms (see Molecular biology, section 1.2.5).
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Apoptosis and necrosis
The process of cell death usually occurs hy one of two processes: Apoptosis or 
necrosis. Apoptosis is characterised hy pyknosis, chromatin condensation, 
membrane blebbing and formation of apoptotic bodies. Necrosis, on the other hand, 
is associated with cell and organelle swelling, lysis and other inflammatory 
responses. In the human condition little is known about the mechanism by which 
cell death occurs and the neurodegeneration seen in the mouse models fits neither of 
these mechanisms well. This alternative mechanism of cell death was identified in 
the R6/2 transgenic mouse model of HD (see section 1.2.7) and has heen termed 
“dark cell degeneration” due to an enhanced affinity for staining hy either toluidine 
blue or osmium (Turmaine et ai, 2000). The neurones show condensation of both 
the nuclear and cytoplasmic compartments and a clumping of chromatin, but the 
subcellular organelles appear intact. During the process of neurodegeneration, 
however, organelles, including the mitochondria and Golgi complex, do undergo a 
transient swelling and then condensation. The plasma membrane appears ruffled 
(Turmaine et al, 2000). All the degenerating cells identified contained at least one 
nuclear inclusion. Dark cell degeneration was primarily seen in all cell layers of the 
anterior cingulate cortex from approximately 14-14.5 weeks of age. From 
approximately the same age (14-15 weeks), hut to a lesser degree, dark cell 
degeneration was also detectable within the anterior striatum and the Purkinji cell 
layer of the cerebellum, and from 16 weeks within the lateral areas of the fi*ontal 
cortex (Turmaine et al, 2000). Importantly, similar dark cell degeneration was 
identified by the same authors within the same hrain regions ofpost-mortem HD 
brain tissue (Turmaine et al, 2000). Furthermore, similar degeneration is seen in
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another transgenic HD model, the drosophila (see section 1.2.7). Degenerating 
neurones within the eye were characterised by enhanced staining with osmium, show 
condensation of the cytoplasm and nucleus, contain intranuclear inclusions, but do 
not show signs of apoptosis (Jackson et al, 1998). An example of the 
neurodegeneration seen in the drosophila is shown in figure 1.2.13.
1.2.3.5 Treatment
Despite the wealth of knowledge of many of the processes involved in the progress 
of the disease, treatment is still limited to symptom relief; no cure is available. In 
this manner, little has changed since the nineteenth century, although the range and 
quality of treatments available to treat the symptoms has improved. Treatment is 
targeted to improve the day-to-day life of the patient by reducing the motor and 
psychiatric abnormalities. In light of the neuropathological changes seen within the 
hrain of HD patients, various approaches to treatment for chorea have been taken. 
Previously, attempts have heen made to either increase or decrease the levels of 
GABA and dopamine within the basal ganglia. The success of these therapeutic 
approaches have varied greatly, with some reports of improvements in both motor 
and psychiatric aspects, while others report no change, or even that such treatment 
compounds the symptoms (for examples see Loeb et al, 1976; Corsini et al, 1978; 
Bartholini & Lloyd, 1980; Tsuneizumi et al, 1994; Tedroff et al, 1999).
More recently it has been proposed that neuronal transplants may be of 
benefit to HD patients. Initial studies have reported some success and may have
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potential role in treatment (for example see Bachoud-Lévi et al, 2000a; Freeman et 
al, 2000a; Gaura et al, 2004).
Interestingly, evidence from one of the mouse models suggests that 
environmental enrichment can delay the onset of disease (van Dellen et al, 2000). In 
light of this, comprehensive occupational therapy may be of benefit to known gene 
carriers and to patients in the early stages of the disease.
Dopaminergic strategies
Attempts to reduce choreic movements using dopaminergic strategies are based on 
the theory that depletion of dopamine within the basal ganglia should reduce 
nigrostriatal dopaminergic transmission and hence inhibition of the indirect motor 
pathway (van Vugt & Roos., 1999). Reserpine is an example of a monoamine 
depleting agent (depletes all monoamines, including dopamine, at all presynaptic 
terminals of the brain) that has been employed in suppressing chorea. Several 
studies have reported a reduction in involuntary movements (summarised in van 
Vugt & Roos., 1999), however a decline in manual dexterity has been reported with 
this drug (Oliphant et al, 1960). Furthermore, extrapyramidal effects, including 
depression, are associated with this treatment, which limits its use in HD.
Similarly, antipsychotic (neuroleptic) drugs have frequently heen used in the 
treatment of chorea and, to a degree, have helped suppress these unwanted 
movements. In particular the dopamine receptor antagonists chlorpromazine, 
haloperidol, sulpiride and pimozide are commonly employed. Haloperidol is perhaps 
the most successful of these drugs and, while the precise pharmacological action of 
this drug is not fully understood, it would appear to involve the blockade of the D2
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subclass of dopamine receptor (see van Vugt & Roos., 1999). Chronic 
administration of haloperidol in primates has been associated with an up-regulation 
of D2 dopamine receptors and a down-regulation of Di (Lidow & Goldman-Rakic,
1994). This change in the expression levels of dopamine receptor subclasses could 
explain the depression associated with long-term use of this drug.
GABAergic strategies
Attempts to increase GABA levels have met with less success. Administration of 
GABA precursors, GABA itself, GABA receptor agonists or inhibitors of GABA 
transaminase have all been tried but have rarely heen reported as beneficial to HD 
patients (see van Vugt & Roos., 1999). The antichoreic effects observed can often be 
explained by the sedative side effects of these substances.
The management of the wide variety of psychological and psychiatric 
problems includes both medicine and a comprehensive counselling regime. The 
success of these regimes is, however, often only anecdotal and vary immensely. 
Common drugs in use are atypical antidepressants and the 5-HT re-uptake inhibitors 
(Nance & Westphal, 2002).
While the motor and psychological aspects of HD are often treated (if not 
completely successfully), attempts to improve cognition are generally overlooked.
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Transplants
Given that the striatum shows the greatest degree of atrophy, attempts have been 
made at transplanting neural stem-cells into the striatum. Initial studies were carried 
out in models of HD created hy inducing striatal lesions in rats (see section 1.2.7) 
(for example see Wictorin & Bjorklund, 1989; Wictorin et al, 1989; Pundt et al,
1996). It was shown that transplanted striatal neuroblasts (foetal neurones) integrate 
into the host brain and even ameliorates the locomotor deficits induced hy the striatal 
lesion. Similar improvements were shown in primate lesion models following 
transplant (for example see Hantraye et al, 1992b; Kendall et al, 1998; Palfi et al, 
1998). Moreover, striatal transplants into human HD patients have been shown to he 
successful. One study followed a patient for 18 months following transplant (the 
patient died of coronary associated problems). Upon post-mortem examination it 
was found that, like normal striatal cells, the grafted cells received topographically 
organised cortical afférents and had established appropriate efferents to globus 
pallidus and substantia nigra pars reticularta. Furthermore, selective markers for 
both striatal projection and intemeurones (for example dopamine and cyclic 3’,5’ 
adenosine monophosphate (cAMP)-related phosphoproteins, acetylcholine 
acetyltransferase, tyrosine hydroxylase, calbindin, encephalin and substance P) 
showed areas of positive transplants that were innervated by host tyrosine 
hydroxylase fibres. Lastly it was noted that grafted neuronal cells did not develop 
inclusions, nor was there any sign of degeneration (Freeman et al, 2000b).
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In another report, PET was used to assess metabolic activity within the 
striatum of HD patients following striatal transplant of foetal cells. In three of the 
five patients studied an increase in metabolic activity was observed that correlated 
with motor and cognitive improvements (Bachoud-Lévi et al,  2000b). More 
recently the same research group has reported that striatal grafting also improves 
metabolic activity within the motor cortex, suggesting that the whole corticostriatal 
loop is improved (Gaura a/., 2004).
Despite the improvement in day-to-day life resulting from striatal grafts of 
foetal neurones, such therapy can not aid improvement to areas outside of the 
corticostriatal loop, nor provide a complete cure and therefore drug-based therapies 
are (and probably will remain) necessary.
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1.2.4 The genetics of Huntington’s disease
The hereditary nature of this form of chorea was one of the main traits that caught 
George Huntington’s attention. Many studies have since been carried out looking at 
family pedigrees and patterns of inheritance. In particular families in the Zulia 
region of Venezuela have been studied extensively, with over 10, 000 members listed 
and over 100 living affected subjects, all derived from a single founder. A full 
account of the project is not available (touched upon in Wexler, 1996), but this 
project has proved invaluable, providing subjects for the gene mapping which was 
finally achieved in 1993 (see helow). HD is inherited in an autosomal dominant 
fashion and appears to follow standard Mendelian rules, with parental transmission 
fitting closely to the expected 50per cent (Harper & Jones, 2002, see figure 1.2.6). 
Families that have both parents carrying the HD gene have extra considerations, as 
three out of four offspring will develop the disease, one of whom is likely to be 
homozygous. All offspring from homozygous individuals, irrespective of their 
partner’s genotype, will carry the gene (see figure 1.2.6).
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Figure 1.2.6: Pedigree showing typical Mendelian inheritance of HD. When one 
parent is affected offspring have a 50% chance of inheriting the disease (1). If both 
parents are heterozygous for the gene 75% of offspring are likely be affected; one in 
four will be homozygous (2). All offspring from a homozygous individual, 
irrespective of their partner’s status, will inherit the abnormal gene (3). The sex of 
an individual is not important.
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1.2.4.1 Identification of the gene
Mapping of the gene started in the early 1970s (Lindstrom et al, 1973) and the first 
confirmed linkage of Huntington’s disease came in 1983 when the gene responsible 
was located to the short arm (p) of chromosome 4 by using a DNA probe (G8), 
known to be linked to Huntington's disease (Gusella et al, 1983). It took another ten 
years before the actual gene was mapped and found to contain an expanded 
trinucleotide repeat (Huntington's Disease Collaborative Research Group, 1993).
The gene (which is presented in a simplified form in figure 1.2.7) was termed 
interesting transcript 15' (JT15), contains 67 exons and encodes a large protein of 
approximately 348 kDa which has been termed huntingtin. Near to the iV-terminal 
and located within exon 1, is a trinucleotide repeat of cytosine-adenine-guanine 
(CAG), which, following translation, encodes a tract of the amino acid glutamine 
(Q). Following the CAG repeat there is a CAA codon followed by another CAG. As 
CAA also encodes glutamine the polyglutamine stretch is actually two Qs longer 
than the initial CAG number (Huntington's Disease Collaborative Research Group, 
1993); this often causes confusion in reports of repeat length (Gellera et al, 1996).
Huntington’s disease is one in a growing list of diseases caused by 
expansions in polyglutamine repeats. The list includes spinal and bulbar muscular 
dystrophy (SBMA, also known as Kennedy’s disease. La Spada et al, 1991), 
dentatorubral-pallidoluysian atrophy (DRBLA, Koide et al, 1994) and several 
variants of spinocerebellar ataxia (SCA), namely type 1 (Orr et al, 1993), type 2 
(hnbert et al, 1996), type 3 (also known as Machado-Joseph disease, Kawaguchi et 
al, 1994), type 6 (Zhuchenko et al, 1997), type 7 (David et al, 1997) and type 17
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(Koide et a l , 1999). These diseases present with a wide range of symptoms, hut 
also have many in common. They often have a midlife onset, are progressive 
neurodegenerative diseases and have complex motor, cognitive and psychiatric 
components (Bates & Benn, 2002). Identifying how the CAG repeat expansion 
bestows toxicity in one disease may aid developments in the other polyQ disorders.
1.2.4.2 CAG repeat length
Development of Huntington’s disease is highly CAG repeat length-dependent. In the 
normal population, the CAG repeat is of between 7 and 35 repeats. Individuals 
carrying more than 35 repeats will, however, go on to develop the disease at some 
point within their lifetime (Andrew et al, 1993; Duyao et al, 1993; Snell et al, 
1993). The age of onset (and to a degree the severity of the disease) and hence the 
age at death, are inversely correlated with the length of the expanded CAG repeat, 
such that those with longer repeats develop the disease earlier. Individuals with 
greater than approximately 60 CAG repeats often develop juvenile Huntington's 
disease (Harper, 1999). The relationship between CAG repeat length and age of 
onset can be clearly seen in figure 1.2.7 and is summarised in table 1.2.1.
There is a large variation in age of onset for any given CAG repeat length 
within the intermediate range (35-50 CAGs). For example, a repeat length of 40 
CAGs leads to an onset ranging from 40 to 70 years of age (North American and 
Canadian population, figure 1.2.7). This variation means that, although logarithmic 
algorithms have been proposed for predicting the age of onset (for example see
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Rubinsztein et al, 1997), in reality predicting the precise age at which clinical signs 
will manifest is not practical.
The correlation between polyQ length and clinical symptoms is harder to 
dissect because of the overriding age of onset correlation. The clearest correlation is 
shown by juvenile onset HD, consequential of an extremely large CAG expansion, 
resulting in not only an earlier onset but also far more aggressive symptoms 
including rigidity and seizures (see next section). A correlation between psychiatric 
symptoms and repeat length has failed to be shown in several reports (see MacMillan 
et al, 1993; Claes et al, 1995; Weigell-Weber et al, 1996; Zappacosta et al, 1996). 
There does appear, however, to be a correlation between delayed visual reaction 
times and CAG repeat in “pre-symptomatic” gene-carriers (Siemers et al, 1996). 
These patients also show delayed decision making. Other early cognitive 
impairments have been correlated with CAG repeat, particularly in other assessments 
of visual perception and verbal recall (Foroud et al, 1995). It would therefore 
appear that CAG repeat length, while playing a role in early events, does not 
influence the severity of the clinical symptoms.
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Figure 1.2.7: CAG repeat expansion and age of onset. Top A representation of 
the gene responsible for Huntington's disease. In the normal population the gene 
carries a CAG repeat of up to 35 near to the A-terminal. Individuals with HD have 
an expanded CAG repeat of greater than 35. Bottom Age of disease onset is highly 
correlated with CAG repeat length. Each point corresponds to an individual with 
Huntington's disease. Best fit line is represented. Axes represents CAG repeat 
number and age of onset in years, using a log-log scale. (Adapted from Rosenblatt et
(CAG), Disease status
<28 Normal
29-34 Normal, but next generation at risk
35-40 D isease likely, offspring at high risk
41-85 Will develop the d isease, 50% of offspring also at risk
>85 Juvenile onset
Table 1.2.1: CAG repeat length determines disease status.
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Similarly, there is no evidence to support the theory that polyQ repeat length 
influences the rate of disease progression, although this may, again, be complicated 
by the age of onset (Harper & Jones, 2002).
Pathological studies have shown a correlation between CAG repeat length 
and cell death. One study shows a linear correlation between the degree of striatal 
atrophy at death with the CAG repeat length (Penney et al., 1997). Other studies 
have demonstrated the number of inclusions in post-mortem brain are also correlated 
with CAG repeat (Becher at., 1998; Sieradzan et al, 1999).
1.2.4.3 Juvenile HD
Soon after George Huntington’s description of the disease it was realised that a 
juvenile form also occurs. One of the most detailed cases is that of a three generation 
HD family with daughters that presented with a severe form of the disease at the ages 
of four and ten. Symptoms included rigidity, hypokinesia, seizures and choreic 
movements (Hoffmann, 1888). This form of the disease is often referred to as the 
‘Westphal variant’, although Westphal attributed these symptoms to a cause other 
than HD (Westphal, 1883). Juvenile cases account for approximately one per cent of 
all HD patients and two per cent of these show symptoms before the age of ten years 
(Rasmussen et al, 2000). The youngest case presenting clinical signs was two years 
old (Osborne et al, 1982). As mentioned earlier, juvenile HD is caused by 
extremely long glutamine repeats, generally over 50 in length (Kremer, 2002) 
although individuals with as many as 250 have been reported (Nance et al,  1999). 
The first indications of juvenile HD are often poor performance at school, coupled
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with behavioural disorders and possibly schizophrenic-like problems (Woldag et al, 
1997). As the disease develops a fiall, progressive dementia becomes apparent. 
Chorea is present in most cases, but is often mild and short-lived, soon replaced by 
rigidity, bradykinesia, hyperreflexia and other motor disturbances. Tonic-clonic and 
absence seizures are extremely common, occurring in up to 50% of cases (Hayden et 
al, 1981; Osborne e/a/., 1982).
While giving rise to an exceptionally aggressive form of the disease, the 
extremely long CAG repeats have been utilised in producing many of the genetic 
models of HD discussed in section 1.2.7
1.2.44 Repeat instability
The number of CAG repeats can be unstable between generations. Interestingly the 
majority of juvenile cases arise from paternal transmission. This was confirmed in a 
study of seven families with 14 affected children and these data were complemented 
with a review of over 100 previously reported cases (Merrit et al, 1969). The sex of 
the affected offspring was approximately 50:50. In contrast 80% of transmissions 
were from the father. Another intriguing observation is that successive generations 
of paternally transmitted cases show progressively earlier onsets (Newcombe et al, 
1981), a phenomenon known as anticipation.
The cause of anticipation is a sex-specific increase in CAG repeat length; 
large repeat expansions of larger than seven are almost exclusively seen in males 
(21% of all male transmissions versus 0.7% of all female transmission, Kremer et al,
1995). Anticipation is thought to occur more in males than females due to the
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differences in the process of gametogenesis between the sexes. In males, sperm is 
produced throughout sexual maturity by meiosis. In contrast, the dogma of oocyte 
generation in females, is that all meiotic events occur prenatally and thus a full 
complement is laid down before birth (Zuckerman, 1951). Therefore the frequency 
of meiotic events and the duration over which they take place is far greater in males 
than in females. It would appear CAG repeats are particularly unstable during 
meiotic division. Indeed, the size of repeat lengths in sperm shows a greater repeat 
length than other tissues from the same patient (Andrew et al, 1993; Huntington's 
Disease Collaborative Research Group, 1993) and an increased variability (Leeflang 
et al, 1995). Interestingly it has recently been shown that meiotic events may occur 
throughout female sexual maturity in order to maintain oocyte number (Johnson et 
al, 2004). The incidence of meiotic events in females still remains low compared to 
males and this could explain the differences observed in the incidence of maternal 
and paternal anticipation.
Repeat lengths in the normal range appear to be stable. Very few, if any, 
truly spontaneous HD cases have been reported. Early studies estimated that isolated 
cases represent approximately 5% of all HD cases. Following more rigorous criteria 
this value falls to just 0.04% (see Harper & Jones, 2002). Since the isolation of the 
gene, it has become apparent that the isolated cases arise in transmissions where the 
parents have repeat lengths at the upper end of the normal region (33-36 CAGs, 
Huntington's Disease Collaborative Research Group, 1993, see table 1.2.1). It would 
appear, therefore, that there is an intermediate range in which an individual is not 
likely to develop the disease, but offspring are at risk of inheriting an expanded CAG 
repeat and thereby be at risk.
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1.2.4.5 Huntingtin expression
Wild-type huntingtin is ubiquitously expressed in all tissues, with highest levels 
within the brain (Sharp et al, 1995). Within the brain all regions, including cerebral 
cortex, striatum, globus pallidus, cerebellar cortex, hippocampus, amygdala and 
substantia nigra, express the protein (Landwehrmeyer et al, 1995; Sapp et al, 1997). 
Within the cerebral cortex, huntingtin expression is particularly high in cell layers II- 
IV and VI (Landwehrmeyer et al, 1995). Expression is almost exclusively 
cytoplasmic, with higher levels within the soma than in the dendrites (Sapp et al,
1997). Huntingtin is also particularly concentrated within nerve terminals (Sharp et 
al, 1995).
In the HD brain, huntingtin is expressed in all regions and, with the exception 
of the putamen and globus pallidus, is expressed at normal levels. Within the 
putamen a significant increase in expression is seen, while in the pallidus region 
huntingtin is reduced (Landwehrmeyer et al, 1995). At the cellular level, huntingtin 
expression within the HD brain is altered. There is an increased level of staining 
within the perinuclear region and a reduced labelling in neuronal processes (Sapp et 
al, 1997). Moreover, there is intense staining of huntingtin within the nucleus, 
which is absent in control brains. Furthermore there is punctate staining both within 
the neuropil and soma.
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1.2.4.6 Mosaicism
As suggested in the above text, different tissues within the same individual may 
contain CAG repeats of various lengths, with sperm carrying the highest repeat 
lengths. Mosaicism has also been reported in most somatic tissues, particularly the 
brain. Cells within the striatum and cerebrum show the largest increases in repeat 
number (Telenius et al, 1994; Aronin et al, 1995) and a similar pattern of 
mosaicism has been reported in some mouse models of HD (Mangiarini et al, 1997; 
Wheeler et al, 1999; Kennedy & Shelboume, 2000).
The precise mechanism by which repeat expansion occurs is unclear, but 
could involve DNA replication, recombination, transcription or repair (see Jones, 
2002).
1.2.5 Molecular biology of mutant huntingtin
Given the strong correlation between CAG repeat length and the age of onset (and to 
a degree the severity of disease) it is clear that the toxic nature of mutant huntingtin 
derives from the expanded glutamine stretch. A common feature of mutant 
huntingtin is its propensity to form insoluble aggregates, both in vivo and in vitro. 
How the aggregation of mutant protein confers selective neurotoxicity is unclear. 
Conversely it has been argued that aggregation could be a neuroprotective 
mechanism where by the toxic mutant huntingtin is removed from the system thereby 
defending neurones against mutant huntingtin-induced cell death (for example see 
Saudoueffl/., 1998).
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1.2.5.1 Aggregation
The idea that protein aggregation could be a key turning point in disease progression 
came in 1997 when it was reported that mice transgenic for exon 1 of the human 
gene develop inclusions within the nucleus of striatal, cortical, hippocampal, 
cerebellar and spinal cord cells before the onset of a neurological phenotype (Davies 
et al, 1997; Scherzinger et al, 1997). The inclusions were immunopositive for both 
huntingtin and ubiquitin. They were never seen in brains of non-transgenic mice. 
Similar inclusions had been reported previously in biopsy tissue from human cases 
(Roizin et al, 1979) but largely ignored because of their apparent absence in post­
mortem tissue (Fomo & Norville, 1979). Credence for neuronal intranuclear 
inclusions came later when it was found that human patients do develop inclusions 
(DiFiglia et al, 1997), a finding that has since been corroborated (Gutekunst et al, 
1999; Sieradzan et al, 1999). As discussed in the animal models section (1.2.7), 
aggregates have also been observed in many transgenic models of HD.
The idea that large stretches of glutamines could lead to covalent cross- 
linking was proposed in 1993. In this model it was suggested that when a number of 
glutamine repeats exceeds a certain threshold, a protein (huntingtin or any other 
polyQ-containing protein) could become a transglutaminase substrate (Green, 1993). 
Transglutaminases catalyse the formation of insoluble, cross-linked proteins by way 
of covalent bonds (Greenberg et a/., 1991) and have been shown to be elevated in 
HD brains (Karpuj et al, 1999). In light of both this suggestion and the CAG repeat 
length-dependency of HD onset (Huntington's Disease Collaborative Research 
Group, 1993), an atomic model of aggregation was formed (Perutz et al, 1994). The 
model, known as the ‘polar-zipper’ model, proposes that the glutamine stretch forms
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Figure 1.2.8: Neuronal intranuclear inclusions. A-C: Huntingtin 
immunoreactivity in the cortex of a juvenile HD patient. Examples of single (B) and 
double (C) inclusions in cortical pyramidal neurones. A, bar = 50 /an; B & C, bar = 
10 /an. (Adapted from DiFiglia et al, 1997.) D: Proposed inclusion structure. 
Expanded glutamine repeats lead to the formation of (3-sheets, linked together by 
hydrogen bonds (dashed lines). (From Perutz et al, 1994.)
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antiparallel y^sheets (Perutz et al, 1993). The hairpins that form then associate 
together and precipitate the protein. The polar-zipper model is shown in figure 1.2.8. 
It appears that aggregated huntingtin sequesters other proteins into the inclusion. In 
particular, transcription factors, caspases, protein kinases, parts of the proteasome 
and wild-type huntingtin have been identified within inclusions (see Jones, 2002 for 
review). Requisition of other proteins into huntingtin aggregates results in loss of 
function of those proteins and thereby affects their cellular processes.
1.2.5.2 Cleavage
Interestingly, in human brains, aggregates were only detectable by antibodies raised 
to the V-terminus, but not the C-terminus, of huntingtin (DiFiglia et a/., 1997). This 
suggested that accumulation was of truncated segments rather than full length 
protein. Indeed it has been found that mutant huntingtin is highly susceptible to 
proteolysis, which has been shown to be mediated by caspases (Wellington et al,
2002) and calpains (Gafiii & Ellerby, 2002).
Caspases are a family of proteolytic enzymes that are so named for having 
cysteine (C) residues at their active sites and cleave after aspartic acid (Asp) residues 
in their substrate proteins (Cooper, 2000). Huntingtin was the first neuronal protein 
to be identified as a substrate for caspase activity (Goldberg et al, 1996) and, 
importantly, has been shown to have defined sites for caspases 2, 3 and 6 near to the 
amino-terminal portion (see Wellington et al, 2000; Wellington et al, 2002, see 
figure 1.2.9). Also, caspase-1 expression is increased in a mouse model of HD (Li et 
al, 2000b) and inhibition of caspase-1 activity by mutation of the caspase-1 gene
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within R6/2 mice (see section 1.2.7), delays the onset of inclusion formation, 
prolongs survival and prevents the reduction observed in dopamine receptor binding 
within these mice (Ona et a l , 1999). Although there are viability questions 
associated with double transgenics, this would suggest caspases play an important 
role in the development of the pathogenesis seen in HD.
Similarly, calpains are a group of proteases that are expressed intracellularly, 
are calcium-dependent and may be involved in apoptotic processes. Calpain 
activation is detected in human HD tissue, but not in age-matched controls.
Moreover, they appear to cleave mutant huntingtin in a CAG-repeat length- 
dependent manner into three A-terminal cleavage products (Gafiii & Ellerby, 2002, 
see figure 1.2.9).
The finding that huntingtin appears to aggregate within the nucleus is 
interesting. Huntingtin does not appear to have a nuclear localisation signal, which is 
generally required for nuclear localisation of proteins (Xia et al, 2003). In contrast, 
huntingtin does have a nuclear export signal, which is located near to the carboxy 
terminal (Xia et al, 2003, see figure 1.2.9). The presence of the nuclear export 
signal should confer a cytoplasmic expression of huntingtin and, indeed, this is the 
case for wild-type protein (Sharp et al, 1995; Xia et al, 2003). Following cleavage 
by caspases and/or calpains, the nuclear export signal is no longer associated with the 
A-terminal fragment, allowing nuclear entry of the protein containing expanded 
polyQ tracts (Xia et al, 2003) and subsequent inclusion formation.
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Figure 1.2.9: Cleavage of mutant huntingtin. The huntingtin protein carrying an 
expanded glutamine tract is represented. Cleavage at the caspase/calpain site (C) 
leads to dissociation of the V-terminal fragment from the nuclear export signal (N) 
contained in the C-terminal fragment. The V-terminal fragment can then enter the 
nucleus where it disrupts transcription and forms aggregates. (Based on data in 
Wellington et al, 2000; Wellington et al. 2002; Gafhi & Ellerby, 2002; Xia et al. 
2003.)
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Figure 1.2.10: Processing and consequences of mutant huntingtin. The presence 
of an expanded CAG repeat leads to protein misfolding. This could confer toxicity 
in several ways: 1) Misfolded huntingtin could lead to altered interactions with other 
proteins. 2) Mutant huntingtin forms aggregates within the cytoplasm, where it may 
recruit other proteins. 3) Misfolded huntingtin is susceptible to cleavage by caspases 
and calpains, leading to nuclear localisation and aggregation resulting in 
transcriptional dysregulation. 4) Degradation by the ubiquitin-proteasome system 
(UPS) becomes impaired due to clogging of the pore by the expanded glutamine 
repeats. (Adapted from Ciechanover & Brundin, 2003.)
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CRE-regulated genes are known to be down-regulated early on in HD 
progress (discussed in Wyttenbach et al, 2001). Likewise, CRE-mediated 
transcription is compromised by proteins that carry an expanded poly glutamine 
stretch (McCampbell et al, 2000; Nucifora et al, 2001; Wyttenbach et al, 2001). 
The precise mechanism by which CRE-mediated gene transcription is impaired is not 
clear. CRE is activated by CRE binding protein (CBP), which has been identified 
within polyQ-containing protein aggregates (McCampbell et al, 2000; Nucifora et 
al, 2001). Mutant huntingtin has also been shown to interact with the glutamine-rich 
activation zone (Nucifora et al, 2001) and the acetyltransferase domain (Steffan et 
al, 2001) of CBP, thereby drawing CBP into aggregates and removing it fi*om the 
system. Clearly loss of CBP could lead to decreased expression of CRE-mediated 
genes.
CRE-mediated transcription can also be activated by TAFnl30, which has 
also been shown at elevated levels within aggregates (Shimohata et al, 2000). The 
precise role of TAFnl30 is not understood, but it has been argued that it may 
preferentially bind to expanded polyQ stretches thereby being recruited into 
aggregates (Shimohata et al, 2000). Contrary to this notion it has been reported that 
TAFiil30 bind equally well to both wild-type and mutant huntingtin (Dunah et al, 
2002).
TAFiil30 is also implicated in the Spl transcription pathway. It appears that 
mutant huntingtin prevents the interaction of TAFnl30 with Spl and thereby 
impedes the interaction of Spl with DNA (Dunah et al, 2002). Several gene 
products downstream of the Spl promoter are known to be reduced in HD. 
Particularly pertinent to neuronal dysfunction is the decrease in neurotransmitter 
receptors, such as D] dopamine receptors and a decrease in nerve growth factor (Cha
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et al, 1998; Luthi-Carter et al, 2000). Indeed, Spl has been shown to be reduced 
early in the human disease process (Dunah et al, 2002; Li et al, 2002) and before 
formation of visible aggregates in cell models (see Sugars & Rubinsztein, 2003). 
Importantly the expressions of some genes are unaltered. For example the axonal or 
dendritic neuronal markers microtubular associated protein 2 (MAP2) and 
neurofilaments, preprotachykinin (an mRNA expressed only the MSSNs) and the 
glial marker genes glial fibrillary acidic protein (GFAP), myelin basic protein and 
major histocompatability complex II (MHCII), all show normal mRNA levels. This 
suggests that the reduced mRNA levels observed is due to a specific, rather than 
generalised, impairment in transcription.
It appears, therefore, that abnormalities in transcriptional regulation may play 
an important role in the pattern of pathology seen in HD by down regulating protein 
expression. The impairment seen in transcription is not fully understood, but may be 
a result of activator impoundment into aggregates. Examples of genes that are 
relevant to neuronal activity and survival and show reductions in transcription (as 
detected by mRNA levels) in the R6/2 mouse model (see section 1.2.7) are listed in 
table 1.2.2. Two techniques have been used in the detection of mRNA levels: in situ 
hybridisation and DNA array. In situ hybridisation uses a labelled probe to detect 
mRNA within a section of tissue. The DNA array approach uses labelled 
complementary DNA prepared fi*om mRNA extracted from dissected striata. cDNA 
abundance is then assessed of known DNA sequences.
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GAD (65/67) N/C /
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A denyl cyclase (V) 200 1 5 0
A denyl cyclase (II) 4 8 0
D 4 Dopam ine R 2 4 0
PKCv 5 3 0
P K C bii 1 1 1 ' 5 3 0
GluR6 i 2 or 2 8 0
D 2A D opam ine R 63 □ 3 9 0
Protein phosphatase 1 5 0 D
Neuronal cannabinoid R  (C B l) 611 4 0 0
a 2  Adrenergic R 3 5 L 2 9 0
Ryanodine R 2 6 0 200
k V  channel 2 6 0 2 9 0
K'^ bi channel subunit 59r; 5 6 0
VSCC 8 3 r 5 9 0
IP3 R 4 6 0 4 2 0
G AD 63 f 3 9 0
Preproenkephalin 5 6 0 4 6 0
PP2B (calcineurin) 4 6 0
cAM P-dep PK  inhibitor 3 9 0
Proteasome activator PA 28 l i o n 3 2 0 0
M H C IB (2 ) 120! 2 7 0 0
M H C n N /C 0 N /C 0
M AP2 N /C 0 N /C 0
Neurofilaments N /C 0 N /C 0
GFAP N /C 0 N /C 0
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Table 1.2.2: mRNA levels in R6/2 mice. All values are expressed as a percentage 
of age-matched wild-type mice. *= P<0.05; **= P<0.01 ; P<0.001 ; P<0.0001 ;
^=8 week old mice; 10 week old mice. ■= Decrease called in 4/4 comparisons; 
□= Decrease called in 3/4 comparisons; □= Increase called in 4/4 comparisons; i2= 
Change in less than 3/4 comparisons; S =  No change (N/C) observed. In situ 
hybridisation data adapted from Cha et al (1998); Menalled et al (2000); and Harris 
et al (2001). Array data adapted from Luthi-Carter et al (2000).
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1.2.6.2 Transport
Protein expression at the nerve terminal is dependent on transport from the nucleus 
of either mRNA to the nerve terminal for in situ translation (Eberwine et al, 2001 ; 
Steward & Worley, 2001) and/or transport of previously translated proteins and other 
molecules (Silverman et al, 2001). The distance between the cell body (DNA 
source) and nerve terminal can often be a great distance and transport of gene 
products involves interaction with a number of molecules including the microtubule 
lattice, motor components and adaptor molecules (see figure 1.2.11).
Wild-type huntingtin has been implicated in vesicle transport along nerve 
processes. Huntingtin has been shown to purify with vesicle fractions from human 
and rat brain, to be associated with microtubules and is known to have interactions 
with proteins involved in transport (discussed in Jones, 2002).
The process of vesicle trafficking involves dynactin, which is an activator 
protein that is required by the motor protein dynein to move vesicles along 
microtubule networks. Dynein has adenosine triphosphate (ATP)ase activity which 
provides the energy required for the process. Dynactin is also associated with 
centractin, which in turn binds the vesicle for transportation (Allan, 1996, see figure 
1.2.11). Huntingtin has also been shown to interact with the motor component of 
transport, dynactin, via a huntingtin interactor called huntingtin-associated protein 1 
(HAPl, Engelender et al, 1997; Li et al, 1998, see figure 1.2.11). The interaction of 
huntingtin with these components suggests that huntingtin may play a role in 
neuronal transport. Transport may, therefore, be affected when mutant huntingtin is 
expressed. The effect of abnormal huntingtin on transport has been investigated by
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expressing V-temiinal fragments of human huntingtin carrying 2, 23, 62 or 100 Qs in 
the squid giant axon. Expanded, but not normal, polyQ repeats lead to inhibited 
axonal transport (Szebenyi et al, 2003). Similar results have been obtained in the 
fruit Drosophila melanogaster (Gunawardena et al, 2003).
The impairment in transport is through a direct decrease in the functions of 
huntingtin and its interacting proteins, rather than inclusion into aggregates. But 
clearly the observation that mutant huntingtin can indeed sequester wild-type 
huntingtin (and its interacting proteins) into aggregates could compound impairments 
in vesicle transport.
1.2.6.3 Endocytosis
Endocytosis is an important cellular process that occurs at several places within 
neurones. In particular, endocytosis is required at the synapse where it is involved in 
the removal of neurotransmitter from the synaptic cleft to enable further fast 
neurotransmission and also to replenish vesicle pools within the presynaptic bouton 
(see Jarousse & Kelly, 2001). Endocytosis also occurs at the transGolgi apparatus, 
where loaded vesicles fuse with other organelles. Retrograde transport of proteins 
from the nerve terminal to the soma also requires endocytosis where it may be 
involved in regulating neurotransmitter receptor expression.
There are clear interactions of huntingtin with endocytotic mechanisms. 
Huntingtin has been shown to interact with a-adaptins, endophilins and clathrin, all 
of which are involved in the endocytotic process, via HIPl (Metzler et al, 2001 ; 
Waelter et al, 2001b).
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Figure 1.2.11: The role of huntingtin in vesicular transport along axonal 
processes. Following vesicle formation (i-iii), interaction with centractin binds the 
vesicle to a complex of proteins that mediate transport. One of these proteins is 
dynactin which interacts with dynein, an ATPase that provides energy for the 
process. Huntingtin is known to interact with dynactin though HAPl and also 
interacts with microtubules, suggesting that huntingtin has a role in these processes. 
(From Jones, 2002.)
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There are several examples of mutant huntingtin directly affecting 
endocytosis. Mutations of the yeast HIPl homologue, Sla2p, disrupts endocytosis 
(Raths et al, 1993); Knockout of the HIPl gene in mice leads to decreased AMP A 
receptor trafficking though a decreased interaction with clathrin (Metzler et al,
2003); A-terminal fragments of huntingtin have been shown to bind to synaptic 
vesicles preventing glutamate reuptake from the synaptic cleft (Li et al, 2000a); also 
the interaction between huntingtin and post-synaptic density protein 95 is altered by 
the presence of expanded glutamine repeats. Post-synaptic density protein 95 is a 
scaffold protein that binds the NR2 subunit of the NMDA glutamate receptor in order 
to regulate cell-surface expression (Sun et al, 2001).
1.2.6.4 Exocytosis
The release of intracellular chemicals may also be affected in HD. In particular, 
abnormalities in the proteins involved in exocytosis have been detected in a mouse 
model of HD expressing exon 1 of the HD gene (R6/2 mouse, see section 1.2.7)
Release of neurotransmitter from the presynaptic terminal is under the control 
of a number of proteins. The vesicle pool is bound to the cytoskeleton by synapsins 
that, once phosphorylated, allow mobilisation of the pool towards the membrane 
making them available for exocytosis. A number of proteins are involved in 
exocytotic membrane fusion, including synaptobrevin, syntaxin and SNAP-25, 
collectively known as SNARES. The cell membrane associated SNARES, SNAP-25 
and syntaxin, fuse with the vesicle associated synaptobrevin to pull the two 
membranes together to cause exocytosis. The fusion of the SNARE complex is
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mediated by the accessory proteins synaptotagmin, synaptophysin, rab3 A, a-SNAP 
and complexins I and II (Mochida, 2000; Marz & Hanson, 2002). The complexin 
proteins are in direct competition with a-SNAP by providing an inhibitory role on 
neurotransmitter release (McMahon et al., 1995).
Two of these accessory proteins are known to be affected in mouse models of 
HD. Complexin II expression levels are progressively reduced (Morton & 
Edwardson, 2001) and mutant huntingtin blocks exocytosis in PCI2 cells by direct 
depletion of complexin II (Edwardson et al, 2003). While expression levels of other 
SNARE and accessory proteins are normal (Bibb et al, 2000; Morton & Edwardson,
2001), the phosphorylation state of synapsin 1 is increased (Liévens et al, 2002).
Changes in the expression and phosphorylation states of proteins involved in 
exocytosis could underlie the decrease in glutamate release observed when mutant 
huntingtin is expressed in mice (Li et al, 2003). The results of these experiments 
would predict a presynaptic alteration in synaptic transmission, and this will be 
discussed in section 1.4.
1.2.6.5 Loss versus gain of function
Genetic analysis suggests that a loss of function is not responsible for the HD 
phenotype. Knock-out of the gene (see Animal models section 1.2.7) does not result 
in an HD-like phenotype, suggesting they are caused by events other than loss of 
function. In the human condition, homozygosity does not appear to confer a more 
aggressive syndrome (Huntington's Disease Collaborative Research Group, 1993) 
again suggesting a gain of function.
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Although the precise cellular function of huntingtin has yet to be elucidated, 
it appears (as discussed above) to interact with other cellular proteins, including 
huntingtin interacting proteins 1,2 and 3 (HIPl; HIP2; HIP3), huntingtin associated 
protein (HAPl) and, amongst others, a-adaptin and endophilins. It has been 
suggested that the polyglutamine tract could confer a gain of function by altering the 
interaction of mutant huntingtin with its interacting proteins. Conversely there could 
also be a loss of function, whereby interactions are prevented by the misfolding and 
subsequent cleavage and aggregation of huntingtin and its associated proteins, 
including wild-type huntingtin. The loss of function could lead to cellular death by 
preventing the normal action of huntingtin in axonal transport and neurotransmitter 
release and thereby affecting synaptic dysfunction and excitotoxicity. It is likely, 
therefore, that the toxicity observed in Huntington’s disease is a balance between 
both a gain and a loss of function (Prospero & Tagle, 2000).
1.2.7 Animal models of Huntington’s disease
Several animal models of HD have been produced and, as with all animal models of 
human conditions, each has their relative merits and shortfalls. The first models 
were based on recreating the pattern of neuropathy seen at the end-stages of the 
human condition by targeting lesions in rats and primates. Following the 
identification of the gene responsible for HD (Huntington's Disease Collaborative 
Research Group, 1993), it was possible to target this gene to create genetically 
modified animal models of HD. The first were mice with the mouse huntingtin gene 
homologue {Hdh) knocked out. More sophisticated transgenic models have since
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been produced, including invertebrates with a polyQ insertion, mice with either 
partial or full-length transgenes and also knock-in mice, where a gene insert is 
targeted to replace the mouse homologue gene Hdh, which shares 91% homology to 
human huntingtin (Barnes et al, 1994; Lin et al, 1994). More recently a rat model 
of HD has been generated. These models will be discussed in the following section, 
with a particular focus on the R6 line, which has the largest body of research 
associated and has been utilised in the present thesis.
1.2.7.1 Excitotoxic models
It is widely held that glutamate toxicity may underlie the loss of neuronal cells 
observed in the brains of HD patients. Inappropriate activity of glutamatergic inputs 
could lead to increased levels of glutamate and hence greater glutamate receptor 
activation. The key glutamate receptor involved in excitotoxicity is the NMDA 
receptor, which, when activated under a depolarised membrane state, allows calcium 
influx (Collingridge et al, 1983b). The amount of calcium entering the cells of HD 
patients may be further enhanced by inappropriate activity of the NMDA receptor 
(Chen et al, 1999b; Levine et al, 1999; Zeron et al, 2002). Prolonged elevation of 
intracellular calcium levels leads to cell swelling and damage to the Golgi apparatus, 
mitochondria and clumping of chromatin (Garthwaite, 1994) and glutamate toxicity 
could, therefore, contribute to neuronal cell death. It should be noted, however, that 
other mechanisms, such as oxidative stress, impaired metabolism and cellular 
dysfunction have also been implicated in HD neurotoxicity.
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Rodents
In support of the glutamate toxicity model, injections of glutamate analogues into the 
striatum of rats provided the first models of HD that closely replicated the 
neuropathological damage occurring in HD (shown in figure 1.2.12) and also 
produced an HD-like phenotype including both motor and behavioural deficits (for 
example see Scattoni et al, 2004). The first models used kainic acid (KA) injections 
which resulted in a similar loss of neurones to that observed in the HD condition. 
Projection neurones were lost, while intemeurones were relatively spared and 
decreases in both the GABA synthetic enzyme glutamic acid decardoxylase and 
choline acetyltransferase were observed (Coyle & Schwarcz, 1976; McGeer & 
McGeer, 1976). Similar results were obtained with the glutamate analogue ibotenic 
acid (Isacson et al, 1985).
A closer replication of the pathology observed in HD was created by injection 
of the NMDA receptor specific agonists quinolinic acid (Schwarcz et al, 1983) or L- 
homocysteic acid (Beal et al, 1990). Both quinolinic acid and L-homocysteic acid 
lesions in the rat striatum resulted in loss of spiny GABA and substance P neurones, 
but sparing of NADPH-diaphorase/nNOS/somatostatin/neuropeptide-Y-positive 
neurones.
Similarly to glutamate agonists, inhibitors of mitochondrial activity have 
been found to reproduce aspects of HD. Either systemic or local injection of 
aminooxyacetic acid, 3-nitropropionic acid (3-NP), malonate or azide have been 
shown to cause secondary excitotoxic lesions by inhibition of the mitochondrial 
respiratory chain (see Yohrling IV & Cha, 2002 for review). Malonate and 3-NP are 
both inhibitors of succinate dehydrogenase, which is complex II of the mitochondrial
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electron transport chain. This disruption results in decreased ATP levels by 
preventing oxidative phosphorylation. Reduced ATP levels leads to cell 
depolarisation by effecting Na'^/K'^/ATPase activity. Cell depolarisation relieves the 
magnesium block on the NMDA receptor, again exposing the cell to excitotoxicity. 
Therefore the mechanism by which systemic administration of 3-NP gives rise to 
neuronal loss similar to that in HD is (possibly) two-fold: (1) altered energy 
metabolism may play a direct role; (2) reduced energy metabolism may compound 
the effects of excitotoxicity. How this mechanism confers selective neurotoxicity is 
unclear.
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Figure 1.2.12: Ëxcitotoxic lesions in rats. A: Focal lesion of the basal ganglia 
induced by injection of KA into the left hemisphere. B: Focal lesion induced by 
injection of quinolinic acid into the left hemisphere. Note the marked striatal atrophy 
on the injected (left) side compared to the contralateral hemisphere. C: Systemie 
administration of 3-NP leads to striatal lesions (arrows) and relative sparing of 
substance P-containing neurones. (A & B adapted from Beal et al., 1991; C adapted 
from Reynolds et al, 1998)
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Primates
As the monkey striatum is more similar to the human striatum than the rat, 
neurotoxic models of HD have been expanded to inelude non-human primates. 
Models of chorea have been created by the intrastriatal injection of KA followed by 
the dopamine precursor L-DOPA (for example see Kanazawa et al, 1986; Kanazawa 
et al, 1993). Another primate model has been established by the injection of 
ibotenic acid into the baboon striatum (Hantraye et al, 1992a). These models 
closely recapitulate the HD phenotype seen in humans. Injeetion of the 
mitochondrial inhibitors 3-NP or malonate into primates both caused selective 
lesioning of the caudate-putamen, choreic-like movements and, importantly, also 
impaired cognitive processes (for example see Schulz et al, 1997).
While the excitotoxic lesions in rats and primates model the end stages of HD, they 
do not reproduce the progressive nature of the disorder and therefore early neuronal 
dysfunction is overlooked in these models. The identification of the gene responsible 
for HD has enabled the creation of superior models in the form of transgenic animals 
which have a developmental neurological phenotype.
1.2.7.2 Transgenic models
Recent developments have allowed the manipulation of the mouse embryo such that 
specific genetic mutations can be expressed. These include pronuclear injection, 
which involves microinjeetion of purified foreign DNA sequences into the nuclei of
79
preimplanted embryonic cells. The integration of the transgene occurs at a random 
site within the mouse genome and often multiple copies are incorporated at the same 
chromosomal locus. The zygote ean then be implanted into pseudopregnant mothers, 
allowing the gene to be transmitted to offspring in a Mendelian fashion to fiiture 
generations (see Brusa, 1999 for review).
A second way to produce genetically modified mice is by gene targeting by 
homologous recombination. Mutations are generated in vitro within undifferentiated 
embryonic stem cells. The rare homologous recombinant events are then selected for 
against the relatively high background of non-homologous recombinant events, 
usually using a positive-negative strategy. Targeted stem eells can then be injected 
into a host blastocyst and implanted into a pseudopregnant mother (again, for review 
see Brusa, 1999). This technology has enabled the development of reverse genetics: 
gene knock-out, where one gene is completely inactivated; or gene knock-in, where a 
targeted gene is substituted by a mutated form. Reverse genetics has enabled the 
investigation of gene function in vivo.
One problem in generating a progressive disease phenotype within a mouse 
model is time span. A laboratory mouse lives on average for only two years, while 
disease onset with a typical CAG expansion of 40 repeats is around 40 years. The 
juvenile form of HD, which is caused by exceptionally long CAG repeats, provides 
the opportunity to produce models of HD that potentially express a phenotype within 
the lifespan of the mouse.
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Single cell models
The simplest of genetic model for Huntington’s disease has been produced using 
single cells. A whole host of such models have been produced and these have/will 
be discussed with their appropriate findings. Briefly, immortal cell lines are used for 
their relative inertness, for example human embryonic kidney cells or PC 12 cells. 
Inserts have included exon 1 fi-agments of human DNA, full length constructs of 
huntingtin and simple polyglutamine stretches. Repeats ranging from innocuous 15 
CAGs through to 150 have been used. Most commonly the cytomegalovirus (CMV) 
is used as the promoter to drive expression (for review see Jones, 2002).
Mutant huntingtin has also been expressed in single cell organisms. For 
example full-length huntingtin with 25, 47, 72 or 103 glutamine residues has been 
expressed in yeast (Krobitsch & Lindquist, 2000). Huntingtin was co-expressed with 
green fluorescent protein which was used to visualise aggregate formation. It was 
found that poIyQ repeat length highly correlated with aggregate formation such that 
the 103Q protein formed single large aggregates; the 25Q protein formed no 
aggregates; and the 72Q protein formed some aggregates while some protein 
remained non-aggregated (Krobitsch & Lindquist, 2000).
Flies and worms!
Several transgenic invertebrate models have been produced that contain ployQ tracts 
(see Bates & Benn, 2002 for review). Insertion into the finit fly Drosophila 
melanogaster has been the most successful, with constructs including A-terminal 
fragments of huntingtin (Jackson et al, 1998; Steffan et al, 2001) and simple polyQ
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tracts (Marsh et al, 2000) usually targeted to the eye (see figure 1.2.13). These 
models have a progressive phenotype, demonstrating aggregate formation, 
neurodegeneration, a behavioural phonotype and lethality. This model has proved 
usefiil in identifying genes that modify the phenotype indueed by the polyQ 
expansion and for a high-tum-over therapeutic screen.
The soil nematode Caenorhabditis elegans has been put to similar use to the 
Drosophila. A-terminal fragments of huntingtin with an expanded CAG repeat 
(Faber et al, 1999; Parker et al, 2001) or naked expanded polyQ repeats (two lines 
under the control of different promoters, Satyal et al, 2000) have been inserted into 
the C. elegans genome to produce worms with a modified phenotype. All four of 
these worms have shown cytoplasmic aggregates, an example of which can be seen 
in figure 1.2.13.
Due to their high turn over, both invertebrate models lend themselves 
particularly well to screens for potential interacting genes and drug therapies. 
Indeed, identified drugs are now entering phase III clinical trials (see Bates & 
Hockly, 2003). It should be remembered, however, that these models may have 
significantly different pathways involved in the regulation of and that may be 
perturbed by the HD mutation in man (Rubinsztein, 2002).
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Figure 1.2.13: Invertebrate models of HD. Top: C. elegans expressing green 
fluorescent protein-tagged Q19 {left) and Q82 {right) which is expressed in the body 
wall muscle cells. Expanded polyglutamine tracts result in the formation of 
aggregates (Adapted from Satyal et al, 2000.). Bottom: D. melanogaster ommatidia 
showing normal (wild-type) trapezoid arrangement with seven rhabdomeres {left). 
Expression of an expanded polyglutamine tract (Q108, right) results in large holes 
within the eye and only two rhabdomeres. (Adapted from Marsh et al, 2000.)
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Knock-out mice
Although these mice do not model the disease, knock-out of the mouse HD gene 
homologue Hdh has provided insight into the crucial developmental role of 
huntingtin. Knock-out mice have been generated independently by three separate 
groups (Duyao et al, 1995; Nasir et al, 1995; Zeitlin et al., 1995). In all three cases 
nullizygous (-/-) mouse embryos died at approximately embryonic day E7.5. In 
contrast, heterozyotes {Hdh!-) were indistinguishable from littermate controls 
(Duyao et al, 1995; Zeitlin et al, 1995), indicating that HD is not caused by a 
haploinsuffiency (Bates & Murphy, 2002). The fact that complete inactivation of the 
gene results in a non HD-like phenotype favours a gain of function model for the 
human condition. This theory is supported further by the fact that mutant huntingtin 
can rescue the lethality wrought by gene-knockout (White et a l , 1997).
The severity of the knock-out phenotype means that this is the extent of the 
information gained from this model.
1.2.7.3 Truncated construct models
The transgenic models of HD can be separated into two groups: Those expressing 
full length constructs of the mutant HD gene; and those expressing truncated 
constructs. The R6 line was the first and most studied transgenic model produced 
and falls into the truncated category. I shall concentrate largely on the R6 lines, 
firstly because of the large body of evidence based on these models and secondly, 
because this being the mouse used in the current study.
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R6 Unes
R6 mice carry a fragment of human DNA containing exon 1 of the HD gene under 
the control of the human promoter sequence (Mangiarini et al, 1996). The mice 
were created by microinjeetion of a 1.9 kb fragment from the 5’ end of the human 
HD gene. The fragment was composed of approximately 1 kb of the 5’ UTR 
promoter sequences, exon-1, including the CAG repeat and the first 262 bp of intron 
1. Five lines showed ubiquitous tissue expression at less than endogenous levels and 
three of these lines had an expanded CAG repeat. The R6/1 (116 repeats), R6/2 (144 
repeats) and R6/5 (128-156 repeats) lines each showed a progressive neurological 
phenotype, weight-loss and premature death, reminiscent of the human disorder. The 
other two lines that showed ubiquitous expression of huntingtin, Hdex6 and Hdex27, 
both have repeats within the normal human range and show no neurological 
phenotype.
R6/2
Of the lines that presented a neurological phenotype, the R6/2 line was considered 
the most interesting. This line most probably has three transgene integration sites, 
although two of these may have been silenced by deletions (Mangiarini et al, 1996). 
There is a relatively high expression of the transgene at 75 per cent of the 
endogenous levels.
At weaning R6/2 mice are indistinguishable from their normal littermates.
By the age of nine to eleven weeks, however, mutant mice start to display a 
progressively worsening phenotype (Mangiarini et al, 1996). Dyskinesia (in the
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form of limb clasping, see figure 1.2.14) in response to tail suspension is one of the 
first symptoms to manifest. Other components to the motor phenotype include a 
resting tremor that becomes worse under stress, choreic-like movements that may 
involve the whole body, stereotypic involuntary movements (e.g. repetitive stroking 
of the nose and face), mild ataxia and, as the phenotype progresses, epileptic seizure 
upon handling. The mutants are significantly underweight by 13 weeks (Carter et 
al, 1999) and die of unknown causes by 16 weeks. At this age mutant mice can 
weigh as little as 60% of their littermate controls. Their brains are consistently ~30% 
smaller than controls. The key phenotypes are summarised in figure 1.4.2, where 
they are compared to the R6/1 mouse.
Huntingtin is expressed in all regions of the R6/2 brain. Expression is 
particularly rich in cortical regions with the highest levels seen in layer V pyramidal 
cells (Meade et al, 2002). MSSNs of the striatum show moderate expression. 
Huntingtin has been shown to aggregate within the cytoplasm and nucleus of 
neuronal cells in the human condition (as discussed in section 1.2.4, DiFiglia et al, 
1997; Gutekunst et al, 2002). Similarly, aggregates have been reported within the 
R6/2 mouse line (Davies et al, 1997; Scherzinger et al, 1997). Their emergence is 
progressive and they appear in a prescribed sequence, appearing in the cortex and 
hippocampus before the striatum (Morton et al, 2000; Smith et al, 2001). Within 
the cortical mantle, inclusions appear in a minority of cells by 3.5 weeks, with layers 
II/III and IV showing more inclusions than layer V. By four weeks there is a 
dramatic increase, with between 60 and 85% of cells containing aggregates. At nine 
weeks nearly all neurones have inclusion (Meade et al, 2002). The progression of 
aggregate formation within the striatum follows a similar time scale (Meade et al.
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2002). Within the hippocampus inclusions appear in CAl before CA3 and the 
dentate gyrus, a pattern that is maintained even in slice culture (Smith et al, 2001).
A whole battery of tests, designed to assess the motor, behavioural and 
cognitive phenotype of the R6/2 line have been carried out. The mice show deficits 
in swimming and beam walking, poor performance on a rotarod, abnormal gait and 
reduced prepulse inhibition of an acoustic startle response (Carter et al, 1999).
One demonstration that this mouse line is cognitively impaired came fi*om a 
test of short-term memory, the T-maze. This test assesses alternation, based on the 
observation that rodents tend to spontaneously alternate pathways during exploration, 
maybe to optimise foraging (Dember & Fowler, 1958). The mice developed 
normally, showing no difference from littermates, however by five weeks, R6/2 mice 
made significantly fewer alternations than did their littermate controls. The mice 
could be encouraged to learn the process using visual cues (light and dark) and by 
nine weeks were exhibiting comparable alterations to that of littermates, indicating 
that the deficit was of short-term memory rather than visual deficits (Carter et al,
1999). A spatial learning version of the T-maze was carried out by alternating the 
start arm. In this form of the task mice have to use spatial cues to learn the position 
of the reward. Control animals learn within 10 trials, while R6/2 mice only solve the 
task at low levels (Carter et al, 1999).
Cognitive impairments within these mice have been confirmed in a test of 
spatial cognition, the Morris water maze (Morris, 1981). Initially mice at 7-8 weeks 
were tested and found to have slower escape latencies in a visual version of the test. 
In probe tests, the mutants spent significantly less time in the quadrant that 
previously contained the platform (Murphy et al, 1998; 2000). It was possible that 
the apparent impairment in learning could be attributed the motor deficit rather than
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an impairment in spatial learning per se. Nevertheless, the swim-path of the 
transgenics is clearly different than that of the littermate controls. As clearly shown 
in figure 1.2.14, the controls repeatedly return to the platform quadrant, while 
mutants swim in a more random path. The learning impairment was demonstrated to 
be real when similar experiments were repeated at an earlier stage and it was found 
that 3.5 week old mice also show an impairment in spatial learning, a time point 
before any motor deficits are apparent (Lione et al, 1999).
Non-apoptotic neurodegeneration has been reported within the cingulate 
cortex of the R6/2 line (Turmaine et al, 2000), although this is not detectable until 
long after an overt phenotype is established, suggesting that the behavioural 
phenotype is not a result of cell death, but rather neuronal dysfunction. As will be 
discussed in section 1.3, changes in synaptic plasticity are believed to underlie 
cognitive processes (Bliss & Collingridge, 1993). Indeed, impaired synaptic 
plasticity within the R6/2 line is widely reported (Levine et al, 1996; Murphy et al, 
1998; 2000; Cepeda et al, 2001; Klapstein et al, 2001; Vetter et al, 2003) 
suggesting that abnormalities in synaptic transmission and plasticity may underlie the 
changes in cognitive processing seen in humans with HD. Synaptic plasticity in the 
models of HD will be discussed in section 1.4.
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Figure 1.2.14: The R6/2 mouse. A, Hind-limb clasping. Wild-type littermates {left) 
show normal exploratory behaviour in response to tail suspension. In contrast, 
transgenic R6 mice show dyskinesia in the form of clasping. (Image from 
Mangiarini et al, 1996.). B, Development of hippocampal and cortical aggregates at 
3 weeks {top) and 7 weeks {bottom). (Adapted from Morton et al, 2000.) C, 
Cognitive impairments in the hippocampal-dependent test of spatial cognition, the 
Morris Water Maze. At three weeks of age both wild-type (o) and transgenic (•) 
mice show normal learning, expressed as a reduction in escape latencies for a visible 
platform. At 3.5 weeks, however, R6/2 mice show impairments in the hidden 
platform version of the water maze. Transgenics also show impairments upon 
reversal of the hidden platform quadrant (five weeks). (Adapted from Lione et al, 
1999.) D, Representative swim paths illustrating the impairment of spatial cognition 
during a probe test. Controls concentrate their search in the quadrant where the 
platform was placed during training, transgenic mice show a less focused swim path. 
(Adapted from Murphy et al, 2000.)
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R6/1
The R6/1 line was also interesting in that it showed a neurological phenotype similar 
to the human condition. Generally speaking, this strain is considered very similar to 
the R6/2 line, but importantly the phenotype is prolonged, with mice reaching end- 
stage at approximately fourteen months (see figure 1.4.2). The prolonged phenotype 
is likely to reflect the much lower expression levels of huntingtin in this line (31% of 
the endogenous levels, compared to 75% for the R6/2, Mangiarini et a l, 1996) more 
than the slightly lower CAG repeat length (116 and 156 in R6/1 and R6/2 
respectively); although, given the strong correlation between these two parameters, 
there is likely to be some interaction.
R6/1 mutant mice begin to demonstrate the limb-clasping trait at about 14-20 
weeks (Naver et al, 2003). By the age of 22 weeks the transgenic mice have a 
significantly lower body weight than littermates. At this age R6/1 mice also show 
impairments in motor performance, particularly in an open-field arena, where they 
show less locomotion (Naver et a l, 2003; Bolivar et al, 2004). They also show 
reduced levels of anxiety, as measured in the plus maze, where mutants show fewer 
entries into the arms overall and, moreover, less time in the closed arms (Naver et a l,
2003). R6/1 mice also show a higher rate of failures on the rotarod test, in an age 
dependent manner, compared to littermate controls (van Dellen et al, 2000). 
Furthermore, the onset of this motor impairment can be delayed by environmental 
enrichment (van Dellen et al, 2000; Glass et a l, 2004).
The only data available on cognitive testing within the R6/1 mouse model is 
within a thesis and some unpublished data that reports that barrel cortex-dependent 
discriminations, which require the mouse to distinguish two separate pathways using
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only its vibrissae, is impaired in mice as young as 10 weeks old (Mazarakis, 2003; 
Cybulska-Klosowicz et a l, 2004, unpublished data) before the onset of a motor 
phenotype.
171 lines
Another mouse model of HD that utilises a truncated gene construct is the N171 
model (Schilling et al, 1999; Luthi-Carter et al, 2000). This model expresses the 
first 171 amino acids of an A-terminally truncated huntingtin cDNA construct plus 
either 18 (N171-18Q), 44 (N171-44Q) or 82 (N171-82Q) glutamine residues. 
Expression is at lower than endogenous levels (10-20%) under the control of a mouse 
prion protein vector, which drives expression in almost all neurones within the CNS 
(Borchelt et al, 1996). Similar to the R6 line, these mice develop a progressive 
neurological phenotype. At birth transgenics are indistinguishable firom littermates, 
and develop apparently normally, but by two months the N171-82 mice fail to gain 
further weight. Mutant mice also start to show a resting tremor, hypokinesia, 
abnormal gait and hind limb clasping upon tail suspension and impairments on 
rotarod tests (Schilling et a l, 1999; 2001). Upon histological examination, neuronal 
intranuclear inclusions are clearly seen within the striatum, hippocampus and cortex 
of N171-82Q mice at end-stage (Schilling et al, 1999). The life-span of the N171- 
82Q mice is reduced, ranging between 16 and 52 weeks, which probably reflects the 
level of expression in different founder lines (Schilling et al, 1999).
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HD lines
One more transgenic mouse model using a truncated gene insert has been made, 
known as the HD line (Laforet et al, 2001). These mice express the TV-terminal one 
third of the human HD gene with either normal (CT18) or expanded (HD46 and 
HD 100) glutamine repeats. Expression of the transgene was under the control of the 
rat neurone specific enolase promoter, resulting in expression at less than that of 
native huntingtin. CT18 mice showed no neurological deficits, while from 3 months 
HD46 mice showed impairments in at least one of the tests used as assessment 
(clasping, rotarod, gait and activity); HD 100 mice showed impairments in all of these 
tests (Laforet et al, 2001). The phenotype is more benign than that of either the R6 
orNlVl models. Cortical and striatal neurones commonly had dysmorphic dendrites 
and showed cytoplasmic and nuclear accumulation of huntingtin. The degree of 
dysmorphic dendrites correlated well with the degree of neurological impairment.
Reversible model
An extremely interesting mouse model, in which the expression of mutant huntingtin 
can be reversed, has been produced. This conditional mouse model of HD was 
created by expressing exon 1 of the huntingtin gene under the control of a 
bidirectional tetO operator and the CMV promoter (Yamamoto et al, 2000). The 
transgene contained a CAG repeat of 94 in one direction and a y^-galactosidase (lacZ) 
reporter sequence in the other, thus allowing direct confirmation of the protein 
expression. The HD94 mice were then crossed with mice expressing the tetracycline
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regulated transactivator under the control of the CaMKII promoter, which is 
necessary for the transcription of the tetO/CMV promoter.
Quantitative analysis of expression levels were not reported, although the 
protein is present within the striatum, hippocampus, cortex and, to a lesser extent, the 
amygdala and hypothalamus, but not within the cerebellum. Double transgenics 
displayed a clasping phenotype as early as four weeks and by 20 weeks a mild tremor 
was apparent. By 36 weeks these mice become hypokinetic. Double transgenics 
have a similar life span to wild types (two years). Nuclear aggregates become 
apparent by eight weeks. By 18 weeks brains of the double transgenic mice are 
consistently smaller than age-matched controls and there is distinct enlargement of 
the ventricles. Furthermore there was a decrease in Di dopamine receptor binding 
within the striatum (Yamamoto et al, 2000).
At 18 weeks of age, half the mice were given doxycyclin, which binds to the 
tetracycline regulated transactivator and silences the gene expression (“gene-off’). 
Remarkably the gene-off group then go on to recover from the HD-like symptoms. 
They no longer display clasping and brain atrophy is halted. Inclusions within the 
cortex show a reduction and even completely disappear within the striatum. The 
reduction in D% dopamine receptor binding is also slightly reversed (Yamamoto et 
al, 2000).
This model is important as it reveals that the progression of the disease is 
highly dependent on the continuous expression of the mutant protein and raises the 
hope that the disease may indeed be reversible, if not curable.
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Rat model
More recently a rat model of HD carrying a truncated cDNA construct has been 
reported (von Horsten et al, 2003). The cDNA was formed from a 1962 bp 
fragment of HD gene obtained from a patient carrying 51 CAG repeats. The 
fragment is under the control of 855 bp of the endogenous rat promoter and is 
expressed at much lower levels than native huntingtin (values not available) in all 
tissues examined (von Horsten et al, 2003). Transgenic rats showed only a subtle 
motor phenotype: Dyskinetic and opisthotonos-like movements of the head. No 
tremor, ataxia, clasping or seizures were observed. They also show a lower gain in 
body weight than their littermates and, at 24 months, both males and females were 
20% lighter. The transgenic rats started to die at around 15 months, although many 
survived well beyond the 24 months of the study.
While there were few motor abnormalities observed on home cage behaviour, 
specific behavioural tests did reveal deficits. At five months, rotarod activity 
revealed little difference from littermates. By 10 and 15 months, however, 
impairments in hind- and fore-limb coordination and balance were apparent.
Anxiety levels were found to be reduced as early as two months, as shown by rats 
spending more time in the open arms of an elevated plus maze (von Horsten et a l, 
2003).
A clear cognitive decline was highlighted. Ten month old rats showed a poor 
performance on the spatial learning test of working memory, the radial maze (von 
Horsten a/., 2003).
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Aggregate formation was apparent, particularly in the striatum, both within 
the neuropil and the nucleus. Aggregates were observed in 12,18 and 24 month old 
rats, but not 1 or 6 month old.
One of the advantages of the rat model is its size. Being larger than mice, 
this model lends itself to magnetic resonance imaging, which has revealed 
progressive enlargements of the lateral ventricles and focal lesions of the striatum 
(von Horsten et a l, 2003).
1.2.7.4 Full-length construct models
Two mouse models of HD have been produced that express the entire human 
huntingtin gene. Both mice demonstrate symptoms reminiscent of the human 
condition.
cDNA lines
The first full length model was created by microinjeetion of a 15 kb cDNA construct 
of the human gene that includes 10, 179 bp of HD cDNA that has been modified to 
include either 16, 48 or 89 CAG repeats (Reddy et a l, 1998; 1999). The promoter 
used to express the gene was the CMV in conjunction with an SV40 enhancer, 
resulting in high level expression at endogenous to five-fold endogenous levels. The 
protein was expressed in all tissues examined, including the brain, heart, spleen, 
kidney and gonads (Reddy et al, 1998).
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A progressive neurological phenotype developed in both the HD48 and HD89 
lines. Similar to the truncated mouse models, the first phenotype to manifest was a 
limb clasp at eight weeks of age. The mice then progress through a hyperactive 
phase (characterised by unidirectional rotations, back flips and excessive grooming), 
followed by hypokinetic and then akinetic phases as the mice near to end-stage.
Degenerating neurones were observed in the striatum, cortex and 
hippocampus of both the mice carrying expanded repeats (Reddy et a l, 1998). 
Neurodegeneration was evident in mice in the hypokinetic and akinetic stages, but 
not before. Within the cortex, layer V pyramidal cells and, to a lesser extent, 
neurones of layers II, III and IV, undergo cell death (Reddy et a l, 1999) possibly 
though an apoptotic process (Reddy et al, 1998). Inclusions were apparent in 
striatal, cortical, hippocampal and thalamic neurones of HD48 and HD89 mice from 
12 weeks and throughout the hypo- and a-kinetic stages. Inclusions were also 
observed within the Purkinje cells of the cerebellum, but as in the human condition 
and other mouse models, Purkinje cells are relatively spared in this mouse.
The extremely high levels of expression calls into question the physiological 
relevance of this model as the true effects of the mutant gene may be masked.
YAC lines
A second full length model was achieved by the introduction of a human yeast 
artificial chromosome (YAC), containing 18, 46 or 72 (Hodgson et a l, 1999) and 
128 (Slow et al, 2003) glutamines into mice. The gene was under the control of its 
own promoter. Several lines were produced that carried 72 Qs. One mouse 
expressed the protein at three times the level of endogenous huntingtin (no line was
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established). This mouse showed a neurological phenotype by 9 months, which 
included hyperkinesia (circling, similar to that seen in the cDNA lines), gait ataxia 
and foot clasping. When this mouse was sacrificed at 12 months there was a 50% 
reduction in body weight compared to wild-type controls and clear 
neurodegeneration and inclusions, particularly within the striatum, were detectable.
Another YAC72 mouse was able to be used as a founder to establish a 
breeding line. Mice fi*om this line expressed protein at a much lower level (between 
one third and one half of endogenous levels). They showed no neurological 
phenotype and there was no evidence of aggregate formation. Despite the lack of an 
overt phenotype, there were electrophysiological abnormalities (Hodgson et a l, 
1999) and these will be discussed in section 1.4.
The YAC128 line, produced in 2003 (Slow et al), shows a similar 
behavioural phenotype to the more aggressive YAC72 line reported by the same 
group (Hodgson et al, 1999), including a hyperactive phase followed by motor 
deficits and finally hypokinesia. The line that showed highest huntingtin protein 
expression (at 75% of the endogenous levels) was characterised further. Brain 
weight is significantly decreased compared to wild-type littermates at 9 and 12 
months, but not at 6 months. More specifically striatal volume was decreased by 9 
months and cortical volume by 12 months. Regarding aggregate formation, no clear 
inclusions were observed under light microscopy, however immuno-gold labelling 
for electron-microscopy did reveal small clusters of protein within the cytoplasm of 
striatal neurones from 12 month old mice. The motor deficit is correlated with the 
loss of striatal neurones, which show a trend towards loss at 9 months and are 
significantly reduced by 12 months.
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1.2.7.5 Knock-in mice
The so called knock-in approach utilises gene-targeting to replace the sequence in 
exon 1 of the Hdh gene ((CAG)2CAA(CAG)4) with a CAG repeat within the 
pathological range in humans. Five such lines have been generated to date (see Bates 
& Murphy, 2002; Menalled & Chesselet, 2002; and Rubinsztein, 2002 for reviews). 
In two of the mice the sequence in the Hdh gene was directly replaced by a stretch of 
72-80 (Shelboume et a l, 1999) and 80 or 150 (Lin et al, 2001) glutamine repeats.
In the other three mice a hybrid gene, in which exon 1 of the mouse gene was 
replaced by exon 1 of the human gene carrying an expanded CAG repeat, was used. 
One of these mice has repeats of 20, 50, 92 and 111 Qs (Wheeler et a l, 1999), 
another has either 73 or 96 repeats (Levine et al, 1999) and the last one has 79 
glutamines (Ishiguro et a l, 2001). (It should be remembered that the number of 
glutamine repeats is two more than the number of CAG repeats due to the CAG 
stretch being followed by a CAA, CAG sequence (Huntington's Disease 
Collaborative Research Group, 1993); CAA also encodes glutamine.) By the nature 
of gene-targeting, the knock-in gene is under the control of the mouse promoter and 
therefore the gene is expressed in the context of the mouse gene.
Initially these mice appeared rather disappointing, with no overt neurological 
phenotype within the lifespan of the mice. With the exception of increased male 
aggression in the Shelboume mouse (1999) (which is not likely to be a consequence 
of the mutant huntingtin gene, as this trait has not been reported in any of the other 
genetic mouse models of HD), the only neurological phenotype reported has been in 
the 150Q mouse which showed some limb clasping and gait abnormalities at 25 
weeks of age (Lin et al, 2001). Four of the five models show nuclear staining and
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micro-aggregates (all except Levine et al, 1999), while only one shows distinct 
inclusions (Lin eT fl/., 2001).
Despite the lack of an overt phenotype, there are molecular and cellular 
alterations within these mice. For example a decrease in the levels of mRNA for 
encephalin within the striatum of the 73Q and 96Q mice (Menalled et a l, 2000) and 
an increased sensitivity to NMDA within these same mice (Levine et a l, 1999) has 
been reported. Length-dependent CAG repeat instability has been reported in 
gametes of the Wheeler et al mouse (1999) and within somatic cells in the Ishiguro et 
al mouse (2001) including the liver, kidney, stomach and brain, but not cerebellum. 
The 11 IQ mouse reported by Wheeler et al has also shown to have an enhanced 
susceptibility to the mitochondrial complex II inhibitor 3-NP. Treating these mice 
with 3-NP leads to a greater degree of neuronal cell death within the striatum 
compared to wild-types (Ruan et al, 2004).
The success of the transgenic and knock-in models of HD has meant that 
many new insights into the disease have been possible. Importantly, the generation 
of rodent models that exhibit a progressive phenotype similar to that of HD, 
including a cognitive impairment, has enabled electrophysiological studies, which 
would otherwise be impossible. Electrophysiological studies within these mouse 
models of HD will be discussed in section 1.4.
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1.2.8 Summary
Huntington’s disease is a devastating neurodegenerative disorder caused by an 
expansion in the CAG repeat in the gene encoding the protein huntingtin. HD has 
traditionally been considered a disease starting in midlife, characterised by motor and 
psychiatric symptoms and, on post-mortem examination, associated with marked 
neurodegenerative changes. It has now become apparent that prior to classical 
symptoms there are subtle cognitive deficits, particularly of recognition memory. 
Transgenic mouse models of HD have recently been generated. These mice show a 
phenotype similar to the human syndrome, including early cognitive deficits 
preceding an overt motor phenotype, suggesting that mouse models of HD may 
provide an appropriate experimental tool for examining changes in cognitive 
processing in presymptomatic HD. Learning and memory processes are thought to 
be encoded by plastic changes in the neural circuitry (Bliss & Collingridge, 1993). It 
is possible, therefore, that the early change in cognitive fimction in HD is attributable 
to alterations in synaptic plasticity. In order to explore changes in synaptic plasticity 
within these mouse models the next chapter will discus the mechanisms involved in 
normal synaptic plasticity.
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1.3 Synaptic plasticity
The cellular processes involved in learning and memory are not fully understood, but 
it is widely held that long-term changes in the efficacy of synaptic-transmission 
within the central nervous system are involved. Both long-term increases and 
decreases in synaptic-transmission have been identified and are believed to have 
varying importance in different brain regions. Many of the mechanisms involved in 
inducing and expressing these plastic changes have been elucidated, particularly in 
the hippocampus, but also in other cortical and subcortical regions. The following 
chapter will explore some of the mechanism involved in these changes in order to 
understand how these may be altered in Huntington's disease.
1.3.1 A brief history of neuroscience
1.3.1.1 The brain and cognition
Today it is well established that the brain is the seat of cognitive function, however 
this was not always thought to be the case. Both the ancient Egyptians and Greeks 
held the notion that the primary organ of mental function was not the brain but rather 
the heart (Aristotle, c350 B.C.-a & c); the brain was thought to counterpoise the heart 
by cooling the blood (Aristotle, c350 B.C.-b). Hippocrates questioned this by stating 
that “Men ought to know that from nothing else but the brain comes... joys, delights, 
sorrows, griefs, despondency [and] in an especial manner, we acquire wisdom and 
knowledge...” (Hippocrates, c400 B.C.). During the Roman period it was proposed 
by the Greek physician Galen that the brain transforms sensory information or “vital
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spirits” into psychic pneuma, or “animals spirits” and that these animal spirits are 
carried throughout the body by the nerves, which were thought to be hollow tubes 
(Galenus, cl 80 A.D.). Many of the ideas proposed by Galen endured well into the 
nineteenth century, when it was still believed that the nervous system was made up 
of a continuous network of nerves and that nerve growth was responsible for the 
formation and storage of memories. By the end of the century however, this view 
was challenged and it was suggested that the brain is in fact made up of separate 
elements, not in anatomical connection (Waldeyer-Hartz, 1891). Waldeyer termed 
these elements ‘neurones’ and thereby proposed the ‘neurone theory’. Support for 
the neurone theory came soon after from the pioneering Spanish anatomist Santiago 
Ramon y Cajal, who, using the silver nitrate stain developed by Camillo Golgi 
(1873), demonstrated that the central nervous system is indeed made up of 
discontinuous elements- the neurones (Cajal, 1894). Furthermore, Cajal also showed 
that mature brain cells can no longer undergo cell division and rebirth, thereby 
eliminating this as the process by which learning and memory is encoded. (It should 
be noted that recent evidence shows that neurogenesis occurs throughout life, see van 
Praag et al., 2002.) Based on these findings, Cajal suggested that the connections 
between the neurones may undergo modification and that these modifications may be 
part of the process of learning and memory. These neuronal connections were later 
characterised as specialised chemical junctions and were termed ‘synapses’ by the 
British physiologist. Sir Charles Sherrington (1897).
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1.3.1.2 Hebb’s postulate
The concept that learning could occur by changes at chemical synapses was 
popularised during the first part of the 20^  ^century. In 1949 the Canadian Donald 
Hebb published a theoretical model of how the efficiency of transmission could be 
changed in an activity-dependent manner. In the virtual absence of any experimental 
evidence Hebb postulated that:
'‘'‘When an axon of cell A is near enough to excite a cell B and repeatedly or 
persistently takes part in firing it, some growth process or metabolic change takes 
place in one or both cells such that A ’s efficiency, as one of the cells firing B, is 
increased"'QAéyh, \9A9)
This statement could be reworded to say that the association of activity in pre- and 
post-synaptic neurones induces some change to bring about a strengthening in 
synaptic transmission. Evidence for this proposal was not found until the 1970s 
when an activity-dependent, long-lasting increase in synaptic efficacy was identified 
(see below). Increases in synaptic efficacy are now widely held to be the mechanism 
by which information is encoded within a neural network (Bliss & Collingridge, 
1993).
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1.3.1.3 Behavioural correlates of synaptic plasticity
Evidence that changes in synaptic transmission may be involved in learning and 
memory had previously been reported. The first of these studies was carried out by 
Sherrington (1898) who studied non-declarative (implicit) forms of learning. Non­
declarative memories are those that do not require conscious recall. Sherrington 
showed that stimulation of the cats paw results in a reflex withdrawal of that limb. 
Following repetitive stimulation, however, the reflex withdrawal decreases, an 
observation called ‘habituation’. Habituation has been shown to involve a reduction 
in the underlying postsynaptic potential (PSP) recorded in the motor neurone 
(Thompson & Spencer, 1966), suggesting that a reduction in synaptic transmission is 
responsible. This system was, however, too complex to dissect the precise synaptic 
mechanism.
In contrast to the cat, which contains several million neurones, the marine 
snail Aplysia californica has approximately 20, 000, making it a much simpler 
system. The Aplysia demonstrates habituation of the reflexive siphon withdrawal 
following repetitive stimulation. Habituation is homosynaptic and involves a 
decrease in the release of excitatory neurotransmitter, glutamate, from the 
presynaptic terminal, resulting in a smaller PSP in the motor neurones controlling the 
siphon (see Kandel & Schwartz, 1982; Abrams, 1994a, b).
Conversely, ûiQ Aplysia withdrawal reflex can be increased in another form 
of non-associative learning called ‘sensitisation’. Following exposure to a single, but 
powerful noxious stimulus (for example a strong stimulus to the tail), subsequent 
stimulation of the siphon results in a heightened withdrawal. This is mediated by a
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heterosynaptic mechanism that activates facilitatory intemeurones that contain 
5-hydroxytryptamine (5-HT; serotonin). The release of 5-HT activates G protein- 
coupled receptors located on presynaptic terminals of the sensory neurones. 
Activation of these receptors increases adenylyl cyclase activity and generates cyclic 
3’,5’-adenosine monophosphate. One target of cAMP is protein kinase A (PKA) 
which phosphorylates a variety of proteins, including potassium channels. Potassium 
channel phosphorylation causes them to close, thereby decreasing potassium ion 
efflux and thus broadens the action potential. A broader action potential results in 
greater calcium influx into the presynaptic terminal affecting greater neurotransmitter 
release (reviewed in Kandel & Schwartz, 1982; Abrams, 1994a, b).
The non-associative forms of learning are so called because they involve the 
activation of only one synaptic input at a time. In contrast, classical conditioning 
involves the simultaneous activity of two sets of synapses i.e. an associative form of 
learning. Associative learning is an example of “Hebbian” learning and the best 
known example of this was described by Ivan Pavlov (1927). Pavlov presented dogs 
with food (unconditioned stimulus; US), causing a salivary response. The 
presentation of a neutral stimulus (conditioned stimulus; CS), for example the sound 
of a metronome, did not cause salivation. Following training, consisting of repetitive 
pairing of the US and the CS, the sound of the metronome alone was able to elicit 
salivation. This shows that the dogs can learn to associate the metronome with the 
presentation of food. Importantly the interval between the CS and US was a critical 
factor such that the CS must precede the US by 300-500 ms otherwise pairing was 
ineffective.
Classical conditioning has also been demonstrated in ihQ Aplysia and the 
mechanisms underlying this implicit learning has been identified. Associative
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learning was achieved by pairing tail stimulation (US) with simultaneous stimulation 
of the siphon (CS), resulting in an enhanced withdrawal reflex. Repeated CS 
application resulted in increased calcium levels in the presynaptic terminal, leading 
to activation of a calcium-dependent adenylyl cyclase and thus enhanced production 
of cAMP produced by the US. In this way cAMP acts as a coincidence detector 
where the US and CS pathways converge (for review see Kandel & Schwartz, 1982; 
Abrams, 1994a, b).
Although the mechanisms involved in implicit learning in the relatively 
simple model of the Aplysia was readily identifiable, the ultimate goal was to 
identify synaptic mechanisms involved in the more complex mammalian brain. 
Mammals have explicit (declarative) forms of memories, which involve a conscious 
recall.
1.3.1.4 The hippocampus and long-term potentiation
The first direct evidence for Hebbian synapses in mammals came in the 1970s, when 
it was reported that activity dependent and enduring increases in synaptic efficacy 
could be induced in a region of the medial temporal lobe called the hippocampus 
(Lomo, 1966; Bliss & Lomo, 1973; Bliss & Gardner-Medwin, 1973). This 
experimentally-induced phenomenon of long-lasting synaptic enhancement has since 
been termed long-term potentiation (LTP). LTP and its counterpart long-term 
depression (LTD) are now the leading models for the synaptic and cellular processes 
underlying learning and memory (for review see Bliss & Collingridge, 1993; Bear, 
1999).
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Why the hippocampus?
Evidence from human studies has shown that the hippocampus is important in the 
processing of episodic memory (the memory of places and events). This role was 
realised when a patient, called H. M. for anonymity, had part of his temporal lobe, 
including the hippocampus, bilaterally removed as a treatment for intractable 
epilepsy. Following surgery, H. M. no longer suffered epilepsy, but was unable to 
recall events two years prior to and events following the surgery. H. M. was, 
however, able to recall distant events (Scolville & Milner, 1957). This type of 
memory loss is known as anteriograde amnesia and similar memory deficits can be 
induced in primates following hippocampal lesions (Mishkin, 1978).
Another benefit of using the hippocampus for the study of neural correlates of 
memory is its relatively simple, laminate structure (figure 1.3.1). The hippocampus 
comprises a trisynaptic circuitry, receiving inputs from the entorhinal cortex via the 
perforant pathway, which synapses onto granule cells of the dentate region. The 
mossy fibres of the granule cells project to the CA3 region where they form synapses 
with pyramidal cells. The efferents of these cells are known as the Schaffer 
collaterals and synapse with CAl pyramidal cells. The simple circuitry and laminate 
structure means that the sinks and sources are known and that monosynaptic 
responses can be recorded in response to electrical stimulation.
The hippocampus, therefore, provides a system where memories are known 
to be processed and also possesses a simple architecture giving rise to easily 
interpretable synaptic currents.
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Figure 1.3.1: The human hippocampus. Left, Lateral view of the human cerebral 
mantle. The temporal lobe has been dissected to reveal the underlying hippocampus. 
(Adapted from Gray, 1918.) Right, Transverse section of the human hippocampus. 
The simple laminar structure of the hippocampus is clear, created by distinct cell 
body layers and their dendrites. A, alveus; CAl-4, fields of cornu ammonis; DG, 
dentate gyrus; EC, entorhinal cortex; F, fimbria; S, subiculum. (Adapted from Cajal, 
1901.)
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Long-term potentiation
Evidence for Hebb’s postulate that a lasting enhancement in synaptic activity would 
occur following coincident activity at pre- and postsynaptic cells finally came in the 
early 1970s. Bliss and co-workers described a long-lasting potentiation of synaptic 
transmission in the dentate area of the anaesthetised (Bliss & Lomo, 1973) and 
unanaesthetised (Bliss & Gardner-Medwin, 1973) rabbit following high-frequency 
stimulation of the perforant pathway. The conditioning paradigm used to induce 
LTP was based on the preliminary work on frequency potentiation by Teije Lomo 
that demonstrated an increased level of neuronal firing during and shortly after 
repetitive stimulation (Lomo, 1966). Such a conditioning stimulus is used to mimic 
neuronal activity during a learning event. A relatively low-frequency (10-15 Hz; cf. 
the 100 Hz often used today) conditioning stimulus, applied for several seconds, 
resulted in a series of events including post-tetanic potentiation and a period of 
depression which was followed by potentiation lasting up to ten hours in the 
anaesthetised animal and up to 16 weeks in the unanaesthetised animal. Furthermore 
a control pathway, which did not receive any conditioning stimuli, did not show 
potentiation. Here was a model that was not only long-lasting, but was also pathway 
specific, making it an attractive model for processes underlying memory. The phrase 
“Long-Term Potentiation” was coined in 1975 following a replication of the Bliss 
and Gardner-Medwin experiments within the rat by Douglas and Goddard (1975).
To induce LTP they used a much higher frequency conditioning stimulus than that 
used by Bliss and colleagues. This high frequency stimulation (200-400 Hz) was 
thought to mimic the actions of central neurones more closely than the 10-15 Hz 
used in the earlier experiments and was found to more reliably induce LTP.
109
Brain slices
The initial studies on LTP were carried out using in vivo recording techniques. 
Although such recording may be related closely to events that occur within the brain, 
there are associated problems with this technique, in particular that of availability to 
laboratories. In vivo recording requires suitable equipment for monitoring animal 
health and having to maintain animals with implanted electrodes is costly and 
(arguably) stressful to the animal. Chronically implanted electrodes may also lead to 
gliosis around the site, calling into question the credibility of results. Similarly, 
movement of electrodes can occur over time, causing changes in responses.
A technique that made studying synaptic plasticity far more readily available 
to many laboratories was the in vitro slice. In the mid 1960s it was shown that slices 
of piriform cortex, taken from the guinea-pig, can be kept alive by submerging them 
in an oxygenated glucose-saline medium within a recording bath. The responses 
recorded were found to be similar to those obtained in vivo (Yamamoto & Mcllwain, 
1966). The in vitro slice technique has proved successful in other brain regions, 
including the hippocampus (Skrede & Westgaard, 1971), thus allowing this relatively 
simple structure to be studied without the need of maintaining animals with 
implanted electrodes. Furthermore, by using slices, the simplicity of the preparation 
can be kept to a minimum by isolating only the area of interest. A slice preparation 
also allows rapid application of pharmacological agents, whereas administration of 
these agents to intact animals can have added complications, such as metabolism 
effects or damage by canulation.
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The first demonstration of LTP in the in vitro hippocampal slice came in 
1975, showing a large potentiation of the pop-spike, recorded within CAl, following 
high-frequency stimulation (Schwartzkroin & Wester, 1975).
1.3.1.5 LTP: A neural correlate for memory?
Following the discovery of long-term potentiation several questions arose, the most 
pertinent, perhaps, being “Is it real?”. Quite clearly this matter had to be addressed. 
In order for LTP (and long-term depression) to be fully established as a mechanism 
for learning and memory four criteria have been proposed (Martin & Morris, 2002):
(i) DETECTABILITY: Any changes in synaptic weights should be 
detectable following learning.
(ii) ANTEROGRADE ALTERATION: Altering the mechanisms of 
induction and/or expression of synaptic plasticity should also alter the 
ability to learn.
(iii) RETROGRADE ALTERATION: Altering the pattern of synaptic 
weighting following a learning experience ought to affect the ability 
for the animal to remember that previous learning event.
(iv) MIMICRY : A learning event could be mimicked by altering the 
appropriate synaptic weights, making the animal behave as though it 
had leamt.
Three of these criteria have, at least partially, been met, while the last (and 
perhaps the most fanciful of them), the ability to create a memory, has yet to be 
achieved. For a full review of the evidence for each of the criteria see the reviews by 
Martin and Morris (2000; 2002; 2003).
I l l
Many studies have been carried out to identify synaptic changes following 
learning. The clearest evidence for an LTP-like phenomenon following learning is 
within the primary motor cortex. Rats were trained to retrieve food from a small 
hole in a plastic box using their preferred paw. Following several days training 
motor cortical slices were prepared from both ipsilateral and contralateral 
hemispheres. Synaptic responses recorded from the contralateral side were 
consistently larger than those from the ipsilateral side in slices from trained rats. No 
differences were detectable between hemispheres in slices obtained from untrained 
animals (Rioult-Pedotti et a l, 1998). Furthermore, the capacity for LTP induction 
was reduced in rats that had undergone motor training (Rioult-Pedotti et a l, 2000). 
Similarly hippocampal-dependent learning tasks have been shown to increase EPSP 
size (Sacchetti et a l, 2001) and occluded further induction of LTP (Sacchetti et al, 
2002). These data suggest that LTP and learning may share common mechanisms.
Evidence that interference of the mechanisms of LTP induction affects 
learning and memory (anterograde alteration) largely arises from tests to assess 
spatial memory. The first was work within the watermaze developed by Richard 
Morris in the early 1980s (Morris, 1981; 1982). The watermaze is a learning task 
where a rat or mouse learns the location of a hidden platform within a pool of water. 
Once the platform has been removed, the animal’s ability to remember the platform 
location is assessed by its swim path. The ability to succeed in this learning task is 
dependent upon the hippocampus, as demonstrated by the fact that lesions of this 
brain region severely impair an animal’s ability to perform within the watermaze 
(Morris et a l, 1982). The NMD A receptor antagonist, AP5, previously 
demonstrated to block hippocampal LTP induction (Collingridge et a l, 1983b, see 
section 1.3.2), also impairs hippocampal-dependent place navigation in the water-
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maze (Morris et a l, 1986). Secondly, prior electrophysiological saturation of LTP 
impairs subsequent, but not established, spatial learning (McNaughton et a l, 1986). 
Since these initial experiments, several independent research groups have 
demonstrated similar findings (e.g. see Moser et a l, 1998), supporting the idea that 
interfering with the induction of synaptic plasticity does indeed impair learning.
McNaughton (1986) also demonstrated that retrograde disruption, by high- 
frequency stimulation, was possible for recently leamt locations, but not established 
ones. Similar reports have since confirmed these findings and shown also that rats 
can subsequently learn new locations (Otnæss et al, 1999; Bmn et a l, 2001).
Attempts to mimic learning by inducing LTP have yet to prove successful. 
One approach was to try to mimic the activity within the neuronal circuitry and 
thereby replicate learning. A pattern of electrical stimuli, applied to the lateral 
olfactory tract, was used in an attempt to recreate odour sniffing in rats and thereby 
make rats “think” they had leamt (Roman et al, 1987). Indeed, it was found that 
stimulation of the lateral olfactory tract can be substituted for real odours in an 
olfactory discrimination task. Long-term potentiation was not, however, detected in 
these rats (Roman et al, 1987), but it was realised that the pattem of stimulation used 
in attempting to create the memories closely resembled the natural rhythmic activity 
of neuronal outputs seen within the hippocampus, known as theta rhythms (see 
Lynch, 2003). The pattem of stimulation was therefore renamed Theta Burst 
Stimulation (TBS) and has been shown to induce a robust form of LTP (Larson & 
Lynch, 1986).
In light of these results LTP appears as a very attractive candidate as the 
cellular mechanism underlying leaming and memory processes.
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1.3.1.6 Properties of LTP
By definition, LTP is long-lasting. The initial reports by Bliss et a l demonstrated 
LTP lasting for hours in the anaesthetised animal (Bliss & Lomo, 1973) and up to 16 
weeks in the unanaesthetised animal (Bliss & Gardner-Medwin, 1973). Since these 
initial reports LTP has been shown to be extremely stable and has been found to last 
for over one year in the rat dentate gyrus (Abraham et a l , 2002).
LTP is often quoted as having three basic properties: Cooperativity, 
associativity and input specificity (Bliss & Collingridge, 1993). Somewhat 
confusingly, however, both cooperativity and associativity describe the same 
phenomenon; the two names have arisen fi*om groups presenting the same findings, 
achieved using different stimulation paradigms (see McNaughton, 2003). 
Associativity/cooperativity describes how a weak input, at a subthreshold level for 
LTP induction, can be potentiated if it is active at the same time as other inputs, thus 
bringing that input above threshold (McNaughton et al, 1978; Levy & Steward, 
1979). LTP is also considered input-specific, in that synapses that are not active at 
the time of induction are (generally) not potentiated (Bliss & Lomo, 1973; Andersen 
et a l, 1977; Lynch et al, 1977; but see Bradler & Barrionuevo, 1989).
Another characteristic of LTP is its reversibility. Previously potentiated 
synaptic responses can consequently be reduced by the application of a low- 
frequency conditioning paradigm, a phenomenon known as depotentiation 
(Barrionuevo et al, 1980; Staubli & Lynch, 1990; Fujii et a/., 1991; Milner et al, 
2004b). This has been suggested as being a mechanism by which synapses can be 
“reset” (Dudek & Bear, 1993) thereby preventing saturation. The properties of LTP 
are shown in figure 1.3.2.
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Figure 1.3.2: The properties of LTP. A. Simplified diagram of the rodent 
hippocampus. Test-shocks applied to independent perforant pathway (PP) inputs (SI 
and S2) gives rise to EPSPs. DG, dentate gyrus; mf, mossy fibres; Sub, subieulum.
B. The first demonstration of LTP as shown in the anesthetised rabbit dentate area. 
Following tetanus (arrows) to the SI pathway (•), that pathway demonstrates LTP, 
while the control pathway (S2; O), which receives no conditioning, remains at 
baseline, demonstrating input-specifieity. (A & B adapted from Bliss & Lomo,
1973.) C. Cooperativity. A weak tetanus (L) applied to SI induces a large increase 
in EPSP amplitude, but is only transient. Co-applieation of a strong tetanus (H) to S2 
at the same time as a weak tetanus to S1 induces a long-lasting potentiation in the S1 
pathway (Adapted from McNaughton, 2003.) D. Bi-directional plasticity.
Application of a low-frequency conditioning paradigm (solid bar) leads to the 
induction of long-term depression (see section 1.3.3). Application of a high- 
frequency conditioning paradigm subsequently induces LTP. LTP can then be 
reversed using further low-frequency stimulation, resulting in depotentiation. 
(Adapted from Milner et al, 2004b)
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1.3.2.7 Short-term plasticity
While long-term synaptic plasticity is likely to underlie cognitive functions and 
memory storage, there are also short-term forms of synaptic plasticity. One example 
of this is facilitation, which describes how, following a single synaptic event, 
excitatory synapses remain in a state that allows more neurotransmitter release. 
However, this only lasts for a short period, of around a hundred milliseconds (Feng, 
1941). Application of a short burst of stimulation leads to a marked increase in 
synaptic transmitter release that lasts up to a few seconds following the tetanus. This 
was first reported by Cragg & Hamlyn (1955) and later termed augmentation by 
Magleby (Magleby & Zengel, 1976). Post-tetanic potentiation (PTP) describes the 
increase in neurotransmitter release that lasts for minutes following a period of high- 
frequency synaptic activity (Feng, 1941) and, prior to the identification of LTP, was 
the main player for the mechanism underlying leaming in such areas as the spinal 
cord (Eccles, 1953).
While these mechanisms may be involved in physiological functions at the 
synapse, they are far too transitory a mechanism for the long-term storage of 
information.
1.3.2 Mechanisms of LTP induction
LTP is usually induced experimentally by applying a high frequency stimulation 
paradigm to the afferent neurones. Three paradigms are commonly used. Tetanus 
(e.g. 100 stimuli at 100 Hz), theta-burst stimulation (e.g. several bursts of four
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stimuli at 100 Hz delivered at an inter-burst interval of 200 ms) and primed-burst 
stimulation (e.g. a single priming stimulus followed at 200 ms by a single burst of 
four shocks at 100 Hz) (Bliss & Collingridge, 1993). The significance of these 
paradigms is that they mimic learning-related neuronal firing patterns seen within the 
hippocampus during leaming (Otto et a l,\9 9 \).
1.3.2.1 The glutamatergic synapse
In order to discuss the mechanisms involved in the induction of LTP, the structure 
and function of the central synapse under basal transmission needs to be considered. 
L-glutamate is known to be the most common excitatory neurotransmitter within the 
central nervous system (Collingridge et al, 1983b). Glutamate, released from the 
presynaptic terminal, diffuses across the synaptic cleft where it activates a range of 
glutamate receptors. The main post-synaptic receptor activated is a ligand gated ion 
channel, known as the a-amino-3-hydroxy-5-methyl-4-isoazolepropionate (AMPA) 
class of glutamate receptors. There are four mRNA transcripts (GluRl-4) that give 
rise to AMPA receptor subunits (Gasic & Hollmann, 1992). Splice variants of these 
transcripts then form tetrameric transmembrane proteins with an intracellular 
carboxy terminal and an extracellular amino terminal. AMPA receptors are of the 
ionotropic type of receptor and are predominantly permeable to sodium (influx) and 
potassium (efflux). AMPA receptors that lack the GluR2 subunit are also, to a 
degree, permeable to calcium ions (Gasic & Hollmann, 1992). Kainate receptors are 
also present at the synapse and, like AMPA receptors, are principally permeable to 
sodium ions. KA receptors are comprised of the subunits GluR5-7 and KA-1 and 2
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(Chittajallu et a l , 1999). AMPA/KA receptors are the main mediators of the 
postsynaptic response, known as an excitatory postsynaptic potential (EPSP). 
Blockade of these receptors by the AMPA/KA receptor antagonist 6-cyano-7- 
nitroquinoxaline-2, 3-dione disodium (CNQX) abolishes the postsynaptic response. 
There is also another class of ionotropic glutamate receptor, the A-methyl-D- 
aspartate (NMDA) receptor (Collingridge et al, 1983b) which allows sodium and 
potassium flux, but is also highly permeable to calcium ions. The NMDA receptor 
does not play a role in basal synaptic transmission, but comes into play at high levels 
of activity. NMDA receptors are thought to be either a tetramer or pentamer 
comprising of assemblies of the NRl subunit and a combination of NR2 subunits, 
which can be the product of four separate genes, NR2A-D. In addition to glutamate, 
the NMDA receptor requires the co-agonist glycine to fonction. The glycine site also 
binds polyamines that can modulate the fonction of the channel. Importantly, at 
resting membrane potential, the ion pore is blocked by a magnesium ion, which is 
expelled upon depolarisation. The role of the NMDA receptor in LTP induction will 
be discussed in section 1.3.2.3. One more class of glutamate receptor also exists. 
This last group is the G-protein coupled (metabotropic) class of glutamate (mGlu) 
receptors, of which there are eight known receptor clones, which fall into three broad 
classes. The role of mGlu receptors in synaptic plasticity is discussed in section 
1.3.2.6.
The modem day view of a glutamatergic synapse within the CNS is shown in 
figure 1.3.3.
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Figure 1.3.3: The glutamatergic synapse. L-glutamate (•), released from the 
presynaptic nerve terminal, diffuses across the synaptic cleft and binds with 
glutamate receptors. Activation of the AMPA/KA subclass of receptor leads to 
sodium influx and potassium efflux. Under basal conditions, opening of the NMDA 
channel by glutamate is prevented by a magnesium ion (•) within the pore. 
Activation of presynaptic metabotropic glutamate receptors may regulate the release 
of further transmitter. Relative proportions of receptors are not indicated.
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1.3.2.2 Calcium influx
The high-frequency conditioning paradigms lead to cellular events that bring about 
the induction of LTP. The expression of LTP is dependent on the influx of calcium 
into the postsynaptic cell. The first demonstration of the calcium dependency for 
LTP induction came fi*om moderating the amount of calcium entering the cell 
following depolarisation by altering the extracellular calcium and/or magnesium ion 
concentrations. Limiting the calcium entry into the cell resulted in the blockade of 
LTP, but not short-term plasticity (Dunwiddie & Lynch, 1979). Further evidence 
came a few years later from the same group when it was shown that buffering the 
intracellular calcium using a calcium chelator completely blocked the induction of 
LTP (Lynch «/., 1983).
1.3.2.3 NMDA receptor dependent LTP
At around the same time as the discovery of the calcium-dependence of LTP, it was 
shown that application of A-methyl (D, L) aspartate to hippocampal slices results in a 
depression of synaptic transmission followed by a lasting potentiation of the field 
EPSP (Collingridge et al, 1983a; 1983b). Furthermore, the induction of LTP (but 
not the expression of pre-established LTP) is reversibly blocked by the application of 
the NMDA receptor specific antagonist (D,L)-2-amino-5-phosphonopentanoic acid 
(AP5, Davies & Watkins, 1982). (N.B. AP5 was formally known as (D,L)-2-amino- 
5-phosphonovalerate, APV Evans et al, 1977.) The importance of the NMDA 
receptor in LTP induction has also been demonstrated by drugs that target the
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NMDA channel (for example MK-801, Coan et al, 1987) and the allosteric glycine 
site (for example 7-chlorokynurenic acid, Bashir et al,  1990).
It was noted that the magnesium cation is a potent antagonist of the NMDA 
glutamate receptor (Coan & Collingridge, 1985; Herron et al, 1985a) and therefore 
the role of magnesium in the induction process of LTP was investigated by using a 
Mg^-free medium. This resulted in the generation of epileptiform activity which 
could then be reversed by the application of D-AP5 (Herron et al,  1985b) indicating 
that the NMDA receptor is not involved in basal transmission, but suggesting that it 
may be involved, somehow, in the induction process of LTP. Further evidence came 
in 1984, when it was shown that the M g^ cation interacts directly with the ion pore 
of the NMDA receptor and that this interaction is strongly voltage dependent (Mayer 
et al,  1984; Nowak et al, 1984). These data led to the formation of the NMDA 
receptor-dependent theory for LTP induction. Activation of AMPA receptors leads 
to a significant depolarisation within the postsynaptic cell during high-fi*equency 
activity to eject the magnesium ion firom the NMDA receptor, thus allowing 
activation of the NMDA channel and calcium influx (Collingridge, 1985).
Moreover, the NMDA receptor can be thought of a coincidence detector for both pre- 
and post-synaptic activity (Collingridge, 2003).
NMDA receptor-dependent LTP has been since been demonstrated in many 
regions of the cerebral cortex, including visual (Artola & Singer, 1987), perirhinal 
(Bilkey, 1996), piriform (Jung et al, 1990) and prefirontal (Jay et al,  1995) cortices.
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Figure 1.3.4: LTP induction mechanisms. Top, High-frequency activity leads to a 
large influx of sodium, depolarising the cell and ejecting the magnesium ion from the 
NMDA channel pore. Bottom, Calcium can now enter the postsynaptic spine and 
activate protein kinases, leading to phosphorylation of receptors, which may mediate 
an increase in responsiveness to activation by glutamate. Generation of retrograde 
messengers (possibly nitric oxide (NO) and/or arachidonie acid (AA)), may lead to 
an increase glutamate release upon subsequent presynaptic activity. Alternatively, 
activation of the metabotropic glutamate receptors may lead to the activation of 
protein kinases to affect LTD by increasing calcium release from intracellular stores 
(endoplasmic reticulum, ER); by altering transmitter release; or by other biochemical 
cascades.
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1.3.2.4 NMDA receptor independent/calcium dependent LTP
Interestingly, a form of LTP requiring calcium influx can be induced independently 
of the NMDA receptor. Very high frequencies of stimulation (200 Hz) have been 
demonstrated to induce LTP that sources calcium influx through mechanisms other 
than the NMDA channel. In this form of LTP, calcium enters the postsynaptic cell 
via voltage-sensitive calcium channels (VSCCs, also known as voltage-gated or 
voltage-dependent calcium channels, Grover & Teyler, 1990). Furthermore, 
inhibitors of VSCCs also impair NMDA receptor-dependent LTP (Magee & 
Johnston, 1997), suggesting that calcium influx though the NMDA channel is not the 
sole source of calcium in NMDA-receptor dependent LTP. Indeed, calcium release 
from intracellular stores has also been shown to be involved in the raised calcium 
required for LTP induction. Inhibition of calcium-induced calcium release via the 
ryanodine receptor and/or depletion of calcium stores by thapsigargin both block 
LTP induction (Obenaus et al, 1989; Harvey & Collingridge, 1992; Bortolotto & 
Collingridge, 1993).
1.3.2.5 GABA disinhibition
In contrast to the excitatory nature of glutamate, inhibitory systems are also present 
within the brain. In particular, a class of neurones release y-aminobutyric acid, 
which is the major inhibitory neurotransmitter within the CNS. Like glutamate, 
GABA acts on both ligand-gated ion channels and metabotropic receptors. GABAa 
receptors are ionotropic and activation of this receptor leads to influx of chloride
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ions, which leads to hyperpolarisation of the cell (see Johnston, 1996 for review). 
GABAb receptors are metabotropic in nature and coupled to an inward-rectifying 
potassium channel and mediate a slow inhibitory postsynaptic potential (see Marshall 
fl/., 1999 for review).
Within the hippocampus there are GABAergic intemeurones that receive 
recurrent collateral axons from glutamatergic neurones and control the excitability 
and synchronisation of excitatory pyramidal cells (Chapman & Lacaille, 1999).
Given the inhibitory nature of the GABAergic system, it is conceivable that LTP 
could be mediated by a mechanism involving the reduction of inhibition 
(disinhibition). While several studies suggest that disinhibition does not contribute 
to CAl LTP (for example see Haas & Rose, 1982,1984; Taube & Schwartzkroin, 
1988), other studies have demonstrated that stronger intensity conditioning 
paradigms may indeed reduce the inhibition on hippocampal CAl pyramidal cells 
(Misgeld et al, 1979; Miles & Wong, 1987). A mechanism by which disinhibition 
could be brought about is that of long-term depression of the glutamatergic input 
onto the intemeurones. Such long-term depression has been shown to occur 
simultaneously with the induction of LTP in the neighbouring CAl pyramidal cells 
(McMahon & Kauer, 1997) and may, therefore, play a role in the induction of LTP.
124
1.3.2.6 mGlu receptor-dependent LTP
In contrast to the calcium-dependent forms of LTP described above, the induction of 
long-term potentiation can be mediated though metabotropic glutamate receptors. 
Based on their coupling to signal transduction cascades and their pharmacology there 
are three groups of mGlu receptor. The three types are made up of subclasses of 
cloned receptor: Group I comprise mGlul and mGlu5; group II comprises of mGlu2 
and mGlu3; and mGlu4, mGlu6 , mGlu? and mGlu8  comprise group III. Several 
splice variants of the mGlu receptors have also been identified. Generally, group I 
are considered to be positively coupled to the phospholipase C (PLC) cascade, while 
groups II and III are negatively coupled to adenyl cyclase (AC) and hence the 
suppression of cAMP production. Other cascades have also been associated with the 
mGlu receptors and for full reviews see Conn and Pin (1997) and Anwyl (1999).
The classification and down-stream signal cascades of mGlu receptors are 
summarised below in table 1.3.1.
Interest in the role of mGlu receptors in synaptic plasticity came at the end of 
the 1980s when it was realised that the weak and rather unspecific mGlu receptor 
antagonists AP3 and AP4 could reduce the duration of LTP in the hippocampus 
(Reymann & Matthies, 1989; Izumi et al, 1991). These findings have since been 
confirmed using the relatively more-potent broad-spectrum mGlu receptor antagonist 
(R5)-a-methyl-4-carboxyphenylglycine (MCPG, Sergueeva et al, 1993).
Conversely, specific activation of mGlu receptors by (15', 3R)-1 -aminocyclopentane- 
1,3 dicarboxylic acid (ACPD) can augment the degree of both short and long-term 
potentiation obtained in response to a tetanic stimulation (McGuinness et al,  1991).
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It has since been demonstrated that several brain regions, including CAl (Grover & 
Yan, 1999) and mossy fibre (see Bortolotto et al, 1999) synapses of the 
hippocampus, the prelimbic (Vickery et al, 1997; Morris et al, 1999; Bindman et 
al, 2000) and visual (Wang & Daw, 2003) cortices, each support NMDA receptor- 
independent/mGlu receptor-dependent forms of LTP.
The role of NMDA and mGlu receptors in LTP induction has been found to 
be mutually exclusive; LTP that requires mGlu receptor activation does not require 
the activation of NMDA receptors and, conversely, NMDA receptor dependent LTP 
is mGlu receptor independent (Bortolotto et al, 1999). Although prior mGlu 
receptor activation may have a priming effect, lowering the threshold for induction, 
thereby enabling subsequent NMDA receptor activation to more readily induce LTP 
(Bortolotto et al, 1994). This hypothesis, known as the "molecular switch", remains 
controversial and it is argued that mGlu receptors play only a modulatory role in LTP 
within the hippocampus (Thomas & O’Dell, 1995).
1.3.2.7 Signal transduction
The influx of calcium into the postsynaptic cell is but the first step in the induction of 
LTP. Raised calcium concentration within the postsynaptic cell activates various 
signal transduction cascades including protein kinases, phosphatases, and 
phospholipases-see figure 1.3.8.
The calcium/phoholipid dependent protein kinase (PKC) was the first protein 
kinase to be implemented in LTP (Bar et al, 1984; Akers et al, 1986; Lovinger et 
al, 1986). Inhibitors of this protein kinase invariably prevent the induction and
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Class Subunit Transduction cascade
Group I mGluRl |P L C ^  ÎIPs-^ TCa^ release
mGluRS
Group II mGluR2 |A C ^  icA M P^ iPKA
mGluR3
Group III mGluR4
iAC-> icAMP-> iPKA
mGluR6
mGluR7
mGluRS
Table 1.3.1: Metabotropic glutamate receptor classification and signal 
transduction.
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maintenance of LTP, even if applied after the tetanus (Lovinger et al, 1987;
Malinow et al,  1988; Reymann et al, 1988b). Conversely, injection of the catalytic 
subunit of PKC into the postsynaptic cell (Hu et al  ,1987) or extracellular 
application of PKC activators (Madison et al, 1986; Malenka et al, 1986) leads to 
synaptic potentiation.
Another protein kinase involved in LTP is the Ca^/calmodulin-dependent 
protein kinase type II (CaMKII). An activated, autophosphorylated form of CaMKII 
has been observed following LTP induction (Barria et al, 1997) and inhibition of 
this protein kinase prevents the induction of LTP (Mody et al, 1984; Reymann et 
al,  1988a; Malenka et a/., 1989; Malinow et al, 1989; Ito et al, 1991). Transgenic 
mice studies have further demonstrated the importance of this molecule: Knockout 
of the gene results in impaired LTP (Silva et al, 1992; Mayford et al, 1996). 
Additionally, a constitutively active form of the protein kinase induces a lasting form 
of synaptic potentiation within the hippocampus (Giese et al, 1998).
The other key protein kinase involved in LTP is protein kinase A (PKA). 
PKA is directly activated in an NMD A receptor-dependent manner within the CAl 
region of the hippocampus (Chetkovich & Sweatt, 1993) where it is thought to gate 
the activity of CaMKII-mediated signal cascades. The calcium that enters the cell 
via the NMDA channel is thought to activate calcium/calmodulin dependent adenyl 
cyclase, which generates cAMP, in turn leading in the activation of PKA 
(Chetkovich & Sweatt, 1993; Blitzer et al,  1995). PKA may then phosphorylate 
inhibitor 1, which inhibits protein phosphatase-1 (PPl) (Huang & Glinsmann, 1976; 
Blitzer et al, 1998) thereby maintaining the phosphorylation state of CaMKII. This 
activity is in direct competition with that of protein phosphatase 2B (calcineurin) 
which dephosphorylates CaMKII (Blitzer et al, 1998). In this scheme, it would
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appear that the balance between kinase and phosphatase activity is the crucial 
determinant in the development of LTP.
PKA also is thought to play a role in late stage LTP. This form of LTP is 
known to be protein synthesis dependent (Krug et al, 1984; Frey et al,  1988). The 
activation of PKA in this form of LTP may be via the activation of the Di-like class 
of dopamine receptors which leads to the activation of adenyl cyclase and hence 
cAMP production (^xeyetal, 1991). Alternatively, mGlu receptor activation may 
lead to PKA activation though a calcium dependent pathway (Roberson et al,  1999) 
Once activated, PKA is thought to phosphorylate the cAMP-response element 
binding protein (CREB, Nguyen et al, 1994), which is known to be increased in a 
PKA-dependent manner following LTP induction (Impey et al,  1996). Other signal 
transduction cascades have also been shown to alter the phosphorylation state of 
CREB, including mitogen-activated protein kinase (MAPK, Impey et al,  1998) and 
the nitric oxide (NO)- cGMP-dependent protein kinase (PKG, Lu et al,  1999), both 
of which have been implemented in LTP. It therefore appears that multiple pathways 
converge on to CREB to produce a long lasting change in protein synthesis (figure 
1.3.8).
1.3.2.8 Locus of expression
While the locus of induction is indisputably postsynaptic, the mechanisms involved 
in expressing and maintaining LTP are a little more contentious. Many arguments 
have been put forward for both a presynaptic and postsynaptic locus of expression 
for LTP, with some people favouring the post-synaptic arguments, others the
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presynaptic ones. As new evidence arises the arguments for each get stronger, 
making this a very controversial subject.
There are four feasible mechanisms by which the increase in postsynaptic 
potential observed following LTP induction could be brought about (see Bliss & 
Collingridge, 1993):
(i) Presynaptic modifications that give rise to increased neurotransmitter 
release.
(ii) Postsynaptic changes by which the number of receptors, or the 
functionality of postsynaptic receptors are increased (or both).
(iii) Extra-synaptic changes, for example altered glia-neurone interactions 
resulting in an increased neurotransmitter level within the synaptic 
cleft.
(iv) Morphological changes, including increased number of functional 
synapses or restructuring of existing synapses.
In reality it is likely that a mixture of all of these changes is involved, each with its 
own particular different time course.
Evidence for pre- and post- synaptic mechanisms
Initial studies to determine the locus of expression utilised a stimulation protocol 
known as paired-pulse stimulation, in which two stimuli are applied to the synapse in 
quick succession. At hippocampal CAl synapses, this results in an enhancement of 
the second response with respect to the first, a phenomenon known as paired-pulse 
facilitation (PPF). PPF is thought to be mediated by a presynaptic mechanism
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involving calcium preloading of the synaptic bouton, thereby increasing transmitter 
release on the second pulse (Zucker, 1973). If LTP were associated with a change in 
PPF ratios this would be evidence for a presynaptic locus of expression. LTP is not, 
however, associated with changes in PPF suggesting a postsynaptic locus of 
expression (McNaughton, 1982; Manabe et al, 1993).
Further evidence for a postsynaptic mechanism comes from studies of AMP A 
and NMDA receptor-mediated currents before and after LTP induction. If LTP were 
expressed presynaptically by an increase in transmitter release one would expect to 
see increases in both AMP A receptor-mediated and NMDA receptor-mediated 
currents. Following LTP induction AMP A, but not NMDA receptor-mediated 
components of the EPSP have been shown to be increased, suggesting that 
potentiation is mediated through changes in the AMP A receptor (Kauer et al,  1988; 
Muller & Lynch, 1988). Contrary to this, when pharmacologically isolated NMDA 
receptor components are examined it would appear that NMDA currents do indeed 
undergo LTP (Bashir et al, 1991; Berretta et al, 1991; Xie et al, 1992; Asztely et 
al, 1992). This is consistent with a presynaptic increase in transmitter release. 
Interestingly it has recently been reported in the primary sensory cortex that both 
AMP A and NMDA currents undergo potentiation, but on a different time scale (Watt 
et al, 2004). AMPA currents showed a rapid LTP following induction, while 
NMDA currents only showed an increase at two hours post induction. Furthermore, 
the increase in NMDA currents was dependent on the AMPA LTP and restored the 
original NMDA/AMPA ratio. This would indicate that the increase in functional 
AMPA receptors at the synapse induces a proportional increase in functional NMDA 
receptors which may be important for maintaining the normal contributions of the 
receptors to synaptic transmission.
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Other experimental approaches that show a postsynaptic locus of expression 
investigate the sensitivity of neurones following LTP induction. The postsynaptic 
response to the exogenous agonists AMPA or quisqualate gradually increases 
following LTP induction (Davies et al, 1989), consistent with an increase in AMPA 
receptor number or the function of AMPA receptors already present.
A more direct method of assessing locus of expression is that of quantal 
analysis, which was used in the 1950s by del Castillo and Katz (1954) at he frog 
neuromuscular junction. The frog neuromuscular junction utilises acetylcholine as 
its neurotransmitter and is extremely simple compared to the CNS synapse. Del 
Castillo and Katz noticed that, in the absence of stimulation, small spontaneous 
postsynaptic potentials occurred, which they termed ‘miniature end-plate potentials’ 
(mepp’s). Each mepp represents one unit, or ‘quantum’, of transmitter released from 
a single vesicle from the presynaptic terminal. The release of each quantum is an all- 
or-none event under the control of the action potential and has a probability of 
release (p). The average number of quanta released (m) is obtained by multiplying 
the number of release sites (n) by ‘p’. The release of a single quantum gives rise to a 
miniature postsynaptic potential of a given size (a), which is determined by the 
number of postsynaptic receptors. The parameters ‘m’, ‘n’, ‘p’ and ‘a’ can be 
estimated by fitting a binomial distribution to frequency histograms of the evoked 
synaptic potential amplitudes. Such analysis generates a distribution with equally 
spaced peaks, each peak representing the postsynaptic response to single or multiple 
fixed quanta and the spaces between peaks is equal to the quantal size. Variance of 
the mean synaptic potential amplitude is termed the ‘coefficient of variance’ and is 
inversely proportional to the quantal content.
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The formidable task of applying quantal analysis to central synapses to 
investigate changes following LTP induction has been attempted. Many problems 
are associated with this including variability in synapse size and shape, receptor 
distributions and non-fixed release probabilities. These problems are compounded 
by the fact that a single neurone receives inputs from maybe thousands of synapses, 
of which only a few may exhibit LTP. To circumvent these problems both minimal 
stimulation (in an attempt to achieve miniature postsynaptic potentials) and 
pharmacology (replacement of calcium with strontium ions to cause asynchronous 
release at activated synapses only) have been used.
LTP at central synapses has been associated with a decrease in the coefficient 
of variance and also in the failure rate (Malinow & Tsien, 1990; Bekkers & Stevens, 
1990; Kullmann & Nicoll, 1992; Manabe et al, 1993). Both of these changes 
suggest a presynaptic mechanism of expression.
Presynaptic mechanisms of expression had previously been suggested. The 
most direct evidence coming from measurements of neurotransmitter release prior to 
and following LTP induction. The first of such experiments showed that release of 
radio-labelled glutamate increases following LTP induction in the dentate gyrus 
(Dolphin et al, 1982). Furthermore, endogenous glutamate levels, as measured by 
high pressure liquid chromatography following in vivo sampling from a push-pull 
cannula, are increased after LTP induction in the dentate gyrus (Bliss et al,  1986; 
Errington et al,  1987; Lynch et al, 1989) and CAl (Ghijsen et al, 1992). In 
addition, these increases are dependent on NMDA receptor activation and are 
specific to glutamate (Errington et al, 1987). Depolarisation-induced glutamate 
release is also enhanced following LTP induction (Skrede & Malthe-Sorenssen,
1981; Errington et al, 1987; Canevari et al, 1994). The importance of the evidence
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for a presynaptic mechanism of expression is underlined by the fact that similar 
enhancements in glutamate release are observed following hippocampal-dependant 
learning in the Morris water maze (Richter-Levin et al, 1995,1998).
Postsynaptic mechanisms
The simplest model for a postsynaptic mechanism of LTP expression is of AMPA 
receptor modification. Changes in AMPA receptor function could be brought about 
by direct phosphorylation by protein kinases activated by LTP induction. The potent 
protein kinase inhibitor K-252b prevents the increase in AMPA receptor sensitivity 
following LTP induction (Reymann et al, 1990). Conversely, addition of the PKA 
catalytic subunit can directly increase AMPA receptor conductance (Greengard et 
al, 1991; Wang 1991).
An alternative model is based on the finding that AMPA receptors exist in 
two distinct isoforms each with different conductance properties, termed ‘flip’ and 
‘flop’, whereby the relative expressions of the two could change following LTP 
induction (Sommer et al, 1990). There could also be a change in the general 
expression of the cloned AMPA subunits GluRl-4 (Gasic & Hollmann, 1992).
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Silent synapses
In light of the apparent increase in glutamate release highlighted by quantal analysis, 
a postsynaptic mechanism (rather than the obvious presynaptic ones) was proposed 
in which the number of functional synapses increases following LTP. This theory 
has been termed the ‘silent synapse’ and describes the presence of electronically 
inactive synapses existing under basal conditions (Kullmann, 1994). This could be 
achieved by the absence of AMPA receptors at a synapse where NMDA receptors 
are expressed. Such a receptor distribution would result in a silent synapse, as the 
NMDA receptor is inactive at resting membrane potential. The insertion of AMPA 
receptors into this synapse following LTP would un-silence the synapse, thereby 
converting it into a functional one (see figure 1.3.5). Such a mechanism fits both the 
apparent increase in transmitter release indicted by quantal analysis (which is 
assessed using the postsynaptic response) and the increase in AMPA receptor- 
mediated currents (see Kullmann, 2003 for review.)
Silent synapses have been demonstrated electrophysiologically by two 
independent research groups (Isaac et al, 1995; Liao et al, 1995). These synapses 
showed no discernable AMPA receptor-mediated currents, but had normal NMDA 
channel-mediated currents in response to minimal stimulation. Following LTP 
induction AMPA components were detectable. These results have also been 
correlated with immunocytochemical studies. While virtually all excitatory synapses 
contain NMDA receptors, only a portion of synapses stain for AMPA receptors (Rao 
& Craig, 1997; Gomperts et al, 1998; Liao et al, 1999), a result confirmed at the 
ultrastructural level (Nusser et al, 1998; Petralia et al,  1999).
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Figure 1.3.5: Silent synapses. A, synapse i expresses only NMDA receptors and no 
functional AMPA receptors, making this a silent synapse. In contrast, synapse ii 
expresses both receptors, making this a functional synapse. B, Glutamate spill-over 
activates only NMDA receptors in a presynaptically inactive synapse. The releasing 
varicosity (ii) is likely to be in synaptic contact with a different neurone (i), 
explaining why no AMPA-mediated component is detected. C, Un-silenceing by 
LTP could be mediated by different mechanisms, i) AMPA receptor insertion into 
the synapse; ii) movement of perisynaptic AMPA receptors to the synaptic cleft; iii) 
change in the release probability of glutamate from the presynaptic terminal; iv) 
conversion of a presynaptically inactive synapse to an active one triggered by 
activity of neighbouring synapses; v) structural changes of the postsynaptic spine 
could lead to its approach to a release site. (Adapted from Kullmann, 2003.)
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An alternative mechanism to that of un-silencing by AMPA receptor insertion could 
be glutamate spill-over (see Kullmann & Asztely, 1998, figure 1.3.5). In this model, 
high levels of glutamate released from a group of synapses could activate NMDA 
receptors in the AMPA-absent synapses. This mechanism is not purely a 
postsynaptic mechanism, as it requires an increase in glutamate release for the 
activation of receptors outside the synaptic clefl: of the activated synapse. Equally 
this mechanism is no longer strictly homosynaptic.
Another mechanism of un-silencing may involve growth of synaptic spines, 
thereby reducing the distance between pre- and post-synaptic membranes. The 
proposed mechanisms of un-silencing are summarised in figure 1.3.5.
Presynaptic mechanisms
Although the mechanism of induction is indisputably postsynaptic there is significant 
evidence for both a pre- and post-synaptic locus of expression. To reconcile this 
apparent discrepancy between a postsynaptic induction and a presynaptic expression 
it has been proposed that an intracellular signal is released firom the postsynaptic cell 
to initiate the increase in release of neurotransmitter fi*om the presynaptic terminal 
(see figure 1.3.4).
In order for a molecule to act as a retrograde messenger it must meet a 
number of criteria (see Bliss & Collingridge, 1993): 1, it must have a postsynaptic 
synthesis that is amplified following LTP induction; 2, it must be released into the 
synaptic cleft to diffuse into the presynaptic terminal; 3, it must affect increased 
transmitter release. Several studies have provided potential candidates for the 
retrograde messenger including peptides (Duffy et a/., 1981; Fazeli et a/., 1988;
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Otani et al, 1992), arachidonic acid (see below) and nitric oxide (NO; discussed 
below). Peptides were soon dismissed on the basis that their onset was too slow to 
cause the presynaptic change. In contrast both arachidonic acid and NO have been 
considered suitable candidates.
Arachidonic acid
Arachidonate is synthesised by the enzyme phospholipase A2 , inhibiters of which 
block the induction of LTP (Okada et al, 1989; Williams & Bliss, 1989).
Conversely, the transient application of arachidonate to hippocampal slices induces a 
slow-onset potentiation (Barbour et al, 1989; Williams et al, 1989). It has been 
shown to be released into the extracellular matrix following activation of the NMDA 
receptor (Dumuis et al, 1988) and shows increased efflux and postsynaptic 
availability following LTP induction (Williams et al, 1989). Targets of arachidonic 
acid are both the presynaptic terminal, where it increases glutamate release (Williams 
et al, 1989) and glia, where it suppresses glutamate uptake (Barbour et al, 1989).
Nitric oxide
The other candidate for the retrograde messenger is nitric oxide. NO is a membrane- 
permeable gas that is synthesised from L-arginine by the calcium/calmodulin- 
dependent enzyme nitric oxide synthetase (NOS). CAl pyramidal cells express NOS 
and, moreover, release NO gas following NMDA receptor activation (Schuman & 
Madison, 1994). Pharmacological inhibition of NOS (Schuman & Madison, 1991), 
haemoglobin scavenging of NO (Arancio et al, 1996) and gene knock-out of NOS
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(O'Dell et al, 1994; Son et al, 1996) ail prevent the induction of LTP. Furthermore, 
photolytic release of NO from caged compounds, paired with simultaneous afferent 
stimulation, induces potentiation (Arancio et al, 1996).
Contradictory, however, some groups have failed to replicate NO-induced 
LTP (for example see Haley et al, 1993 and; Cummings et al, 1994), that blockade 
of LTP by NOS inhibitors was temperature- and age-dependent (Williams et al, 
1993) and, furthermore, that NO could actually depress NMDA receptor-mediated 
currents (Murphy et al, 1994; Murphy & Bliss, 1999). These findings suggest that 
NO may modulate the NMDA receptor to raise the threshold for subsequent LTP 
induction.
1.3.3 Long-term depression
In contrast to long-term potentiation, long-lasting decreases in synaptic transmission 
can also be induced at central synapses (see figure 1.3.6). The idea that synaptic 
connections could undergo décrémentai changes was proposed by Gunther Stent who 
suggested a complementary postulate to that of Donald Hebb: Synapses that are 
inactive during periods of activity in the postsynaptic neurone could undergo a 
process by which synaptic transmission is weakened (Stent, 1973). Long-lasting 
synaptic depression was identified in the late 1970s, when it was found that a 
reversible depression was induced in the non-tetanised pathway during LTP 
induction within the CAl region of hippocampal slices (Lynch et al, 1977). These 
decreases in synaptic transmission were termed heterosynaptic depression and has 
also been demonstrated in vivo within the dentate gyrus (Levy & Steward, 1979).
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Depression of previously potentiated synaptic responses has also been shown, termed 
depotentiation (Hesse & Teyler, 1976). Identification of homosynaptic long-term 
depression of naïve synapses was, however, elusive and the phenomenon of 
depression was largely ignored until the early 1990s. De novo homosynaptic LTD 
was eventually identified in response to a low-frequency conditioning stimulus 
applied to CAl synapses of hippocampal slices prepared from young rats (Dudek & 
Bear, 1992; Mulkey & Malenka, 1992). The input-specific nature of LTD is an 
important observation as it excludes the attribution of the decreased synaptic 
transmission to a general decline in slice health. Furthermore, homosynaptic LTD, 
like LTP, fits many of the requirements for a mechanism underlying learning and 
memory.
LTD within the hippocampus was found to be developmentally down- 
regulated and by approximately 35 days, LFS was no longer effective at inducing 
LTD in the rat. A similar down regulation of LTD has recently been demonstrated in 
the mouse hippocampus (Milner et al,  2002a; 2003b; 2004b). The down regulation 
of LTD observed in the rat has been shown to be overcome by using an enhanced 
LFS protocol. At ages where standard LFS fails to induce depression (12-16 weeks) 
a train of paired-pulse stimuli has been found effective at inducing LTD (Kemp & 
Bashir, 1997).
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Figure 1.3.6: The first demonstration of homosynaptic LTD. Low-frequency 
stimulation (LFS) applied to the experimental pathway (A)  results in a long-lasting 
depression in that pathway, but not the control pathway (A) which does not receive 
LFS. (Adapted from Dudek & Bear, 1992.)
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It has been established that many regions of the forebrain also support 
homosynaptic LTD including striatum (Calabresi et al, 2000; Spencer & Murphy,
2000), visual cortex (Artola et al, 1990), preffontal cortex (Hirsch & Crepel, 1990), 
amygdala (Wang & Gean, 1999) and perirhinal cortex (Cho et al, 2000). 
Importantly, LTD in these regions is not developmental and persists into adulthood 
using standard LFS protocols.
1.3.3.1 NMDA receptor-dependent LTD
The initial studies carried out in CAl of the hippocampus demonstrated that LTD 
was dependent on the activation of NMDA receptors (Dudek & Bear, 1992; Mulkey 
& Malenka, 1992) and this finding has subsequently been supported by other studies 
(Kemp & Bashir, 1997; Kemp et al, 2000; Milner et al, 2004b). Direct application 
of NMDA has also been demonstrated to induce CAl LTD with similar properties to 
that induced by LFS, in that it is down-regulated with age, is reversible and saturable 
(Lee et al, 1998). The down-regulation of NMDA receptor-dependent LTD has 
been proposed to be mediated by an age-dependent shift in NMDA receptor subunit 
expression fi*om NR2B to NR2A (Insel et al, 1990; Monyer et al, 1994). Contrary 
to this view, however, mice over expressing the NR2B subunit into adulthood do not 
show facilitated LTD (Tang et al, 1999).
NMDA receptor-dependent, homosynaptic LTD has also been demonstrated 
within the dentate gyrus of intact animals (Thiels et al, 1994; Heynen et al ,  1996). 
Within the cortex several reports have demonstrated NMDA-receptor dependent 
LTD, including visual (Kirkwood & Bear, 1994; Sawtell et al, 1999), somatosensory
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(Feldman et al, 1998) and perirhinal (Cho et al, 2000, perirhinal cortical plasticity 
will be discussed in section 1.5) cortices. Generally, LTD that is dependent on 
NMDA receptor activation is independent of the mGlu receptor subclass (for 
example see Kemp & Bashir, 1997; Sawtell et al, 1999; Milner et al, 2004b; but see 
Wang & Gean, 1999; Cho et al, 2000).
1.3.3.2 mGlu receptors and LTD
In contrast to NMDA receptor dependent LTD there are many examples of LTD 
induction that is dependent on the activation of metabotropic glutamate receptors. 
Within the hippocampus the broad-spectrum mGlu receptor antagonist MCPG blocks 
several forms of LTD (for example see Manahan-Vaughan, 1997; Oliet et al, 1997; 
Otani & Connor, 1998; Bortolotto et al, 1999). The mechanisms involved in mGlu 
receptor-mediated LTD are likely to be different than those of NMDA receptor- 
dependent LTD because saturation of one type does not occlude the induction of the 
other (Palmer et a l , 1997; Oliet et al, \991)
Metabotropic glutamate receptor-dependent LTD has also been demonstrated 
in cortical regions including prefrontal cortex (Otani et al, 1999), perirhinal cortex 
(see section 1.5) and between intemeurones of the somatosensory barrel cortex 
(Eggere^a/., 1999).
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1.3.3.3 LTP or LTD?
The induction mechanism for both LTP and LTD is an increase in postsynaptic 
calcium. How does this common signal confer bi-directional plasticity?
Donald Hebb (1949), in the first postulate of activity-dependent facilitation of 
synaptic transmission, predicted that there is an activity threshold for increases to 
occur. Conversely, Gunther Stent (1973) proposed that synapses that are inactive 
during postsynaptic activity might undergo a weakening process. In a conglomerate 
theory, it was proposed that the direction of plasticity is correlated with the degree of 
activity, such that active synapses are strengthened when a ‘modification threshold’ 
(0m ) is exceeded (same as Hebb’s proposal), and (in contrast to Stent) that depression 
only occurs at active synapses when the postsynaptic activity is less than 0 m but 
higher than a lower threshold (Cooper et al, 1979). An addition to this theory was 
later added that previously integrated postsynaptic activity can alter the value of 0 m 
(Bienenstock, Cooper and Munro, 1982, BCM theory, see figure 1.3.7).
A demonstration of the BCM theory was provided by differential induction of 
LTP or LTD by application of the same high-firequency stimulation protocol to 
neurones of the rat visual cortex. The direction of plasticity was found to be 
dependent on the degree of depolarisation achieved in the postsynaptic cell, with 
higher degrees of depolarisation leading to LTP and lower degrees to LTD (Artola et 
al,  1990).
The BCM theory came to the fore when it was realised that both LTP and 
LTD are calcium dependent. It was then proposed that input activity giving rise to 
calcium concentrations exceeding 0m would result in LTP, while calcium
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concentrations lower than 0m, but exceeding a lower threshold, would induce LTD. 
Furthermore, the upper threshold could vary depending on the previous activity at the 
synapse which could alter NMDA receptor function (Bear et al,  1987). Similar 
proposals have been made by Lisman (1989) and Artola and Singer (1993)
Direct evidence for distinct calcium thresholds for LTP or LTD induction was 
provided by fluorescence measurements of calcium transients following glutamate 
ionophoresis to induce plastic changes in CAl hippocampal neurones (Cormier et al,
2001). It was found that discrete ranges of calcium levels correlate with either LTP 
or LTD induction. Below ~180 nM calcium, no plasticity was observed; between 
~180 and ~450 nM LTD was induced; another aplastic range was found between 
~450 and 540 nM; levels above -540 nM led to LTP; a finding that fits the BCM 
theory exactly (see figure 1.3.7).
The above description is probably an over simplification, as both spatial and 
temporal considerations, including decay time; distal or proximal sources of calcium; 
and duration of activity are likely to play important roles. For instance a protracted 
duration of activity and calcium influx is needed for the induction of LTD, while a 
shorter burst of activity is required for LTP (Mizuno et a l , 2001 )
1.3.3.4 Signal transduction
The mechanisms involved in the expression of LTD are less understood than those of 
LTP. Some of the biochemical cascades involved have been identified and are 
discussed here and are summarised in figure 1 .3 .8 .
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Figure 1.3.7: The BCM theory of bidirectional plasticity. The degree of activity 
achieved in and hence the degree of calcium entering, the postsynaptic cell during 
conditioning determines the direction of plasticity (black curve). Previous activity at 
a synapse may modify the threshold for the induction of LTD or LTP (grey curves). 
(Based on figures in Bear, 2003.)
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Calcium dependent biochemical cascades
The different calcium signals achieved during LTP and LTD induction could confer 
differential activity of protein kinases and protein phosphatases. The short, large 
increase associated with LTP will activate CaMKII and the associated cascades 
mentioned in section 1.3.3, while a prolonged smaller calcium signal will activate 
protein phosphatase 2B: calcineurin (proposed by Lisman, 1989). While CaMKII 
will lead to phosphorylation of AMPA receptors (Barria et al, 1997) and mediate 
LTP (Lledo et al, 1995), activation of protein phosphatase 2B will dephosphorylate 
and thereby activate inhibitor 1 , in turn activating protein phosphatases 1 and 2  
resulting in dephosphorylation of AMPA receptors (see Kemp & Bashir, 2001 for 
review).
Similarly to LTP, other cascades are implicated in LTD. The phospholipase 
Ai pathway, in a dose dependent manner, is thought to alter AMPA receptor affinity 
states to enable LTP/LTD expression (Chabot et al, 1998). The cGMP/NO pathway 
is potentially involved, with exogenous application of NO inducing a long-lasting 
depression (Izumi & Zorumski, 1993; Murphy et al, 1994; Murphy & Bliss, 1999).
G-protein linked pathways
Activation of the metabotropic class of glutamate receptors is linked to a variety of 
pathways. Group I mGlu receptors are associated with the activation of PLC which 
can 1) affect release of calcium fi*om internal stores through the IP3 pathway (see 
Conn & Pin, 1997) and 2) increase PKC levels leading to CREB-dependent protein 
synthesis via the MAP kinase pathway (Fiore et al, 1993; Orban et al, 1999).
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Interestingly the levels of MAP kinases have been shown to be decreased following 
LTD induction (Norman et ah, 2000).
Group II mGlu receptors are negatively coupled to the production of cAMP, 
thereby suppressing PKA-dependent phosphorylation of AMPA receptors 
(Kameyama et al, 1998; Tzounopoulos et al, 1998). Conversely, inhibition of PKA 
blocks LTD induction (Huang & Glinsmann, 1976), a finding consistent with the 
observation that mice lacking the PKA catalytic subunit or regulatory subunit are 
deficient in LTD (Brandon et al, 1995; Qi et al, 1996). These contradictory 
findings could be explained by a basal level of PKA activity governing the 
phosphorylation state of AMPA receptors, thereby either increases or decreases in 
PKA activity can effect synaptic transmission.
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Figure 1.3.8: Schematic illustration of some of the biochemical cascades 
involved in synaptic plasticity. Abbreviations: AC, adenylate cyclase; AA, 
arachidonic acid; CaMKII, calcium-calmodulin dependent protein kinase II; CREB, 
cAMP response element binding protein; DAG, diacylglycerol; IP3, inositol 
triphosphate; KA, kainate receptor; mGlu, metabotropic glutamate receptor; MAP 
kinase, mitogen-activated protein kinase; PI, phosphatidyl inositol; PLC, 
phospholipase C, PKA, cAMP-dependent protein kinase; PKC, protein kinase C; 
PP1/2A, protein phosphatase 1/2A; and TKR, tyrosine kinase receptor. (Taken from 
Kemp & Bashir, 2001.)
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Group III mGlu receptors are also negatively coupled to adenyl cyclase and 
the production of cAMP. Until recently a role for type III mGlu receptors in LTD 
had not been demonstrated (for examples see Palmer et al, 1997; Fitzjohn et al, 
1999; Cho et al, 2000; Mellentin & Abraham, 2001). An article published this year 
has shown that inhibition of group III mGlu receptors by (RS)-a-cyclopropyl-4- 
phosphonophenylglycine (CPPG) inhibits the induction of LTD in the dentate gyrus 
of freely moving rats (Klausnitzer et a l , 2004).
1.3.3.5 Expression of LTD
The biochemical cascades involved in LTD suggest that alterations in the function of 
AMPA receptors could underlie the depression of synaptic transmission. Another 
mechanism that has been proposed is that of silencing synapses; the converse of the 
mechanism proposed for LTP. LTD in cell cultures has been associated with a 
decrease in surface expression of AMPA receptors (Carroll et al, 1999b) and also 
exposure to low levels of glutamate can decrease the ratio of GluRl to NRl subunits 
(Lissin et al, 1998). The mechanism by which synapses are silenced could involve 
endocytosis of AMPA receptors. Disruption of dynamin-dependent endocytosis 
could lead to an increase in AMPA-mediated currents (Carroll et al, 1999a; 1999b). 
Conversely, application of insulin induces endocytosis, leads to decreased 
postsynaptic responses and induces LTD that occludes further LFS-induced LTD. 
Furthermore, restricting endocytosis precludes LTD induction (Man et al,  2000).
Presynaptic changes are also likely to occur and, as with LTP, a mixture of 
both loci is probable. Evidence for a presynaptic mechanism is provided by studies
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of failure rate, quantal size, coefficient of variance and number of vesicles available 
for release (for examples see Bolshakov & Siegelbaum, 1994; Stevens & Wang, 
1994; Goda & Stevens, 1998; Liithi et al, 1999).
Similarly to LTP expression, it is likely that LTD involved a mixture of both 
pre- and postsynaptic alterations.
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1.4 Synaptic plasticity in Huntington’s disease
As highlighted in section 1.3, cognitive decline is the earliest manifestation of 
Huntington’s disease, seen long before evidence of cellular pathology and neuronal 
death; and full dementia is a classical hallmark of the later stages. Similarly, 
transgenic mouse models show deficits on learning tasks, particularly in the 
hippocampal-dependent test of spatial memory the Morris water maze (Lione et al, 
1999; Murphy et al,  2000). Given that cognitive processes are encoded within the 
brain by changes in synaptic transmission, synaptic plasticity has been investigated 
within these mice.
The electrophysiology of two brain regions has been investigated: The 
striatum, being the region showing greatest susceptibility to neurodegeneration; and, 
in light of the deficits in hippocampal-dependent learning tasks, the hippocampus. In 
contrast there are no extensive reports on synaptic transmission or plasticity within 
cortical regions of any transgenic mouse models of HD.
1.4.1 Striatum
The basal ganglia are particularly susceptible to neurodegeneration during the 
progress of HD. In particular there is a selective loss of MSSNs in the striatum 
(Vonsattel et al,  1985). Similarly, in the R6 mouse lines, a selective, late-onset 
neurodegeneration is observed within the dorsal striatum (Turmaine et al, 2000). 
There is growing evidence, however, that neuronal dysfunction predates the actual
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loss of cells, suggesting that impairments in subcortical cognition may occur in the 
absence of neuronal death. The principle input to the striatum is from the cortex and 
the corticostriatal pathway in several mouse lines has received extensive 
investigation.
1.4.1.1 Basal cellular properties
Several studies have shown MSSNs to have a depolarised resting membrane 
potential. In the R6/2 mouse the majority of MSSNs have been found to be 
depolarised in the resting state within symptomatic, but not presymptomatic mice 
(Levine et al, 1999; Klapstein et al, 2001). In contrast a knock-in mouse with 100 
glutamine repeats has MSSNs with normal membrane potentials (Laforet et al, 
2001). Interestingly, another knock-in mouse, with either 71 or 94 CAG repeats, has 
a subpopulation of MSSN cells exhibiting depolarisation at rest (Levine et al,  1999). 
In the 94Q mouse approximately 40% of MSSNs are depolarised, while in the 71Q 
mouse 20% show a depolarisation. A depolarised resting membrane potential could 
be a result of impaired energy metabolism which has been reported in HD (see 
section 1.2.7.1). Reduced ATP availability would decrease the activity of 
Na' '^/KVATPase that is crucial in maintaining the intracellular concentrations of 
potassium and sodium ions, the principle determinants of membrane potential.
The input resistance of MSSNs has been reported to he increased in both 
symptomatic and presymptomatic R6/2 mice (Levine et al, 1999; Klapstein et al,  
2001). Again in contrast to R6/2 mice, the input resistance of MSSNs from the
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HD 100 knock-in mouse show a reduced input resistance (Laforet et al, 2001), while 
the 71 and 94 repeat mice show no change (Levine et al, 1999).
With the exception of a reduced action potential amplitude in MSSN cells of 
symptomatic R6/2 mice, most aspects of the action potential (including threshold and 
duration) have been reported as normal in all mouse lines studied (Levine et al,
1999; Klapstein et al, 2001 ; Laforet et al, 2001).
1.4.1.2 Basal synaptic transmission
The frequency of spontaneous EPSPs recorded from MSSNs is reduced in R6/2 at 5- 
7 weeks of age and this reduction is more pronounced at 11-15 weeks. At 3-4 weeks, 
however, spontaneous activity is similar to wild-types. There is also an increased 
incidence of large synaptic events in R6/2 at the later ages (Cepeda et al,  2003). 
Similar reductions in spontaneous activity are also seen in the R6/1 mouse (Cepeda 
a/., 2003).
The size of evoked EPSPs are smaller in both R6/2 and HD 100 knock in mice 
(Klapstein et al,  2001; Laforet et al, 2001). Furthermore, the stimulus intensity 
required to evoke an action potential in both presymptomatic and phenotypic R6/2 
mice is increased (Klapstein et al, 2001). These results may be indicative of less 
neurotransmitter release, or reduced postsynaptic responsiveness. In support of a 
presynaptic change, paired-pulse facilitation is reduced in both presymptomatic and 
symptomatic mice (Klapstein et a l , 2001).
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In support of postsynaptic changes, the NMD A receptor has been shown to 
have enhanced function. Currents induced by NMDA application show increases in 
the R6/2, both knock-in mice studied and the YAC72 model (Cepeda et al,  2001 ; 
Zeron et al, 2002). This may be a direct result of the depolarised state of the 
neurones, however when cells were held at standardised holding potentials, NMDA 
current densities were still enhanced in mutant mice over those of wild-types. 
Furthermore, calcium flux in response to NMDA is increased (Laforet et al,  2001). 
The increased degree of calcium entering the cell is likely to underlie the enhanced 
NMDA-induced cell swelling observed by Levine et al  (1999).
The enhancement in NMDA receptor function by mutant huntingtin appears 
to be subtype-specific. Coexpression of either normal or mutant huntingtin, with 
NRl and either NR2A or NR2B subunits in HEK293 cells highlighted subclass 
specific enhancements in NMDA-mediated currents (Chen et al, 1999b). 
Coexpression of the NR2B subunit with mutant huntingtin results in an increased 
NMDA receptor-mediated current above that seen when normal huntingtin is 
coexpressed. In contrast, no such increases were seen with the NR2A subunit with 
either normal huntingtin or a control protein (p-gal). Similarly, NMDA mediated 
excitotoxicity is enhanced in a subtype specific manner within acutely dissociated 
MSSNs from YAC72 mice (Zeron et al, 2001) and this enhancement is reduced by 
the application of the NR2B subtype specific antagonist Ifenprodil (Zeron et a l , 
2002).
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1.4.1.3 Synaptic plasticity
The corticostriatal pathway provides the main glutamatergic inputs to the MSSNs of 
the striatum and corticostriatal synapses are known to support both LTP and LTD 
(Calabresi et al, 2000; Spencer & Murphy, 2000). No published data is available on 
synaptic plasticity within the corticostriatal pathway of HD mice. Preliminary data 
from within our lab suggests that LTP is enhanced in the R6/2 mouse (see Bates & 
Murphy, 2002) and this may be due to the increased NMDA function.
1.4.2 Hippocampus
The most comprehensive characterisation of synaptic plasticity in mouse models of 
HD is within the hippocampus. Crucially R6 mice are impaired in hippocampal- 
dependent spatial learning tasks prior to an overt phenotype (Murphy et al,  2000). 
Three HD mouse models have been reported with abnormal synaptic plasticity within 
the hippocampus: a knock-in with 72 and 80 CAG repeats, the YAC frill length 
transgenic and the R6/2 mouse. I will first describe the data from each mouse and 
then discuss the common and divergent findings.
1.4.2.1 HD72 and 80 knock-in
The first report of long-term synaptic plasticity in the hippocampus was within the 
Shelboume knock-in mouse (Usdin et al, 1999). One will recall that the only
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reported behavioural phenotype in this mouse was increased aggression (which is 
probably attributable to other causes then the CAG repeat per se) and is therefore a 
model of the early stages of the disorder.
Basal transmission at CAl synapses was found to be normal, as demonstrated 
by input-output curves from mutant and wild-type mice being identical.
Long-term potentiation was induced by high-frequency stimulation. LTP was 
found to be impaired in the majority of transgenic slices compared to that recorded in 
slices from wild-type animals. Because some slices exhibited apparently normal 
LTP the authors proposed that the mechanism for induction may be ftinctional, but 
that the threshold for induction is increased. Indeed, when a stronger tetanus was 
applied, LTP was indistinguishable from that recorded in slices from wild-type mice.
Post-tetanic potentiation (PTP) was, however, still impaired. As PTP is an 
indicator of presynaptic function, Usdin and co-workers predicted a presynaptic 
mechanism for this impairment, a proposal confirmed by reduced paired-pulse 
facilitation. To test this hypothesis further the properties of the activity-dependent 
NMDA channel blocker MK801 was used to assess transmitter release. The rate of 
decay of NMDA receptor-mediated currents is directly proportional to the amount of 
transmitter released. At low-frequency stimulation (basal transmission) there was no 
difference between the decay rate at HD and wild-type synapses, while at high- 
frequency, NMDA currents showed a slower rate of decline in mutant mice (Usdin et 
al,  1999). This was interpreted as an impaired ability to sustain transmitter release 
under high-frequency rather than an increased induction threshold as initially 
proposed.
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1.4.2.2 YAC transgenics
The second report of abnormal synaptic plasticity in HD was within the YAC mouse 
expressing the entire human HD gene with either 46 or 72 CAG repeats (Hodgson et 
al, 1999). It should be noted that these experiments were carried out in artificial 
cerebrospinal fluid (ACSF) that lacked the magnesium ion, which would normally 
regulate NMDA receptor activity.
Repetitive tetanic stimulation was used to induce saturated LTP at CA3-CAl 
synapses. At six months old both YAC46 and YAC72 mice (both presymptomatic) 
show normal LTP. By ten month the YAC 46 mice (still aphenotypic) completely 
failed to express LTP and the YAC72 mice (phenotypic) display a slow onset, 
homosynaptic LTD in response to tetanic stimulation.
At six months, slices prepared from YAC72 mice showed hyperexcitability 
that was sensitive to the NMDA receptor antagonist D-AP5. The hyperexcitability 
was not, however, reported as a comparison to wild type or transgenic mice at other 
ages or carrying different repeats. Given that magnesium-free ACSF is known to 
induce NMDA receptor-dependent epileptiform activity (Herron et al, 1985b), this 
evaluation is an important control experiment that was not reported.
Slices prepared from the YAC46 mice showed decreased glutamate-induced 
calcium currents. Decreased calcium currents could be mediated by less NMDA 
receptors or decreased NMDA receptor function and this appears to be contradictory 
to their claim of increased NMDA receptor activity. It was found, however, that the 
suppressed calcium influx was due to a raised resting concentration of intracellular 
calcium and hence a reduction in driving force, in the YAC mouse. The raised 
calcium concentration could indeed be due to enhanced NMDA receptor activity.
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No changes in paired-pulse facilitation were observed in either mouse at any 
age tested. There was evidence of presynaptic alterations, however, as post-tetanic 
potentiation was reduced. It would appear, therefore, that presynaptic terminals react 
normally to a single stimulus, but are unable to sustain trains of repetitive transmitter 
release.
The authors assign some of their observations to altered NMDA receptor 
function (Hodgson et ah, 1999), however the caveat that Mg'^-free ACSF was used 
throughout is not considered.
1.4.2.3 R6/2 mouse
The third and perhaps the most comprehensive study to date was carried out within 
the hippocampus of the R6/2 mouse (Murphy et al, 1998; 2000). Some basal 
properties and plastic changes were reported as abnormal, while others appeared 
normal. Within the CAl region there was no age dependency observed for any of 
the reported changes below and therefore results from mice aged 5-18 weeks were 
pooled.
Resting membrane potential, membrane resistance and action potential 
threshold were found to be normal, while the amplitude and duration of the action 
potential were found to be reduced. This was reflected at the field level, where 
greater stimulation intensity was required to evoke a pop spike, although input- 
output relationships were found to be normal for both the EPSP and pop-spike field 
responses.
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Long-term synaptic changes were reported as abnormal. LTP of the EPSP 
recorded from the CAl field was impaired, while depotentiation was enhanced. The 
impairment of CAl EPSP LTP was not age-dependent, with mice from five to 18 
weeks displaying a similar deficit. In contrast LTP within the dentate gyrus was age- 
dependent with a greater impairment at >12 weeks than at 4-7 weeks.
PTP was found to be smaller in transgenics than in littermate controls, a 
difference ameliorated by the application of D-AP5, suggesting a modified NMDA 
receptor function rather than impaired transmitter release. Pharmacologically 
isolated NMDA-mediated EPSPs were, however, identical to littermate controls, 
suggesting a normal NMDA receptor function.
Interestingly, CAl synapses were shown to support homosynaptic and 
reversible LTD, a phenomenon normally down-regulated by this age (Dudek & Bear, 
1993; Milner et al., 2004b). Furthermore, the induction of LTD was found to be D- 
AP5-sensitive (see figure 1.4.1).
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Figure 1.4.1: LTD in the R6/2 hippocampus. Low-frequency stimulation (solid 
bar) induces homosynaptic LTD at R6/2 (•) CAl synapses, but not wild-type 
littermates (•). (Adapted from Murphy et al, 2000.)
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The development of inclusions within the hippocampus was also studied. 
Aggregate formation was developmental, with aggregates detectihle in the CAl field 
at 3 weeks, dentate area at 7 weeks and granule cells at 10 weeks. As the appearance 
of inclusions coincided with the development of both cognitive and synaptic 
impairments, the authors propose that inclusion formation may underlie the 
development of aberrant synaptic plasticity observed in these mice. This proposal is 
a very attractive one, suggesting that as mutant huntingtin builds up within the 
nucleus and aggregates, so the synaptic and cognitive phenotypes become apparent. 
In the reversible mouse model (Y amamoto et al, 2000), switching off the transgene 
led not only to a clearance of aggregates but also a reversal of the behavioural 
(clasping) phenotype. This would suggest that aggregates are an important factor in 
disease progression. Conversely, there is a temporal difference between the rate of 
aggregate clearance and the reversal of the behavioural phenotype. Striatal cells, 
prepared from the double transgenic reversible mouse, showed aggregate formation 
within 2 days of gene expression and reached a plateau at 6 days. Following dox 
treatment to turn off gene expression, aggregates showed a decline within 3 days and 
were totally absent by 5 days of treatment (Martin-Aparicio et al, 2001). Given this 
rapid turnover of aggregates in vitro, the temporal relationship between aggregate 
clearance and the behavioural phenotype was restudied. Aggregates were found to 
be totally cleared within 3 weeks of dox treatment. At 4 weeks, mice were still 
found to be deficient on a rotarod test and it was not until 8 weeks of treatment that 
transgenic mice were indistinguishable fi*om age-matched controls (Martin-Aparicio 
et al, 2001). While these results demonstrate that continued expression of mutant 
huntingtin is required for the maintenance of a phenotype, the disparity in aggregate
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clearance and motor phenotype suggests that aggregates may not be an important 
factor in symptom development.
1.4.2.4 R6/1 mouse
The R6/2 mouse study of hippocampal synaptic plasticity (Murphy et al,  2000) 
suggested there to be a progressive onset of an aberrant phenotype. This was 
particularly evident in the dentate area, while the CAl field showed abnormal 
plasticity fi-om an early age. The general deficit may be a reflection of the R6/2 
mouse which is a relatively aggressive model of HD. In contrast the R6/1 mouse line 
is a more progressive model, with key phenotypic developments (including 
cognitive, motor and behavioural phenotypes) showing a greater separation than in 
the R6/2 (figure 1.4.2). Given its more protracted phenotype, the R6/1 mouse lends 
itself particularly well to linear studies. A study of LTD in the CAl-field of the R6/1 
mouse has been carried out in our lab and preliminary data have been presented in 
abstract form (Milner et al, 2002b; 2003a; Milner et al, 2004a). The study 
demonstrates a normal developmental down-regulation followed by a re-emergence 
of LTD, even prior to mice exhibiting a behavioural phenotype.
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Mutant human gene 
Exon 1, CAG(.^5o,: R6/2 m ouse 
Exon 1, CAG(_iig): R6/1 m ouse
Cognitive Motor phenotype &
impairment ^  U n ^  weight Death
R6/2 ' ^
R6/1
Cognitive Motor phenotype &
impairment  ^ Underweight Death
2 m onths 4 m onths 6 m onths 14 months
Figure 1.4.2: R6/2 versus R6/1 mouse model. Top, Representation of the HD 
mutation in humans (juvenile) showing an expanded CAG repeat in red. The 
truncated gene fragments inserted into the R6/2 and R6/1 mice are shown below. 
Bottom, timelines showing the advantages of the R6/1 mouse over the R6/2 mouse 
for linear studies of early onset phenotypes. In the R6/2 mouse the key phenotypic 
features manifest approximately simultaneously, whereas the R6/1 phenotype is 
more progressive, showing a gradual development closer to that seen the human 
syndrome.
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1.4.2.5 Other models
Synaptic plasticity has also been briefly investigated in the reversible mouse model 
of HD (Y amamoto et al, 2000). This model shows similar cognitive deficits to the 
R6/2 mouse which are correlated with a similar down regulation in LTP (see Bates & 
Murphy, 2002). As with the remarkable recovery and reversal of behavioural and 
pathological changes observed in this mouse following “gene-off’, the 
electrophysiological and cognitive abnormalities also show a recovery.
The presynaptic SNARE-associated protein complexin II is down regulated in 
R6/2 mice (Morton & Edwardson, 2001). A complexin II knock-out mouse has been 
produced (Takahashi et al, 1999). These mice show no abnormal behaviour and 
have normal basal synaptic transmission (input-output relationships and PPF). LTP 
recorded in both the CAl field and the CA3 field showed impaired LTP compared to 
wild types, a finding very similar to that in the R6/2 (Murphy et a l , 2000).
1.4.2.6 Summary of synaptic plasticity in HD mouse models
A summary of the mouse models of HD can be found in table 1.4.1, which lists their 
key phenotypic features and the electrophysiological data. A consistent finding firom 
the mouse models of HD is that synaptic plasticity is abnormal, even before the onset 
of a motor phenotype. Although the findings of Hodgson and colleagues are hard to 
directly compare with the other two reports because of the absence of magnesium in 
the ACSF, all three show that long-term potentiation is impaired compared to wild- 
type littermates. This finding is possibly mirrored in the striatum, where the
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incidence of LTP may be increased, suggesting that a global deficit in LTP is not the 
case.
While the authors of the YAC and knock-in studies suggest a presynaptic 
modification may underlie abnormalities in plasticity, the R6/2 data would suggest a 
post-synaptic deficit involving downstream events of the NMDA receptor. The fact 
that the synaptic phenotype of the R6/2 and complexin II knock-out mice are similar 
(Takahashi et al, 1999; Murphy et al, 2000) would suggest, however, that a 
presynaptic mechanism underlies the deficits observed in the R6/2 mouse. A 
complexin II deficit (Morton & Edwardson, 2001) could also account for the 
impairments observed in sustained neurotransmitter release at high firequency. A 
lack of inhibitory complexin II in HD could lead to a disinhibition of transmitter 
release resulting in rapid synapse depletion during periods of high-fi*equency activity 
(as described by Usdin et al 1999).
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1.4.3 Summary
Evidence obtained from electrophysiological studies within the hippocampus of 
mouse models of HD demonstrates that synaptic plasticity is abnormal within these 
mice. There are, however, no data on electrophysiological studies of long-term 
synaptic plasticity within the cerebral cortex. The cerebrum is a region that 
undergoes severe neurodegeneration by the later stages of HD. Prior to the onset of 
the motor and psychiatric conditions that are associated with cell death, there are 
early cognitive deficits that correlate with loss of neurochemical markers. In 
particular, impairments in recognition memory are discernable before other cognitive 
deficits. Evidence suggests that aspects of recognition memory are encoded within a 
region of the telepencephalon known as the perirhinal cortex. The cellular 
mechanism by which recognition memory is encoded within this region is thought to 
be that of long-term depression. Given the aberrant up-regulation of LTD in the 
hippocampus of R6/2 mice, it is reasonable to suggest that LTD may be abnormal in 
regions, such as the perirhinal cortex, where LTD is a normal form of synaptic 
plasticity.
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1.5 The perirhinal cortex
The perirhinal cortex is located within the medial temporal lobe (for review see 
Burwell et al,  1995). More specifically it is located at the posterior region of the 
rhinal sulcus and encompasses areas 35 and 36 as illustrated by Korbinian Brodmann 
in the human brain (Brodmann, 1909, figure 1.5.1). The perirhinal cortex has been 
demonstrated to be involved in various cognitive tasks (for review see Suzuki, 1996; 
Murray & Bussey, 1999) including stimulus-stimulus associations (usually evaluated 
by cue associations: "If cue A then respond X but not Y, if cue B then respond Y not 
X", Murray et al, 1993; Buckley & Gaffan, 1998; Bussey et al, 2003), fear 
conditioning (the acquirement of a neutral stimulus to evoke a strong emotional 
response following temporal pairing with an aversive stimulus, Corodimas & 
LeDoux, 1995) and also a more general role in visual processing, for example the 
retention of previously learned object discriminations are lost following lesion of the 
perirhinal cortex (Gaffan & Murray, 1992; Buckley & Gaffan, 1997; Thornton al, 
1997). There is also strong evidence that the key role of the perirhinal cortex is that 
of discrimination between novel and familiar cues (Brown & Xiang, 1998; Brown & 
Aggleton, 2001). This type of discrimination is known as recognition memory which 
will be discussed in section 1.5.2.
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Figure 1.5.1: Location of the human perirhinal cortex. Top, One of Brodmann’s 
original illustrations showing areas 35 and 36 (red numbers) which make up the 
perirhinal cortex, (Adapted from Brodmann, 1909.) Bottom, An MRI scan of the 
human head. The location of the perirhinal cortex is highlighted by the yellow circle. 
The green line indicates the approximate plane of the Brodmann figure above 
(Adapted from Johnson & Becker, 1995-1999.)
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1.5.1 Neuroanatomy
The neuroanatomy of the perirhinal cortex has been described in several species 
including monkey (Suzuki & Amaral, 1994a, b), cat (Witter & Groenewegen, 1986), 
dog (Woznicka & Kosmal, 2003) and rat (Burwell et al, 1995). The same general 
structure is common in all species, with the perirhinal cortex located in Brodmann 
areas 35 and 36 along the full extent of the rhinal sulcus and is bordered by 
entorhinal and temporal association cortices. The rodent perirhinal cortex is shown 
in figure 1.5.2
In rat (and other species) area 35 and area 36 have distinct architectures (see 
(Burwell & Amaral, 1998; Burwell, 2001). While area 36 has a granular layer IV, 
area 35 is considered agranular, having only few granule cells dispersed into the 
pyramidal cells of the inner region of layer III and outer region of layer V. In both 
areas layer I is (almost) cell fi*ee, containing collateral inputs from adjacent regions. 
Layers II/III are densely packed with medium-sized pyramidal cells, while the 
pyramidal layer V contains widely spaced, large pyramidals. Layer VI can be 
separated into superficial and deep regions; the superficial region consists of 
polygonal cells; the deep region contains elongated, flat cells. Below layer VI is 
found the corpus callosum (white matter) and then the hippocampal formation. The 
interconnectivity of the cellular layers is represented in figure 1.5.2.
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Figure 1.5.2: The rodent perirhinal cortex. Top, Lateral view of the rodent brain 
showing the location of areas 35 and 36, the perirhinal cortex, which sits along the 
extent of the rhinal sulcus (rs). Bordering this region are the entorhinal cortex (EC), 
temporal cortex (Te) and postrhinal cortex (POR). (Adapted from Brown & 
Aggleton, 2001.) Bottom, Schematic of the cytoarchitecture of the perirhinal cortex. 
Afferents synapse with layer II/III pyramidal cells in the surface layer. Pyramidal 
cells project to other pyramidals in both layer II and in the deeper layers V and VI. 
Interspersed in layer V are granule cells which provide an inhibitory input. The 
axonal output of the perirhinal cortex (red lines) projects to other regions of the 
brain, see figure 1.5.3. (Adapted from Faulkner & Brown, 1999.)
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Figure 1.5.3: The connectivity of the perirhinal cortex with other cortical 
regions. Connectional diagrams showing the parallel routes by which sensory 
information reaches the perirhinal cortex and adjacent regions. The thickness of the 
arrows indicates the size of the projection (DG, dentate gyrus; EC, entorhinal cortex; 
POR, postrhinal cortex; STG, superior temporal gyrus; STS, superior temporal sulcus; 
TE, temporal cortex). (Adapted from Brown & Aggleton, 2001.)
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1.5.1.1 Glutamatergic pathways
There are three major connections between the perirhinal cortex and other brain 
regions (see Suzuki, 1996): 1) Reciprocal projections with the hippocampus and the 
entorhinal cortex; 2) Inputs from both unimodal and polymodal association cortices; 
3) Interconnections with the amygdaloid complex. The main connections of the 
perirhinal cortex are summarised in figure 1.5.3.
The above connections are not uniformly distributed between areas 35 and 36 
(Burwell & Amaral, 1998). Temporal cortex provides the source of afferentation for 
50% of all inputs into area 36, but only 10% of area 35. In contrast, area 35 receives 
22% of its inputs from entorhinal cortex and 12 % from temporal cortex. Projections 
from layer V cells terminate on layer V perirhinal cells. Inputs to layer III cells 
originate in layer III of adjacent cortex. Likewise area 35 receives 25% of its cortical 
input from the piriform cortex, which provides only 6% of the input to area 36.
These afferents terminate in the superficial layers and are represented in figure 1.5.2.
1.5.1.2 Dopaminergic pathways
An input that is commonly overlooked when considering the perirhinal cortex is that 
of dopaminergic connections from the mesolimbic system. The mesolimbic system 
contains dopaminergic neurones within areas AS and A9 (substantia nigra) and AlO 
(ventral tegmental area, VTA) of Dahlstrom and Fuxe (1964). These pathways are 
thought to be involved in reward and pleasure and long-lasting enhancements in 
these pathways are thought to underlie opiate addiction (see Thomas & Malenka,
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2003). There is good evidence that the perirhinal cortex receives a substantial 
afferentation from the VTA neurones, but not particularly from the substantia nigra.
It was realised in the early 1970s that cortical innervation by dopaminergic 
neurones was evident (Thierry et al, 1973a; 1973b; Berger et al, 1974; Lindvall et 
al,  1974). Initial studies highlighting a dopaminergic input into the perirhinal cortex 
were carried by dopamine uptake experiments, visualised by fluorescence following 
lesions of the noradrenergic neurones. This technique showed that all regions of 
cortex have dopaminergic fibres, but the region immediately dorsal to the rhinal 
sulcus in rat receives a high proportion of the overall cortical dopaminergic 
innervations. Other cortical areas particularly rich in innervation were the prefrontal 
and frontal cortices (Berger et al, 1976).
A more refined study was carried out by Simon and colleagues using 
anterograde tracing. Tritiated leucine was injected into VTA neurones and found to 
project through the medial forebrain bundle to the amygdala and cortical regions 
(Simon et al, 1979). Although the perirhinal cortex was not specifically analysed, 
there is clear labelling within the region, demonstrating a direct path from VTA to 
perirhinal cortex.
The first quantitative study of dopaminergic afferentation of the perirhinal 
cortex was carried out again using tritiated dopamine. Two groups of rats were 
studied, one normal and one that received 6-hydroxydopamine lesions to the VTA. 
Following lesioning, slices were taken from rats and incubated in a chamber 
containing a monoamine oxidase inhibitor and desipramine (a drug that prevents 
monoamine uptake into noradrenergic and 5-HT neurones), exposed to the tritiated 
dopamine and then fixed for histochemical examination and measured per cubic 
millimetre of tissue. Labelled varicosities were found to be particularly high in the
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cingulate and prefrontal cortices; the perirhinal, entorhinal and piriform cortices 
received an intermediate degree of innervation; and other cortical regions, including 
visual and parietal cortices, showed only a low level of labelling (Descarries et al, 
1987). The rats that received lesions showed almost no cortical labelling. The 
laminar densities were assed to a degree and found to be higher in layers III-VI (as 
assessed as a whole) than in layers I/II.
Consistent with the dopaminergic afferentation of the perirhinal cortex a 
number of autoradiographic studies have demonstrated the presence of both Di and 
D2 dopamine receptors. In these experiments tritiated receptor-specific ligands were 
applied to sections of perirhinal cortex from a range of species to identify the 
distribution of receptors. The first of these reports showed that, in rats, cats and 
macaque monkeys, there is laminar distribution of both receptor subclasses 
(Richfield et al, 1989). D% receptors were present at an order of magnitude higher 
than D2 receptors in all layers of cortex from all species. Furthermore layers I/II had 
the most intense labelling of both receptors, closely followed by layers V/VI; layers 
Ill/rV were always lower than the other two bands.
Another autoradiographical study was carried out examining only D2 
dopamine receptors in rat, cat and human temporal cortex. Similar results to the 
aforementioned article was found for the human perirhinal cortex (Goldsmith & 
Joyce, 1994,1996). The rat and cat perirhinal cortex, however, showed a different 
trilaminar distribution (although it should be noted that the representative 
autoradiograph is far from convincing). There was intense emission from layers I 
and III, while the deeper layers were totally devoid of labelling, as were the 
entorhinal and temporal cortices (Goldsmith & Joyce, 1994).
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Also consistent with the human studies is the distribution of the dopamine 
transporter in the human perirhinal cortex. Dopamine transporter-containing fibres 
were found in all layers and staining was particularly intense in the surface and deep 
layers (Ciliax et al, 1999), consistent with both the innervation and dopamine 
receptor distribution.
In light of the two contrasting autoradiographical reports, it is apparent that 
the distribution of D2 (and, with the lack of replication, Di) is questionable within 
rodents and should, therefore, be addressed.
It appears, therefore, that inputs from multiple regions converge at the perirhinal 
cortex. This is consistent with the different cognitive functions in which the region 
has been implicated i.e. the declarative aspects can be associated with the 
hippocampal connections; emotional memories with the amygdala; and associative 
properties with other regions of cortex. The dopaminergic input from mesolimbic 
regions may provide a reward aspect to cognitive processes encoded within the 
perirhinal cortex.
1.5.2 Recognition memory
Several lines of evidence implicate the perirhinal cortex as having a crucial role in 
recognition memory (see Brown & Xiang, 1998; Brown & Aggleton, 2001). 
Recognition memory requires the ability to discriminate between a novel or familiar 
cue and judgement concerning prior occurrences, for example recency or context. 
Various studies have implemented temporal lobe structures as being important in
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recognition memory. Amnesic patients that have suffered sustained ventromedial 
temporal cortical damage show impairments in recognition memory (Aggleton & 
Shaw, 1996). Similarly, bilateral ablation of the hippocampal formation, the 
amygdala and adjacent cortex, including entorhinal and perirhinal cortices, in 
monkeys produces severe memory impairments (Mishkin, 1978; Zola-Morgan et al, 
1982; Murray & Mishkin, 1984).
In an attempt to dissect the exact roles of the amygdala and hippocampus in 
recognition memory, Murray and Mishkin (1986) removed the rhinal cortices in 
conjunction with either the amygdala or the hippocampus. Monkeys that underwent 
hippocampectomy were found to be far less impaired than those that underwent the 
amygdalectomy. Furthermore, the amygdalectomised group were equally as 
impaired as those that had undergone complete removal. Similarly, in humans, 
amnesic patients with damage restricted to the hippocampus perform well in 
recognition tests (Murray & Bussey, 1999).
The role of the amygdala was later called into question when it was found 
that bilateral lesions of the amygdala, which spared the overlying cortex, did not 
exacerbate the memory loss arising from hippocampectomy alone (Zola-Morgan et 
al, 1989). This suggests that neither the hippocampus, nor the amygdala are the 
location of recognition memory encoding, but rather the overlaying cortex. Further 
evidence for the exclusion of the amygdala in a role in recognition memory came 
following new architechtonic and connectional studies in 1987, when it was realised 
that the perirhinal cortex extends far more rostral than previously considered (Amaral 
et al, 1987; Insausti et al, 1987). Following this new definition of the perirhinal 
cortex the results of the 1986 Murray and Mishkin paper were reassessed and it was 
found that the cortical damage caused by the amygdalectomy was concentrated far
178
more on the perirhinal region than first appreciated. Experiments were carried out to 
separate the contributions provided by the entorhinal and perirhinal cortices and it 
was found that entorhinal (only) ablation in monkeys led to only mild impairments of 
recognition, while perirhinal (only) ablations led to severe impairments (Meunier et 
al, 1993). This perirhinal cortical specific impairment was almost as severe as that 
seen with the total parahippocampal ablations (cross-laboratory comparisons). 
Furthermore, the impairments following perirhinal ablations applies to both visual 
and tactual recognition (Suzuki fl/., 1993).
It appears, therefore, that the ability to discriminate between novel or familiar 
cues is encoded within the perirhinal cortex, while contextual elements of 
recognition memory are encoded in perirhinal cortex-associated brain regions. 
Pharmacological studies have implicated a range of neurotransmitter systems in 
recognition memory.
Glutamatergic transmission is important in object recognition. Blockade of 
AMPA/KA receptors by CNQX prevents the acquisition of object recognition 
memories in rats (Barker et al, 2003). Reports of NMD A receptor involvement in 
recognition memory varies. MK801 blockade of NMD A receptors does not affect 
novel object exploration, but does affect contextual (spatial) aspects of recognition 
memory (Bevins & Bardo, 1999). In contrast, application of high (but not low) doses 
of D-AP5 does affect the performance of rats in recognition tasks (Abe et al,  2004). 
Metabotropic glutamate receptors appear to be involved in longer-term recognition 
memory (more than 24 hours) but not short-term memory (20 minutes), as 
demonstrated by the broad-spectrum antagonist LY341495(Barker et al,  2003). 
When group-specific antagonists were used, it was found that neither mGlu5, group 
II nor group Ill-specific antagonists significantly impaired object recognition at 24
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hours. In contrast, co-application of the mGluS and group II antagonists impaired the 
rats performance (Barker et al,  2003/ personal communication).
Dopaminergic activity is important for recognition memory. Blockade of 
either Di dopamine receptors with SCH23390 (Besheer et al, 1999) or D2 receptor 
antagonism with raclopride (Woolley et al, 2003) reduces the time spent by rats 
exploring novel objects in an open field arena test. A role for dopaminergic 
pathways in recognition memory is also provided by methamphetamine-induced 
monoamine toxicity, which also impairs a rats ability to perform on these tasks 
(Bisagno et al, 2002; Belcher et al, 2003).
Inhibition of acetylcholine activity at cortical and hippocampal muscarinic 
receptors by scopolamine impairs object recognition in both young (3-6 months) and 
old (20-24 months) rats (Vannucchi et al, 1997). The cholinergic-induced deficit is 
dose-dependent and has been shown to be reversed by an antagonist of the 5-HT6 
receptor (Woolley et al, 2003) or 5-HTi receptor (Pitsikas et al, 2003). Similarly, 
the 5-HTô antagonist reverses impairment in recognition memory in rat induced by 
the D2 dopamine receptor antagonist raclopride (Woolley et al, 2003).
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1.5.3. Neural correlates of recognition memory
Several electrophysiological studies have identified a potential neural correlate for 
recognition memory. Recordings firom neurones in the monkey perirhinal cortex 
show that some cells fire fewer action potentials upon the second and subsequent 
presentation of stimuli than on the first (figure 1.5.3, Brown et al,  1987; Fahy et al,  
1993; Xiang & Brown, 1998). Approximately 25% of all recorded neurones show 
decrements in firing rate upon repeated cue presentation (Miller et al, 1993; Xiang 
& Brown, 1998). Of these cells, 50% show such reductions for more than 24 hrs 
after the first presentation (Xiang & Brown, 1998). The change in firing rate occurs 
within 90 ms of the stimulus presentation. This rapid response is too fast for the 
involvement of feedback firom other brain regions (Brown & Bashir, 2002) meaning 
that familiarity encoding is inherent to the perirhinal cortex. Importantly, reductions 
in neuronal firing rate are seen independently of reward or even prior training on 
recognition tasks (Fahy et al, 1993; Brown & Xiang, 1998; Brown & Bashir, 2002) 
and therefore the decrements in firing rate are intrinsic to familiarity. The system has 
a high capacity, which is demonstrated by the observation that such reductions in 
neuronal firing are seen despite the animal having seen many hundreds of items 
(Xiang & Brown, 1998). Similar reductions have also been reported in the 
anaesthetised (Zhu & Brown, 1995) and awake (Zhu et al, 1995) rat perirhinal 
cortex, indicating that this mechanism is common to other species.
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Figure 1.5.4: An example of décrémentai repetition-related neuronal response.
Note the much weaker response of perirhinal neurones to the repeat stimulus (lower 
histogram and raster plot) compared to the first stimulus (upper histogram and raster 
plot). Responses were recorded from monkey perirhinal cortical neurones during a 
serial recognition memory task. 10 different pictures were presented to the monkey 
for three seconds (bar) and the occurrences of action potentials in each trial are 
represented as dots in each row of the raster. Variable numbers of trials using other 
pictures intervened between the first and second presentation of each stimulus used 
in the first trial. The order of the ten raster plots is the same for both the first and 
repeat traces. (Adapted from Brown & Xiang, 1998.)
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1.5.4. Plasticity in the perirhinal cortex
It is possible that changes in synaptic transmission at perirhinal cortical synapses 
may underlie the changes in neuronal firing rate observed during familiarisation. 
Plastic changes in synaptic transmission have been reported in the perirhinal cortex. 
Both long-term potentiation (Bilkey, 1996; Ziakopoulos et al, 1999) and long-term 
depression (McCaffery et al, 1999; Cho et al, 2000) can be expressed in acute slices 
taken from rat perirhinal cortex. It is likely that long-term depression is the 
underlying mechanism by which a décrémentai neuronal firing rate is mediated.
Short-term changes
Application of paired-pulse stimuli to perirhinal cortical synapses results in 
depression of the second response (Paired-pulse depression; PPD; figure 1.5.5). This 
is in contrast to the response obtained in the hippocampus where PPF is observed. In 
the hippocampal system, PPF is known to be a presynaptic phenomenon involving 
calcium preloading of the presynaptic terminal to affect greater transmitter release on 
the second stimulus. PPD results form modulation of this mechanism by the 
expression of presynaptic autoreceptors, commonly metabotropic glutamate 
receptors (Scanziani et al, 1997; Vogt & Nicoll, 1999).
Within the rat perirhinal cortex PPD is observed between stimulus intervals 
of 25 and 2000 ms, with a maximal depression at 200 ms. The paired-pulse profile 
closely follows the temporal profile of GABAb mediated inhibitory postsynaptic 
potentials, suggesting that GABAb receptors may mediate the PPD observed.
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Indeed, blockade of GABAb receptors alters the profiles to that of facilitation 
(Ziakopoulos et al, 2000). PPD was not affected by CPPG (group II/III mGlu 
receptor antagonist at the concentration used) or the adenosine A1 receptor 
antagonist DPCPX (Ziakopoulos et al, 2000 235). PPD in the rat perirhinal cortex 
was found to be heterosynaptic, such that either temporal followed by entorhinal 
stimulation, or vice versa, resulted in PPD.
Long-term depression
Long-term depression was first demonstrated in the perirhinal cortex by 
pharmacological activation of mGlu receptors using group-specific agonists 
(McCaffery et al, 1999). The broad spectrum agonist of group I/II mGlu receptors, 
(1*5, 3R)-1 -aminocyclopentane-1,3 ,dicarboxilic acid (ACPD), bath applied to slices 
of rat perirhinal cortex, induced a robust depression in synaptic transmission that 
lasted for over 60 minutes following washout of the drug. A less consistent result 
was obtained with the group I mGlu receptor specific agonist {R, *S)-3,5- 
dihydroxyphenylglycine (DHPG). Group II mGlu receptor agonism using {IS, 2’R, 
3’R)-2-(2’, 3’-Dicarboxycyclopropyl)glycine (DCG-IV) induced a significant and 
long-lasting depression. In contrast, activation of the group III subclass of mGlu 
receptors by the specific agonist (*S)-2-amino-4-phosphonobutanoate (L-AP4) failed 
to induce a lasting depression in synaptic transmission following washout of the 
drug.
Initial attempts to induce an extracellularly recorded LTD resulted in 
depression that returned to approximately 10% of baseline within 30 minutes and had 
essentially returned to baseline one hour post conditioning (Ziakopoulos et al,  1999,
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figure 1.5.5). The maximal degree of depression obtained in the temporal pathway 
was significantly greater than in the entorhinal input. The maximal depression 
exhibited by the temporal, but not the entorhinal pathway, was reduced by 
application of D-AP5. Neither pathway was affected by the mGlu receptor 
antagonist MCPG (Ziakopoulos et al, 1999). This would suggest that NMD A, but 
not mGlu receptors, are involved in this short-lasting depression.
In contrast, intracellularly recorded currents did show LTD in response to 
low-fi*equency stimulation (Cho et al, 2000, figure 1.5.5). An interesting activity- 
dependent form of LTD was found to be supported at perirhinal synapses that is co­
dependent on both NMDA and mGlu receptors. The co-dependency is a feature that 
is shared with only one other brain area: The amygdala (Wang & Gean, 1999). 
Interestingly mGlu receptors demonstrate a voltage-dependency for involvement in 
LTD induction. When perirhinal neurones were voltage clamped at -70 mV, LTD 
was found to be dependent on the co-activation of the NMDA receptor and both 
group I and group II mGlu receptors. When the cell was depolarised to -40 mV, 
however, the requirement of group II mGlu receptor activation was removed (Cho et 
al, 2000). One plausible explanation of the voltage-dependent involvement of group 
II mGlu receptors is a synergistic interaction between group I and II mGlu receptors 
(Schoepp et al,  1996; Mistry et al, 1998) such that there is enhanced calcium 
release from intracellular stores when calcium influx though the NMDA channel is 
limited (i.e. at -70 mV). It appears, therefore, that the rat perirhinal cortex supports 
a novel form of LTD.
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Figure 1.5.5: Synaptic plasticity in the rat perirhinal cortex. A, Paired-pulse 
depression resulting from paired stimuli applied to either the superficial or 
intermediate (layer I or layer III) afférents of the temporal and entorhinal pathways 
(logarithmic scale). No difference was observed between the entorhinal and 
temporal superficial pathways, while the intermediate temporal pathway showed a 
greater degree of depression (**= ?<0.005). B, Synaptic depression recorded at the 
field level in the perirhinal cortex. While LFS (bar) led to a frequency-induced 
depression, responses returned to baseline within one hour. The degree of depression 
observed in the intermediate temporal pathway was greater than that observed in the 
other pathways. (A & B adapted from Ziakopoulos et al, 1999.) C, Long-term 
depression recorded intracellularly. LFS induces a homosynaptic LTD of synaptic 
currents as recorded from the intermediate pathway (no difference between temporal 
and entorhinal). (Adapted from Cho et al, 2000.)
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Modulation of LTD
Other classes of receptor have been confirmed as playing a role in the induction of 
LTD at rat perirhinal cortical synapses. As discussed above, muscarinic 
acetylcholine receptors appear to be involved in recognition memory (see also 
Warburton et al, 2003). A muscarinic receptor antagonist also prevents the decrease 
in neuronal firing observed in rats during exploration of novel objects and also 
blocks the induction of activity-dependent LTD (Warburton et a l , 2003).
Conversely, the application of the cholinergic agonist, carbachol, induces LTD 
(Massey et al, 2001). Agonist-induced LTD was prevented by pirenzepine (an 
antagonist of the Ml class of muscarinic acetylcholine receptor, but was not affected 
by the NMDA receptor antagonist D-AP5 (Massey et a l , 2001 ).
Despite the evidence for a substantial dopaminergic innervation of the 
perirhinal cortex and the demonstration that antagonists of dopamine receptors affect 
recognition memory, to my knowledge no electrophysiological investigations have 
been targeted towards the modulation of glutamatergic transmission and plasticity by 
dopamine receptors within this region.
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1.5.5 Synaptic integration
A complementary mechanism to that of LTD of synaptic transmission has been 
suggested in which synaptic activity may give rise to altered firing patterns of 
perirhinal cortical neurones. Thomas Brown and co-workers have identified multiple 
cell types within the perirhinal cortex based both on morphology and their 
electrophysiological properties (Faulkner & Brown, 1999). The pyramidal cells of 
the perirhinal cortex can be split into three sub groups based on their firing patterns. 
Regular-spiking cells are characteristic of many glutamatergic cell-types within the 
brain, in that they fire action potentials near to the beginning of and throughout, a 
depolarising current step and show accommodation (figure 1.5.6). In contrast, late- 
spiking cells show a delayed onset firing of up to several seconds delay (figure 
1.5.6). The third class, burst-spiking cells, show a stereotyped cluster of firing upon 
depolarisation, followed by a prolonged after hyperpolarisation.
Within layer II/III, 78% of pyramidal neurones studied by Faulkner and 
Brown (1999) were late-spiking cells and 22% regular-spiking cells. In layer V, 80% 
of pyramidal cells were regular-spiking neurones and the remaining 20% were burst- 
spiking neurones. Other cells types identified within the perirhinal cortex include 
fast-spiking neurones (which fire at a rate of over 100 Hz), are of different cellular 
morphologies (small round and bitufted) and are found in most cortical layers. The 
final class of cell are irregular-spiking neurones, which have an unpredictable inter­
spike interval, again have a varying morphology and are found in all layers except 
layer II/III.
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The two main cell types in layer II/III (regular- and late-spiking) were shown 
to have different integrational properties in response to prolonged activation via 
superficial synapses (Beggs et al,  2000, figure 1.5.6). Regular-spiking neurones 
reached firing threshold soon after the start of a 20 Hz train of stimulation, but 
rapidly showed accommodation. In contrast, late-spiking cells showed a delay in 
reaching firing threshold and then maintained firing during the remainder of the 
repetitive stimulation.
It is possible that such a short-term modification of the pattern of action 
potential generation in the perirhinal cortex may directly underlie some cognitive 
processes within this brain region. Indeed, computational studies based on firing 
patterns within a series of such neurones has shown that stimulus representations 
could be encoded within the perirhinal cortex in the order of seconds to tens of 
seconds (Tieu al, 1999; McGann & Brown, 2000). While the short-lasting 
changes reported here may not fully explain the fiinctions of the perirhinal cortex, 
one can envisage that a complete, complex network of neurones could encode 
longer-term memory. Furthermore, a longer-term change in firing rate though a 
synaptic mechanism may indeed be the cellular mechanism for perirhinal cortex 
cognitive processes.
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Figure 1.5.6: Regular- and late-spiking pyramidal cells of the perirhinal cortex.
A: Regular-spiking (RS) neurones typically fire shortly after the passing of a 
depolarising current step and demonstrate accommodation. Late-spiking (LS) 
neurones fire at a longer latency and do not accommodate. B: RS and LS cells 
respond differently to trains of synaptic inputs (20 Hz). Increasing stimulation 
intensities are shown in both cases. RS neurones fire action potentials soon after the 
onset of the train of stimuli, and then accommodate. In contrast, LS neurones show a 
long delay before firing and then maintain action potentials for the remainder of the 
train. (Adapted from Beggs et al, 2000)
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1.6 Cortical synaptic plasticity in HD
As discussed in section 1.4, the majority of studies of synaptic plasticity within 
Huntington's disease have concentrated on either the striatum (being the most 
affected brain region in HD) or the hippocampus (being the most commonly studied 
region generally in electrophysiology). Therefore very little is known about the 
changes that occur at cortical synapses during the progress of the disease. The 
studies that have been carried out to date have concentrated on altered basal 
transmission rather than synaptic plasticity per se and these, along with other studies, 
may be used to gain insight into potential changes that may occur to cortical synaptic 
plasticity in HD.
1.6.1 Altered receptor expression
Neurotransmitter receptor mRNA levels, protein expression and ligand binding has 
been found to be reduced in both the human HD the R6/2 brain (see table 1.4.1). In 
particular the metabotropic receptors appear to be susceptible, with mGlu, dopamine, 
cannabinoid, 5-HT, histamine, and noradrenalin receptors showing a decline in the 
striatum, a pattern that is mirrored in the cortex for those receptors that have been 
assessed in this region. In particular, the R6/2 striatum shows a massive reduction in 
both Di and D2 receptors, with as low as 33% expression compared to wild-types 
(Cha et al, 1998; 1999). While these authors do not report expression levels in the 
cortex, preliminary data from the Levine lab indicates a decrease in both receptor
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subtypes (Ariano et al, 2001). Given that there are reductions in the receptors 
involved in synaptic plasticity (if only in a modulatory role), it is likely that cortical 
plasticity could be affected.
Protein trafficking could also affect receptor expression. As discussed in 
section 1.2.6, both huntingtin and huntingtin interacting proteins are involved in 
vesicle trafficking which has been shown to be defective in HD. HIPl deficient mice 
show a dose-dependent defect in endocytosis of AMP A receptors. Given that AMP A 
receptor trafficking is thought to be important in synaptic plasticity, particularly 
expression of LTD, it is possible that plastic changes could be affected by this defect.
1.6.2 Altered NMDA receptor activity
In particular it has been demonstrated that pyramidal neurones within the frontal 
cortex (and striatum) of both R6/2 and knock-in mice show an enhanced sensitivity 
to NMDA, as demonstrated by enhanced NMDA-induced cell swelling (Levine et 
al,  1999). Cell-swelling is thought to be an early indication of neurotoxicity and cell 
death (Dodt & Zieglgansberger, 1990,1994; Colwell et al, 1996; Colwell & Levine, 
1996). The enhanced cell swelling observed within the medium-sized spiny 
neurones within the striatum of these transgenic mice are associated with increased 
NMDA-mediated currents (Levine et al,  1999; Laforet et al, 2001) and there is 
evidence this could be specific to the NR2B subunit (Chen et al, 1999b; Zeron et al, 
2002). It is possible that NMDA receptors in the cortex could demonstrate a similar 
enhancement, thereby altering calcium currents important in induction of synaptic 
plasticity.
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1.6.3 Altered glutamate uptake
Alterations in glutamate uptake have been reported in R6 mouse cortex. Glutamate 
transporters are important for the maintenance of the low-level of glutamate in the 
extracellular matrix that is required for effective glutamatergic synaptic transmission 
and the prevention of excitatory amino acid-induced excitotoxicity (Danbolt, 1994). 
Glutamate transporters can be either located directly on the neurones themselves or 
on astroglia. Following uptake, glutamate is metabolised by glutamine synthetase 
into the non-toxic amino-acid glutamine. Glutamine is then returned to the neurone 
to be converted back to glutamate and made available for neurotransmission 
(Yudkoff et al, 1993). Both messenger RNA and protein expression of the astrocyte 
glutamate transporter, GLTl, have been shown to be significantly reduced in an age 
dependent manner within the cortex (and striatum) of both the R6/2 and R6/1 
transgenic mouse lines (Liévens et al, 2001). Moreover, D-aspartate binding, which 
is a measure of glutamate uptake (Danbolt, 1994), is also decreased in the R6/2 
cortex (and striatum) at 12 weeks, but not 4 weeks (Liévens et al, 2001). Decreased 
glutamate uptake within the cortex could result in glutamate remaining within the 
synapse for a longer period and, hence, potentially increased postsynaptic receptor 
activation or, more drastically, glutamate-induced cell death. This effect could be 
compounded further by the increased activity of the NMDA receptor discussed 
above.
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1.7 Summary
Huntington’s disease is an incurable neurodegenerative disease caused by an 
expanded CAG repeat in the gene encoding the protein huntingtin. Classically 
characterised by loss of motor control and dementia, it is now appreciated that a 
subtle cognitive decline is a common feature of the early stages of the disease. At 
this stage patients are otherwise asymptomatic, including no overt neurological 
problems or dementia, or indeed cell death. In particular recognition memory is 
affected early in the progress of HD. Recognition memory is thought to be encoded 
within the perirhinal cortex by a mechanism involving the phenomenon of long-term 
depression. Synaptic plasticity is known to be perturbed in the striatum and 
hippocampus of different mouse models of HD. It is not, however, known what 
affect expression of the mutant gene has on cortical plasticity. This issue will be 
addressed within this thesis by employing the R6/1 mouse model to assess synaptic 
plasticity within the perirhinal cortex.
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1.8 Aims
There has been no investigation to date of the effects that the gene responsible for 
HD has on cortical synaptic plasticity. This is an important issue as emerging 
evidence suggests that the earliest symptoms of HD may be attributable to alterations 
in cortical function. The aim of the work presented here is to address this question, 
using the R6/1 mouse model of HD.
Defects in recognition memory are apparent in HD gene carriers several 
years, sometimes decades, prior to the onset of the classical symptoms. One of the 
key cortical regions involved in recognition memory is the perirhinal cortex and it is 
this region which was investigated in this study. Perirhinal cortical synaptic 
plasticity has been well characterised in the rat, there have been no 
electrophysiological studies of the mouse perirhinal cortex. Therefore, in order to 
assess changes in the R6/1 mouse model of HD, the first part of this thesis 
characterises the electrophysiological properties of perirhinal cortical neurones and 
synapses in the normal mouse. The second part is a linear age study of the 
electrophysiological properties of the perirhinal cortex in R6/1 transgenic mice and 
age-matched littermates. Finally, immunohistochemical techniques are used to 
identify some of the cellular pathological changes that may underlie the changes 
observed in the electrophysiological study.
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2. Materials and Methods
The majority of my research is based within the field of in vitro electrophysiology, 
using a mixture of both field and sharp electrode techniques. The results obtained 
fi*om these experiments have been complement with histological applications to 
assess neuropathological changes within the cerebral cortex of the R6/1 mouse model 
of Huntington’s disease.
2.1 Electrophysiology
2.1.1 Coronal slice preparation
Perirhinal slices were prepared from CBA x C57BL/6 mice or R6/1 mice and their 
wild type littermates. Despite obvious weight differences between male and female 
R6/1 mice (see figure 3.3.1), animals of both sexes were used throughout this study. 
Animals of the appropriate age were killed by cervical dislocation and decapitation 
in accordance with U.K. legislation (Animal (Scientific Procedures) Act 1986). The 
skull was exposed by cutting the scalp along the midline of the head with a scalpel. 
The skull was then cut along the midline using a pair of fine surgical scissors and 
removed with a pair of curved forceps. The meninges were carefiilly removed 
without damaging the underlying brain. A micro-spatula was then used to scoop the 
brain fi*om the remaining skull and was then chilled in ice-cool (1-4°C) dissection 
artificial cerebrospinal fluid (ACSF; comprising, in mM: 124 NaCl, 3 KCl, 26 
NaHCOs, 1.25 NaH2P0 4 , 10 D-glucose, 10 MgS0 4  and zero calcium)
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Figure 2.1.1: Coronal brain slice. Left, Schematic representation of the lateral view 
of the mouse brain. 400 //m coronal slices were cut from the area of cortex marked 
by the horizontal lines. Right, Hemispheres of the brain were trimmed to include the 
area marked by the dotted box. Abbreviations: Aul/2, primary/secondary auditory 
cortex; CAl/3, fields of cornu ammonis; DG; dentate gyrus; ec, external capsule 
(corpus callosum); EC, entorhinal cortex; Ect, ectorhinal cortex; hf, hippocampal 
fissure; IPC, interpeduncle nucleus; LEnt, lateral entorhinal cortex; ml, medial 
lemniscus; Rn; Raphe nucleus; rs, rhinal sulcus; PAG, periaquiductal grey; SNc 
substantia nigra pars compacta; SNr substantia nigra pars reticula; Vl/2, 
primary/secondary visual cortex; VTA; ventral tegmental area. (Right-hand image 
adapted from Paxinos & Franklin, 2001.)
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bubbled with 95% O2 and 5% CO2 (Carbogen; British Oxygen Company). The 
cerebellum, hindbrain, a section of the forebrain and a section of the ventral portion 
of the brain were then removed using single razor blade cuts. Excess ACSF was 
removed from the rostral end of the brain with a filter paper (Whatman hardened 
circles) and the brain fixed to a silicone stage with cyanoacrylate glue (Radio Spares, 
Corby, United Kingdom). The silicone stage was then placed in a cutting carriage 
and submerged in ice-cool dissection ACSF and continuously bubbled with 
Carbogen. Coronal sections (400 in thickness), containing the perirhinal cortex, 
were cut with a manual vibrotome (Campden Instruments Ltd., Sileby, UK). The 
rhinal sulcus and the shape of the underlying hippocampus were used as anatomical 
markers for the perirhinal cortex. Slices were then bisected into separate 
hemispheres and each trimmed to leave the perirhinal and adjacent temporal (dorsal 
side) and entorhinal/ectorhinal (ventral side) cortices as shown in figure 2.1.1.
2.1.2 Oblique slice preparation
Previous studies carried out in the rat perirhinal cortex utilised slices cut at a 45° 
oblique angle to the dorsoventral axis. Therefore this preparation was also 
investigated for mouse perirhinal cortical slices. The brain was removed as 
described above and 45° oblique cuts were made, as shown in figure 2.1.2 and the 
brain glued to the silicone stage. 400 jam slices were cut and trimmed to leave the 
perirhinal and surrounding cortices.
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Figure 2.1.2: Oblique slices. 400 jum 45° oblique slices were cut from the region of 
cortex marked by the diagonal lines. (See figure 2.1.1 for abbreviations)
199
H eating
re s e rv o ir
S lic e  Og/COg A C SF
in te rfa c e  IN IN
S tim u la tin g  A C SF
e le c tro d e  o u t
R e c o rd in g
e le c tro d e
Humidified OJCO.
T is s u e
B rain
s l ic e
W a s te
A C SF
Figure 2.1.3: The interface chamber. A, Photograph of the interface recording 
chamber and electrodes positioned in the slice. B, Schematic of the interface 
chamber. Oxygenated ACSF was pumped into the chamber at a flow rate of 
-125 fAImm and heated to 28°C. A thin layer of ACSF formed over the slice and 
was then removed to waste. The region immediately above the slice was supplied 
with a constant flow of humidified Carbogen (95% 02/5% CO2).
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2.1.3 Interface recording chamber
Following preparation, slices were transferred to an interface recording chamber 
(Scientific Systems Design Inc., Mercerville, NJ, U.S.A.; figure 2.3), lined with a 
double layer of lens cleaning tissue (Whatman pic. Brentford, U.K.), using a sable 
bristle watercolour paint brush (size 4; H. G. Rant, High Wycombe, U.K.). Standard 
ACSF (as dissection ACSF with 2 mM CaCli and 1 mM MgSÛ4), bubbled with 
Carbogen, was continuously pumped into the chamber at a flow rate of 
approximately 125 //l.min’  ^(Watson-Marlow Ltd., U.K.) and heated (Proportional 
Temperature Controller; Scientific Systems Design Inc., Mercerville, NJ, U.S.A.) to 
27°C in a water jacket before reaching the slice. A layer of ACSF formed over the 
slice before being pumped away to a waste reservoir. The space above the slices was 
supplied with humidified Carbogen. The chamber was illuminated using a cold-light 
source (KL1500LCD; Schott UK Ltd. Stafford, U.K.). Slices were allowed to 
recover for one and a half hours prior to experimentation.
2.1.4 Extracellular recording
Extracellular recording electrodes were pulled fi*om borosilicate glass capillaries 
(Harvard Apparatus Limited, Edenbridge, U.K.) using a horizontal micropipette 
puller (Flamming/Brown Micropipette Puller P87, Sutter Instruments Corp., Novato, 
CA, U.S.A.) and filled with 1 M sodium chloride and 2% pontamine sky-blue 5BX 
(electrode impedance 4-8 MQ). Recording electrodes were connected to an
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Axoclamp 2B DC-preamp amplifier (Axon Instruments Inc., Foster City, CA, 
U.S.A.), via an Axoclamp head-stage (gain; xO.l), by sliver/silver chloride wire. By 
using a coarse control micro-manipulator, the recording electrodes were positioned in 
layer II/III of the perirhinal cortex directly below the rhinal sulcus (see figure 2.1.4). 
The circuitry for electrophysiological recording is shown in figure 2.1.5.
2.1.5 Intracellular recording
Intracellular recording electrodes were pulled firom borosilicate glass capillaries 
(Harvard Apparatus Limited, Edenbridge, U.K.) on a horizontal micropipette puller 
(Flamming/Brown Micropipette Puller P87, Sutter Instrument Corp., Novato, CA. 
U.S.A.) and filled with 3 M potassium acetate (electrode impedance 60-140 Mfl). 
Electrodes were connected to an Axoclamp 2B head-stage (gain: xQ.l) by a 
silver/silver chloride wire. The head-stage was attached to a micro-manipulator and 
in addition attached to a fine control micro-driver (Newport Components Ltd., C&D 
Technologies Inc. U.S.A.), allowing stepped advancements of 2 /jm through the 
slice. Electrodes were positioned at layer II/III of the perirhinal cortex, directly 
below the rhinal sulcus (figure 2.1.4) and brought into contact with the slice as 
indicted by the formation of a closed circuit. The head-stage was connected to an 
Axoclamp 2B DC-preamp amplifier (Axon Instruments Inc., Foster City, CA, 
U.S.A.) operated in bridge mode (current clamp). See figure 2.1.5.
202
2.1.6 Stimulating electrodes
Stainless steel, monopolar stimulating electrodes (A-M Systems, Carlborg, WA, 
U.S.A.) were positioned approximately 150-350 fjm from the recording electrode in 
either layer I or layer III to study the superficial and intermediate pathways 
respectively (figure 2.1.4). Responses were evoked by constant current stimulation 
(1-600 //A, 40 //s). In some experiments two electrodes were placed either side of 
the recording electrode. This setup allowed the stimulation of two independent 
pathways, thus enabling the homosynaptic nature of long-term synaptic plasticity to 
be assessed within the perirhinal cortex. Stimulating electrodes were connected, via 
Neurolog isolated stimulators (NL800, Digitimer Ltd., U.K.), to an IT-16 computer 
interface digital-analogue converter (Instrutech Corp., NY, U.S.A.). Coarse control 
micro-manipulators were used to position the stimulating electrodes at the 
appropriate locations.
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Figure 2.1.4: Positioning of stimulating and recording electrodes within a 
perirhinal slice. Cortical layers are indicated (note the absence of layer IV on the 
entorhinal side of the perirhinal cortex). A recording electrode was positioned in 
layer II/III directly below the rhinal sulcus. Stimulating electrodes were positioned 
either side of the sulcus either in layer I (superficial pathways; SI & S2) or within 
layer III (intermediate pathway; S3 & S4).
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Figure 2.1.5: Basic electrophysiological recording set up. Recording electrodes 
were positioned in the perirhinal slice and connected to an Axoclamp 2B DC-preamp 
amplifier or a Neurolog AC-preamp amplifier. The electrical signal was then passed 
simultaneously to an oscilloscope and, via an A/D converter, to a Macintosh 
computer. Electrical stimuli were controlled by the computer and applied to the slice 
though an isolated stimulator box.
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2.1.7 Prevention of mechanical and electrical interference.
To reduce mechanical disturbance, the recording chamber and micro-manipulators 
were placed on an anti-vibration air-table (Technical Manufacturing Corp., Peabody, 
MA, U.S.A.). All electrical apparatus was earthed to one central point. In addition, 
the room was electrically shielded to prevent electrical noise from external sources.
2.1.8 Stimulation paradigms
2.1.8.1 Extracellular recordings
Synaptic responses
Constant current stimulation was applied though monopolar stimulating electrodes to 
layer I or III of the cortex. The duration of the stimulus was set to 40 //s.
Input/output relationship
To ascertain the maximum amplitude of the synaptic response test shocks were 
applied at increasing stimulus intensities between 10 and 600 //A.
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Paired-pulse stimulation
Stimulus intensity was set to evoke responses at 30, 50 and 80% of the maximal 
amplitude. Two identical test shocks were applied at intervals between 20 and 2000 
ms and the ratio of these responses were calculated as a percent change:
100^-100
Pathway independence
In experiments where two stimulating electrodes were placed, pathway independence 
was determined by ensuring no heterosynaptic depression occurred. A series of 
stimulation paradigms were used to assess this. Firstly, homosynaptic paired-pulse 
depression was confirmed at an interval of 100 ms in each separate pathway. 
Secondly, the absence of heterosynaptic depression was confirmed by applying a test 
shock to the second pathway at a delay of 100 ms after the first. Finally, test shocks 
were applied to both pathways simultaneously to ensure summation occurred, further 
demonstrating the independent nature of the pathways. If pathway independence 
was not evident then the electrodes were re-positioned and independence confirmed.
Long-term potentiation
Stimulus intensity was set to evoke responses at 30% of the maximal amplitude. 
Synaptic potentials were evoked at 0.033 Hz and collected for 15-20 minutes. 
Following a stable baseline, theta-burst stimulation was applied. TBS comprised of 
four trains applied every 15 seconds. Each train consisted of 10 bursts of 10 pulses
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at 100 Hz, (inter-burst interval 200 ms) applied at test shock intensity. Following 
TBS, responses were recorded for 1 hour at a frequency of 0.033 Hz.
Long-term depression
Stimulus intensity was set to evoke responses at 80% of the maximum amplitude. 
Test shocks were applied every 30 seconds (0.033 Hz) and synaptic potentials were 
recorded for 15-20 minutes. Low-frequency stimulation (LFS) was then applied to 
induce LTD. LFS consisted of 900 pulses at 1 Hz applied at test shock intensity. 
Following LFS, responses were monitored every 30 seconds for at least 1 hour.
2.1.8.2 Intracellular recordings 
Neuronal impalement
The micro-driver was used to slowly step the intracellular recording electrode 
through the slice. Neuronal impalement was achieved by a brief pulse of positive 
current (40-60 nA, <2 ms) or a brief period of over-compensated capacitance. 
Spontaneous action potentials were often observed upon initial impalement which 
ceased upon an immediate ramped negative current (typically approximately -1 nA) 
applied to the cell. As the neurone stabilised, the negative current was slowly 
removed. Once fully stabilised, healthy neurones were selected on the basis of a 
stable membrane potential and an action potential with an overshoot greater than 60 
mV above firing threshold. Neurones failing to meet these criteria were discarded.
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Passive membrane properties
Once the cells were stabilised passive membrane properties were measured. Current- 
voltage (W ) relationships were measured by intracellular injection of 
hyperpolarising and depolarising constant current pulses (-0.8 nA to +0.8 nA,
150 ms). Action potentials were evoked upon the application of depolarising current. 
Membrane properties of the neuronal cells were determined, including threshold 
potential, action potential amplitude and width at half way between threshold and 
maximum potential. The gradient of the IN  plot in response to hyperpolarising 
current was used to estimate the input resistance (Rin) of each neurone. Membrane 
capacitance (Cm) was calculated from the membrane input resistance and the time 
constant (Xm) using the following relationship: Cm= Xm / Rin- Values of Xm were 
obtained using the protocol in Bindman et al (1988) as follows: Semi-logarithmic 
plots were made of the voltage response against time during the charging of the cell 
by hyperpolarising current pulses. The charging response was always well fitted by 
a single exponential line (R  ^value greater than 0.99) and the time constant calculated 
as the negative reciprocal of the best-fit line at (1-1/e x 100)% of the maximum 
deflection.
Synaptic responses
Intracellular EPSPs were evoked by constant current stimulation (1-200 //A, 40//s) 
via monopolar stimulation electrodes positioned in layer I of the cortex, either ventral 
or dorsal to the recording electrode. To ensure that a pure EPSP was recorded a
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subthreshold EPSP was evoked during the steady-state period of both a 
hyperpolarising and depolarising current step. Early experiments showed that there 
was indeed an inhibitory component to the recorded response. It was found that a 
low concentration (2.5 //M) of GABAa antagonist picrotoxin (PTX, Curtis et a l, 
1970), added to the ACSF, was required to remove this component. Therefore in all 
intracellular experiments 2.5 pM PTX was present.
Long-term depression
Induction of long-term depression of the intracellularly recorded response was 
attempted by the application of various protocols including 900 pulses applied at 1 
Hz, 300 pulses applied at 1 Hz and also pairing synaptic activity with a depolarising 
current to the cell.
2.1.9 Pharmacology
Drugs were dissolved in standard ACSF at the appropriate concentration and applied 
by perfusion into the chamber in place of the standard ACSF. Drugs reached the 
chamber within 5-10 minutes and were then allowed a minimum of 30 minutes to 
equilibrate within the chamber before electrophysiological manipulations were 
carried out. If available, water soluble drugs were always obtained. Where suitable 
water soluble drugs were not available, the effect of the appropriate vehicle (e.g. 
ethanol, dimethylsulphoxide (DMSO), sodium hydroxide (NaOH)) was assessed on 
basal transmission, paired-pulse and long-term depression prior to experimentation.
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2.1.9.1 List of drugs used
Drugs supplied by Tocris-Cookson Ltd. (Avonmouth, U.K.):
UPF 523/(RS)-l-aminoindan-l,5-dicarboxylic acid (AIDA; group I mGlu receptor 
antagonist); 6-cyano-7-nitroquinoxaline-2, 3-dione disodium (CNQX;
AMPA/kainate receptor antagonist); (RS)-a-cycIopropyI-4-phosphonophenylgIycine 
(CPPG; group III mGlu receptor antagonist); D-(-)-2-amino-5-phosphonopentanoic 
acid (D-AP5; NMDA receptor antagonist; also supplied by Sigma-Aldrich, see 
below); (2S)-2-amino-2-[(lS,2S)-2-carboxycycloprop-l-yl]-3-(xanth-9-yl) propanoic 
acid (LY341495; group II mGlu receptor antagonist); 2-(2-amino-3-methoxyphenyl)- 
4H-1 -benzopyran-4-one (PD98059; MAP kinase kinase inhibitor); Quinpirole 
hydrochloride (D2 dopamine receptor agonist); (R)-(+)-7-chloro-8-hydroxy-3- 
methyl-1 -phenyl-2,3,4,5-tetrahydro-1 H-3-benzazepine hydrochloride (SCH23390;
Di dopamine receptor antagonist); (2S)-(+)-5,5-dimethyl-2-morpholineacetic acid 
(SCH50911; GABAb receptor antagonist); (±)-l-phenyl-2,3,4,5-tetrahydro-(lH)-3- 
benzazepine-7,8-diol hydrobromide (SKF38393; Di dopamine receptor agonist); 
Remoxipride hydrochloride (Da dopamine receptor antagonist).
Drugs supplied by Sigma-Aldrich Company Ltd. (Poole, U.K.):
(-)-bicuculline methiodide (BMI; GABAa receptor antagonist); D-(-)-2-amino-5- 
phosphonopentanoic acid (D-AP5; NMDA receptor antagonist; also supplied by 
Tocris, see above); dimethylsulphoxide (DMSO; solvent); picrotoxin (PTX; GABAa
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receptor antagonist); Pontamine sky-blue 5-BX (dye); Sodium hydroxide (NaOH; 
solubility aid); (-)-sulpiride (Da dopamine receptor antagonist).
2.1.10 Analysis
Responses were visualised on a digital oscilloscope (Tektronix Inc., Beaverton, OR, 
U.S.A.), collected on an Apple Macintosh computer and analysed using A/D VANCE 
3.6 software (Robert McKellar Douglas, Vancouver, Canada). The amplitude of the 
synaptic component of the recorded potentials was measured as the difference in mV 
between a baseline value and the peak amplitude. Maximum slope was calculated in 
V.s'^ firom the initial deflection of the synaptic component of the recorded potential. 
The area of the synaptic response was measured in picovolt seconds (pVs) from the 
initial synaptic component to the end of the recording period. All measurements 
were made by the manual placement of cursors. Data were transferred to Microsoft 
Excel 1998 or 2002 for further analysis.
In experiments looking at the outcome of paired-pulse stimulation, the second 
response was expressed as a percentage change from the first (P2/P1 x 100)-100. For 
summary figures a “composite paired-pulse ratio” was produced by summing the 
individual ratios obtained at all paired-pulse intervals. Changes in the composite 
paired-pulse ratio represent differences in the overall profile, but do not identify 
specific changes at a given interval. Therefore, for statistical analysis two-way 
ANOVA were carried out to verify effects of both condition (e.g. drug or phenotype) 
and interval.
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In experiments designed to investigate long-term changes in synaptic 
efficacy, responses were normalised to the last 10 minutes of baseline prior to 
conditioning and expressed as a percentage change from baseline. LTP was defined 
as a stable increase of greater than 10% and LTD as a stable decrease of greater than 
10% in the synaptic potential, 50-60 minutes after the end of the conditioning period. 
Data for each condition were pooled together, irrespective of experimental outcome 
and are expressed as mean ± standard error of the mean (SEM):
standard deviation 
V(n-1)
Graphical representations were produced in Microsoft Excel 2002 and 
presented in Microsoft PowerPoint 2002 or Adobe Photoshop 7.0 (2002). Student t- 
tests, Welch corrected t-tests and one-way ANOVA were carried out using InStat 
3.05 (GraphPad Software Inc., 2000). Two-way ANOVA were carried out using 
Statistica 6.0 or 6.1 (StatSoft Inc., 2002/2003).
Both slice and animal n values are reported in the following format: n= 
number of slices (number of animals). Statistical significance is indicated in 
summary charts as follows: * = P<0.05; ** = P<0.01; *** = P<0.001.
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2.2 R6/1 transgenic mice
2.2.1 Breeding
Founder mice for the Open University R6/1 transgenic mouse colony were obtained 
from the University Laboratory of Physiology, Oxford University, U.K., courtesy of 
Drs. Anthony Hannan and Anton van Dellen. Mice transgenic for exon 1 of the 
mutated human gene responsible for Huntington’s disease were then bred in-house by 
backcrossing transgenic males to CBA x C57BL/6 females (Open University 
colony). Maintenance and care of the mouse line was carried out by Dawn Saddler.
2.2.2 Genotyping
Genotyping was carried out by Ph.D. students Austen J. Milner and Sarat C. 
Vatsavayai in our lab and in strict accordance with the procedure described in the Dr. 
Murphy HD Project Licence. A brief overview of the method is provided below.
2.2.2.1 Tissue retrieval
For identification purposes, mice were ear-marked upon weaning using a small 
punch and then tail tipped to provide tissue for genotyping. Tail tipping was carried 
out following the application of spray local anaesthetic (ethyl chloride; Roche 
Products Ltd.) to the tail. Approximately 5 mm was then severed using scissors and
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forceps (cleaned in 99.9% alcohol between each animal). The tip was transferred to 
a 500 //I Eppendorf® vial and stored at + 4°C until DNA extraction was carried out.
2.2.2.2 DNA extraction
250 jA of lysis buffer was added to each tissue sample and incubated overnight at 
<50°C (proteinase K rapidly denatures at temperatures exceeding 60°C). 125 fA 
saturated sodium chloride solution was then added and agitated vigorously by hand 
for 5 minutes and then microcentrofiiged at 1300 RPM for 30 minutes. 325 /A of 
100% ethanol was added to empty sterile Eppendorf tubes and the supernatant from 
the original samples were then added to the new vials. A DNA flocculent formed, 
which was then pelleted by centrifugation at 1300 RPM for 10 minutes. The 
supernatant was removed and 300 jA of 70% ethanol added and re-centrifuged for 
one minute and the ethanol removed and allowed to air dry for at least 15 minutes. 
The DNA was then resuspended in 30 //I TE overnight at room temperature.
2.2.2.3. Polymerase chain reaction
A master mix was prepared in a sterile Eppendorf® tube and mixed thoroughly. 1 jA 
of sample DNA was added to a tube and as controls R6/1 DNA and PCR H2 O was 
added to two other tubes. 9 //I of the master mix was then added to each tube, which 
were then loaded into a Hybaid Omni PCR machine. The following PCR cycle was 
then used:
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1) 94°C for 2 minutes
2) 94°C for 30 seconds
3) 65°C for 30 seconds
4) 72°C for 45 seconds
5) Steps 2-4 repeated for 36 cycles
6) 72°C for 10 minutes
2.2.2.4. DNA detection
The transgene was identified following gel electrophoresis in ethidium bromide- 
agarose. 2.5 //I loading buffer was added to the PCR products and then 6 jA of each 
sample was loaded onto a 1.5% agarose gel submerged in IxTBE. At either end of 
the gel a 1 kb DNA ladder was also loaded. The gel was run at 100 Volts for 30-45 
minutes and the bands were visualised under a fluorescent gel reader. The presence 
of the transgene was indicated by a band at 272 bp.
2.2.2.5. Solutions for genotyping
Saturated sodium chloride solution
Approximately 5 M solution was made up in deionised water.
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Lysis buffer
Lysis buffer consisted of 50 mM Tris-HCl at pH 8.0,100 mM EDTA and 0.5 % SDS 
made up in deionised water.
Proteinase K
To purify the target material from contaminating proteins proteinase K was used.
This is a non-specific endolytic protease that cleaves peptide bonds at carboxylic 
sides of aliphatic, aromatic or hydrophobic amino acids. Proteinase K was obtained 
from either Fisher Scientific U.K. (Loughborough, U.K.) or Sigma-Aldrich Company 
Ltd. (Poole, U.K.).
TE
A Tris-EDTA buffer at pH 7.0 -  8.0 was used to reduce hydrolysis of bases by 
chelating divalent cations.
Master mix
Each 10 //I reaction consisted of 3.35 /A PCR H20, 1 jA 2 mM dNTPs, 1 jA forward 
primer, 1 fA reverse primer, 1.5 jA Expand™ lOx Buffer (with Mg^ "^ ), 1 jA DMSO 
and 0.15 //I Expand™ polymerase.
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Forward primer
5’-3’: CGC AGG CTA GGG CTG TCA ATC ATG CT (26 bases)
Reverse primer
5’-3’: TCA TCA GCT TTT CCA GGG TCG CCA T (25 bases)
2.3 Behaviour
Limb-clasping
The limb-clasping aspect of the R6/1 phenotype was assessed by tail suspension. 
Mice were considered as positive for clasping if they demonstrated this trait in three 
or more out of ten trials. Percentage of mice displaying limb-clasping was then 
plotted against age.
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2.4 Histochemistry
Histochemical techniques were used to visualise pathological changes within the 
R6/1 mouse brain. A haematoxylin and eosin (H & E) stain was used to highlight the 
cellular architecture of the perirhinal slice. Immunohistochemistry, using a primary 
antibody targeted to N-terminal mutant huntingtin, was used to investigate aggregate 
development within the R6/1 brain. Thirdly, fluorescent labelling of antibodies 
raised to Di and D2 dopamine receptors was used to quantify progressive changes in 
the expression of these receptors.
2.4.1 Section preparation
In order to visualise sections of perirhinal cortex a variety of procedures were 
employed to provide tissue. Initially mice were fixed by intracardial perfusion of 4% 
paraformaldehyde (PEA). Perfusions were performed by either Mark Eyre or 
Christopher Peddie following anaesthesia with Sagatal.
It was found that submerged-fixed brains do not show overt differences from 
perfusion-fixed brains when visualised at the light-level. Following extraction of the 
brain from the skull (see dissection for electrophysiology) the whole brain was rinsed 
in ice-cold ACSF and then immediately submerged in 4% PFA for 48 hours followed 
by 2% PFA overnight and finally transferred to PBS.
Various techniques were attempted in the harvesting of slices from the 
chamber following electrophysiological analysis. Retrieval into ice-cold ACSF
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followed by immersion fixation in 4% PFA for 48 hours was found to yield results 
similar to those obtained from perfused animals. Slices harvested firom the chamber 
following electrophysiological analysis (6-10 hours) were found to yield poorer 
quality images for immunohistochemistry than those fixed directly following 
dissection. Therefore, to enable a direct comparison between electrophysiological 
and histological results, a slice that was prepared for electrophysiology was instead 
fixed immediately after dissection in 4% PFA for 48 hours and then transferred to 
PBS. Most sections in this study were prepared in this manner.
Following fixation, slices were resectioned at 50 /mi. Cryostat (Leica 
CM1900; Leica Instruments, Germany) sections were found to be unsuitable, as the 
surface layers of the cortex, particularly the perirhinal region, were prone to 
detachment. Even cryoprotection and embedding in Tissuetech (Histological 
Equipment Ltd., Nottingham, U.K.) failed to provide suitable sections. Resectioning 
using a vibrotome (Leica VT1000s, Leica Instruments, Germany) was far superior. 
Sections were embedded in a high clarity agarose gel and resectioned at 50 fjm on 
the vibrotome and collected in PBS.
2.4.2 Toluidine blue stain
In an attempt to highlight the cell bodies, several different staining techniques were 
investigated. The fluorescent acridine orange produced a far too intense stain that 
faded almost immediately. Cresyl violet revealed the cell bodies, however also faded 
relatively quickly. It was found that staining the neuronal cell bodies with toluidine
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blue and counterstaining the cytoplasm with eosin pink was the most suitable stain 
and revealed the cortical layers.
The protocol used was adapted firom a standard toluidine blue stain (Bodian 
and Lake, 1963, In Bancroft & Stevens, 1990). Sections were immersed over night 
in a full strength xylene solution to permeabilise the cells. Following the clearing 
solution, the sections were sequentially immersed in 90% and 70% propan-2-ol (2 x 
5 minute washes). Cell nuclei were then stained using 0.01% (w/v) toluidine blue in 
phosphate-citrate buffer, applied for approximately 10 seconds followed by two 
washes with 90% propan-2-ol. The cytoplasm was then counter stained using 1% 
eosin pink (aqueous, pH 7.4) for approximately 5 seconds. Sections were then 
reimmersed in 90% and 100% propan-2-ol and rinsed in xylene ( 2x5  minute 
washes) and finally mounted onto glass slides and cover slipped using DPX 
mountant.
2.4.3 Inclusion mapping
To visualise the formation of inclusions within the R6/1 mouse brain a primary 
antibody, raised against exon 1 of the huntingtin protein and carrying 53 glutamine 
residues (S830 sheep polyclonal; gift from Prof. Gillian Bates, Division of Medical 
and Molecular Genetics, Guy’s Hospital, London, U.K.), was used. 50 jjm free 
floating sections were first rinsed in PBS before unspecific binding was blocked 
using 2% bovine serum albumin in TBS for 15 minutes. Endogenous peroxidase 
activity was then blocked using 3% hydrogen peroxide. The primary antibody 
(S830) was added at a 1 *.2000 dilution and left overnight at +4°C. Biotinylated rabbit
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anti sheep IgG (H+L) (Vector Laboratories, Ltd., Peterborough, U.K.) secondary 
antibody was applied for one hour at room temperature. ABC elite (avidin-biotin) 
(Vector Laboratories, Ltd.) was prepared and added to each set of sections for 45 
minutes. Sections were submerged in 0.05% diaminobenzidine for 6 minutes and 
then washed in distilled water. 3 x 5  minute washes in TBS were carried out 
between each step.
Following the DAB reaction slices were counter stained with either methyl 
green or aqueous eosin and then dehydrated in 70, 90 and 100% ethanol, cleared in 
xylene and then mounted and cover slipped using DPX mountant.
2.4.4 Dopamine receptor expression
To visualise the distribution of dopamine receptors, antibodies raised to specific 
subclasses were used. Di primary antibodies were Rabbit anti-dopamine DI A 
affinity purified polyclonal antibodies (Chemicon International, Temecula, CA, 
U.S.A.). D2 primary antibodies were Rabbit anti-human dopamine D2 (long and 
short isoforms) affinity purified polyclonal primary antibodies (Chemicon 
International). To determine D2 antibody specificity the brains of D2 deficient mice 
(gift from Professor M. Levine, Mental Retardation Research Center, University of 
California, Los Angeles, U.S.A. Kelly et al, 1997; 1998) were used as a control. To 
highlight Di and D2 dopamine receptors a fiuorescently tagged antibody was used. 
The signal was amplified using Tyramide Signal Amplification (TSA™) kit #14 
supplied by Molecular Probes. TSA provides a system whereby low intensity signals 
are amplified, allowing enhanced visualisation. This is achieved by conjugating the
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secondary antibody to horseradish peroxidase (HRP). Tyramide residues on the 
fluorescent dye are then activated by the HRP activity forming a highly reactive and 
short-lived species. This activated dye forms a covalent bond with neucleophilic 
residues in the close proximity of the primary antibody/antigen site (Molecular 
Probes, 2003, see figure 2.4.1). The protocol underwent several adaptations from 
that supplied by Molecular Probes. The final protocol is as follows:
50 fjm resectioned slices were washed in PBS (3x10 minutes) and then cells 
were permeabilised and unspecific binding blocked using a “blocking reagent” for 
two hours. Endogenous peroxidase activity was quenched using a 3% peroxidase 
quenching buffer for 60 minutes. Primary antibodies were then applied at the 
optimum concentration of 2.5 //1/ml (previously titres of 20,10, 5, 2.5 and 1.25 //1/ml 
were tested), dissolved in the blocking reagent, for 3 days. A horseradish peroxidase 
conjugate of a goat anti-rabbit IgG secondary antibody (1:100 of the blocking 
reagent) was applied and left to incubate for 24 hours. This was followed by the 
application of the tyramide solution diluted 1:100 in amplification buffer/0.0015 
hydrogen peroxide solution (supplied in the TSA kit) for 5 hours. Finally, slices 
were rinsed 3 times in PBS buffer (10 minutes each wash) and then transferred to 
acid/alcohol-washed glass slides and allowed to dry slightly. Sections were then 
cover slipped using Fluoromount mountant. Unless stated otherwise, slices were 
washed between in each step 3 x 10 minutes in blocking reagent. All incubations 
were carried out at +4°C. In control experiments where slices were exposed to either 
primary or secondary antibodies only, slices underwent all solution changes stated 
above, but during exposure of experimental slices to the appropriate antibody, 
control slices were washed in blocking reagent.
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Figure 2.4.1: Tyramide Signal Amplification. Primary antibodies (Y) bind to the 
antigen (Ag) of interest i.e. Di or D2 dopamine receptors. Horseradish peroxidase 
(HRP) conjugated secondary antibodies (Y) are then bound. HRP mediates the 
conversion of inactive (■) fluorescent dye to a short-lived active (•) form that binds 
to neucleophilic residues (o) in the near vicinity of the antigen. (From Molecular 
Probes, 2003.)
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2.4.5 Histochemical solutions
Blocking Reagent (for fluorescent microscopy)
2% fish gelatine, 0.01% sodium azide, 0.1% Triton X-100 made up in 0.1 M PBS, 
pH 7.4 (Personal communication, Prof. Victor Popov).
Phosphate-citrate Buffer
Phosphate-citrate buffer solution was prepared according to Bancroft and Stevens 
(1990) and consisted of 0.2 M Na2HP0 4  and 0.1 M citric acid at pH 4.7.
Phosphate Buffered Salt solution
0.1 M phosphate buffered saline (PBS) solution was prepared.
Tris Buffered Saline solution
500 nM Tris and -0.09% saline solution (TBS) was prepared.
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Toluidine blue
0.01% (w/v) toluidine blue was made up in a phosphate-citrate buffer, pH 4.7
2.4.5.1 Chemical sources
Chemicals supplied by Molecular Probes Europe BV, Leiden, The Netherlands:
TSA™ Kit #14 * with HRP-goat anti-rabbit IgG and Alexa Fluor ® 568 tyramide*
Chemicals supplied by Sigma-Aldrich Company Ltd,, Poole, U.K:
Acridine orange; Type VII, low gelling temperature agarose; Gelatine from cold 
water fish skin; 30% hydrogen peroxide solution; Paraformaldehyde; Sodium azide; 
Toluidine Blue, Triton-X-100.
Chemicals supplied by Prolabo, Paris, France:
Cresyl violet
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Chemicals supplied by Vector Laboratories, Ltd., Peterborough, U.K.:
VECTASTAIN® Elite ABC kit; Biotinylated rabbit-anti sheep IgG (H+L);
Chemical supplied by VWR International Ltd., Lutterworth, U.K.:
DPX mountant for microscopy; Aqueous Eosin Pink; Fluoromount mountant ‘Gurr’.
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2.4.6 Light microscopy
Toluidine blue stained sections were visualised on a Zeiss Axiophot microscope 
(Carl Zeiss Ltd, U.K.) and images captured using a 35 mm colour film camera.
Sections that were prepared using S3 80 antibodies raised to mutant huntingtin 
were visualised on a Nikon Microphot-FX microscope (Nikon, Tokyo, Japan) fitted 
with a JVC-KY-F75V digital video camera (JVC Professional Europe Ltd, London, 
U.K.) and images captured onto computer using Image Pro v5.0 (Media Cybernetics, 
U.S.A.).
2.4.7 Confocal microscopy
Sections that were prepared by fluorescent immunolabelling were visualised using a 
Leica DM IBRE scanning confocal microscope (Leica Microsystems Heidelberg 
GmbH, Germany). A confocal microscope was used rather than a standard 
fluorescent microscope to reduce the level of glare fi-om emissions in surrounding 
tissue, thereby increasing the definition of tissue structure. This is achieved as the 
confocal microscope images only a thin layer of tissue at one time; where as a 
standard microscope images the full thickness of the section.
Images from each experimental set of slices were taken at a standardised 
photomultiplier tube (PMT) intensity. The PMT threshold intensity was set to give a 
suitable level of fluorescence in the wild type mice, thereby maximising any decrease 
in intensity to be observed in the R6/1 mouse. The laser intensity was constant in all
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experiments that were directly compared and to further reduce the probability of 
fluctuations in the laser intensity all slices were imaged on the same day.
The confocal microscope was controlled by Leica Confocal Software 
(Version 2.5) and images taken using the TRIT-C channel optimised for 576 run 
emissions. The fluorochome (Alexa Fluor 568) was excited at 568 run. A fixed 
number of images were taken in series at 0.5 fjm steps and an average composite 
image produced. A mean fluorescence value for each cortical layer was calculated 
(arbitrary units) for each slice using three non-overlapping square sampling windows 
(mean fluorescence of a 2000 //m^ area). Fluorescence intensity was standardised 
between slices by firstly imaging sections on the same day using the same lazar and 
PMT intensities and, secondly, by the Leica Confocal Software’s internal 
standardisation of arbitrary units between 0 and 255. Concerns of an “edge effect” 
leading to artificially high fluorescent values within layer I were evaded by the 
positioning of sampling windows at the inner portion of layer I (see figure 2.4.2). 
Sampling means were then pooled to give an overall mean ± SEM for each cortical 
layer (maximum intensity recorded: 234.65 arbitrary units). In an attempt to remove 
background fluorescence, the minimum level of fluorescence was determined for the 
whole slice (minimum values ranged from 30 to 42 arbitrary units) and subtracted 
from the slice sample mean. This is an under estimation of background and, 
therefore, any percent changes highlighted in this study are, in reality, larger.
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Figure 2.4.2 Example sampling windows used for fluorescence quantification.
A typical fluorescent image is shown with cortical layers indicated. The three boxes 
indicate typical placement of non-overlapping sampling windows within each layer. 
To avoid the potential “edge effect”, layer I samples were taken from the border of 
layers I and II. Blood vessels (bv) were also avoided. Scale bar 100 /mi; image 
obtained using a x40 objective.
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3. Results
Previous in vitro studies have extensively characterised long-term and short-term 
synaptic plasticity in the rat perirhinal cortex. There is, however, no confirmation 
that the mouse perirhinal cortex behaves in a similar fashion. In order to assess 
synaptic plasticity in the perirhinal cortex of a transgenic mouse model of HD the 
first part of my results will describe synaptic plasticity and transmission in the CBA 
X C57BL/6 mouse (the background strain of the R6/1 mice). The second part of this 
section uses pharmacological manipulations to investigate receptors involved in the 
induction of long-term depression and paired-pulse depression, again in the normal 
perirhinal cortex. The third part is a linear study of synaptic plasticity in the R6/1 
mouse in comparison to age-matched littermates. I will then describe how 
pharmacological manipulation can be used to recover normal synaptic function. The 
final part describes the use of histological techniques to assess pathological changes 
in the R6/1 cortex that may underlie the differences observed in the synaptic 
phenotype. Throughout the results section all figures are colour coded as follows:
Control (wild-type): Blue
Drug condition (wild-type): Green
Transgenic animals: Red
Drug condition (Transgenic): Orange
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3.1 Perirhinal cortical synaptic plasticity in the mouse
The aim of this section of the project was to characterise synaptic transmission and 
induction of synaptic plasticity in the normal mouse perirhinal cortex. Previously, 
LTF, LTD and short-term plasticity (paired-pulse depression) has been described 
extensively in the rat perirhinal cortex. It is not known, however, if the mouse 
perirhinal cortex behaves in a similar way. To assess this, acute perirhinal cortical 
slices were prepared from CBA x C57BL/6 mice and a mixture of field and sharp 
intracellular recordings were made.
3.1.1 Synaptic responses
Initial experiments were aimed at recreating in the mouse some of the results 
obtained by Bashir and colleagues in the rat, including expression of paired-pulse 
depression and long-term depression (Ziakopoulos et al, 1999; Cho et a l, 2000). 
For these experiments mice of between 6 and 10 weeks of age were used.
3.1.1.1 Slice orientation
The rat studies were carried out using acute in vitro slices cut at a 45° oblique angle 
to the dorsoventral axis (see methods, figure 2.1.2). The same dissection applied to 
the mouse perirhinal cortex did not, however, yield suitable field responses. Field 
EPSPs were very small, with a maximum amplitude of approximately 1 mV and
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often less (see figure 3.1.1). In contrast, slices cut in the coronal plane (methods, 
figure 2.1.1) consistently provided responses that were much larger and, moreover, 
appropriate for electrophysiological analysis. Therefore coronal sections were used 
in all subsequent experiments.
3.1.1.2 Slice cytoarchitecture
To visualise the cortical layers of the mouse perirhinal cortex and thus aid 
appropriate electrode placement, some slices were harvested from the 
electrophysiological chamber and stained using toluidine blue with an eosin pink 
counterstain (figure 3.1.2). As reported previously in other species, layer I was 
almost devoid of cell bodies, while layer II/III was characterised by the presence of 
pyramidal cells, the density of which was higher in layer II than layer III. Layer IV 
could be identified in area 36 (temporal cortex side), but was absent in area 35 
(entorhinal cortex side). Within layer V were pyramidal cells that appear larger than 
cells of layers II/III, but less densely packed. Layer VI comprised of densely packed, 
polymorphic cell types.
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Figure 3.1.1 Field responses recorded from the intermediate pathways of an 
oblique slice. Left A typical input-output relationship. Right Typical field 
potentials (single traces) at the points indicated on the input-output relationship. 
Responses are clearly not suitable for electrophysiological analysis. Similar 
responses were obtained from the superficial pathways.
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Figure 3.1.2 Slice architecture and electrode positioning. 50//m slices were 
stained using haematoxylin with an eosin counterstain. The typical perirhinal 
cortical structure can be seen, with the prominent rhinal sulcus to the right. Cortical 
layers are indicated above and below the slice. Layer I shows very few cells, while 
layer II is characterised by a relatively high density of pyramidal cells. Pyramidal 
neurones are more sparsely distributed within layer III. Layer IV is evident in 
Brodmann area 36, but not in area 35. Layer V contains larger pyramidal cells than 
layer II/III. Polymorphic cells are relatively densely packed in layer VI. The white 
mater is also evident. The positioning of electrodes is superimposed over the 
photograph. Scale bar 250 jum. Image obtained with a x 10 objective.
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3.1.1.2 Intermediate pathways
Previous experiments in the rat perirhinal cortex were concentrated on the 
intermediate pathway. The intermediate pathway comprises predominantly of inputs 
from layers II/III of entorhinal and temporal cortices, which synapse onto basal 
dendrites of layer II/III pyramidal neurones of the perirhinal cortex. My initial 
experiments examined synaptic plasticity in this pathway.
Responses from the intermediate pathway were more difficult to obtain than 
by stimulation of the superficial layer, although responses that were recorded were 
suitable for analysis. A typical sigmoidal input-output relationship was obtained and 
is shown in figure 3.1.3 (maximum amplitude: 4.0±0.5 mV; n=l8(6)).
Test-shock intensities were set to evoke responses at 30, 50 and 80% of the 
maximal amplitude. Pairs of stimuli were applied at intervals between 20 and 2000 
ms. Unexpectedly, the intermediate pathways did not express paired-pulse 
depression (PPD), but favoured the expression of paired-pulse facilitation (PPF) 
(figure 3.1.3; n=36(l 1)). PPF was particularly evident between the intervals of 60 
and 200 ms at both 30 and 50% stimulation intensities. A greater degree of 
facilitation was achieved at 30% than at 50% stimulation intensities. At 80% 
stimulation intensity the 20 ms interval gave rise to PPD. At intervals greater than 
200 ms, the second response was the same as the first.
Long-term depression was not readily inducible in the intermediate pathways. 
Low-frequency stimulation led to a frequency dependent depression, however, of 13 
slices, only three exceeded the criterion for LTD (greater than 10% depression at one 
hour) while another two came near to this value (>9% depression at one hour). At 30
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minutes post-conditioning, the mean degree of depression was -9.6±4.0% and at 60 
minutes was -6.7±2.8%. While these values do not meet the set criterion for LTD, 
they are both a significant degree of depression (P<0.05 at both time points; two- 
tailed, paired-t-test; n=13(8); figure 3.1.3).
3.1.2 Superficial synapses
While a significant LTD was induced at intermediate synapses, the incidence of LTD 
at these synapses is relatively low (23%), making pharmacological experiments 
designed to investigate LTD induction difficult. Furthermore, PPD does not appear 
to be supported at these synapses. Attention was therefore turned to the superficial 
synapses and these proved to be more plastic than those of the intermediate inputs 
and were therefore the target of extensive investigation as described below. This 
pathway comprises collateral inputs, predominantly from adjacent cortical regions, 
that synapse onto apical dendrites of layer II/III pyramidal cells.
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Figure 3.1.3 Plasticity in the intermediate pathway. Top left The intermediate 
pathway shows a typical input-output relationship in response to an increasing 
stimulus intensity (in this and subsequent input-output figures, the abscissa is plotted 
on a logarithmic scale). Top right Paired-pulse profiles obtained at 30 (•), 50 (•) 
and 80 (o) per cent maximal stimulation. Paired-pulse facilitation was seen at 
intervals up to 200 ms and no-change at intervals over 200 ms (in this and 
subsequent paired-pulse profile figures the abscissa is plotted on a logarithmic scale). 
Bottom Long-term depression in the intermediate pathway. The solid bar in this and 
subsequent figures represents the period of low-frequency stimulation; 900 pulses at 
1 Hz.
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3.1.2.1 Interpretation of the field response
In order to understand the cellular events underlying the recorded field response, dual 
recordings were made using both intracellular and extracellular recording techniques. 
Potentials were obtained simultaneously from layer II/III of the perirhinal cortex in 
response to increasing intensity test-shocks applied to layer I. Representative traces 
can be seen in figure 3.1.4. At stimulation intensities that evoke field responses 
greater than approximately 40% of the maximum amplitude, individual cells fire 
action potentials. Therefore, from -40% maximum amplitude, the field potential is a 
mixed response comprising both an EPSP and population spike. Given that the 
recorded field response has a large population spike component, slope measurements 
are not meaningful and therefore amplitude was used as the measure of the field 
post-synaptic potential for all experiments in sections 3.1 and 3.2.
Bath application of the AMPA/KA receptor antagonist CNQX (20 juM) 
(Honore et a l, 1988) abolished the evoked response confirming the glutamatergic 
and synaptic origin of the recorded potentials (figure 3.1.5).
Increasing the stimulus intensity (10-600//A) increased the amplitude of the 
synaptic response and produced a typical sigmoidal input-output relationship (figure 
3.1.5). There was no significant difference between the superficial temporal or 
entorhinal pathway assessed either by maximum amplitude (2.7±0.2 mV, n=27(16) 
and 2.9±0.2 mV, n=28(15), respectively; P>0.5, unpaired, two-tailed t-test) or as an 
overall profile (P>0.5, two-way ANOVA) and therefore data form these pathways 
were pooled (maximum amplitude: 2.8±0.2 mV, n=55 (21); figure 3.1.5).
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Figure 3.1.4 Interpretation of the field response. Dual intracellular and 
extracellular responses were made from layer II/III in response to increasing stimulus 
intensities. Top The synaptic response in this slice showed a typical sigmoidal 
input-output relationship. Bottom Responses recorded simultaneously via a sharp 
intracellular electrode (top row) and a field electrode (bottom row) in response to 20, 
50 and 100 pA  stimuli (corresponding approximately to 30, 50 and 80% stimulation 
intensities). It is apparent that the field response is dominated by a population spike 
at 50 and 100 //A stimuli. With the exception of responses that show an action 
potential, all traces are the average of five consecutive responses. Note the different 
vertical scale bar for intracellular and extracellular responses. All recordings were 
made in the absence of PTX
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Figure 3.1.5 Input-output relationship in the superficial pathway. Left Typical 
sigmoidal input-output relationship (n= 55(19)). Right Single traces at 30, 50 and 
80% stimulation intensities. The bottom trace shows the effect of the AMPA/KA 
receptor antagonist CNQX (10 //M), which abolishes the synaptic response.
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3.1.2.2 Short-term plasticity
Short-term plasticity was examined at shock intensities set to evoke field responses 
at 30, 50 and 80% of the maximum amplitude (figure 3.1.5), Paired-pulse stimuli 
were applied at intervals between 20 and 2000 ms to the superficial layer of the 
cortex. At each of the three intensities, both the ST and SE pathways preferentially 
displayed PPD. No significant difference was found between the paired-pulse 
profiles exhibited by these pathways (P>0.5, two-way ANOVA) and therefore data 
firom both pathways has been pooled (figure 3.1.6). PPD was found to be maximal at 
an inter-pulse interval of 20 ms and also between 400-600 ms. At 30 and 50%, a 
small degree of PPF was observed at inter-pulse intervals between 60 and 100 ms, 
whereas at 80% PPD was seen at all inter-pulse intervals up to and including 1000 
ms. By increasing the stimulus intensity though 30, 50 and 80%, the degree of 
paired-pulse depression was increased for any given interval (figure 3.1.6).
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Figure 3.1.6 Paired-pulse depression in the superficial pathway. Paired pulses 
applied to the superficial pathway leads to depression of the second response at 30 
(•), 50 (•) and 80% (o) stimulation intensities. At 30 and 50% paired-pulse 
facilitation is seen at intervals between 60 and 100 ms. Increasing the intensity 
though 30, 50 and 80% increases the degree of depression observed. n=48(15) for all 
three intensities. Example traces, obtained at 80% stimulation intensity, are shown 
from the time points indicated (i-iii) (averages of 5 consecutive traces).
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3.1.2.3 Pathway independence
A paired-pulse protocol was used to assess pathway independence. Test-shocks were 
applied to alternate pathways at 60 ms intervals. Pathway independence was 
determined by the absence of heterosynaptic depression, while displaying 
homosynaptic depression. Further evidence for input specificity was provided by the 
coincidental application of a test-shock to both pathways leading to summation of the 
EPSP to amplitudes greater than the maximum recorded from either pathway alone 
(see figure 3.1.7 for an example). This analysis was carried out for all two-pathway 
analyses prior to experimentation and electrode placement altered to ensure pathway 
independence.
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Figure 3.1.7: Determination of pathway independence. A paired-pulse protocol 
was used to ensure pathway independence. Top row Expression of homosynaptic 
PPD was ensured in each pathway by applying paired stimuli to an individual 
pathway (PI or P2) at a 100 ms interval. Middle row The absence of heterosynaptic 
PPD was ensured by applying stimuli to the second pathway 100 ms after the first 
and vice versa . Bottom Summation of the EPSP occurred when both pathways were 
simultaneously stimulated, indicated a different population of synapses underlies the 
recorded EPSP in each pathway.
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3.1.2.4 Long-term depression
A standard low-frequency conditioning paradigm (900 pulses applied at 1 Hz at test- 
shock intensity) was used in an attempt to induce LTD at superficial perirhinal 
synapses. A stable baseline was recorded for at least 15 minutes before a 
conditioning stimulus was applied. During the conditioning period a frequency- 
dependent depression was observed, characterised by a rapid decrease in EPSP 
amplitude during the first five minutes of conditioning. Following EPS a stable 
depression was observed for more than one hour. There was no significant 
difference between the levels of LTD expressed in the ST and SE pathways 
(-12.7±5.8%, n=8(5) and -13.3±5.0%, n=10(6), respectively; P>0.5, two-tailed 
unpaired t-test) and therefore data from both pathways has been pooled throughout 
this study (pooled LTD: -12.3±3.0%, n=20(9); figure 3.1.8; pooled LTD value 
obtained from all slices, irrespective of experimental outcome). LTD of greater than 
10% was expressed in 60% of slices studied.
To determine whether LTD was homosynaptic, in some experiments a second 
pathway, which did not receive conditioning stimuli, was also monitored. For this 
analysis, only those pathways that exhibited LTD that was greater than 10% were 
included (in all other experiments throughout this thesis, data for each condition is 
pooled irrespective of outcome). Figure 3.1.8 demonstrates the homosynaptic nature 
of perirhinal LTD (conditioned pathway: -21.5±5.6%; unconditioned pathway 
+1.9±1.0%; n=5(5); P<0.01, paired, two-tailed t-test).
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Induction paradigms
Alternative induction paradigms were investigated in an attempt to more reliably 
induce LTD. Paired-pulse low-ffequency stimulation (two pulses with an inter-pulse 
interval of 60 or 100 ms, repeated 900 times at 1 Hz) did not increase the probability 
of LTD induction, or increase the degree of depression (summarised in table 3.1.1).
The GABAa antagonist PTX (100 //M) was added to ACSF in an attempt to 
aid LTD induction. PTX led to a large, late-onset component to the field EPSP and 
repeated stimulation at test-shock fi’equency (0.033 Hz) resulted in a decline in the 
EPSP until no response was recordable. This is likely to be a result of disinhibition 
of the cortical slice as, when 100 pM PTX was applied during whole cell recording, 
periods of prolonged spontaneous activity was evident. Reducing the PTX 
concentration to 2.5 pM prolonged the duration of the fast EPSP component, but did 
not lead to a late component. Quite the opposite to enhancing LTD, PTX prevented 
the induction of LTD induction and was not, therefore, utilised in field experiments. 
A similar result was found with the GABAa antagonist bicuculline methiodide (100 
p M ) .
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Figure 3.1.8 Homosynaptic LTD at superficial synapses. Top left Long-term 
depression in the superficial temporal pathway. Top right Long-term depression in 
the superficial entorhinal pathway. Bottom left No significant difference was found 
between the two pathways and were therefore pooled in all subsequent experiments. 
Typical traces are shown from baseline (i) and 60 minutes post-conditioning (ii) and 
are overlaid on the right (averages of 5 consecutive traces). Bottom right In some 
experiments two pathways were recorded, one of which did not receive LFS (o). 
Only the conditioned pathway (•) showed LTD. (For this analysis only slices 
showing LTD of greater than 10% were included, in all other experiments all data 
were included irrespective of outcome.)
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Conditioning paradigm Total trials 
(n)
LTD
(n)
No change 
(n)
LTP
(n)
900 pulses @ 1 Hz 20 12 8 0
900 paired-pulses (60 ms) @ 1 Hz 5 1 3 1
900 paired-pulses (100 ms) @ 1 Hz 7 4 3 0
2.5 pM  PTX; 900 pulses @ 1 Hz 10 1 5 4
100/^M BMI; 900 pulses @ 1 Hz 10 0 7 3
Table 3.1.1 Experimental outcomes of the paradigms used to induce LTD at 
superficial synapses of the mouse perirhinal cortex. Criteria for LTD or LTP
were-10% and+10% respectively.
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3.1.2.5 Long-term potentiation
High-frequency stimulation was used to induce long-term potentiation at superficial 
synapses in the mouse perirhinal cortex. Various tetanic stimulation paradigms were 
used in attempts to induce LTP (see table 3.1.2), none of which successfiilly induced 
LTP. Theta-burst stimulation, on the other hand, did induce reliable LTP. The 
optimum paradigm was four trains applied every 15s, each train comprising of 10 
bursts of 10 pulses at 100 Hz, with an inter-burst interval of 100 ms.
No significant difference was found between the temporal and entorhinal 
pathways (16.5+5.8%, n=5(3) and 20.0+7.4%, n=6(4) respectively; P>0.5) and 
therefore data from the two pathways were pooled. TBS induced a potentiation (18.4 
+ 4.7%; n=l 1(6); P<0.01 ; figure 3.1.9) that lasted for more than one hour after 
conditioning. Some experiments were designed to assess the homosynaptic nature of 
LTP. Only those experiments that showed greater than 10% potentiation were 
included in this analysis (in all other conditions, all experiments were included 
irrespective of outcome). The control pathway, which did not receive a conditioning 
stimulus, did not show potentiation (4.0+3.5%) and was significantly different than 
the experimental pathway (30.4+2.6%, n=5(3); P<0.004, paired-test; figure 3.1.9).
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Conditioning paradigm Total trials 
(n)
LTP
(n)
No change 
(n)
LTD
(n)
Tetanus: (Is 100 Hz)x4 every 15s 5 0 5 0
Tetanus: (Is 100 Hz)x6 every 15s 2 0 2 0
TBS: ((10@100 Hz)xl0@5 Hz)x4 (15s) 9 4 5 0
TBS: ((10@100 Hz)xlO@10 Hz)x4 (15s) 15 11 4 0
TBS inPTX(2.5//M) 5 0 3 2
Table 3.1.2 Outcomes of high-frequency paradigms used to induce LTP. Either 
tetanus (4 or 6 trains delivered every 15 s, each train 100 Hz, 1 s) or TBS (4 trains 
every 15s, each train comprising 10 bursts of 10 pulses at 100 Hz, inter-burst interval 
of either 100 or 200 ms). LTP or LTD was defined as +10 or -10% of baseline 
respectively.
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Figure 3.1.9 Homosynaptic LTP in the perirhinal cortex. Left Theta-burst 
stimulation (in this and subsequent figures TBS is represented by a solid arrow) 
induces a long-lasting potentiation at superficial synapses. Example traces are 
shown above from the time points indicated (i & ii) and are overlaid on the right 
(averages of 5 consecutive traces). Right In some experiments two pathways were 
recorded, one of which received TBS conditioning (•), the other did not (o). LTP 
was induced only in the conditioned pathway, indicating the homosynaptic nature of 
LTP in the perirhinal cortex of mice.
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3.1.3 Intracellular recordings
Cellular properties of perirhinal neurones were assessed using sharp electrodes. 
Pyramidal neurones of layer II/III were impaled by stepping through the slice until a 
cell was found and then a small amount of negative current was applied to aid the 
formation of a seal between the cell membrane and glass electrode. Once this current 
was fully removed and the cell had stabilised, the electrophysiological properties 
were ascertained
3.1.3.1 Cellular properties
The properties of layer II/III perirhinal cortical neurones are summarised in table 
3.1.3. Resting membrane potential (Em) varied from approximately -66 mV to -90 
mV with a mean o f-79.2+0.6 mV (n= 51 cells). The distribution of Em followed a 
Gaussian distribution (figure 3.1.10; P>0.3). Injection of square, negative current 
pulses (-0.2 to -0.8 nA) into the cell gave rise to a hyperpolarisation (figure 3.1.10). 
Initially following the current injection, a charging of the cell membrane was 
observed until a steady-state membrane potential was reached. The slope of the plot 
of current injection against voltage deflection at steady-state was used to calculate 
the membrane input resistance (Rin). The R^  values for the best-fit lines were greater 
than 0.98 and gave a mean Rm of 39.2+2.4 MQ (n=35 cells). Membrane capacitance 
(Cm) was calculated from the membrane input resistance and the time constant (Tm) 
using the following relationship: Cm= Tm / Rin- Values of Tm were obtained using the
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protocol in Bindman et al. (1988) as follows: Semi-logarithmic plots were made of 
the voltage response against time during the charging of the cell by hyperpolarising 
current pulses. The charging response was always well fitted by a single exponential 
line (R  ^value greater than 0.99) and the time constant calculated as the negative 
reciprocal of the best-fit line at (1-1/e x 100)% of the maximum deflection. Tm was 
found to be 9.1+0.7 ms. Membrane capacitance was then calculated for each cell and 
was found to be 0.24+0.02 nF.
Injection of positive current (+0.2 to +2.0 nA) gave rise to a depolarisation. 
Action potentials were evoked at depolarised membrane potentials above the action 
potential threshold (-51.3+1.3 mV). The action potential typically overshot to 
+26.8+2.7 mV, with a mean action potential amplitude of 78.2+1.8 mV. The action 
potential duration (measured at half way between threshold and peak) was 1.83+0.09 
ms (n=35 cells). All the cells impaled in this study were of regular-spiking 
characteristics; no late-spiking neurones, as described by Beggs et al (2000), were 
identified. Cells typically fired within the first 500 ms of a depolarising current step 
and showed rapid accommodation, settling to a firing rate of approximately 1 Hz (for 
example, see figure 3.1.10).
When an EPSP was evoked during a sub-threshold depolarising current step, 
a substantial inhibitory component was evident. The GABAa receptor antagonist 
PTX was therefore bath applied. 100 pM PTX resulted in epileptiform activity and 
excessive spontaneous activity. The relatively low concentration of 2.5 pM PTX 
abolished the inhibitory component of the post-synaptic potential, while not inducing 
inappropriate activity. 2.5pM PTX was therefore used in all intracellular 
experiments to ensure a pure EPSP.
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Figure 3.1.10 Passive membrane properties of layer II/IIl perirhinal cortical 
ceils. Top left Resting membrane potential follows a normal Gaussian distribution. 
Top right Membrane deflections in response to hyperpolarising (0, -0.2, -0.4, -0.6 
and -0.8 nA) square current pulses. Following an initial charging of the membrane, 
a steady state membrane potential is reached (averages of 4 consecutive traces). 
Middle left Current-voltage plot of the traces shown top left. The slope of the best- 
fit line (R^>0.99) equals the input resistance (Rin). Middle right Time course of the 
voltage deflection obtained in response to -0.6 nA current injection. The difference 
of the maximum deflection (Vm) and the voltage at a given time after current 
injection (VJ is plotted on a logarithmic scale. The negative reciprocal of the 
exponential line of best fit (R^>0.99) was used to calculate the membrane time 
constant Tm. Bottom Response to a positive current injection (+0.6 nA). Action 
potentials fire at membrane potentials above the threshold o f-52 mV. The cell 
showed rapid accommodation, settling to a firing rate of approximately 1 Hz.
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Cellular property Mean ± SEM n
Em —79.2 ± 0.6 mV 51
Rin 39.2 ± 2.4 U a
Tm 9.1 ± 0.7 ms
Cm 0.24 ± 0.02 nF
35AP threshold -51.3 ± 1.3 mV
AP overshoot +26.8 ± 2.7 mV
AP amplitude 78.2+ 1.8 mV
AP width at half amplitude 1.83 + 0.09 ms
Table 3.1.3 Electrophysiological properties of neurones within layer II/III of the 
perirhinal cortex. Intracellular recordings were made from cells within layer II/III 
of the perirhinal cortex. The current-voltage relationship was used to calculate input 
resistance, membrane time constant and, from these values, the capacitance of the 
cell. Action potential (AP) amplitude was calculated from threshold to maximum 
overshoot. Action potential width was measured at half amplitude.
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3.1.3.2 Short-term plasticity
Paired-pulse stimuli were applied to the superficial layer whilst recording 
intracellularly from layer II/III neurones. Test-shock intensity was set to evoke 
responses at 50% of the action potential threshold value. At paired-pulse intervals up 
to 200 ms the second response was larger than the first. At intervals over 200 ms, the 
second response was similar in size to the first response. Typical responses and the 
mean paired-pulse profile are shown in figure 3.1.11.
3.1.3.3 Intracellular LTD
Long-term depression was also studied using sharp intracellular electrodes. EPSP 
slope was set to 50% of the threshold value and a stable baseline recorded for at least 
10 minutes. The standard LES paradigm of 900 pulses at 1 Hz was not suitable for 
inducing LTD at mouse perirhinal synapses under these conditions; LES invariably 
resulted in loss of the intracellular recording during the conditioning period.
In the rat studies carried out in the Bashir Laboratory (for example see Cho et 
al, 2000), a shorter LES paradigm (300 pulses at 1 Hz) has been used to induce LTD 
recorded at the intracellular level. This paradigm did not compromise the integrity of 
the recording when applied to mouse perirhinal afferents. During the conditioning 
paradigm there was a fi-equency-dependent depression, however, subsequent 
responses were at baseline values (EPSP slope: -0.1+3.3%; n=8(6); figure 3.1.12). 
Pairing conditioning with depolarising current such that the cell spiked during each 
conditioning stimulus did not aid LTD induction.
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Figure 3.1.11 Intracellularly recorded paired-pulse profiles. Paired-pulse stimuli 
applied to layer I led to paired-pulse profiles favouring PPF. Example traces are 
shown above from 60 and 500 ms intervals (single traces).
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Figure 3.1.12 Aplasticity in the superficial pathways when recorded 
intracellularly. LFS (300 pulses at 1 Hz) failed to induce LTD in the superficial 
pathways. Typical responses are shown from the baseline (i) and 60 minutes post­
conditioning (ii) and are overlaid on the right (average of 5 traces).
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3.1.3.4 Spike LTD
In the absence of plasticity of the EPSP, the plasticity of the suprathreshold action 
potential was investigated. During baseline recordings responses were set to 
suprathreshold levels and, interestingly, LFS (300 pulses at 1 Hz) led to a long- 
lasting reduction in the number of test-shocks that evoked an action potential (spike- 
depression). During the baseline period, test-shocks evoked action potentials in 
>75% of trials. In contrast, following LFS, action potentials were evoked in <30% 
of post-conditioning trials (n=3(3)). Of the three experiments, two showed a 
complete absence of firing following conditioning, (figure 3.1.13). Evoked 
responses remained subthreshold for the duration of recording (up to one hour). An 
alternative pathway, which did not receive LFS, did not show spike-depression, but 
could be subsequently depressed upon application of LFS to this pathway. 
Importantly, in the absence of a conditioning stimulus, cells remained suprathreshold 
for the duration of the experiment (up to 7 hours; n=3(3); figure 3.1.14).
The induction of spike-depression was not a function of firing of the 
postsynaptic cell. 300 pulses (1 Hz) of depolarising current, sufficient to bring the 
neurone to firing threshold, did not lead to the induction of spike depression (n=3(3)) 
but subsequent LFS applied to superficial afferent inputs did lead to spike-depression 
(figure 3.1.15).
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Figure 3.1.13 Long-term spike depression. Top Homosynaptic depression of 
action potential firing in the perirhinal cortex. Two independent pathways were 
stimulated at just suprathreshold intensities. One pathway received LFS (300 pulses 
at 1 Hz; conditioned p a t h w a y ;  o), the second pathway received no LFS (non­
conditioned pathway; o). Only the conditioned pathway showed spike depression. 
Example traces are shown above from the baseline and at 60 minutes post­
conditioning. Bottom Another example of spike LTD demonstrated in a different 
slice.
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Figure 3.1.14 Persistent action potential firing in the absence of conditioning.
Two examples demonstrating that, in the absence of conditioning stimuli, cells 
continue to fire for the duration of recording. Note the different time scales.
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Figure 3.1.15 Spike LTD is dependent upon synaptic activity. Top Action 
potentials were evoked during baseline recording. The first period of LFS (open bar) 
comprised of 300 pulses of square depolarising current pulses such that action 
potentials were evoked. Following conditioning the cell continued to fire action 
potentials in response to test-shocks. A second period of LFS, this time consisting of 
synaptically evoked action potentials, resulted in an increase in the number of 
failures to evoke an action potential in response to test-shocks. Middle and bottom 
Further examples of cellular depolarisation by current injection failing to induce 
spike LTD.
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3.1.4 Summary
Similarly to synapses of the rat perirhinal cortex, mouse perirhinal cortical synapses 
support paired-pulse depression, long-term depression and long-term potentiation. 
Cells within layer II/III are typical of other neocortical neurones, with a resting 
membrane potential at around -80 mV. While LTD of the intracellularly recorded 
EPSP was not observed, a long-lasting, homosynaptic depression of action potential 
firing, that was dependent on synaptic activation, could be induced by LFS applied to 
the superficial afferent pathways.
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3.2 Neurotransmitter modulation of synaptic plasticity
Having identified some of the forms of synaptic plasticity expressed at mouse 
perirhinal synapses, the neurotransmitter subclasses involved in the induction of 
plasticity were investigated. Previously, LTD in the rat was found to be co­
dependent on both NMD A and mGlu receptors (Cho et a l, 2000). The 
neurotransmitter receptor-dependency of synaptic plasticity in the mouse is 
summarised in figure 3.2.11.
3.2.1 Glutamate receptors
Initially the glutamate receptor subclasses were investigated using bath application of 
group-specific antagonists.
3.2.1.1 NMDA receptors
The involvement of NMDA receptors in mouse perirhinal synaptic plasticity was 
investigated at the field level. Bath application of the NMDA receptor antagonist, D- 
(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 50//M) (Evans et a l, 1982) 
decreased the field potential. This is reflected in the input-output relationship, 
which, as a profile, is significantly different than control (P=0.013, F m , i o 8 o = 2 .0 3 ) .  
The maximal amplitude (2.8±0.1 mV, n=14(4)) was not, however altered (P>0.3, 
two-tailed Welch test).
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D-AP5 did not significantly alter paired-pulse depression (P>0.3; two-way 
ANOVA; see figure 3.2.1). Unexpectedly, D-AP5 did not block the induction of 
LTD (4 out of 10 experiments showed LTD), however, the pattern of transmission 
was altered. Initially, during the conditioning period the evoked response was 
dramatically reduced, but after the first five minutes of conditioning, the response 
tended to recover towards control levels. Immediately after conditioning, the EPSP 
amplitude returned to baseline values, but then decreased to give a stable LTD 
(-10.4±5.9%; n=10(4);P<0.05; paired t-test; figure 3.2.1) that was not significantly 
different than controls (-12.3±3.0%, n=20(9); P>0.5, two-tailed unpaired Welch- 
test). LTD obtained in the presence of D-AP5 is also homosynaptic (data not 
shown).
Similarly, D-AP5 did not effect the induction of LTP. Following TBS, a 
potentiation of 22.3 ±6.1% (n=8(4); P<0.01, paired t-test) was observed, which was 
not significantly different than control (18.4 ± 4.7%; n=l 1 (6); P>0.5, two-tailed 
unpaired Welch-test; figure 3.2.1).
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Figure 3.2.1 NMDA receptor-independent plasticity in the mouse perirhinal 
cortex. Top left 50 pM D-AP5 (in this and subsequent figures drug-conditions are 
represented by •) altered the input-output curve, but did not alter the maximum 
amplitude compared to that of control experiments (this and subsequent figures: o). 
Bottom Left Paired-pulse depression was not affected by the addition of D-AP5 at all 
three stimulation intensities (in this and subsequent drug-condition figures: 30(#), 
50(o) and 80(o)%). Top right LTD was still induced in the presence of D-AP5. The 
drug did, however, alter the profile of the conditioning period and prevented post­
conditioning depression. Bottom right LTP was unaffected by D-AP5.
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3.2.1.2 Group I metabotropic receptors
The participation of metabotropic glutamate receptors in both paired-pulse plasticity 
and long-term depression was examined. Bath application of the group I mGlu 
receptor antagonist UPF 523/(RS)-l-aminoindan-l,5-dicarboxylic acid (AIDA,
500 juM) (Pellicciari et a l, 1995) did not alter basal transmission (see input-output 
relationship in figure 3.2.2).
AIDA abolished PPD at all stimulus intensities, producing paired-pulse 
profiles that favoured facilitation at both 30 and 50% stimulation intensities, but 
neither PPD nor PPF at 80% (figure 3.2.2). The change in profile was found to be 
statistically significant (P<0.01, Fn,729=2.30 and P<0.05, Fn ,7 3 2 =1.76 for 30 and 
80% test shock intensities respectively; two-way ANOVA).
AIDA also affected the induction and expression of LTD. The degree of 
firequency-dependent depression seen during the conditioning period was reduced 
compared to control slices. Following conditioning, a transient depression was 
observed, but responses returned to baseline levels within ten minutes. Moreover, 
blocking group I mGlu receptors prevented the induction of LTD in all ten slices 
studied (2.6 ± 1.7%; n=10(6); figure 3.2.2). This result is significantly different than 
the LTD seen in control slices (-12.3±3.0%, n=20(9); P<0.001; unpaired, two-tailed 
Welch t-test).
Conversely, AIDA did not alter the degree of LTP induced by TBS (17.3 ± 
8%; n=8(3)) compared to controls (18.4 ± 4.7%; n=l 1(6); P>0.5, two-tailed unpaired 
Welch-test; figure 3.2.2).
266
1
a■a 2
CL
E
s
Si
10 100 
Stimulus intensity (/A)
5  o - - - | ----
100 1000
SOOuMADA I
100
500mM
-20
0 20 40 8060
inter-pulse interval (ms) Time (min)
Figure 3.2.2 Group I mGlu receptor dependency of synaptic plasticity in the 
mouse perirhinal cortex. Top left The group I mGlu receptor antagonist AIDA did 
not alter the input-output relationship. Bottom left Antagonising group I mGlu 
receptors shifted the paired-pulse profile towards that of facilitation at all three 
stimulus intensities. Top right AIDA blocked the induction of LTD at superficial 
synapses, but did not affect LTP induction {bottom right). For fiscal reasons, AIDA 
was only present during the baseline and conditioning periods of the experiments 
investigating long-term synaptic plasticity.
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3.2.1.3 Group II metabotropic receptors
The group II mGlu receptor-specific antagonist LY341495 (1 pM) (Kingston et a l, 
1998) was applied to an additional set of slices. Drug application did not 
significantly alter input-output relationships compared to controls (P>0.5, two-way 
ANOVA; figure 3.2.3). When paired-pulse stimuli were applied in the presence of 
LY341495, facilitation was produced upon the second stimulus at all intensities in 
the paired-pulse paradigm (figure 3.2.3). The change in profile was significantly 
different than control values (P<0.01, Fn, 65? = 2.45 and P<0.01, Fn, 648 =2.60 for 30 
and 80% stimulus intensities respectively; two-way ANOVA).
LY341495 also suppressed the level of fi*equency-dependent depression seen 
during conditioning and, moreover, prevented the induction of LTD in 9 out of 10 
experiments (-1.1 ± 2.7%; n=10(3); significantly different than controls; 
-12.3±3.0%, n=20(9); P<0.01, unpaired, two-tailed Welch t-test; figure 3.2.3).
Antagonising group II mGlu receptors did not alter LTP. There was no 
significant difference in the degree of potentiation at 1 hr after conditioning observed 
between control (18.4 ± 4.7%; n=ll(6)) and drug conditions (20.9±4.3%; n=8(2); 
P>0.5; figure 3.2.3).
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Figure 3.2.3 Group II mGlu receptor dependency of synaptic plasticity in the 
mouse perirhinal cortex. Top left The group II mGlu receptor antagonist 
LY341495 did not alter the input-output relationship. Bottom left Antagonising 
group II mGlu receptors shifted the paired-pulse profile to that of facilitation at all 
three stimulus intensities. Top right LY341495 blocked the induction of LTD at 
superficial synapses, but did not affect LTP induction {bottom right).
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3.2.1.4 Group III metabotropic receptors
In contrast to the group I and II mGlu receptor-dependency, antagonism of group III 
mGlu receptors using 10 juM (RS)-a-Cyclopropyl-4-phosphonophenylglycine 
(CPPG) (Jane et a l, 1996; Toms et al, 1996) did affect the overall input-output 
relationship (P<0.001, F14,815=1 3 .0 7 , two-way ANOVA) and increased the maximal 
amplitude to 3.3±0.2 mV (n=10(4); P<0.01, two-tailed t-test versus control). Also in 
contrast to antagonism of groups I and II mGlu receptors, CPPG did not affect 
paired-pulse depression (P>0.5, two-way ANOVA; figure 3.2.4) or the induction of 
LTD (-11.2 ± 3.1%), which is not significantly different than controls (-12.3±3.0%, 
n=20(9); P>0.5; two-tailed, unpaired t-test; n=6(3); figure 3,2.4). In the presence of 
CPPG, there was a trend for TBS to evoke a smaller degree of potentiation 
(10.1±7.82; n=8(3)) than in control experiments (18.4 ± 4.7%; n=l 1(6); figure 3.2.4), 
however this failed to reach significance (P>0.3 ; two-tailed, unpaired Welch-test).
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Figure 3.2.4 Group III mGlu receptor dependency of synaptic plasticity in the 
mouse perirhinal cortex. While the group III mGlu receptor antagonist CPPG 
altered the input-output relationship (top left) paired-pulse ratios {bottom left) were 
not affected by the drug. Nor did CPPG alter LTD induction {top right). CPPG 
slightly reduced the degree of LTP achieved following TBS, but this failed to reach 
significance {bottom right).
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3.2.2 Dopamine Receptors
In light of the substantial dopaminergic input that the perirhinal cortex receives from 
the VTA (Descarries et a l, 1987), the involvement of Di and D2 dopamine receptors 
in perirhinal synaptic plasticity was assessed using both antagonists and agonists 
specific to either Di-like or D2-like dopamine receptors.
3.2.2.1 Di-like receptors
The Di dopamine receptor antagonist SCH23390 hydrochloride (10 fJM) (Schulz et 
al, 1985) reduced the maximum EPSP amplitude recorded under basal stimulation 
(2.0±0.2 mV, n=14(3); P<0.01 two-tailed t-test) but did not alter the overall input- 
output profile (P>0.5 two-way ANOVA; figure 3.2.5). SCH23390 had a modest 
effect on paired-pulse depression (figure 3.2.11; figure 3.2.5) but failed to achieve 
statistical significance using two-way ANOVA (P>0.5).
SCH23390 did affect the induction of LTD, reducing the level of depression 
attained during conditioning and preventing the expression of LTD (6.0 ± 3.2%; 
n=6(2); significantly different than controls: -12.3±3.0%, n=20(9); P<0.01; two­
tailed-unpaired t-test; figure 3.2.5). In contrast, the Di antagonist did not, affect LTP 
(18.8±4.8%; n=7(2); P>0.5, unpaired, two-tailed Welch-test; Figure 3.2.5).
The affect of a Di agonist (SKF38393,10 //M) (Sibley et a l, 1982) on LTP 
induction was investigated and found to block induction in 5 out of 6 experiments 
(2.6±3.2%; n=6(3)). This degree of potentiation is significantly different than 
controls (18.4 ± 4.7%; n=l 1(6); P<0.02, unpaired, two-tailed Welch-test; 
summarised in figure 3.2.11).
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Figure 3.2.5 D, dopamine receptor dependency of synaptic plasticity in the 
mouse perirhinal cortex. SCH23390 reduced the input-output relationship (top left) 
but had little effect on paired-pulse outcome (hottom left), long-term depression (tope 
right) or long-term potentiation (bottom right).
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3.2.2.2 D2-like receptors
The typical D2 dopamine receptor antagonist sulpiride (10 //M) (Seeman & Van Toi, 
1994) was initially used in examining the involvement of D2 dopamine receptors in 
perirhinal cortical plasticity. While this drug appeared to alter the paired-pulse 
profile towards that of facilitation, the precise action of sulpiride was masked by its 
solvent, ethanol. When ethanol alone was present in ACSF there was a similar shift 
in profile towards PPF. The water-soluble D2 dopamine receptor-specific antagonist 
Remoxipride hydrochloride (10 juM) (Mohell et al., 1993) was therefore used and 
was found to alter synaptic plasticity.
Remoxipride significantly increased the maximum amplitude evoked by test- 
shocks (3.2±0.2 mV, n=12(3); P<0.05, two-tailed t-test) but did not alter the overall 
profile of the input-output relationship (P>0.2 two-way ANOVA; figure 3.2.6). 
Remoxipride had a more overt affect on the paired-pulse profile than the Di 
dopamine receptor antagonist. The paired-pulse profile was again shifted towards 
facilitation (figure 3.2.6) and was significant at the 30% and 80% stimulus intensities 
(P<0.01; Fi 1,657 =2.68 and P<0.001; Fn,645=2.98 respectively; two-way ANOVA). 
Remoxipride also blocked the induction of LTD in 6/8 slices (-0.3 ± 4.3%, n=8(3); 
significantly different than controls: -12.3±3.0%, n=20(9); P<0.03, unpaired two- 
tailed t-test; figure 3.2.6). Interestingly, the degree of frequency-dependent 
depression seen during the conditioning period was enhanced compared with control 
slices. When TBS was applied to superficial afferents in the presence of 
Remoxipride, LTP was still reliably induced (22.3±6.1%, n=9(3); P<0.01; two-tailed 
paired t-test) and was not significantly different than control (P>0.5 two-tailed t-test).
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The D2 dopamine receptor-specific agonist Quinpirole (10 /^M) was applied 
to slices and the induction of LTD and LTP examined. While Quinpirole had little 
effect on LTD induction (4/7 slices; -1 1.7±6.8%; P>0.5, unpaired two-tailed t-test, 
n=7(3); figure 3.2.7) the agonist significantly increased the degree of potentiation 
achieved by TBS which induced LTP in 100% of experiments (39.1±6.8%; 
significantly different than controls: 18.4 ± 4.7%; n=l 1(6); P<0.05 unpaired two- 
tailed t-test, n=7(3); figure 3.2.7).
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Figure 3.2.6 Antagonising D2 dopamine receptors blocks synaptic depression.
Top left The D2 dopamine receptor antagonist Remoxipride increased the maximum 
amplitude of field responses. Bottom Left Remoxipride blocked PPD, resulting in 
the expression of PPF. Top right LTD induction was prevented by the antagonist, 
while LTP was unaffected {bottom right).
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Figure 3.2.7 Perirhinal cortical long-term synaptic plasticity in the D2 dopamine 
receptor antagonist Quinpirole. 10 pM  Quinpirole has no effect on LTD induction 
(top), while enhancing LTP (bottom).
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3.2.2.S Co-application of dopamine antagonists
In an attempt to resolve the apparent disparity between the actions of Di and D2 
dopamine receptor antagonists on synaptic plasticity within the perirhinal cortex, 
both agents were co-applied to slices. Curiously, the co-application of the two 
dopamine receptor antagonists resulted in the full recovery of PPD at superficial 
synapses such that profiles were indistinguishable fi*om controls (P>0.5; two-way 
ANOVA; figure 3.2.8). Furthermore, there was a partial recovery in the ability to 
express LTD (-9.1 ± 4.9%; n=9(3); figure 3.2.8), though this failed to achieve 
statistical significance.
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Figure 3.2.8 Co-application of both Di and dopamine receptor antagonists 
restores normal synaptic plasticity. Top left Input-output relationships are normal. 
Bottom left Paired-pulse profiles show normal PPD ratios. Right While a significant 
LTD is not induced, in the presence of both drugs, LFS showed a trend towards 
depression.
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3.2.2.4 Dopamine receptors are located postsynaptically
Sharp intracellular recordings were used to identify cellular events following 
activation of dopamine receptors on pyramidal cells in layer 11/111 of the perirhinal 
cortex. This technique also demonstrates the postsynaptic localisation of these 
receptors. An example experiment is shown in figure 3.2.9.
Following impalement of a cell, input resistance of the individual cell was 
obtained and a stable Em baseline recorded (-75.7±2.0 mV; n=3 cells). Bath 
application of the D2 receptor agonist Quinpirole (10 juM) led to hyperpolarisation of 
the cell membrane potential (-8.8±2.1 mV; P<0.03, paired-t-test; n=3 cells). 
Hyperpolarisation was associated with a reduced input resistance from 49.7±3.3 MQ 
to 40.8±3.1 MQ (P<0.001, paired t-test; n=3 cells). Washing off the drug led to re­
polarisation of the cell back to -78±1.9 mV and a return of the input resistance to 
47.5±3.4MQ. Replotting the 1/V data as absolute membrane potential against 
current injection created an intersect at approximately -120 mV, indicating a change 
in potassium conductance.
Conversely, application of the Di dopamine receptor agonist SKF38393 
(10 juM) led to a slight, but insignificant, depolarisation (+1.4±2.4 mV) that was 
associated with a small (but again insignificant) increase in input resistance 
(+3.5±2.5 MQ).
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Figure 3.2.9 Dz dopamine receptors are expressed postsynaptically. Top left 
The D2 dopamine receptor agonist Quinpirole reversibly hyperpolarises layer II/III 
perirhinal neurones. Bottom Membrane responses to hyperpolarising current 
injeetions before {left), in the presenee of Quinpirole {middle) and after washout 
{right). Input resistanee was redueed in the presenee of the drug and returned to 
baseline values following washout. Top right The cross over of the best fit lines 
(R^>0.98) indicates an inereased potassium conductance in response to D2 receptor 
activation.
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3.2.3 GABA receptors
Antagonists of GABA receptors were bath applied to slices in order to identify the 
importance of inhibitory activity in perirhinal cortical plasticity. Both GABAa and 
GABAb receptor antagonists alter the paired-pulse profile and impair LTD.
3.2.3.1 GABAa
Antagonising GABAa receptors using bicuculline methiodide (BMI; 10 //M) 
increased the input-output relationship such that larger EPSP amplitudes were 
recorded at all stimulus intensities (P<0.00001, Fw, io2o=3.881, two-way ANOVA; 
figure 3.2.10). BMI enhanced paired-pulse depression at all intervals and produced 
profiles that were indistinguishable at 30, 50 and 80% stimulus intensities (figure 
3.2.10). The presence of BMI did not, however, facilitate the induction of LTD. 
During conditioning there was an initial depression of the response similar to that 
seen at the 1000 ms paired-pulse interval and responses remained at this level 
throughout conditioning. After conditioning, however, there was an immediate 
return to baseline levels followed by a slight potentiation during the first 30 minutes 
that reached a plateaux at 7.1±2.4% (60 minutes, n=10(5), figure 3.2.10). The degree 
of potentiation was not, however, significantly different than the non-conditioned 
pathway (1.7±2.7%; P>0.1, paired-t-test), while it was significantly different than 
control slices (-12.3±3.0%, n=20(9); P=0.0001, two-tailed unpaired t-test).
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Figure 3.2.10 GABAa receptor dependency of synaptic plasticity in the mouse 
perirhinal cortex. Top left BMI increased the amplitude of the field potential. 
Bottom left Antagonising GABAa receptors enhanced the degree of PPD at each 
interval studied such that the profile obtained at each stimulus intensity was 
indistinguishable. Right Low-frequency stimulation led to a frequency-dependent 
depression, but responses returned to baseline following LFS and a slow-onset 
potentiation developed.
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3.2.3.1 GABAb
Antagonising GABAb receptors increased the maximum EPSP amplitude (3.5±0.2 
mV; n=19(3); P<0.01, unpaired t-test; figure 3.2.11) and the overall input-output 
relationship was altered (P<0.0001, F h , 96o= 3 . 2 ) .  Paired-pulse profiles were also 
altered (figure 3.2.11). At intervals of less than 100 ms there were no overt 
differences between control and drug-treated profiles, while paired-pulse depression 
was no longer expressed at intervals over 100 ms at all three stimulus intensities 
(P<0.001 at all three intensities, two-way ANOVA). In the presence of SCH50911, 
LFS led to impaired fi*equency dependent depression during conditioning. 
Immediately after conditioning, responses returned to baseline amplitude followed 
by a slow-onset depression which returned to baseline within one hour (-9.7±3.1% at 
30 minutes; +1.1±3.0% at 60 minutes).
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Figure 3.2.11 GABAb receptor dependency of synaptic plasticity in the mouse 
perirhinal cortex. Top left An antagonist of GABAb receptors increased EPSP 
amplitude at the larger stimulation intensities. Bottom left GABAb receptors are 
important for the expression of PPD at intervals greater than 200 ms. Right Blockade 
of GABAb receptors reduces the degree of frequency-dependent depression achieved 
during LFS. Immediately following conditioning, responses returned to baseline and 
a slow-onset, short-lasting depression was seen.
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3.2.4 Summary
The neurotransmitter receptor-dependency of mouse perirhinal cortical plasticity is 
summarised in figure 3.2.12. The receptor-dependency of synaptic plasticity in the 
mouse perirhinal cortex is interesting. While showing many similarities to the rat 
perirhinal cortex, there are some key differences. Namely, unlike in the rat, LTD in 
the mouse does not appear to be NMDA receptor-dependent; in contrast, like the rat, 
LTD induction is dependent on group I and 11 mGlu receptor activation, but not 
group 111. Interestingly a similar receptor dependency is seen for short-term 
plasticity, which suggests that LTD in this brain region may, in part, have a 
presynaptic locus of expression.
The finding that synaptic plasticity within the perirhinal cortex is dependent 
on dopamine receptor activation is a novel finding and has important implications in 
the interpretation of synaptic transmission within this brain region. In particular, 
blockade of D2 dopamine receptors blocks LTD induction and produces a 
pronounced change in paired-pulse profile, suggesting that activation of this class of 
dopamine receptor and the subsequent down regulation of cAMP is crucial for the 
expression of plasticity within the perirhinal cortex.
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Figure 3.2.12 Summary of receptor dependency for perirhinal synaptic 
plasticity. Top: Composite paired-pulse ratios (see methods section 2.1.10) at 80 
(A) and 30 (B) percent stimulation intensities. The mean ± SEM of the paired-pulse 
ratio was calculated from all inter-pulse intervals (20-2000 ms) recorded from each 
pathway, giving a value that represents the total degree of depression or facilitation 
in each condition. Statistics represent significance obtained using two-way ANOVA 
(see main text). Middle: Receptor-dependency of LTD induction. Mean EPSP 
amplitudes at 60 minutes post conditioning (C) and probabilities of inducing LTD in 
each condition (D). Bottom Receptor dependency of LTP induction. Mean EPSP 
amplitudes at 60 minutes post-conditioning {E) and probability of LTP induction in 
each condition {F). Dotted line in each chart represents control levels. Asterisks on 
the probability plots indicate significant differences using Fisher’s Exact Test. X = no 
result.
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3.3 Abnormal Synaptic plasticity in R6/1 mice
Following the characterisation of synaptic plasticity within the perirhinal cortex of 
CBA X C57BL/6 mice, a linear study of the R6/1 mouse was made. For these 
experiments, data obtained from transgenic slices were compared to age-matched 
wild type littermate controls.
3.3.1 Characterisation of the R6/1 phenotype
Aspects of the R6/1 phenotype were assessed as follows. Clasping was used as the 
key determinant of the R6/1 phenotype.
3.3.1.1 Weight
Mice were grouped by sex and genotype and their weights binned by age to the 
nearest month. Mean weight ± SEM was then plotted against age (figure 3.3.1). 
Transgenic males were significantly underweight compared to age- and sex-matched 
littermate controls at five months of age and older. In contrast, female transgenic 
mice did not show a significant loss of weight, although they did show a trend to be 
lighter than wild types. Upon full dissection of male transgenic mice, it was noted 
that they appeared to have comparable fat deposits, suggesting that the loss in body 
weight may be at the expense of muscle tissue.
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Figure 3.3.1 Characterisation of the R6/1 gross phenotype. Top left Photographs 
showing the clasping phenotype in an eleven month old R6/1 mouse (right) and its 
absence in an age-matched littermate (left). Top right Percent of animals showing 
the clasping trait at each age (• wild type; •  transgenic) Bottom left Comparison of 
body mass of female transgenic and wild type mice. Bottom right Body mass of 
male animals. Males show a divergence from approximately 5 months of age 
(P<0.001, two-tailed t-test).
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3.3.1.2 Clasping
The clasping phenotype was assessed in mice from 1 week up to 37 weeks of age. 
Clasping was never seen in wild-type mice. Clasping was observed in transgenic 
mice from the age of 13 weeks and by 19 weeks over 80% of animals were clasping 
in at least 3/10 trials. Figure 3.3.1 shows the clasping phenotype and summarises the 
onset of this motor defect.
3.3.2 Electrophysiological phenotype
The cellular and synaptic phenotypes of R6/1 perirhinal cortex were investigated in 
asymptomatic mice (2 month), mice that were just starting to show neurological 
symptoms (5 months), symptomatic (7 months) and nearing end-stage (9 months) 
(Home Office regulations prevented the study of end-stage mice).
3.3.2.1 Cellular properties
It was noted that it was generally easier to find and impale layer II/III perirhinal cells 
in transgenic slices than in wild type slices. At 3 months of age, cells in transgenic 
slices showed a normal resting membrane potential (Em= -79.4±1.0 mV, n=l 0). At 
5 months, however, there were two discernable populations of cells. The first 
showed a normal resting membrane potential (-77.5±0.9 mV, n=6), the second
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Figure 3.3.2 Progressive alterations in the passive membrane properties of R6/1 
perirhinal cortical neurones. Row A Distributions of the resting membrane 
potentials of layer II/III perirhinal neurones at 3, 5 and 7 months of age. At 3 months 
old, neurones show a similar resting membrane potential to neurones in the 
CBAxC57BL/6 mice. At 5 months, however, two subpopulations were identified. 
Some cells showed a normal resting membrane potential, the other had a depolarised 
resting membrane potential. By 7 months the majority of cells had a depolarised 
resting membrane potential. Rows B & C Current-voltage relationships in response 
to negative current injections. At both 3 and 5 months old input resistances were 
higher than in control experiments, but were within the normal range. At 7 months, 
Rin was increased above that of either 3 or 5 months old cells. Row D Time courses 
of the hyperpolarising membrane response to a -0.4 nA current injection. At 3 and 5 
months old, Tm was similar to control mice, while at 7 months old, the membrane 
time constant was reduced. Row E Cellular responses to positive current injection.
At 3 months action potential generation appeared normal, while at 5 and 7 months, 
action potentials fired irregularly and had smaller amplitude.
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Cellular property Mean ± SEM
3 month
n=6
5 month 
n=7
7 month 
n=5
Em -79.4 ± 1.0 mV^ -69.5 ± 2.5 mV " -63.1 ± 2.6 mV"
Rin 42.5 ± 2.5 MQ 47.5 ± 2.5 MO 57.8 ± 6.7 MQ***
Tm 10.0 ± 0.3 ms 9.8 ± 0.5 ms 6.6 ± 0.4 ms
Cm 0.23 ± 0.02 nF 0.21 ± 0.02 nF 0.12 + 0.01 nF*
A P  threshold -47.3 ± 2.5 mV -51.4 ± 4.5 mV -52.9 ± 3.9 mV
A P  overshoot +28.2 ±1.5 mV +27.3 ± 5.4 mV +5.2 ±2.1 mV
A P  amplitude 75.7 ±1.6 mV 78.7 ± 6.9 mV 60.0 + 2.1 mV*
A P  width 1.73 ± 0.10 ms 2.75 ± 0.48 ms 4.05 ± 0.21 ms*
Table 3.3.1 Cellular properties of layer II/III perirhinal neurones in R6/1 
transgenic mice. Asterisks denote significant difference against previous age group. 
 ^n = 10 cells. ^  over all mean, in reality there are two sub-populations, one showing 
normal Em the other with depolarised Em (see main text); n = 11 cells.  ^n=  10 cells, 
n = Number of cells.
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showed a depolarised membrane state (-64.8+2.5 mV, n=5). By 7 months of age 
90% of cells showed a depolarised resting membrane potential (-63.1+2.6, n=10).
Both wild type and transgenic cells showed membrane hyperpolarisation in 
response to a negative current injection (-0.2 to -0.8 nA). There was an initial 
charging of the membrane until a steady state was reached. Current-voltage plots 
highlighted a progressive increase in input resistance in the transgenic slices. At 3 
months of age, Rin values were not significantly different than those obtained in the 
control study (42.5+2.5 MQ; P>0.5; n=6). At 5 months there was a trend towards an 
increased input resistance (47.5+2.5 MQ, n=7) but this failed to reach significance 
(P=0.14). At 7 months of age there was a significant increase in input resistance 
(57.8+6.7 MQ, P<0.001, two-tailed t-test; n=5).
The membrane time constant (Tm) was found to be normal at both 3 (10.0+0.3 
ms; P>0.5) and 5 (9.8+0.5 ms; P>0.5) months of age. At 7 months, there was a trend 
for Tmto be reduced (6.6+0.4 ms) but this did not reach significance (P=0.19). 
Membrane capacitance was calculated firom Rm and Tm. At both 3 and 5 months. Cm 
was similar to controls (0.23+0.02 nF; 0.21+0.02 nF respectively; P>0.5 in both 
conditions). At seven months of age membrane capacitance was significantly 
reduced by as much as 50% compared to the control experiments (0.12+0.01 nF; 
P<0.05).
Injection of positive current (+0.2 to +0.8 nA) depolarised the cell and 
evoked action potentials in both wild type and transgenic slices. Action potentials 
were analysed at 3, 5 and 7 months of age and action potential threshold, overshoot, 
amplitude and duration (at half-maximum amplitude) were ascertained (table 3.3.1). 
Threshold was not significantly altered at any age, while overshoot was reduced at 7
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months, leading to a significant reduction in action potential amplitude (60.0+2.1 
mV; P<0.05; n=7 cells). The duration of the action potential was also found to be 
significantly increased at 7 months (P<0.05 vs. 5 month-old and P<0.00001 vs. 1 
month-old; two-tailed t-test).
3.3.2.2 Field responses
The field potential recorded firom wild type slices appeared to be identical to that 
seen in the background strain. In contrast, the R6/1 perirhinal cortical field potential 
was markedly different (figure 3.3.3; figure 3.3.4). Strikingly, a prolonged late 
component (onset latency of -9.4 ms) is seen in the majority of transgenic slices that 
is absent in wild type potentials. This late component was seen in slices prepared 
firom transgenic animals of all ages. The late component was not susceptible to 
pharmacological manipulation and persisted in the presence of the NMDA receptor 
antagonist D-AP5 (50 //M; figure 3.3.4); the group II mGIu receptor agonist DCG-IV 
(10 /uM); the Di dopamine receptor antagonist SCH23390 (10/fM) or agonist 
SKF38393 (10 //M); the D2 dopamine receptor antagonist Remoxipride (10/zM) or 
agonist Quinpirole (10 //M; figure 3.3.4); and also the GABAa receptor antagonist 
PTX (2.5 //M; figure 3.3.4).
In order to account for the late component, EPSP area was used to measure 
the field potential in all experiments investigating LTD that are reported in section 
3.3.
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Figure 3.3.3 Progressive alterations in the input-output relationship in 
transgenic mice. The input-output relationship for transgenic mice aged 3,5 ,7  and 
9 months old are represented by • (in all subsequent figures, results obtained from 
transgenic animals are shown in red). For comparison only, input-output 
relationships from the wild-type animals at 2 months of age are also shown (o). An 
example trace from a slice prepared from a 7 month old transgenic mouse is shown 
above compared to wild type (average of five traces).
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Figure 3.3.4 Example field potentials recorded from the R6/1 perirhinal cortex.
A-C Representative EPSPs obtained at approximately 30, 50 and 80% maximal 
amplitude. Responses from slices prepared from two month old (A); five month old 
(B); and seven month old (C) animals. D: The NMDA receptor antagonist D-AP5 
(top); GABAa receptor antagonist PTX (middle); or the D] dopamine receptor 
agonist Quinpirole (bottom) failed to affect the late component. N.B. traces in D are 
obtained from different slices. All traces are the average of 5 consecutive responses.
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3.3.3 Plasticity
Both short-term and long-term plasticity was studied in the R6/1 perirhinal cortex 
and compared to age-matched littermate controls.
3.3.3.1 Paired-pulse
Paired-pulse stimuli were applied to sets of slices prepared from transgenic and wild 
type animals from each age group (figure 3.3.5; for clarity purposes, only the 80% 
paired-profiles have been shown; see figure 3.3.6 for profiles obtained at both 30 and 
50% intensities). Wild-type slices exhibited paired-pulse depression profiles similar 
to those seen in the background strain, at all ages studied. At one to two months of 
age, slices showed a similar paired-pulse profile to wild types (P>0.5, two-way 
ANOVA). At 5 months there was a trend to show a lesser degree of depression, but 
this was not significant (P>0.5, two-way ANOVA). At seven months, however, 
paired-pulse facilitation was favoured over depression at all three stimulus intensities 
(P<0.00001, two-way ANOVA). At 9 months, facilitation was still favoured over 
depression, but PPF was not as large as that seen at 7 months. There was a 
significant difference between transgenic and wild type profiles at 80% stimulation 
intensity only (P=0.008, F 11,37g = 2.34; two-way ANOVA).
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Figure 3.3.5 Progressive loss of paired-pulse depression in R6/1 perirhinal 
cortex. Paired-pulse profiles are shown for the 80% stimulation intensity. Profiles 
were obtained from 2, 5, 7 and 9 month old age groups. At both 2 and 5 moths of 
age, normal PPD is expressed. At 7 and 9 months of age, however, profiles show a 
significant shift towards that of facilitation. Aged-matched littermate controls are 
also shown. See also figure 3.3.6.
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Figure 3.3.6 Outcomes of paired-pulse stimulation in the R6/1 perirhinal cortex.
Profiles are shown at stimulation intensities set to evoke responses at 30 (•), 50 (•) 
and 80 (o) % maximal amplitude. Profiles were obtained in slices prepared from one 
month (top left), five month {bottom left), seven month {top right) and nine month 
{bottom right) old mice.
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3.3.S.2 LTD
Similarly to the paired-pulse analysis, there was a progressive loss of long-term 
depression at transgenic superficial perirhinal synapses, but not in wild types (shown 
in figure 3.3.7 and summarised in figure 3.3.8). LTD induction in slices prepared 
firom two month old transgenic animals was enhanced compared to their littermate 
controls (-42.7±14.8%; n=5(2) vs. -19.4±4.7%; n=16(6); P<0.05, unpaired, two- 
tailed t-test). At five months of age, LTD showed a trend towards a decrease, but 
this failed to reach significance compared to littermates (-10.9±5.9%; n=7(3) vs. 
-24.6±7.2%; n=7(3); P>0.2). By seven months, however, LTD was hardly ever 
induced (14% of experiments) and was highly significantly different than littermates 
(+8.1±6.8%; n=7(3) vs. -16.5±5.7%; n=6(3); P<0.0001, two-tailed t-test). At 9 
months, LTD was never observed and again LFS gave rise to a small degree of 
potentiation (+7.3±6.0%; n=l 1(4)) while LFS applied to control slices resulted in 
LTD (-30.0±9.9%, n=7(3)). The difference between wild type and transgenic LFS 
outcome was significant to P<0.003 (two-tailed t-test).
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Figure 3.3.7 LTD expression in R6/1 perirhinal cortex. The progressive change in 
the outcome of LFS is clearly seen. At 2 moths of age LFS gives rise to an enhanced 
LTD with respect to littermate controls. At 5 months there is a slight, but 
insignificant reduction. At 7 and 9 months of age LTD is not expressed, while wild- 
type mice maintain LTD expression at all ages.
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Figure 3.3.8 Summary of LTD induction in the R6/1 perirhinal cortex. Left 
Mean LTD induced in wild type (blue) and transgenic (red) slices at the ages 
indicated. Asterisks indicate significant differences between transgenic and age- 
matched littermates. Right Probability of LTD induction in transgenic and wild type 
slices.
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3.3.3.3 Spike LTD
Spike depression was investigated in slices prepared from seven-month-old 
transgenic animals using intracellular recording techniques. During baseline 
recordings, test-shocks evoked an action potential in >90% of trials (example shown 
in figure 3.3.9; n=2(2)). During LFS, spikes were observed during the first ~1 
minute of conditioning and then subthreshold responses were evoked. Following 
LFS there was a period of post-conditioning depression, but firing recovered within 5 
minutes and continued to fire in >76% of trials. Conditioning, however, led to a 
potentiated component to the response immediately after the action potential (figure 
3.3.9).
In an attempt to recapitulate the R6/1 conditions in a wild type slice, a wild- 
type cell was depolarised to approximately -66 mV during a conditioning train of 
synaptic inputs. This, however, did not prevent the induction of spike LTD as, 
following conditioning, the cell ceased to fire action potentials (figure 3.3.9).
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Figure 3.3.9 Seven month old transgenic slices do not show spike depression.
Top Lack of spike-LTD in transgenic animals. During baseline recording the cell in 
this example fired reliably upon application of test-shocks. Following conditioning 
there was a period of depression and then a return to action potential firing. Example 
traces from baseline and 60 minutes after conditioning are shown above (single 
traces). Bottom Depolarising a wild-type cell to -66 mV during conditioning did not 
prevent the induction of spike-LTD. Note the different time scales.
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3.4 Recovering normal synaptic plasticity
There is a marked loss of dopamine receptors within the brains of HD gene carriers 
prior to the onset of a neurological phenotype (Andrews et a l, 1999) and a similar 
reduction is seen in the R6/2 mouse brain (Cha et a l, 1998). Agonists of dopamine 
receptors were therefore applied to transgenic slices to investigate if a decrease in 
perirhinal expression of dopamine receptors could underlie the altered synaptic 
phenotype.
3.4.1 D2 dopamine receptors
The D2 dopamine receptor antagonist Quinpirole was bath applied to transgenic 
slices and synaptic plasticity investigated. Interestingly, Quinpirole reduced the 
degree of paired-pulse facilitation observed in 5 and 7 month old transgenic animals 
(figure 3.4.2; see also figure 3.4.1) (9 months not tested) such that PPD of drug- 
treated slices was not significantly different than that of wild type mice (P>0.3, two- 
way ANOVA). Quinpirole had no effect on paired-pulse profiles in wild-type slices.
Quinpirole also affected the expression of LTD (figure 3.4.2). LTD was 
enhanced at 5 months with respect to untreated transgenic slices (-31.3±4.1%; 
P<0.02 n=6(2)) and the degree of LTD induced in the presence of the drug was 
indistinguishable from wild type slices (P>0.3; unpaired t-test). Quinpirole also 
restored LTD expression at 7 months of age (-42.1±13.7%; P<0.01, paired t-test; 
n=9(3)). In the presence of the drug, LTD was significantly different than untreated 
slices (P<0.02) and not significantly different than age-matched littermate controls 
(P>0.1). Importantly, as discussed earlier, Quinpirole did not affect LTD induction 
in wild type slices.
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Figure 3.4.1 Quinpirole recovery of PPD in transgenie slices. The D2 dopamine 
receptor agonist Quinpirole restores normal PPD in transgenic slices prepared from 
five (left) and seven (right) month old R6/1 mice. Profiles are shown at 30 (•), 50 
(•) and 80 (o) per cent maximal stimulation.
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Figure 3.4.2 Quinpirole recovers normal synaptic plasticity at transgenic 
perirhinal synapses. The D2 dopamine receptor agonist Quinpirole (•) was found 
to recover paired-pulse depression {top; see also figure 3.4. Q and long-term 
depression {bottom) at transgenic synapses at both 5 and 7 months of age.
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Figure 3.4.3 Summary chart showing Quinpirole recovery of LTD in transgenic 
animals. Left Mean EPSP amplitude 60 minutes after conditioning. Right 
Probability of LTD induction.
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3.5 Immunohistochemistry
Immunohistochemical techniques were used to study the development of 
mutant huntingtin aggregation and dopamine receptor expression. Primary 
antibodies raised to the appropriate antigen were applied to slices prepared from 
animals aged 1, 3 and 7 months old. Aggregate formation was highlighted using a 
diaminobenzidine reaction and then slices viewed at the light level. A separate set of 
slices prepared from the same animals were exposed to antibodies raised to 
subclasses of Di and D2 dopamine receptors and visualised, using a fluorescent 
marker, with a confocal microscope.
3.5.1 Inclusion formation
The polyclonal sheep antibody S830, raised against exon 1 of the huntingtin protein 
carrying 53 repeats, was used to investigate the formation of intranuclear inclusions 
in the perirhinal cortex of the R6/1 mouse. Sections were prepared from animals 
aged 1, 3 and 7 months old. Neuronal intranuclear inclusions were only observed in 
the 7 month old group.
Perhaps more interesting was a progressive development of a diffuse staining 
of mutant huntingtin within nuclei of cortical cells (table 3.5.1; figure 3.5.1). Within 
sections prepared from 1 month old animals, all cells showed none to low levels of 
staining. By three months, however, the majority of cells in layers II/III showed a 
dark, dispersed nuclear staining, while all other cortical layers showed no such
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staining. At seven months of age, nuclear staining was seen in all cortical layers 
from II through to VI. Slices from age-matched littermate controls showed no 
nuclear staining at any age. Examples of sections prepared from transgenic animals 
of each age and a wild-type of seven months old is shown in figure 3.5.1.
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1 month 3 month 7 month
WT R6/1 WT R6/1 WT R6/1
Layer I — — — — — —
Layer II/III — + — +++ — 4 -H -
(inclusions)
Layer V/VI — — — — — +++
(inclusions)
Table 3.5.1 Mutant huntingtin staining in neuronal nuclei of the perirhinal 
cortex. Key: - , no nuclear staining; +, some nuclear staining; +++, dark nuclear 
staining; blue, wild types litter mates; red, transgenic animals. n=9(3).
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Figure 3.5.1 Progressive localisation of mutant huntingtin with the nucleus of 
perirhinal cortical neurones. Mutant protein was bound by an antibody raised 
against exon-1 huntingtin carrying 53Qs and visualised using DAB. Wild-type slices 
never showed any staining at any age (7 month old wild type shown here). Dark 
nuclear staining was not seen until 3 months of age, when layer II/III showed a 
disperse nuclear stain. Layer IV of area 36 also showed some staining. Aggregates 
were not, however, identified at this age. By 7 months, all cortical layers showed 
nuclear staining and some cells contained aggregates (*). Scale bar: x IQO objective 
images (top four): 500 //m; x400 objective images (bottom two) 10 pm. 
x400 images have been counter stained with eosin pink. Cortical layers are indicted 
above the 7M wild type image.
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3.5.2 Dopamine receptors
Confocal microscopy was used to assess changes in dopamine receptors in the 
perirhinal cortex during the development of the R6/1 phenotype. Sections were 
prepared from the same animals used for the aggregate development study in section 
3.5.1. In order to obtain fluorescence intensities for each age group, three to four 
animals were used per group. Images were taken from three sections prepared from 
each animal and composite images prepared using the Leica Confocal Software. 
Fluorescence measurements were obtained from each cortical layer by taking the 
mean of three sampling windows within each area of interest. All sections were 
imaged using identical confocal setting and were processed on the same day to avoid 
discrepancies in settings.
3.5.2.1 D2 dopamine receptors
The expression of D2 dopamine receptors in the perirhinal cortex were investigated 
in both wild-type and R6/1 transgenic mice. Preliminary studies indicated a large 
reduction in receptor expression in the surface layers of cortex (figure 3.5.2).
Control slices, which underwent identical solution changes as experimental slices, 
but in the absence of either primary, secondary or both antibodies, showed very little 
fluorescence (figure 3.5.2). Sections prepared from D2 knock-out mice showed little 
staining and, at a high PMT, no punctate staining was seen (figure 3.5.2). The D2 
dopamine receptor antibodies therefore have a high specificity.
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WT, r  only WT, 11“ only
D2K0 D2 KO 
(High PMT)
7M0W TLM 7M0 R6/1
Figure 3.5.2 Control experiments for D] dopamine receptor 
immunofluorescence. Top left Wild type slices exposed only the primary 
antibodies showed only a low level of background staining. Top right A low level 
of autofluorescence was also seen when slices were exposed to secondary antibodies 
only. Middle left Slices prepared from D2 knockout mice showed little fluorescence 
and no definition even at a high PMT {middle right). Bottom left Wild type slices 
prepared from a seven month old animal showed punctate staining predominantly in 
layer I. Bottom right Seven month old transgenic animals showed clear reduction in 
labelling within layer I. (N.B. All images are composite maximal fluorescence, 
while in the for analysis, confocal images are composite mean fluorescence.)
Cortical layers are indicated. Scale bar = 100 pm. Images taken using a x40 
objective.
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For analysis, three sections were prepared from three animals in each of the 
three age groups. Slices were prepared from the same animals as those used for the 
inclusion formation and the Di dopamine studies. Mean fluorescence was generated 
by taking the mean of three sampling windows in each cortical layer on images taken 
from each slice. Wild-type mice showed an intense band of fluorescence in layer I. 
During development, there was a trend towards an increase in D2 receptor expression 
in all layers. This only reached significance at seven months, when all layers were 
significantly higher than either three or one month groups.
Layer I also showed the highest expression in the R6/1 mice. There was not, 
however, a developmental change in expression and intensity levels remained similar 
at all ages. Due to the increase seen in wild type, but not transgenic brains, there was 
a relative deficit of D2 dopamine receptors in layer I transgenic perirhinal cortex at 
seven months (-28%; P<0.05; Fisher LSD test). Results are summarised in figure 
3.5.3 and example images are shown in figure 3.5.4.
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Figure 3.5.3 D] dopamine receptor expression in wild type and transgenic 
perirhinal cortex. Primary antibodies were raised against D] dopamine receptors 
and visualised using a fluorescent signal amplification system. Confocal images 
were obtained and intensity measurements ascertained. Will type mice (blue) 
showed a developmental increase in receptor expression. In contrast, R6/1 mice 
showed little increase with age, reflected as a reduced intensity compared to age- 
matched litter mates. (*= P<0.05 Fisher LSD test).
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WT R6/1
1M
3M
7M
WM VI
Figure 3.5.4 D2 dopamine receptors in the perirhinal cortex. Example images 
obtained from both wild type and transgenic animals at each of the three age groups. 
The most striking difference can be seen at 7 months, where transgenic slices are 
clearly darker than wild types. Scale bar: 100 //m. Images obtained using a x40 
objective. Cortical layers are indicated on the top left image.
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3.5.2.2 Di dopamine receptors
To assess Di dopamine receptor expression, a polyclonal antibody, raised against the 
DI A subclass of dopamine receptor, was used. In initial experiments, three sets of 
control slices, which underwent identical treatments to the experimental slices, but 
were not exposed to either primary, secondary or neither antibody, were prepared 
(figure 3.5.5). These slices showed little fluorescence when viewed under the 
confocal microscope. A fourth control group comprised of slices prepared fi*om the 
D2 knock-out mouse. These slices showed staining similar to slices prepared from 
CBA mice (figure 3.5.5). While this does not directly show specificity towards DI A 
receptors, it at least demonstrates discrimination from D2 receptors.
For analysis, slices were prepared fi*om the same animals used for the D2 
experiment in section 3.5.2.1 and the inclusion study of section 3.5.1. Again, three 
sections were prepared fi*om three animals in each age group (1, 3 and 7 months). 
Slice mean intensity was obtained for each cortical layer and three-way ANOVA 
tests carried out.
Similarly to the pattern of expression of D2 receptors in wild-type mice, Di 
showed a band of higher fluorescence in layer I than other layers at all ages. There 
was a developmental decrease in receptor expression in layer I (-27%; P<0.05, 
Tukey HSD post-hoc test) and a less significant reduction in layer II (P<0.05; Fisher 
LSD post-hoc test).
Fluorescence in layer I of one-month-old R6/1 mice was greatly reduced with 
respect to their age-matched littermates (-40%) and this reduction was highly 
significant (P<0.0001; Tukey HSD test). While the other cortical layers showed a 
trend towards a reduction in Di receptor expression, these layers failed to reach
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significance. The R6/1 brains did not show a developmental down regulation in 
expression, although the significance in layer I was maintained at both 3 months 
(-22%; P<0.02; Fisher LSD test) and 7 months (-20%; P<0.02; Fisher LSD test).
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WT, 1° only WT, ir  only
WT DjKO
Figure 3.5.5 Control experiments for Di dopamine receptor 
immunofluorescence. Top left Little fluorescence is seen when wild-type slices 
were exposed to only the primary antibody. Top right Similarly, exposure to 
secondary antibodies only resulted in a low level of auto-fluorescence. Bottom right 
In contrast, when wild-type slices were treated fully with both antibodies, a typical 
pattern of fluorescence was seen. Bottom right When perirhinal cortical slices 
prepared from D2 knockout mice were exposed to both antibodies a pattern of 
fluorescence similar to that seen in the wild-type mice was evident. While not being 
the ideal control to show antibody specificity for Di receptors, it demonstrates that 
they are not specific for D2 dopamine receptors. The images shown here are 
composite images of the maximal fluorescence from a stack of 10, 1 pm images. 
(N.B. confocal used for analysis are composite images of the mean fluorescence 
from a stack of images.) Cortical layers are indicated. Scale bar =100 pm. Images 
taken with a x40 objective.
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Figure 3.5.6 Di dopamine receptor expression in the mouse perirhinal cortex.
Bound antibodies raised against DI A dopamine receptors were visualised using 
confocal microscopy. At one month of age, transgenic animals showed a highly 
significant reduction in receptors in layer I compared to age-mated littermates 
P<0.0001 Tukey HSD test). Wild type slices showed a developmental 
reduction in Di dopamine receptor expression at 3 and 7 months of age, while 
transgenic slices showed no such reduction. At 3 and 7 months, Di dopamine 
receptor expression was still reduced compared to age-matched littermates 
(*= P<0.05 Fisher LSD test).
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WT R6/1
1M
3M
7M
Figure 3.5.7 Di dopamine receptors in the perirhinal cortex. Example images 
obtained from both wild type and transgenic animals at each of the three age groups. 
Scale bar: 100 pm. Images obtained using a x40 objective. Cortical layers are 
indicated on the top left image.
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3.6 Summary
Perirhinal cortical synaptic plasticity in the normal mouse is predominantly that of 
depression, expressed as both paired-pulse depression and long-term depression.
The degrees of LTD induced in slices from two though to nine months of age are 
comparable, as are the probabilities of induction. The age-dependency of LTD in 
R6/1 transgenic animals is interesting. At two months of age, LTD appears to be 
enhanced compare to that seem in littermate controls. The degree of depression then 
declines until LFS induces a slight potentiation. Remarkably, the expression of LTD 
could be recovered by the D2 dopamine receptor agonist Quinpirole at both 5 and 7 
months of age. Importantly, Quinpirole did not affect LTD in wild type slices.
The expression of dopamine receptors mirrors the loss of LTD. There is a 
progressive loss of Di and D2 dopamine receptors in the surface layer of the 
perirhinal cortex. There are other neuropathological changes observed in the 
perirhinal cortex. There is an age-dependent developmental expression of mutant 
huntingtin within the nuclei of perirhinal cortical cells. Punctate inclusions do not 
appear until seven months of age, while diffuse nuclear staining is apparent in layers 
II/III at 3 months of age and in all layers at 7 months.
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Figure 3.6.1 Key changes in synaptic plasticity at superficial synapses of R6/1 
transgenic perirhinal cortex. LTD is expressed at all ages in littermates (blue). 
Transgenic animals (red) show enhanced LTD at 2 months and then a gradual 
decline, until LTD is not expressed. LTD can be recovered by applying the D% 
dopamine receptor agonist Quinpirole (orange), which does not affect LTD in wild 
types (green). Some of these changes may correspond to neuropathological changes 
observed in the R6/1 perirhinal cortex, namely loss of dopamine receptors and 
nuclear translocation of mutant huntingtin.
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4. Discussion
4.1 Synaptic plasticity in normal mouse perirhinal cortex
This study describes both paired-pulse depression and homosynaptic long-term 
depression at synapses of the mouse perirhinal cortex. Both LTD and PPD have 
been described previously in the rat perirhinal cortex. The LTD observed in the 
mouse shares some properties with rat perirhinal LTD, but there are also differences. 
LTD induction in both rat and mouse is dependent on the activation of mGlu 
receptors. In contrast, NMDA receptor activation is also required for LTD induction 
at rat perirhinal synapses, a dependency which was not observed in the mouse. 
Furthermore, I have shown that long-term depression in the mouse perirhinal cortex 
requires the activation of dopamine Di and D% receptors; a result previously 
unreported.
4.1.1 Basal properties
Field potentials recorded in layer II/III in response to stimulation applied to the 
superficial layer I are similar in nature to responses recorded from the rat perirhinal 
cortex (Ziakopoulos et a l, 1999) and those obtained in other cortical regions (for 
example see Jung et al, 1990; Hess & Donoghue, 1999; Sawtell et a l, 1999; Yun et 
al, 2000). To enable interpretation of the field response, dual intracellular and 
extracellular recordings were made from layer II/III. At field responses up to -40%
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of the maximum amplitude, individual cells showed subthreshold EPSPs. At 
stimulus intensities that evoked field potentials greater than -40% of the maximum, 
action potentials were evoked in individual cells, indicating that the field responses 
above this threshold are comprised of a population spike component.
Cells exhibited typical passive membrane properties of cortical pyramidal 
neurones, with resting membrane potential, input resistance and membrane time 
constant all comparable to other cortical regions (in particular see Bindman et a l, 
1988). Action potentials were also typical of cortical pyramidal neurones, with a 
firing threshold of approximately -55 mV and amplitude of around 80 mV. While 
cell-type was not specifically confirmed using cytochemical techniques, taken 
together, the cellular properties suggest these cells to be pyramidal neurones.
4.1.2 Paired-pulse depression
The intermediate pathway does not appear to support paired-pulse depression at any 
of the intensities studied. In contrast, the superficial synapses of mouse perirhinal 
cortex have paired-pulse profiles that favour depression over facilitation. This is 
similar to the rat perirhinal cortex (Ziakopoulos et al, 1999) and to other areas of 
neocortex (for example see Kang, 1995; Kirkwood et a l, 1999; Xiang et a l, 2002). 
The rat studies indicated a significant difference between the temporal and entorhinal 
pathways, with the temporal pathway showing greater PPD than the entorhinal 
pathway. Unlike the rat, no difference was seen between the two pathways in the 
mouse perirhinal cortex. This suggests that both pathways have equal importance in
324
the mouse, while in the rat, the temporal cortex may be more important than the 
entorhinal pathway in short-term modulation of perirhinal cortical function.
The degree of paired-pulse depression exhibited in any given pathway is 
always greater at higher stimulation intensities. The underlying postsynaptic cellular 
events may be explained by comparing both intracellularly and extracellularly 
recorded responses. While dual recordings were not made during paired-pulse 
stimulation, as discussed above, the data obtained from dual input-output 
relationships indicate that, from approximately 40% maximal stimulation, the field 
response comprises a large population-spike. It is therefore likely that the paired- 
pulse depression seen at paired-pulse intervals up to 1 0 0 0  ms at 80% stimulation 
intensity is a reflection of the second shock evoking fewer action potentials than the 
first. Intracellularly recorded paired-pulse profiles were only obtained at stimulation 
intensities giving rise to subthreshold responses (corresponding approximately to 
intensities used to evoke a 30% maximal field response). At these intensities, 
intracellular paired-pulse profiles are similar to those obtained at the field level in 
that they are dominated by paired-pulse facilitation at intervals up to 200 ms. In light 
of this, it is likely that the firing of action potentials is important for PPD expression 
within the perirhinal cortex. Dual recordings of both field and suprathreshold 
intracellular potentials would reveal whether this is the case.
Paired-pulse depression is believed to have a presynaptic mechanism 
involving receptors located on the terminals of glutamatergic afferents. The 
activation of these receptors leads to the suppression of further glutamate release 
(Scanziani et al., 1997; Vogt & Nicoll, 1999). The subclasses of glutamate receptors 
involved in this mechanism were investigated using receptor-specific antagonists of 
glutamate receptors, the results of which are summarised in figure 3.2.12. The group
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II mGlu receptor antagonist had the greatest affect, altering the paired-pulse profile 
such that facilitation predominated. These results are consistent with presynaptic 
mGlu autoreceptors inhibiting further glutamate release. Similarly, application of the 
group I mGlu receptor antagonist also shifted the profiles towards that of facilitation. 
This would suggest that group I mGlu receptors are also present presynaptically at 
perirhinal synapses and are involved in the regulation of neurotransmitter release.
The antagonism of group III mGlu receptors had no effect on the paired-pulse 
profile, suggesting these receptors are not involved in the short-term regulation of 
neurotransmitter release within this brain region. The failure of D-AP5 to effect the 
paired-pulse profile demonstrates that activation of NMDA receptors is not required 
for the expression of PPD in the perirhinal cortex.
4.1.3 Long-term depression
The intermediate pathways of the mouse perirhinal cortex do not readily support 
LTD at a field level. This result is similar to those obtained in the rat which also 
failed to show a long-lasting depression following LFS (Ziakopoulos et a l, 1999). 
In contrast, superficial synapses of the mouse perirhinal cortex did support a long 
lasting and homosynaptic form of long-term depression. No differences were 
observed between entorhinal and temporal pathways. This is in contrast to the rat 
studies, which showed a greater degree of frequency dependent depression in the 
temporal pathways than in the entorhinal pathways (Ziakopoulos et a l, 1999). This 
may reflect a relatively greater importance for the temporal cortex over the 
entorhinal cortex in the rat, which may not be the case in the mouse.
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Glutamate receptor subtype-dependency of LTD induction at superficial 
synapses of the mouse perirhinal cortex was investigated by the use of antagonists 
and the results are summarised in figure 3.2.12. Bath application of either a group I 
or a group II mGlu receptor antagonist prevented the induction of LTD, showing that 
LTD of superficial perirhinal synapses in the mouse is mGlu receptor-dependent. 
Similar results were obtained in the rat perirhinal cortex when LTD was recorded at 
the single cell level (Cho fl/., 2000).
When a group III mGlu receptor antagonist was applied to perirhinal slices, 
there was no effect on either the induction of LTD or the expression of paired-pulse 
depression. Again, this is in agreement with results obtained in the rat (Cho et a l, 
2000). Both group II and group III mGlu receptors are classically viewed as being 
negatively coupled to adenyl cyclase and hence down regulate cAMP production (for 
review see Conn & Pin, 1997). In light of this classical view of mGlu receptor 
coupling, it is interesting that antagonism of the group II, but not group III mGlu 
receptors, affected both short-term and long-term plasticity. There is evidence, 
however, that the cAMP pathway may not be the only transduction cascade for group 
III mGlu receptors. Evidence firom retinal ON bipolar cells has shown that mGluR6  
may also be coupled to a cyclic GMP phosphodiesterase (Shiells & Falk, 1992) and 
thereby regulate cGMP. This provides an alternative pathway to which the group III 
mGlu receptors may be coupled in the perirhinal cortex. Alternatively, there may be 
limited expression of group III mGlu receptors in the perirhinal cortex. In situ 
hybridisation has shown that there is no significant expression of mGluR4 and only 
moderate expression of mGluR7 mRNA in rat perirhinal cortex (Ohishi et a l, 1995). 
It is therefore likely that group III mGlu receptors are not functionally important in 
the perirhinal cortex.
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Surprisingly, the NMDA receptor antagonist D-AP5 failed to block LTD 
induction and therefore I conclude that LTD is not NMDA receptor-dependent at 
mouse perirhinal cortical synapses. This is in contrast to findings in rat perirhinal 
cortex, where application of LFS induced a novel form of LTD that is co-dependent 
on the activation of both mGlu- and NMDA- receptors (Cho et a l, 2000). Recent 
preliminary data obtained in the rat has shown that application of 5 Hz low fi*equency 
stimulation (3000 pulses) leads to an NMDA receptor-independent form of LTD in 
neonatal and adult perirhinal cortex (Jo et al, 2003). Both the results in mouse and 
those obtained in the rat demonstrate that the perirhinal cortex is capable of 
supporting different forms of synaptic plasticity and these may reflect the range of 
cognitive functions processed within the perirhinal cortex. In agreement with the 
NMDA receptor-dependency reported here, preliminary experiments in monkeys, in 
which AP5 was infused into the perirhinal cortex, failed to diminish accuracy on a 
visual recognition memory task (Turchi et a l, 2003). It would appear, therefore, that 
NMDA receptors may not be involved in such tasks in primates.
Whilst my data is in broad agreement with the published observations in the 
rat, there are nonetheless, as discussed above, some important differences. Several 
factors might account for these disparities. The first is species difference; rat and 
mouse perirhinal cortical synapses may support different forms of LTD. Secondly, 
the rat data are obtained from oblique (45°) slices. This study used coronal slices, as 
oblique slices of mouse perirhinal cortex did not yield robust synaptic responses. It 
is possible that this difference in preparation will produce slices with differentially 
preserved connectivity, which could affect the efficacy of the conditioning paradigms 
used.
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When LFS was applied to synapses during intracellular recording, LTD of 
subthreshold EPSPs was not induced. In contrast, when a suprathreshold response 
was evoked during baseline, LFS gave rise to a depression of spike firing that lasted 
for more than one hour. Importantly, spike-LTD was found to be homosynaptic and 
dependent on synaptic activity rather than simply the cell firing during the 
conditioning period. This spike-depression is reminiscent of the decrease in action 
potential firing seen in perirhinal cortical neurones during the process of 
familiarisation. It is therefore possible that spike LTD underlies this process rather 
than LTD of synaptic transmission as previously proposed. The importance of 
altered firing properties of perirhinal cortical neurones was first suggested by 
Thomas Brown and colleagues, who showed that regular-spiking and late-spiking 
cells respond differently to trains of electrical stimuli: Regular-spiking cells reduced 
their firing rate during repetitive stimulation, while late-spiking cells increased their 
firing rate (see introduction figure 1.5.5, Beggs et a l, 2000). The long-term 
maintenance of such changes in firing rate was not, however, studied. To my 
knowledge, the data presented here is the first report of synaptically induced 
depression of action potential firing within a brain slice preparation. In contrast, 
forms of spike potentiation have been studied (for example see Bindman & Boisacq- 
Schephens, 1966; SekiefaA,2003) In the Bindman and Boisacq-Stephens report, 
repetitive limb stimulation was found to induce prolonged discharges within 
neurones of the primary somatosensory cortex of rat that could last for over one hour. 
The extent and duration of this increase was dependent upon the degree of activity 
achieved within the postsynaptic cell during conditioning. While this form of spike 
potentiation was reported several years prior to the identification of LTP, it is clear 
that such increases in neuronal activity may underlie cortical function. In the more
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recent Seki et a l (2003) article, LTP induction in the rat auditory cortex was 
associated with a slow depolarisation with two to five spike discharges, which was 
not seen either before conditioning or in those neurones that did not exhibit LTP. 
Given that increases in spike firing have been reported to occur within the cortex, it 
is conceivable that the converse, spike depression, also occurs in other brain regions.
Given that field LTD was studied at stimulus intensities set to evoke 
responses at 80% of the maximum, it is likely that the field LTD following LFS 
reflects a decrease in the number of cells firing and hence a decrease in the 
population-spike component. Some preliminary experiments were carried out to 
investigate LTD induced at different stimulation intensities. LFS failed to induce 
LTD at 30% stimulation intensity (n=3(l)), which fits with the lack of LTD recorded 
intracellularly at subthreshold intensities.
It should be noted that the protocols used to induce LTD at the field and 
intracellular levels were different. At the field level, 900 pulses applied at 1 Hz were 
used to induce LTD, while LFS applied during intracellular recordings consisted of a 
shortened period of shocks (300 pulses at 1 Hz). This difference was required 
because the longer LFS paradigm led to the loss of the intracellular recording. This 
may simply be a consequence of the sensitivity of cellular impalement. Conversely, 
it may reflect cellular death during conditioning. If this were the case, the LTD 
recorded at the field level would be the corollary of many cells dying during the 
conditioning period and hence less ionic currents underlying the field response. 
However, given that the shorter period of LFS gives rise to spike-depression and not 
cell death, the later is not likely to be the underlying cause of the field LTD. In 
contrast, preliminary field experiments in which 300 pulses were used to induce LTD 
failed to demonstrate depression of the field potential (n=3(l)). This is not, however.
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necessarily an indication that the prolonged 900 pulse-LFS causes cell death. The 
field LTD induced by 900 pulse-LFS maybe a reflection of multiple cells displaying 
spike-LTD, while 300 pulse-LFS may induce spike-depression in only a few cells. 
Thus, the ionic currents resulting from spike depression induced by the shorter 
conditioning period may be masked by the many cells that still fire action potentials. 
It is also possible, given LTD is only seen 60% of the time in the original control 
experiments, that these preliminary experiments fall into the 40% that do not show 
LTD.
It would be interesting to record intracellularly from multiple cells, both 
proximal and distal to the field electrode, in order to estimate the number of neurones 
that undergo spike-depression during LTD.
4.1.4 GABA receptors
The inhibitory activity of GABA receptors is important for the expression of both 
short-term and long-term plasticity in the mouse perirhinal cortex. The role of 
G A B A a  receptors is complicated. Antagonists of G A B A a  receptors enhanced the 
degree of depression seen at any given paired-pulse interval. This is perhaps 
contrary to what one may predict as the effect of removing the inhibitory activity of 
G A B A a  receptors. As reported previously, blockade of G A B A a  receptors within the 
geniculo-cortical visual pathway of rat prevents the expression of PPD (Jia et a l, 
2004). A possible explanation of the result obtained in the perirhinal cortex could be 
that paired-pulse depression in this region is not mediated by G A B A a  receptors per 
se, but rather PPD is a glutamatergic phenomenon in which G A B A a  activity
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regulates the excitability of afférents within the perirhinal cortex. With the removal 
of the regulatory role of GABAa receptors, more glutamate may be released from the 
presynaptic terminal, thereby activating more autoreceptors and hence greater PPD. 
Alternatively, the location of the GABAa receptors could be on the dopaminergic 
terminals. In this scheme, the normal dopaminergic transmission that is required for 
PPD in this brain region is increased and hence the expression of PPD enhanced.
Blockade of GABAa receptors prevented the induction of LTD. The profile 
of the conditioning period reflected the altered paired-pulse profile in that a large 
degree of depression was achieved immediately following onset of LFS. Responses 
returned to baseline levels immediately following conditioning. This would suggest 
that LTD of the glutamatergic response could be a reflection of LTP in the 
GABAergic pathways of the perirhinal cortex. While this mechanism has not 
previously been reported for LTD, the converse, disinhibition (LTD of GABAergic 
inputs giving rise to LTP), has been demonstrated in the rat CAl field (McMahon & 
Kauer, 1997). It should also be taken into consideration that neurosteroids, levels of 
which maybe elevated during the stress of slice preparation, have a potentiating 
effect upon GABAa receptors by increasing chloride currents (Puia et a l, 1990). It 
is therefore possible that GABAa inhibitory currents maybe more susceptible to 
potentiation as an artefact of stress responses.
GABAb receptors are also involved in short-term plasticity in the mouse 
perirhinal cortex. Application of a GABAr receptor antagonist (SCH50911) 
prevented the expression of PPD at intervals between 100 and 1000 ms, but not at 
intervals less than 100 ms. This result is similar to that obtained in the rat, where the 
role of GABAb receptors was first suggested by the paired-pulse profile which has a 
maximum depression at 2 0 0  ms (the typical time course of metabotropic GABAb
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receptor activity). The role of G A B A b  receptors was then confirmed using two 
different G A B A b  receptor specific drugs (3 - A [  1 -(S)-(3, 4- 
dichlorophenyl)ethyl]amino-2-(S)-hydroxypropyl-p-benzyl-phosphinic acid 
(CGP55845A) or 3-amino-propyl(diethoxymethyl)phosphinic acid (CGP35348)), 
both of which blocked PPD at the intervals between 100 and 1000 ms (Ziakopoulos 
et a l, 1999; 2 0 0 0 ; Garden et al, 2 0 0 2 ). Given that G A B A b  receptors are coupled to 
inwardly rectifying potassium channels (see Marshall et al, 1999 for review) and 
that blockade of G A B A b  receptors block PPD, one would predict that inward 
rectifying potassium channels may underlie PPD. However, in the rat, blockade of 
these receptors using barium does not prevent the expression of PPD (Ziakopoulos et 
al, 2 0 0 0 ), suggesting a mechanism other than inward potassium rectification in 
perirhinal cortical PPD. One such mechanism has been recently highlighted in the 
rat CNS in which presynaptic G A B A b  receptors are negatively coupled to adenyl 
cyclase and thus down regulate PKA (Kubota et a l , 2003). Activation of PKA is 
known to enhance currents through L-type voltage sensitive calcium currents 
(Catterall, 2000) and therefore suppression of PKA by G A B A b  receptor activation 
could underlie PPD in the perirhinal cortex. The PKC pathway may also be linked to 
G A B A b  receptors and may exert an effect on transmitter release either directly 
(Kamatchi & Ticku, 1990) or indirectly through cross-talk with the PKA pathway 
(Kubota et a l, 2003).
The G A B A b  receptor antagonist also precluded the induction of LTD. The 
degree of firequency-dependent depression achieved during conditioning was 
reduced. Immediately following LFS, responses returned to baseline, but then 
showed a slow-onset depression that returned to baseline within one hour. It 
therefore appears that G A B A b  receptors are also important for the induction of LTD.
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4.1.5 Dopamine receptors
In addition to the involvement of glutamate and GABA receptors in synaptic 
plasticity, the involvement of Di and D2 dopamine receptors was also examined. The 
cerebral cortex receives dopaminergic inputs that originate principally in the ventral 
midbrain tegmentum (Lindvall et al, 1974). Consistent with this, Di and D2  
dopamine receptors have been identified in the perirhinal cortex where they are 
reported to be located predominantly in the superficial layers I and II and also the 
deep layers V and VI (Richfield et al, 1989). Despite their identification, there has 
previously been no electrophysiological demonstration of dopamine receptor 
function in the perirhinal cortex.
The results presented in this thesis provide evidence that dopaminergic 
modulation, with respect to Di and D2 receptors, affects both short-term and long­
term synaptic plasticity of glutamatergic transmission in the perirhinal cortex. The 
classical view of dopamine transduction is that Di and D2 receptors are positively 
and negatively coupled to the cAMP cascade respectively (Stoof & Kebabian, 1981). 
In terms of their distribution, it is generally assumed that they follow that of other 
brain regions, that is Di receptors are predominantly postsynaptic whereas D2 
receptors are found either side of the synapse (for review of dopamine receptors see 
Jaber et al{\996)). It is interesting, therefore, that blockade of either Di or D2 
receptors prevented the induction of LTD, suggesting that the role of dopamine in 
perirhinal LTD may be contrary to a traditional interpretation.
In an attempt to resolve this apparent disparity both Di and D2 receptor 
antagonists were co-applied. Curiously, the co-application of the two dopamine 
receptor antagonists resulted in the full recovery of PPD at superficial synapses.
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Furthermore, there was a partial recovery in the ability to express, though this failed 
to achieve statistical significance. The partial recovery of the inductive mechanism 
for LTD in the presence of both Di and D2  receptor antagonists suggests that the role 
of dopamine in the perirhinal cortex is complex.
One possible explanation could be that an appropriate balance between the 
two opposing roles of the dopamine receptor subclasses is needed for LTD 
expression. Separate blockade of either subclass of receptor would therefore lead to 
failure to express plasticity, while preventing activation of both receptors restores the 
balance of Di:D2 receptor activity, resulting in the expression of PPD and LTD. The 
lack of significance of the LTD result in the presence of both antagonists may be an 
artefact of varying affinities for, or potencies at, the respective dopamine receptors of 
the two drugs. If the correct concentrations were used to reinstate the normal balance 
between the subclasses, LTD that is identical to controls may have been induced.
Another factor that may be important in determining the role of dopamine 
receptors is their synaptic localisation. Given the assumption that paired-pulse 
depression is a presynaptic phenomenon, the fact that D2 and, to a degree, Di 
dopamine receptors alter the paired-pulse profiles, indicates that these receptors are 
heterosynaptic receptors located on the presynaptic glutamatergic terminal, where 
they regulate the release of glutamate. On the other hand, the experiments reported 
in section 3.2.2.4, in which application of the D2 receptor agonist leads to 
hyperpolarisation of the cell membrane and an associated reduction of input 
resistance, indicates a postsynaptic location of this subclass of receptor. In contrast, 
application of a Di dopamine agonist had little effect on either membrane potential or 
input resistance. This would indicate that Di dopamine receptors have limited 
postsynaptic expression in the perirhinal cortex. The synaptic distribution of
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dopamine receptors has not been studied extensively in the cerebral cortex. Electron 
microscopic studies within prefrontal cortex indicates both a pre and postsynaptic 
localisation of D2 (Wang & Pickel, 2002) and Di (Bergson et a l, 1995) receptors.
In the striatum, similar experiments reveal that both subtypes of dopamine receptor 
are located predominantly postsynaptically, with both receptors also showing some 
presynaptic expression (Levey et al, 1993). There is no reason, however, to assume 
that the distribution within the perirhinal cortex should have the same receptor 
distribution as that of the prefrontal cortex, the striatum or any other brain region.
4.1.6 Receptor transduction pathways
There is an intriguing link between the synaptic distribution of the receptor classes, 
their down-stream messenger cascades and the receptor antagonism that produced 
the most overt affects on paired-pulse depression. Antagonists of the Di dopamine- 
and group I mGlu- receptors produced only modest shifts in the paired-pulse profiles. 
Both of these receptor classes are reported as having a predominantly postsynaptic 
location (Bergson et al, 1995; Lopez-Bendito et al, 2002). (Although a 
predominantly presynaptic locale cannot be ruled out, as antagonists of both 
receptors altered PPD and, as discussed above, Di agonism does not have a large 
postsynaptic effect.) In contrast, antagonism of the D2 and the group II mGlu 
receptors produced highly significant changes in paired-pulse outcome and blocked 
the induction of LTD. These two receptor classes have a presynaptic distribution, 
with D2 also located postsynaptically (Wang & Pickel, 2002; Petralia et a l, 1996). 
Furthermore, both of the receptors are negatively coupled to adenyl cyclase and
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down-regulate cAMP production (Stoof & Kebabian, 1981; Conn & Pin, 1997 
(review)). Therefore, both pre- and postsynaptic decreases in cAMP production 
appear to play an important role in both short-term and long-term synaptic plasticity 
in the perirhinal cortex.
Another transduction cascade that maybe important in perirhinal LTD maybe 
the MAP kinase pathway. In the prefrontal cortex, the four receptor classes that have 
the largest effect on perirhinal cortical plasticity, have been proposed to be coupled 
to the mitogen activated protein kinase (MAPK) pathway, where they converge 
postsynaptically to induce LTD (Otani et a l, 1999). Preliminary experiments using a 
MAPK-kinase inhibitor 2-(2-amino-3 -methoxyphenyl)-4.H-1 -benzopyran-4-one 
(PD98059, Alessi et a l, 1995; Dudley et a l, 1995) were carried out in the mouse 
perirhinal cortex to investigate this potential pathway. While the drug appeared to 
preclude LTD induction, the results are difficult to interpret reliably. This drug is not 
water soluble and required dimethylsulphoxide (DMSO) as a solvent. Unfortunately, 
DMSO itself had adverse long-term affects on slice integrity, leading to a decline in 
the quality of responses. To ensure comparability between experiments, slices were 
incubated in DMSO prior to experimentation and at least one hour allowed after the 
addition of PD98059 for the drug to equilibrate. Despite these complications, it 
appears that the MAPK-kinase inhibitor does impede the induction of LTD above 
that of the vehicle alone experiments (figure 4.1.2). LTD in the presence of DMSO 
was significant at one hour post conditioning (~15.2±5.4%; n=5(3); P<0.05, two- 
tailed, paired t-test). Moreover, PD98059 blocked the induction of LTD 
(-1.2±4.9%; n=5(4)) and this was significantly different at the 10% level compared 
to the vehicle condition (P=0.09; two-tailed, unpaired t-test). With a larger n value, I 
predict this would reach significance at the 5 % level.
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Activation of the MAPK pathway is associated with an increase in protein 
synthesis of the early immediate gene zif268 which is known to play important roles 
in both long-term potentiation and memory formation (Spektor et al, 2002; Bozon et 
al, 2003a; 2003b). Down regulation of the MAPK pathway through the activation 
of either D2 dopamine or group II metabotropic glutamate receptors is therefore 
proposed to bring about LTD though a reduction in postsynaptic protein synthesis.
The mechanisms highlighted by this study that appear to be important in 
perirhinal cortical synaptic plasticity are summarised in figure 4.1.3.
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Figure 4.1.2 Dependency of long-term synaptic plasticity on the MAP kinase 
transduction cascade. Top The MAP kinase kinase inhibitor, PD98059 (•; 10 //M) 
prevented the expression of LTP. The drug solvent DMSO (•) did not significantly 
alter LTP induction from that seen in control experiments (o). Bottom PD98059 
also blocked the expression of LTD above that of DMSO.
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Figure 4.1.3 Signal transduction in the perirhinal cortex. Short-term modulation 
of the release of glutamate (•) from the presynaptic terminal is mediated by both 
group I and group II mGlu autoreceptors. An important modulator of glutamate 
release is also dopamine (•) acting on D2 heteroreceptors located on the presynaptic 
terminal. Postsynaptic receptors important in the expression of long-term synaptic 
plasticity are again groups I and II mGlu receptors and D2 dopamine receptors. The 
common transduction cascades of group II mGlu and D2 dopamine receptors include 
the down regulation of cAMP and possibly MAPK. Activation of the group I mGlu 
receptor subclass leads to both IP3 and DAG production and hence the activation of 
their subsequent cascades. Red arrows indicate pathways thought to be activated 
during perirhinal cortical LTD. Blue arrows indicate down regulated pathways.
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4.1.7 Is LTD in the perirhinal cortex presynaptic?
A consistent observation throughout this study is that drugs that alter the paired-pulse 
profile from depression to facilitation also block the induction of LTD. This may 
suggest that LTD in the perirhinal cortex has a presynaptic locus of expression. 
Preliminary experiments aimed at resolving the locus of expression did not yield 
consistent results. Paired-pulse ratios were monitored before and after LTD 
induction; such experiments have previously been used to determine presynaptic 
changes in the probability of release during synaptic plasticity (for example see 
McNaughton, 1982; Kuhnt & Voronin, 1994; Schulz et al, 1994; Kleschevnikov et 
al, 1997). In the perirhinal cortex, some experiments showed an altered paired- 
pulse ratio, which is consistent with a decreased probability of release following 
conditioning. Other experiments showed no change in paired pulse depression and 
these later results are consistent with a postsynaptic locus of expression. It is 
possible that these inconsistencies are a reflection of different forms of LTD 
expressed within the perirhinal cortex.
The link between the expression of paired-pulse depression and LTD 
expression in each drug condition is interesting. This relationship between short and 
long-term plasticities has also been reported at corticostriatal synapses (Akopian et 
al, 2000). At those corticostriatal synapses that displayed PPD, tetanic stimulation 
gave rise to LTD. Conversely, those synapses displaying PPF exhibited LTP 
following tetanus. Similar relationships have been reported in the hippocampus (Son 
& Carpenter, 1996) and neocortex (Volgushev et a l, 1997). In both of these regions, 
high-frequency stimulation gave rise to LTP at synapses displaying large PPF, while
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inducing LTD at synapses with a small PPF ratio. These data suggest the degree of 
presynaptic calcium is an important determinant in the direction of plasticity 
observed. These results are consistent with those obtained here in the perirhinal 
cortex, suggesting that perirhinal LTD may have a presynaptic component.
4.1.8 Long-term potentiation
The superficial pathway of the mouse perirhinal cortex readily supports LTP. This is 
very similar to the rat perirhinal cortex, which supports LTP of the field response in 
both the horizontal (Bilkey, 1996) and oblique (Ziakopoulos et a l, 1999) slice 
preparations. In contrast to both of these independent reports, LTP is not NMDA 
receptor-dependent in the mouse. This discrepancy may be due to the differences in 
preparation firom both the rat studies. However, given the consistency in NMDA 
receptor dependency between the two rat preparations, it seems more likely that rat 
and mouse perirhinal cortex support different forms of LTP.
Blockade of either group I or group II metabotropic glutamate receptors does 
not affect LTP induction. The group 111 antagonist showed a trend to reduce the 
degree of LTP, but this failed to reach significance. The mGlu receptor-dependency 
of perirhinal cortical LTP has not previously been reported in any species. Given 
that in many brain regions LTP is often dependent on either NMDA or mGlu 
receptors, it is interesting that neither NMDA nor mGlu receptors are involved in the 
induction of LTP in the perirhinal cortex. It would be interesting to investigate the 
role of VSCC in perirhinal cortical LTP induction. Blockade of VSCCs have
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previously been reported to prevent the induction of a calcium-dependent/NMD A 
receptor-independent form of LTP in CAl hippocampal neurones.
Despite the apparent independence of LTP on glutamate receptors, there 
appears to be a role for dopaminergic receptors. While antagonists of dopamine 
receptors had little effect on LTP, an agonist of Di dopamine receptors precluded 
LTP induction and an agonist of D2 dopamine receptors enhanced LTP. Taken 
together with the paired-pulse and LTD studies, it is clear that dopamine is an 
important neuromodulator within the perirhinal cortex.
Given that dopamine appears to modulate long-term changes in glutamatergic 
transmission in the perirhinal cortex, it is reasonable to suggest that cAMP and PKA 
are mediators of LTP in this brain region. While experiments designed to study this 
have not been carried out, experiments to elucidate some of the transduction 
mechanisms involved have. The MAP kinase kinase inhibitor PD98059 was applied 
to slices and found to prevent the expression of LTP, but not short-term potentiation. 
In vehicle alone (DMSO), LTP was expressed similarly to control experiments 
(18.0±1.8%; n=4(3)). In the presence of the drug, the EPSP amplitude returned to 
baseline by one hour (3.6±4.7%; n=9(5)). The difference was significant only at the 
10% level (P=0.075; two-tailed, unpaired t-test). Similarly to the LTD experiments 
in the presence of this drug, larger n values would probably increase the significance 
of this result. These results suggest the MAP kinase pathway is involved in the 
expression of LTP in the perirhinal cortex.
A physiological role of LTP in the perirhinal cortex has yet to be suggested, 
but it is likely to underlie one or more of the associative cognitive processes known 
to be processed within the perirhinal cortex (for instance fear conditioning or 
stimulus-stimulus association). It would be interesting to carry out experiments to
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test if LTP in the perirhinal cortex is mediated by a pure increase in the EPSP slope, 
or, as with LTD, a change in action potential firing and hence a change in the field 
pop-spike component.
4.2 Synaptic plasticity in the R6/1 perirhinal cortex
The R6/1 perirhinal cortex shows a progressive abnormal electrophysiological 
phenotype. The development of the synaptic phenotype does not follow the onset of 
the overt motor phenotype. Several months prior to the onset of clasping and notable 
weight loss, aspects of the normal synaptic phenotype are enhanced. As the 
transgenic phenotype starts to become apparent (at approximately five months), both 
perirhinal neurones and synapses start to show declines in normal function compared 
to wild types.
4.2.1 Cellular properties
Perirhinal cortical neurones undergo distinct changes in their basal properties during 
the lifetime of the R6/1 mouse. At three months of age, perirhinal neurones appear 
to be normal with regards resting membrane potential, input resistance, membrane 
time constant, cell capacitance and action potential properties, including threshold, 
size and duration. At five months, two populations of cells were identified: One with 
normal cellular properties; and another with a depolarised resting membrane 
potential. By 7 months, the majority of neurones are depolarised and show a
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significantly reduced membrane capacitance. While hippocampal CAl pyramidal 
cells of the R6/2 mouse were reported as normal with regards membrane potential 
(Murphy et a l, 2000), MSSNs of the striatum do show a similar depolarisation 
(Levine et a l, 1999). Similarly, a subpopulation of MSSNs in a knock-in mouse 
carrying 94 GAG repeats show a greater membrane depolarisation than MSSNs from 
a CAG71 knock-in mouse (Levine et al, 1999).
The depolarised resting membrane potential is likely to be a result of 
impaired energy metabolism, which has been suggested to occur in HD. Evidence 
for energy impairment comes from the systemic administration of mitochondrial 
inhibitors (see introduction, section 1.2.7.1) which can recapitulate an HD-like 
phenotype in rats and primates. The resultant deficiency in ATP availability would 
interfere with Na" /^K" /^ATPase activity, which is necessary for the maintenance of 
intracellular concentrations of potassium and sodium ions, the principle determinants 
of membrane potential. Alternative or additional explanations of a depolarised 
resting membrane potential could be an increased level of extracellular glutamate, a 
result of impaired glutamate reuptake. Impaired glutamate uptake has been reported 
in both the cortex and striatum of the R6/2 mouse as a result of decreased expression 
of the GLTl glutamate transporter (Elevens et a l, 2001). Yet another explanation 
could be the enhanced function of NR2B receptors associated with mutant huntingtin 
(Chen et a l, 1999b). Enhanced currents though these receptors could lead to a 
prolonged depolarisation and thus contribute to the abnormal resting membrane 
potential seen in cortical (and striatal) neurones. If this last explanation is true, this 
sets up a positive feedback loop whereby enhanced NMDA receptor function leads to 
depolarisation, which, in turn, contributes to prolonged activity of the NMDA 
receptor itself.
345
A reduced membrane capacitance is consistent with a reduction in cell size. 
The specific membrane capacitance of all biological membranes is approximately 10 
nF/mm^ (Kandel et a l, 2000). Applying this constant to the data obtained here gives 
an approximate surface area of normal layer II/III pyramidal cells within the mouse 
perirhinal cortex of 0.02 mm^. Similarly, in young transgenic animals, the layer II/III 
pyramidal neurones have an estimated surface area of 0.02 mm^. Neurones in slices 
firom older transgenic animals (7 months) were reduced in size and have an 
approximate surface area of 0.01 mm^. Such a decrease may be a result of 
dystrophic neurites and neurite retraction, which has been reported in human HD 
cerebral cortex (for example see Jackson et a l, 1995; DiFiglia et a l, 1997). A 
decrease in cell size may account for the decrease in brain weight in the absence of 
significant cell death that is observed in the R6  mouse. The reduction in cell size 
may have led to a closer packing of cells and this could explain the observation that 
the transgenic neurones were generally easier to find using the blind techniques used 
in this study. It is also possible that there is a reduction in the size of somatic cells 
throughout the whole body and this may account for the loss of body mass observed 
in R6  mice.
The abnormal action potential properties identified in transgenic slices may 
be attributable to the depolarised resting membrane potential and its proposed 
underlying cause, energy impairment. With a reduced electrochemical gradient, the 
sodium ion flux underlying the action potential will be less, giving rise to a smaller, 
broader action potential. The other notable change in action potential firing was a 
decrease in the number of spikes fired in response to a depolarising current step. 
Impairments in the ability to sustain trains of action potentials may have profound 
implications on information processing within the perirhinal cortex.
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4.2.2 Field responses in transgenic slices
Extracellularly recorded field potentials were also notably different, characterised by 
a large, late component. This slow component appeared similar to that seen when a 
GABAa receptor antagonist is applied to wild type slices, exposing NMDA-mediated 
currents. Application of an NMDA receptor antagonist, however, did not eliminate 
the late component, suggesting other mediators than NMDA channels. The role of 
GABAa receptors were investigated further by applying PTX to the slices at the 
same concentration as that used for intracellular experiments in control slices. PTX 
did not, however, alter the late component. While higher concentrations of PTX 
were not applied to slices, it is not likely that GABAa receptors underlie this 
component. Evidence for this comes fi*om the disparity between the input-output 
relationships, paired-pulse profiles and LTD profiles obtained firom transgenic 
animals compared to those recorded in wild type slices in the presence of a GABAa 
antagonist (compare figure 3.3.5 and figure 3.2.9). Similarly, it is not likely that 
GABAb mediated currents underlie the late component; again, the input-output 
relationships, paired-pulse profiles and LTD profiles of transgenic and wild type 
slices in the presence of a GABAb receptor antagonist do not match (see figure 3.3.5 
and figure 3.2.10).
Despite the recovery of normal synaptic plasticity in transgenic slices by a Di 
receptor agonist, Quinpirole did not abolish the late component. In fact, the late 
component appeared totally resistant to pharmacological manipulation. Both 
agonists and antagonists of both D2 and Di dopamine receptors also failed to abolish 
this late component, as did an agonist of group II mGlu receptors. The underlying 
cause of the late component therefore remains unresolved.
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4.2.3 Paired-pulse stimulation
Short-term synaptic plasticity was affected in the transgenic slices compared to age- 
matched littermates. At two and five months of age, normal paired-pulse depression 
was exhibited at perirhinal cortical synapses. At seven and nine months, however, 
paired-pulse facilitation was evident at intervals from 60 ms to 2 0 0 0  ms.
It is interesting that those receptor antagonists that altered the wild-type 
paired-pulse profiles such that they closely resemble the profiles seen in transgenic 
slices are the group II mGlu receptor antagonist and D2 dopamine receptor 
antagonist. Both of these receptors subclasses have been reported as reduced in the 
R6/2 mouse brain and are therefore likely to be reduced in the R6/1 brain also. 
Moreover, both of these receptors are negatively coupled to adenyl cyclase and 
cAMP production, suggesting that this pathway may be particularly susceptible in 
HD.
The recovery of paired-pulse depression in transgenic slices by a D2 
dopamine receptor agonist is exciting. It suggests that, while the mechanism 
responsible for normal short-term plasticity is aberrant in transgenic perirhinal 
cortex, it is not completely absent and can be activated to induce normal function.
4.2.4 Long-term synaptic plasticity
The outcome of the LTD study in transgenic animals was surprising. Given the 
enhanced expression of LTD at R6/2 hippocampal CAl synapses (Murphy et a l,
2000), one may have predicted that, in a region where LTD is normally expressed i.e.
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the perirhinal cortex, LTD may be induced either more frequently or to a greater 
degree. Conversely, given the intriguing link in the wild-type study that those drugs 
that have the most profound effect on PPD also block LTD, one may have predicted, 
in light of the altered transgenic paired-pulse profiles, that LTD would be impaired. 
At the younger ages studied (approximately two months), the outcome of LFS fitted 
the first prediction and a large LTD was induced. During development, however, the 
frequency of LTD induction and the degree there of, decreased until LTD was never 
seen and low-frequency stimulation induced a small degree of potentiation, thus 
fitting the later prediction.
Similar to the observation noted with the receptor dependency of paired- 
pulse depression, antagonists of both group II mGlu and D2 dopamine receptors 
blocked LTD induction in the wild-type slices. This further suggests that the 
common transduction pathway shared by these receptors, the cAMP pathway, is 
important in the expression of LTD and that interruption of this pathway may be 
evident in HD.
The changes in synaptic plasticity could also be brought about by the many 
components of the signalling cascades involved in synaptic plasticity that are reduced 
in HD. In support of the importance of cAMP regulation in the expression of 
perirhinal cortical plasticity, mRNA levels are altered from the initial step of this 
pathway (see introductory table 1 .2 .2 ); several subtypes of adenyl cyclase show 
reduced mRNA levels (Luthi-Carter et al, 2000). A reduction in basal adenyl 
cyclase means the down regulation in cAMP levels that maybe required for 
perirhinal cortical LTD would not be achieved and hence failure to express LTD.
The downstream components of the group I mGlu receptor cascade are 
affected to a greater degree. One of the pathways activated by these receptors is the
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DAG pathway, which leads to activation of PKC. PKC mRNA is reduced in both the 
cortex (Harris et a l, 2001) and striatum (Luthi-Carter et al, 2000; Harris et a l,
2001) of R6/2 mice. PKC is one of the activators of CREB and hence the expression 
of genes responsible for the expression of synaptic plasticity. Secondly, group I 
mGlu receptor activation leads to the production of IP3 . Messenger RNA for the IP3 
receptor is reduced in HD (Luthi-Carter et al, 2000) and hence calcium release from 
intracellular stores will be affected. Furthermore, the mRNA levels of the 
downstream targets of calcium released from the endoplasmic reticulum are also 
reduced. Both CaMKII and the protein phosphatases 1 and 2B (calcineurin) mRNA 
levels are less in the R6/2 striatum compared to wild types (Luthi-Carter et a l,
2000). The balance between the activities of these synergistic molecules maintains 
appropriate AMPA receptor phosphorylation. Changes in the availability of these 
molecules could affect the ability to modify the phosphorylation state of AMPA 
receptors and hence the ability to express synaptic plasticity. Indeed, in the 
hippocampus of normal rats, a maintained protein phosphatase activity is required for 
the continued expression of LTD (Mulkey et al, 1993).
The importance of other neurotransmitter receptor classes has not been 
assessed in the mouse perirhinal cortex. It is known that muscarinic receptors are 
modulators of LTD expression in the rat perirhinal cortex (Warburton et a l, 2003) 
and the expression of these receptors is reduced in the R6/2 mouse (Cha et a l, 1999). 
Other receptor subclasses are affected in HD, in particular mRNA for CBl 
cannabinoid and a2 adrenergic receptors and VSCC are detected at lower levels in 
the R6/2 striatum (Luthi-Carter et a l , 2000). While the roles of these 
neurotransmitters and channels have not been investigated in the perirhinal cortex.
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they are known to modulate plasticity in other brain regions (for example see Harvey 
& Lacey, 1997; Barbara et a l , 2003).
There could also be a presynaptic deficit underlying the synaptic phenotype 
of the R6/1 perirhinal cortex. As discussed in the introduction, two of the proteins 
involved in the exocytotic process are altered in models of HD. Firstly, the 
phosphorylation state of synapsin 1 is enhanced (Liévens et al, 2002) and therefore 
neurotransmitter vesicles are more likely to be released. Secondly, this situation is 
compounded by complexin depletion (Morton & Edwardson, 2001; Edwardson et a l, 
2003), which leads to a reduced inhibition on vesicle release. With an increased 
probability of neurotransmitter release, it is more likely that depletion of vesicle 
pools could occur during periods of sustained stimulation such as the conditioning 
periods used to induce LTD in this study. Given the similarity between the 
hippocampal electrophysiological phenotypes of the R6/2 and a complexin II knock 
out mouse (Takahashi et al, 1999; Murphy et a l, 2000), it seems likely complexin II 
deficits may underlie the abnormal synaptic phenotype in the hippocampus and this 
may also be true for the perirhinal cortex.
In support of a presynaptic deficit are the results obtained in a study of 
hippocampal long-term synaptic plasticity that indicates an inability to sustain 
prolonged release during high-frequency trains of stimuli (Usdin et a l, 1999). The 
results of the Usdin et al study were obtained using sharp intracellular recordings in 
the presence of the activity-dependent NMDA receptor channel blocker MK801 and 
highlight a reduced decay rate of the NMDA receptor-mediated postsynaptic current 
in the hippocampus of a knock-in mouse model compared to that in wild-type mice. 
Given the NR2B specific enhancement of NMDA receptor function conferred by 
mutant huntingtin (Chen et al, 1999b; Zeron et a l, 2001; 2002), while in normal
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adult animals the NR2A receptor predominates (Insel et al, 1990; Monyer et al, 
1994), an alternative explanation could be applied to the results obtained by Usdin et 
al. NR2B receptors have approximately half the opening probability of NR2A 
receptors (Chen et a l, 1999a) and this could be reflected as a reduced decay rate 
using the techniques utilised in the study. In support of this latter explanation of the 
Usdin et al paper are the results obtained by Murphy et al (2000) which pointed to 
impairments in NMDA receptor function rather than of transmitter release. Further 
evidence for an altered NMDA receptor function came from studies of the Y AC 
mouse, which suggested reduced NMDA receptor activity. The results of this study, 
however, also suggested an impaired ability to sustain transmitter release. It should 
be noted again that these results were obtained using magnesium-free ACSF, making 
the data hard to integrate with those obtained in the other models.
It appears, therefore, that the changes in hippocampal synaptic plasticity may 
be a result of both an altered NMDA receptor function and impairments in 
neurotransmitter release. It is not likely, however, that the results obtained in the 
perirhinal cortex of the R6/1 mouse are due to an altered NMDA receptor function 
because LTD in the normal mouse perirhinal cortex is NMDA receptor-independent. 
Experiments designed to investigate this are, however, yet to be carried out.
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Figure 4.2.1 Proposed mechanisms of altered perirhinal cortical synaptic 
plasticity in the R6/1 mouse. 1) Reduced dopaminergic transmission could occur 
through inappropriate activity, dystrophic neurites or other pathological events 
within the dopamine fibres arising from the VTA. 2) Presynaptic changes could 
include a reduced expression and/or function of D2 dopamine and group II mGlu 
receptors. This leads to less cAMP production, manifest most clearly as a shift from 
PPD to PPF. 3) Similarly, postsynaptically, the D2 dopamine and group II mGlu 
receptors could be reduced, again inappropriately altering cAMP production. There 
could also be alterations in the downstream cascades of group I mGlu receptors. 
Lines with a rounded head indicate steps in the normal cascades that are known to be 
affected in HD. (See figure 4.1.3 for key.)
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4.3 Pathological changes in the R6/1 perirhinal cortex
4.3.1 Expression of mutant huntingtin
The layer specific expression of mutant huntingtin within the nucleus is interesting. 
Previously in the R6 mouse models, mutant huntingtin has been detected either in the 
cytoplasmic cellular compartment or as aggregates within the nucleus. The detection 
of a diffuse nuclear stain prior to the formation of inclusions has yet to be reported in 
the R6 mouse model. In contrast, nuclear staining as been reported in other mouse 
models of HD, including truncated and full-length transgenic models and knock-in 
models.
Nuclear staining within perirhinal cortical neurones appeared in an age- and 
layer-specific manner, becoming evident in the surface cell layers before the deeper 
layers. Layer-specific nuclear localisation of mutant huntingtin is interesting because 
this suggests a differential susceptibility of cell types to early pathogenic events 
within the HD cortex. How a differential propensity for nuclear aggregation is 
conferred is unclear and is a question that remains unanswered throughout the HD 
brain.
Due to the coincidental formation of aggregates and the development of the 
synaptic phenotype in the R6/2 mouse, it had previously been suggested that 
impairments in synaptic plasticity were underpinned by inclusion formation (Murphy 
et a l, 2000). The data obtained in this thesis suggests otherwise. Altered synaptic 
plasticity is observed many months prior to the formation of inclusions in the R6/1
354
perirhinal cortex, a result that was not detectable in the more aggressive R6/2 mouse. 
It should be noted, however, that the formation of inclusions is likely to occur at ages 
younger than 7 months. Due to animal availability and time limitations, animals 
were prepared from 1, 3 and 7 month old animals. Ideally 5 month old animals 
should also be studied, an age where the motor phenotype and a reduction in 
perirhinal LTD is detectable. Within the R6/1 striatum, inclusions are detectable as 
young as 16 weeks (Naver et a l, 2003). It is therefore likely that inclusions are 
present within the cortical mantle at a younger age than highlighted by this study.
4.3.2 Dopamine receptors
All slices incubated with D2 dopamine receptor antibodies showed a similar pattern 
of fluorescence. There was a high-intensity band of fluorescence in layer I, while 
layer II showed only low levels of staining. The pyramidal cell layers III and V 
showed a second band of relatively high fluorescence, but at a much lower level than 
the surface layer. Layer VI showed little staining for D2 dopamine receptors. There 
was a third intense band highlighted in the white matter. This laminar distribution of 
D2 dopamine receptors is in support of the distributions reported by Goldsmith & 
Joyce (1994) in the rat, but contrary to the earlier report by Richfield and colleagues 
(1989). The data presented here demonstrates that, during the development of the 
normal perirhinal cortex, there is an increased D2 receptor expression in all layers 
and this is particularly evident in layer I.
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This study highlights that the R6/1 perirhinal cortex at 7 months of age has a 
lower expression of D2 dopamine receptors than that of age matched wild type 
littermates. The difference in D2 dopamine receptor expression appears to be a lack 
of a developmental increase in expression that is seen in the wild types, but not 
transgenic animals. In fact, at one month of age, transgenic animals show a trend 
towards more D2 dopamine receptors than wild type animals. While the only 
significance obtained in this section of the study was at 7 months within layer I of the 
cortex, at all ages there were consistent trends across all cortical layers. That is, at 
one month of age, all cortical layers showed slightly higher D2 dopamine receptor 
expression than did wild types, while at three and seven months, all layers tended to 
express less receptors.
The pattern of Di dopamine receptor expression with the perirhinal cortex is 
similar to that of D2 . The highest intensity fluorescence was always in layer I, while 
layer II showed the lowest levels. Layers III, V and VI showed a band of 
intermediate intensity staining. The white matter showed another band of high 
intensity fluorescence, but was always less than the surface layer. Again, this is in 
agreement with the rat study by Richfield et al. (1994).
Developmentally, the expression of Di dopamine receptors within the 
perirhinal cortex mirrors that of D2 receptors. While D2 receptors increased, there 
was a down-regulation of Di receptors; again, this change was particularly evident in 
layer I.
There has not previously been a developmental study of the expression of dopamine 
receptors within the cortex. In wild-type mouse perirhinal cortex there is an age- 
dependent increase in D2 dopamine receptors, while Di dopamine receptors are
356
down-regulated and these changes are particularly evident in layer I. The increase in 
D2 :Di dopamine receptor ratio within the perirhinal cortex demonstrates the relative 
greater importance of D2 receptors with this brain region. Taken together with the 
data obtained in the pharmacological experiments presented here and with the 
evidence that methamphetamine toxicity impairs recognition memory, while sparing 
spatial memory (Bisagno et a l, 2002), it is clear these receptors are important in the 
normal function of the perirhinal cortex.
4.4 Drug recovery of normal synaptic plasticity in the R6/1 
perirhinal cortex
The finding that the D2 receptor agonist Quinpirole can restore plasticity that 
resembles that seen in normal mouse perirhinal cortex is interesting and potentially 
important in the development of future therapeutic strategies. The current dopamine 
therapies are aimed at controlling chorea by reducing dopamine levels within the 
striatum. To achieve this, two approaches are taken, that of receptor antagonism and 
that of monoamine depletion. Both of these approaches lead to a reduction in 
dopamine transmission throughout the brain. Given that perirhinal cortical plasticity 
and function is dependent on dopaminergic transmission, preventing dopaminergic 
activity may be compounding recognition memory deficits that are prevalent in HD 
(Lange et a l, 1995; Hahn-Barma et a l, 1998; Lang et al, 2000; Berrios et a l, 2002). 
Therefore, a targeted therapy aimed at increasing dopamine transmission within the 
cortex may be beneficial in HD. By differentially changing dopamine transmission 
such that cortical dopamine is increased, while basal ganglia dopamine is reduced, a
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treatment may be achieved whereby choreic movements are controlled, but at the 
same time sparing cortical function.
The fact that LTD and PPD can be restored at both five and seven months of 
age suggests that, while dopamine receptor expression is reduced, there are still 
enough receptors to affect normal plasticity. This raises the possibility that the 
impairment is of dopamine release within the perirhinal cortex rather than a reduced 
receptor expression and/or function. The primary source of dopamine within the 
perirhinal cortex is from long projection neurones originating in the mesencephalic 
ventral tegmental area AlO (Lindvall et a l, 1974). The release of dopamine from 
these terminals may potentially be affected in several ways. Firstly, these projections 
are particularly long compared to the glutamatergic afférents of the perirhinal cortex 
that arise in the hippocampus and adjacent cortical regions. Their greater length 
means there is greater scope for the development of pathogenic events, e.g. the 
formation of cytoplasmic aggregates and dystrophic neurites. Secondly, mutant 
huntingtin is known to reduce the expression of neurotrophic factors, including 
BDNF, that are required for the maintenance and survival of neurones (Zuccato et 
al, 2001 ; 2003). If there are reduced neurotrophic factors, the survival of the 
dopaminergic afférents from the VTA to the perirhinal cortex may be jeopardised. 
Thirdly, mutant huntingtin is known to directly interfere with axonal transport and 
vesicle trafficking (for example see Gunawardena et al, 2003; Szebenyi et a l, 2003), 
a process that could be further hindered by the structural changes mentioned above. 
Therefore, the expression of critical proteins for neurotransmitter release (e.g. 
voltage sensitive receptors or SNARE proteins) may be reduced at these terminals. 
Finally, evidence from our lab suggests that the basal properties of VTA 
dopaminergic neurones may be altered (Dallérac, unpublished data). In wild type
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mice, these neurones show pacemaker activity, fire in a regular pattern typical of 
dopaminergic neurones and show a typical, large afierhyperpolarisation (see also 
Murphy & Greenfield, 1992). In contrast, in seven month old R6/1 mice, the 
neurones of the VTA show only a small afterhyperpolarisation and do not fire in a 
regular pattern. Furthermore, transgenic VTA neurones show impairments in their 
ability to support continued firing in response to a depolarising current step. Wild 
type mice fire action potentials throughout a positive current injection, while 
transgenic neurones fire in a bursting pattern immediately following the onset, but do 
not maintain firing during the remainder of the current injection. Given this inability 
to maintain sustained firing by the dopaminergic neurones, it is likely that the 
perirhinal cortex is receiving inappropriate dopaminergic inputs. With a reduced 
basal level of dopamine release, the normal function of perirhinal cortical neurones 
will be altered. The D2 dopamine subclass of receptor appears the more important 
both pre- and postsynaptically at glutamatergic synapses of the perirhinal cortex; 
antagonism of this receptor dramatically alters the paired-pulse profile, while 
agonism of these receptors hyperpolarises pyramidal neurones and reduces their 
input resistance. The basal cellular properties of aged transgenic perirhinal cortical 
neurones fit with a reduced dopaminergic basal modulation via D2 dopamine 
receptors. The cells are depolarised and show an increased input resistance. 
Furthermore, synapses show a paired-pulse profile favouring facilitation, again 
consistent with a reduced level of dopaminergic transmission. The proposed 
mechanism underlying the electrophysiological phenotype of R6/1 perirhinal cortical 
neurones and synapses is summarised in figure 4.2.1
Given the co-dependency of perirhinal cortical synaptic depression upon both 
D2 dopamine and group II mGlu receptors and also that LTD could be recovered by
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the D2 receptor agonist Quinpirole, recovery of LTD was also attempted using the 
agonist of group II mGlu receptors (2S,rR,2'R,3'R)-2(2,3- 
dicarboxycyclopropyl)glycine (DCG-IV, Ishida et al, 1993). Preliminary 
experiments were carried out to investigate if activation of group II mGlu receptors 
could bring about a similar recovery of plasticity. Application of the drug to slices 
prepared from seven month old transgenic animals did not, however, improve LTD 
induction (figure 4.4.1). Given the common transduction pathway of this subclass of 
mGlu receptor and D2 dopamine receptors, it is surprising that DCG-IV does not 
improve synaptic plasticity. There are several explanations as to why DCG-IV does 
not restore LTD at transgenic synapses. Perhaps the most obvious may be that the 
synaptic phenotype is not a result of an mGlu receptor deficit and therefore activating 
these receptors does not trigger the appropriate signal cascades required for 
depression in the perirhinal cortex. It would be interesting to carry out a similar 
fluorescent histochemical study to the dopamine experiments to look at mGlu 
receptors in the R6/1 perirhinal cortex. It may very well be the case that these 
receptors are not lost to a significant degree in transgenic mice. Conversely, it could 
be that by seven months, the loss of mGlu receptor expression and/or function is too 
severe and therefore applying an agonist of these receptors is not effective. Again, a 
histological study may go some way to investigate this.
Yet another possibility is the group II mGlu receptors may normally be 
located on dopamine terminals where they could regulate the release of dopamine 
into the perirhinal cortex and hence alter the modulatory role of dopamine within this 
region. If it is indeed the case that the dopaminergic terminals are non-functional, as 
suggested by the VTA data mentioned above, activation of group II mGlu receptors 
may not produce the required response to restore normal plasticity.
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Figure 4.4.1 Pharmacological activation of group II mGlu receptors does not 
restore LTD at seven month old R6/I perirhinal cortical synapses. 10 juM DCG- 
IV, applied to transgenic slices, did not facilitate LTD induction by LFS in the three 
slices studied. Data points represent the mean EPSP area (% change). Due to the 
small n value, SEM has not been plotted. n=3(l).
361
The hypothesis behind these experiments was based on the dependency of 
normal plasticity in the perirhinal cortex, which suggested that the common 
mechanism of cAMP down regulation could be affected. It could be the case, 
however, that the synaptic phenotype is not mediated by a cAMP deficit, but rather is 
seated at or above the level of the receptor and is purely due to a dopaminergic 
deficit.
Summarised in figure 4.4.2 are the results obtained in this study compared to 
those obtained in the R6/2 hippocampus. It is clear that the R6/1 mouse is the 
superior model for a linear study of the progressive phenotype. The development of 
many aspects of the phenotype are masked by the aggressiveness of the R6/2 
phenotype. For example, the nuclear localisation of mutant huntingtin prior to the 
formation of distinct inclusions was not seen in the R6/2, while in the R6/1 mouse 
there was a clear pattern of nuclear translocation. (Data obtained in this laboratory 
shows a similar pattern of dispersed nuclear staining prior to the formation of distinct 
aggregates in the R6/1 hippocampus, Milner, unpublished data.) Similarly, the 
development of the synaptic phenotype in the R6/2 mouse was a single event, with 
no gradual onset, while in the R6/1 mouse a slower onset was observed, with clearly 
definable phases. (Again, demonstrated in this lab, the R6/1 CAl field shows a 
progressive alteration in LTD that was missed in the R6/2 mouse, Milner, 
unpublished data.)
It is clear that there is not a common change in synaptic plasticity that occurs 
throughout the HD brain. While the hippocampus shows a trend towards depression 
(loss of LTP and aberrant LTD), the perirhinal cortex shows a trend towards 
potentiation.
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Figure 4.4.2 Summary of phenotypes in the R6/2 and R6/1 mice. The life spans 
of the R6/2 and R6/1 mice are represented by the blue triangles. Above each age 
span are indicated the onset of various aspects of the phenotype. * Cognitive 
impairments as indicated by Mazarakis, 2003; Cybulska-Klosowicz et al, 2004, 
unpublished data. ** The presence of inclusions and a reduction in D2 dopamine 
receptors may be evident at younger ages. The coloured areas within the life spans 
indicate altered synaptic plasticity within the R6/2 hippocampus (HC) and R6/1 
perirhinal cortex (PRh).
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4.5 Consequences for the human condition
Long-term depression has been previous proposed to underlie the décrémentai 
change in firing rate observed in rats and monkeys during the process of cue 
familiarisation (for example see Fahy et al, 1993; Zhu et al, 1995; Zhu & Brown, 
1995; Xiang & Brown, 1998; Brown & Aggleton, 2001). Further evidence for long­
term depression directly underling this change in firing rate are presented here, where 
LTD of the field response is mediated by a reduction in the probability of the 
postsynaptic cell firing an action potential. Given this relationship between LTD and 
recognition memory and that LTD induction is impaired in the perirhinal cortex of 
the R6/1 mouse, it is likely that the early deficits in recognition memory associated 
with HD are mediated by a reduction in perirhinal LTD. An alternative mechanism 
to explain the deficits in recognition memory are provided by the experiments of 
Thomas Brown et al, which suggest that short-term changes in the firing pattern of 
perirhinal cortical neurones could underlie memory formation within this region. 
Therefore, the aberrant expression of paired-pulse facilitation that is highlighted in 
this study could directly affect the firing patterns of perirhinal neurones and hence 
mediate the impairment in recognition memory. Indeed, the firing pattern of 
perirhinal cortical neurones in R6/1 slices is altered. Unlike wild-type neurones, 
which fire in a regular pattern upon depolarising current injection, R6/1 neurones fire 
a single action potential and are then quiescent for the remainder of the current pulse. 
There is an apparent disparity between this result and the observation of PPF in 
transgenic slices. The expression of PPF suggests an enhanced transmitter release, 
which could lead to prolonged postsynaptic depolarisation similar to that caused by
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current injection and, given the large population-spike component of perirhinal filed 
potentials, PPF is likely to be expressed as an increase in spiking upon the second 
pulse. It is surprising that synaptically evoked depolarisation leads to enhanced 
action potential generation, 'while cells show impaired ability to support repetitive 
firing in response to current injection. It is therefore likely that detrimental changes 
exist both pre- and postsynaptically in the R6/1 perirhinal cortex. Importantly, R6/1 
perirhinal neurones do not express long-term decreases in action potential firing in 
response to a conditioning stimulus. This suggests that deficits in recognition 
memory seen in the human condition may be mediated by this inability of the 
perirhinal cortex to support long-term plasticity.
It would appear that dopaminergic deficits contribute to the changes in 
synaptic plasticity in the R6/1 perirhinal cortex where there is a reduced expression 
of both Di and D2 dopamine receptors. Similar reductions have been highlighted 
within the cortex of symptomatic and presymptomatic HD gene carriers (Ginovart et 
al, 1997; Andrews et al, 1999; Pavese et a l, 2003). While these PET studies did 
not target the perirhinal cortex, it would not be surprising to find altered receptor 
expression here also. Dopamine has been shown to be important for recognition 
memory in rats (Besheer et al, 1999; Bisagno et a l, 2002; Belcher et a l, 2003; 
Woolley et a l, 2003) and, therefore, is likely to also be important in primates 
including humans. A recently published article in which a reward-based task, shown 
to be dependent on the entorhinal/perirhinal cortex was investigated. DNA 
recombination was used to decrease D2 dopamine binding in monkeys and found to 
create similar deficits as those caused by bilateral ablation of these cortices (Liu et 
al, 2004). Given that dopamine receptors are important for cognitive processes
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within the perirhinal cortex, it is possible that a reduced dopamine receptor 
expression in HD patients could mediate early cognitive deficits.
A reduction in dopaminergic transmission may also be mediated by altered 
activity and innervation by dopaminergic neurones arising in the mesolimbic brain 
regions. While preliminary data firom our lab suggests these neurones to have 
abnormal basal properties in the R6/1 mouse, the substantia nigra and ventral 
tegmental area in HD patients have yet to receive an extensive study. The 
GAB A/Substance P containing striatonigral neurones projecting to the substantia 
nigra are, however, known to be lost at intermediate pathological grades of HD 
(Reiner et a l, 1988; Glass et a l, 2000). With an altered GABAergic drive to the 
dopaminergic neurones it is likely that they have different electrophysiological 
properties and thus have aberrant activity in HD, which may, in turn, manifest as 
altered cortical function.
The result demonstrating nuclear translocation of mutant huntingtin correlates 
with the time course of the electrophysiological phenotype better than the formation 
of inclusions indicates that aggregates are consequential, rather than causative, of 
cellular dysfunction in HD. It is possible that inclusions form as a result of excessive 
mutant huntingtin and these may be neuroprotective at their out start, but may 
progress to become detrimental to neuronal function and hence lead to cell death. 
Evidence for a protective mechanism comes from experiments in which cultured rat 
striatal cells were transfected with mutant huntingtin. As expected, mutant 
huntingtin led to aggregate formation and cell death. However, prevention of 
aggregate formation by interfering with the ubiquitination process enhanced the 
degree neurodegeneration observed (Saudou et al, 1998), suggesting that the 
formation of aggregates removes the toxic protein from the cell to confer protection.
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Indeed, a recently published article demonstrates that the amount of diffiise nuclear 
staining in cultured rat striatal neurones closely predicts cell death, while inclusion 
formation correlates with improved cell survival and reduced mutant huntingtin 
elsewhere in the neurone (Arrasate et a l, 2004). Further evidence against a 
causative role of aggregates are the distributions of inclusions within the human HD 
brain. While inclusions are prevalent in areas that undergo extensive degeneration 
(cortex and striatum), they are also detected in areas such as the cerebellum, which 
are generally spared (DiFiglia et a l, 1997).
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Summary
Following the identification of the gene and the development of predictive testing, it 
has become apparent that deficits in recognition memory are discernable many years 
before the onset of classical symptoms. Aspects of recognition memory are believed 
to be encoded within the perirhinal cortex by activity dependent decrements in 
neuronal activity and the cellular mechanism is believed to be that of long-term 
depression.
In brain slices prepared from the R6/1 mouse model of Huntington's disease,
I show that perirhinal cortical long-term depression is aberrantly down-regulated in 
an age-dependent manner. Interestingly, a synaptic phenotype similar to the that 
seen in transgenic slices can be recapitulated in wild-type slices using D% dopamine 
receptor antagonists. Moreover, normal cortical synaptic fiinction can be restored in 
transgenic slices by the application of D2 dopamine receptor agonists.
In slices prepared from the same animals as those used for electrophysiology, 
I show using histological techniques that dopamine receptor expression is decreased 
in the surface layers of perirhinal cortex. Furthermore, this decrease in receptor 
expression coincides with the nuclear translocation of mutant huntingtin, but not the 
development of fiill inclusion bodies. This result differs from the widely held belief 
that inclusions are directly correlated with pathogenesis and cellular dysfunction. 
Interestingly, my data is consistent with recent findings suggesting that cell death is 
positively correlated closely with nuclear mutant huntingtin levels, whilst inclusion 
bodies correlate more closely with cell survival (Arrasate et al, 2004).
Given that normal function can be restored by the application of dopamine 
receptor agonists, it would appear that, while there is a reduction in receptor
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expression within the cortex, normal dopaminergic function is possible, suggesting a 
deficit may lie with the dopaminergic input from the mesolimbic system, along side 
changes within the cortex.
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Limitations and future considerations
There are several aspects of the thesis presented here that could be improved or 
expanded and some of these are discussed belo'w.
The pharmacological experiments presented here could be improved by 
demonstrating a reversal of any blockade following drug wash-out. This would 
enable paired t-tests to be carried out, increasing the significance of these results. 
However, given the relatively large n values and the consistency of these results, 
there is little doubt in my mind that the results obtained were drug related rather than 
a result of aplasticity of any given slice.
While the lab was not equipped to carry out patch clamp experiments, many of the 
experiments presented here would benefit firom the study of the underlying synaptic 
currents. Such experiments may reveal the synaptic currents involved in plasticity 
within the normal perirhinal cortex and, furthermore, highlight pathological changes 
underlying the abnormal field response and plasticity seen in transgenic slices.
The results presented here suggest that alterations in the dopaminergic pathway may 
be an important pathological change within the HD cortex. The data also suggest 
that therapy targeted at restoring normal dopaminergic modulation within the cortex 
maybe beneficial to HD patients. Further characterisation of these changes is 
required in order to assess the feasibility of such a therapeutic approach. Perhaps the 
key experiments required in this line of investigation is to determine whether the
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deficit is at the receptor level or further down the transduction cascade, for example 
inappropriate adenyl cyclase activity or a reduced basal cAMP level. In order to 
assess this, the precise role of cAMP in perirhinal cortical synaptic plasticity should 
be determined. Further investigation of the MAP kinase transduction cascade may 
yield interesting results, as may the role of metabotropic glutamate receptors in 
aberrant plasticity in the HD cortex.
The effect of the transgene on LTP in the perirhinal cortex has not been examined. It 
would be interesting to determine whether LTP is either impaired (as in the 
hippocampus) or enhanced. While LTD is likely to underlie the décrémentai change 
in neuronal firing rate seen in the perirhinal cortex during cue familiarisation, a role 
for LTP has yet to be suggested. It is possible that the many other cognitive tasks in 
which the perirhinal cortex is known to be involved (for example fear conditioning) 
may be mediated by LTP. It would therefore be interesting to not only establish 
whether LTP is altered in the R6 mouse, but also if fear conditioning is impaired. 
However, in asymptomatic gene carriers, the recognition of the emotion of fear is 
normal (Gray et a l, 1997), suggesting that aspects of cognitive processes involved in 
fear are not affected early in the human condition.
A full study of recognition memory in the R6/1 mouse would be beneficial to the 
results presented here, providing complementary cognitive data to the perirhinal 
cortical electrophysiological results. These experiments would follow a similar 
experimental design as a preliminary study carried out in light of the results 
presented here and performed at the University Department of Physiology, Oxford 
University by Anton van Dellen and colleagues. The study used two variations of
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the open field arena. Version one utilised two objects, while version two used three 
objects. Mice were allowed to explore the objects for two minutes before being 
returned to their home cage. When the mice were returned again to the open field 
arena, one object had been replaced by a novel object. The time spent exploring the 
novel or familiar object(s) was then assessed. While the results obtained firom these 
experiments showed a trend towards presymptomatic mice being impaired on these 
tasks, they failed to reach significance. The failure to reach significance is likely to 
be seated in the small number of animals in the transgenic group; a result of the 
experimenters being blind of genotype.
Questions still surround the spike-LTD results, particularly within the R6/1 perirhinal 
cortex. The relationship between the depolarised membrane state of transgenic cells 
and the lack of LTD requires further investigation. This could be addressed by 
hyperpolarising transgenic cells to -80 mV, which may restore the ability to induce 
LTD. Alternatively, as shown in this thesis, depolarisation of normal perirhinal 
neurones to -67 mV does not block the induction of spike LTD. This result suggests 
factors other than depolarisation to be the cause of aplasticity in the R6/1 perirhinal 
cortex.
Importantly, the results presented here should be confirmed in other mouse models of 
HD. While the R6/1 mouse provides a superior model over the R6/2 mouse for 
studying the progressive phenotype seen in HD, other transgenic mice may offer 
more faithfiil models. In particular, the R6 stain of mice contain only a truncated 
gene and, therefore, the effects of the full-length mutant gene maybe missed. 
Therefore, the novel findings presented in this thesis should also be investigated in
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other mouse models. Two models that may provide good complementary data are 
the YAC72 mouse and the knock-in mice carrying 71 and 94 CAG repeats. The 
YAC mouse provides a model carrying the full-length gene, thereby also modelling 
earlier events in disease pathogenesis, such as cleavage. The second model, the 
knock-in mouse, has previous reports of aberrant neuronal properties and plasticity in 
the corticostriatal pathway similar to those seen in the R6/2 mouse (in particular see 
Levine et a l, 1999) and may, therefore, show similar changes in the perirhinal 
cortex.
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